data_1d9s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1d9s _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.743 ' O ' HD13 ' A' ' 25' ' ' LEU . 6.4 p-10 . . . . . 0 C--O 1.211 -0.925 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.501 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . . . -115.47 5.45 14.49 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.239 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.82 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -41.22 -33.58 0.81 Allowed Glycine 0 N--CA 1.499 2.844 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 4.2 pp -53.66 -29.1 36.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.755 -0.85 . . . . 0.0 109.803 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.439 ' N ' HD12 ' A' ' 10' ' ' LEU . . . -88.06 -60.23 2.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.366 -0.834 . . . . 0.0 109.995 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.1 p -53.46 -47.67 69.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.444 -0.785 . . . . 0.0 110.525 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.506 ' CB ' ' HB ' ' A' ' 21' ' ' THR . . . -67.73 -38.69 83.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 109.778 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 46' ' ' MET . . . -56.54 -52.88 63.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.413 -0.805 . . . . 0.0 109.706 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.46 -30.4 40.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.891 . . . . 0.0 109.078 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -90.51 8.88 31.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.64 -0.662 . . . . 0.0 110.084 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.0 58.64 7.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -131.92 81.07 1.95 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -1.133 . . . . 0.0 111.008 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.597 ' CG2' ' HB3' ' A' ' 52' ' ' GLN . 61.1 t -68.67 -29.39 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.065 -1.022 . . . . 0.0 109.217 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -61.8 -42.97 99.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.312 -0.868 . . . . 0.0 109.423 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.506 ' HB ' ' CB ' ' A' ' 13' ' ' ALA . 1.8 m -69.08 -41.25 77.76 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.596 ' HA ' ' HA ' ' A' ' 10' ' ' LEU . 21.6 t -61.61 -34.32 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.496 ' HG2' HD12 ' A' ' 56' ' ' LEU . 1.6 mmt180 -70.24 -33.73 71.99 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.41 -53.42 8.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.67 -0.643 . . . . 0.0 111.092 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.82 ' HG ' ' N ' ' A' ' 9' ' ' GLY . 2.9 tm? -55.91 -25.36 42.64 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.008 -1.058 . . . . 0.0 109.145 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.34 -68.82 0.78 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.053 -1.03 . . . . 0.0 111.713 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -50.54 -17.9 0.58 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.29 -0.881 . . . . 0.0 111.535 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.4 2.98 10.0 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.983 -1.073 . . . . 0.0 110.951 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.35 72.93 1.26 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -132.69 -166.49 1.75 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.412 -1.051 . . . . 0.0 111.42 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.13 140.76 21.55 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.675 -0.64 . . . . 0.0 109.609 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.43 5.36 3.75 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.48 1.253 . . . . 0.0 111.277 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -134.18 42.62 2.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.859 -1.15 . . . . 0.0 111.254 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 8' ' ' ALA . . . -69.36 79.3 0.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.96 -1.087 . . . . 0.0 109.186 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mt -49.5 158.58 0.41 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.532 -0.73 . . . . 0.0 111.397 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -121.26 159.14 26.59 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -22.79 13.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.153 -0.967 . . . . 0.0 110.566 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -77.3 -9.78 59.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 110.356 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.72 28.79 31.49 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 44' ' ' GLN . 13.4 mtm180 -101.77 37.96 1.72 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -1.079 . . . . 0.0 110.084 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.89 177.27 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.312 -0.867 . . . . 0.0 110.674 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -81.53 -24.78 4.12 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.608 1.32 . . . . 0.0 110.816 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.0 mt -102.39 -40.9 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.158 -0.963 . . . . 0.0 110.884 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.43 ' CB ' ' O ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -52.19 -20.68 2.74 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.029 -1.045 . . . . 0.0 110.777 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.92 44.5 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.932 . . . . 0.0 110.85 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.45 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 16.6 ptt? -111.8 26.58 10.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.032 -1.042 . . . . 0.0 110.163 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.41 ' CB ' ' O ' ' A' ' 46' ' ' MET . 3.5 tmm? 67.86 -2.39 1.43 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.583 -0.698 . . . . 0.0 111.086 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.424 ' O ' ' CZ ' ' A' ' 84' ' ' PHE . 14.3 mmt 42.35 31.23 0.25 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.211 -0.931 . . . . 0.0 110.988 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -125.01 -3.36 7.55 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.7 p -133.35 99.69 4.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.993 -1.298 . . . . 0.0 110.695 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.0 67.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.302 -0.874 . . . . 0.0 109.824 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.597 ' HB3' ' CG2' ' A' ' 19' ' ' VAL . 8.3 tp60 -52.01 -27.78 14.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.428 -0.795 . . . . 0.0 110.043 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.406 ' CG2' ' CG2' ' A' ' 19' ' ' VAL . 19.3 t -87.68 -36.46 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.828 . . . . 0.0 109.489 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.16 91.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.428 -0.795 . . . . 0.0 110.424 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.17 -39.95 53.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.0 110.614 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.496 HD12 ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -49.43 -64.59 0.76 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.335 -0.853 . . . . 0.0 111.54 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.434 HD23 HD22 ' A' ' 10' ' ' LEU . 3.2 mt -67.25 -38.12 84.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.106 -0.996 . . . . 0.0 111.152 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.44 ' CD2' ' CG1' ' A' ' 90' ' ' VAL . 1.1 tp -52.79 -66.74 0.33 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.019 -1.051 . . . . 0.0 110.532 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 56' ' ' LEU . 4.0 pp -52.23 -27.57 15.3 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.283 -0.886 . . . . 0.0 110.004 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.41 ' N ' HD11 ' A' ' 59' ' ' LEU . 3.3 m80 -77.24 -68.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.368 -0.833 . . . . 0.0 110.073 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.25 38.34 0.03 OUTLIER Glycine 0 N--CA 1.484 1.842 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.16 -166.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.204 -1.174 . . . . 0.0 110.422 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -121.74 75.26 36.34 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 110.057 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.89 -21.35 11.07 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.831 1.437 . . . . 0.0 110.54 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -95.53 -47.69 6.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 110.457 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.58 172.96 0.44 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.276 -0.89 . . . . 0.0 110.22 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.27 -176.67 2.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.492 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.41 123.21 86.87 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.425 -0.797 . . . . 0.0 109.95 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.31 -13.98 20.61 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.681 1.358 . . . . 0.0 110.97 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.49 -20.95 56.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.197 -0.939 . . . . 0.0 110.85 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.432 ' O ' ' CB ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -155.03 27.15 0.42 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.082 -1.011 . . . . 0.0 110.877 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.527 ' HB2' ' H ' ' A' ' 103' ' ' ALA . 86.1 mt 43.14 45.11 4.62 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.277 -0.89 . . . . 0.0 111.417 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.39 103.48 15.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.223 -0.923 . . . . 0.0 110.56 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.473 ' CG ' ' HD2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -85.54 179.38 1.89 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.849 . . . . 0.0 110.106 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 74' ' ' ARG . 48.8 Cg_endo -78.68 -18.29 12.01 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.544 1.286 . . . . 0.0 110.603 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.94 -36.31 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 110.107 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.457 ' CD2' ' HB2' ' A' ' 102' ' ' ASP . 74.7 m80 -68.4 -39.62 81.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.29 -0.881 . . . . 0.0 110.4 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.408 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 0.7 OUTLIER -57.67 -55.41 35.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.352 -0.843 . . . . 0.0 110.062 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.91 -18.47 63.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.082 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 120' ' ' ILE . . . -82.27 -44.15 16.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.389 -0.819 . . . . 0.0 110.571 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.437 ' HG3' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -64.59 -20.57 66.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.186 -0.946 . . . . 0.0 110.126 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.437 ' N ' ' HG3' ' A' ' 81' ' ' ARG . 2.2 mm-40 -97.02 -48.04 5.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.017 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.49 14.43 10.57 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.424 ' CZ ' ' O ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -78.66 80.05 5.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.124 -1.221 . . . . 0.0 109.804 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.07 -23.66 63.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.448 -0.783 . . . . 0.0 110.431 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -61.54 -52.54 64.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.221 -0.924 . . . . 0.0 110.088 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.407 ' CG2' ' HE1' ' A' ' 46' ' ' MET . 37.6 m -58.59 -34.97 71.68 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.257 -0.902 . . . . 0.0 109.933 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 mp -57.4 -46.82 83.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 71.4 t -57.35 -46.94 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.451 -0.781 . . . . 0.0 109.288 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.44 ' CG1' ' CD2' ' A' ' 58' ' ' LEU . 49.4 t -50.77 -55.4 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.526 -0.734 . . . . 0.0 110.358 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.62 -63.11 1.23 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.233 -0.917 . . . . 0.0 110.161 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -61.28 -21.72 64.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 0.0 110.133 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 48.4 ttt180 -77.91 -8.94 58.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.304 -0.873 . . . . 0.0 110.378 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.2 33.93 3.07 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.291 -0.881 . . . . 0.0 110.43 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.51 90.49 0.08 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -120.75 154.98 34.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -1.065 . . . . 0.0 110.316 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.56 75.15 7.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 110.209 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 mt -83.81 68.63 10.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -170.06 44.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.393 -0.817 . . . . 0.0 109.725 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 74' ' ' ARG . 7.8 p -124.5 171.21 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -121.81 136.71 54.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 109.281 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.457 ' HB2' ' CD2' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -69.37 73.91 0.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.845 . . . . 0.0 109.361 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.527 ' H ' ' HB2' ' A' ' 72' ' ' LEU . . . 66.83 -69.07 0.13 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.344 0.592 . . . . 0.0 109.774 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.421 ' N ' ' O ' ' A' ' 102' ' ' ASP . 1.8 m-90 -140.88 35.5 1.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.482 -0.761 . . . . 0.0 109.379 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 107' ' ' LEU . . . -107.38 24.54 24.11 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.388 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 101' ' ' CYS . 21.8 mtm180 59.52 -73.16 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.408 -1.054 . . . . 0.0 110.78 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -155.84 167.99 13.15 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 110.022 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 46.3 Cg_endo -70.82 -31.49 15.72 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.648 1.341 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.64 -38.99 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.885 . . . . 0.0 110.042 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -66.09 -50.76 62.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.357 -0.839 . . . . 0.0 110.065 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.54 -29.12 58.36 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.376 -0.828 . . . . 0.0 110.288 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.71 -75.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.421 -0.799 . . . . 0.0 110.216 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -52.73 -27.2 16.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.284 -0.885 . . . . 0.0 110.779 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -58.71 -50.48 73.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.321 -0.862 . . . . 0.0 110.685 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -78.02 -76.65 0.18 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.347 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -167.72 34.81 0.21 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -122.77 79.37 1.63 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.333 -1.098 . . . . 0.0 109.925 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.9 mtp85 -81.22 -40.05 24.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.61 -43.44 80.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.315 -0.865 . . . . 0.0 110.273 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.476 HG21 HD11 ' A' ' 120' ' ' ILE . 17.0 tt -76.64 -38.42 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.982 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -58.64 -44.78 90.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.559 -0.713 . . . . 0.0 110.006 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -61.99 -45.2 94.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.352 -0.842 . . . . 0.0 110.012 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -64.53 -37.12 86.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.956 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.1 mt -61.34 -58.94 6.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.858 . . . . 0.0 110.196 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.22 -24.27 10.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.347 -0.846 . . . . 0.0 110.489 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.2 -11.18 44.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.476 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.73 12.08 6.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.967 . . . . 0.0 110.681 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.9 t . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.143 -0.973 . . . . 0.0 110.324 179.793 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 121.153 0.501 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -124.59 -21.88 4.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.925 -1.11 . . . . 0.0 110.603 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.92 -29.21 50.54 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.1 tp -56.78 -53.72 54.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.367 -1.078 . . . . 0.0 110.545 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.69 -52.19 53.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.338 -0.851 . . . . 0.0 110.47 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 p -59.15 -46.67 87.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.351 -0.843 . . . . 0.0 110.452 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.65 76.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 109.926 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.92 -31.71 63.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.903 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.72 -28.69 62.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.392 -0.817 . . . . 0.0 110.017 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -90.44 11.16 22.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.35 -0.844 . . . . 0.0 110.323 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.11 58.5 13.27 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -126.66 81.88 2.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 110.379 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 52' ' ' GLN . 53.8 t -60.43 -50.65 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.142 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -51.66 -51.66 54.05 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.283 -0.885 . . . . 0.0 110.55 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.0 m -61.82 -42.7 99.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.244 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.7 t -67.6 -38.22 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.355 -0.841 . . . . 0.0 110.207 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HG3' HD11 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -69.65 -31.23 69.19 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.309 -0.869 . . . . 0.0 110.217 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -80.48 -51.13 9.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 110.695 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.35 -60.92 3.05 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.254 -0.903 . . . . 0.0 110.483 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.28 -43.68 67.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.215 -0.928 . . . . 0.0 110.588 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -78.1 1.51 20.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.533 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -105.84 -29.33 10.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 110.3 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.75 -26.87 0.1 Allowed Glycine 0 N--CA 1.484 1.858 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.456 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -48.56 135.25 14.68 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.199 -1.177 . . . . 0.0 110.9 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.96 141.43 31.44 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.0 110.164 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.72 -28.35 11.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.663 1.349 . . . . 0.0 110.544 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -92.48 18.83 7.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 110.433 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.33 142.41 31.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -0.922 . . . . 0.0 110.205 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.8 mt -99.47 153.84 18.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.364 -0.835 . . . . 0.0 110.196 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -102.08 30.9 4.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.331 -0.855 . . . . 0.0 110.206 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 54.77 24.67 5.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.363 -0.835 . . . . 0.0 110.496 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.09 2.7 9.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.315 -0.866 . . . . 0.0 110.587 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 54.04 27.31 37.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.445 ' O ' ' CB ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -120.17 18.1 12.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.334 -1.098 . . . . 0.0 110.38 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.443 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 21.1 mmt-85 53.73 175.63 0.03 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.168 -0.958 . . . . 0.0 110.314 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 51.3 Cg_endo -85.17 -0.05 8.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.54 1.284 . . . . 0.0 111.154 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.7 mm -114.29 -41.39 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.987 -1.071 . . . . 0.0 110.628 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.445 ' CB ' ' O ' ' A' ' 40' ' ' ARG . 2.9 tt0 -57.58 -41.49 81.24 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.157 -0.965 . . . . 0.0 109.927 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -75.74 -11.86 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 0.0 110.288 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.3 ttm -51.34 150.07 3.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.337 -0.852 . . . . 0.0 110.431 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -62.42 -15.76 51.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 110.265 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.44 26.27 8.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.216 -0.927 . . . . 0.0 110.192 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.14 19.37 5.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.487 ' N ' ' CZ ' ' A' ' 84' ' ' PHE . 19.8 t -157.84 101.83 1.81 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -1.024 . . . . 0.0 110.243 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.82 -26.93 62.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.614 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 1.1 mp0 -54.82 -34.06 62.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.399 -0.813 . . . . 0.0 110.556 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 89.1 t -76.26 -62.76 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -0.865 . . . . 0.0 110.322 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.407 ' CB ' ' CG2' ' A' ' 87' ' ' THR . . . -47.71 -27.6 2.05 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.393 -0.817 . . . . 0.0 110.894 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -70.9 -56.05 7.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.406 -0.809 . . . . 0.0 110.452 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.408 HD11 ' HG3' ' A' ' 23' ' ' ARG . 15.4 tp -52.36 -56.28 15.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.331 -0.856 . . . . 0.0 110.681 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 3.2 mp -52.13 -53.92 36.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.326 -0.859 . . . . 0.0 110.731 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -28.19 69.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.31 -0.869 . . . . 0.0 110.375 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.0 tp -69.83 -38.18 76.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 110.222 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -83.97 -20.35 33.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.398 -0.814 . . . . 0.0 110.297 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.54 53.54 0.72 Allowed Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.09 -147.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.269 -1.136 . . . . 0.0 109.803 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -125.81 70.69 66.61 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.09 -1.006 . . . . 0.0 110.365 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.36 -28.36 1.9 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.799 1.421 . . . . 0.0 110.042 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.65 -34.98 39.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.41 -0.806 . . . . 0.0 110.255 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 129.49 41.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 110.298 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -118.06 162.69 17.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -0.862 . . . . 0.0 110.24 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.34 124.21 89.98 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.0 109.903 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.89 -23.41 16.4 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.592 1.311 . . . . 0.0 110.556 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.35 -33.21 75.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 0.0 110.512 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.63 24.7 1.22 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.26 49.87 9.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.373 -0.829 . . . . 0.0 110.863 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.48 131.8 45.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 0.0 110.36 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.431 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 9.8 mtp180 -101.54 165.89 13.25 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.479 -0.763 . . . . 0.0 110.166 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 43.1 Cg_endo -69.11 -11.7 32.33 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.66 1.347 . . . . 0.0 110.803 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.4 t -67.09 -28.29 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.903 . . . . 0.0 109.948 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.429 ' CE1' ' HD3' ' A' ' 108' ' ' PRO . 72.1 m80 -67.75 -53.23 28.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 110.252 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.439 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 4.3 m-20 -51.84 -57.09 10.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.53 -0.731 . . . . 0.0 110.858 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.39 -16.05 59.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.314 -0.866 . . . . 0.0 110.693 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.53 -37.08 13.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.162 -0.961 . . . . 0.0 110.53 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.439 ' HG2' ' HA ' ' A' ' 78' ' ' ASP . 14.9 ptt180 -70.76 -18.67 62.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.327 -0.858 . . . . 0.0 110.826 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.95 11.17 38.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.707 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.471 ' N ' ' CE1' ' A' ' 117' ' ' HIS . . . 56.89 42.15 92.1 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.487 ' CZ ' ' N ' ' A' ' 50' ' ' SER . 0.7 OUTLIER -110.81 98.39 7.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.485 -1.009 . . . . 0.0 110.147 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.15 -34.05 24.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 0.0 110.35 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 14.5 p30 -51.07 -44.43 61.16 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.244 -0.91 . . . . 0.0 110.599 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.429 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 45.1 m -76.21 -31.77 58.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 109.456 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.48 -37.59 81.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.466 -0.771 . . . . 0.0 109.429 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.3 t -68.22 -44.04 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.507 -0.746 . . . . 0.0 109.325 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.77 -41.64 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.46 -0.775 . . . . 0.0 110.172 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.03 -52.03 67.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.438 -0.789 . . . . 0.0 109.984 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -72.09 -29.4 64.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 0.0 109.762 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -68.01 -57.76 5.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.439 -0.788 . . . . 0.0 109.89 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.49 -61.85 1.61 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.412 -0.805 . . . . 0.0 110.365 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 170.86 105.92 0.19 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -168.04 133.42 1.86 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.275 -1.132 . . . . 0.0 110.245 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.483 ' CZ ' ' HB ' ' A' ' 100' ' ' VAL . 3.7 ttp180 -65.75 163.43 16.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 0.0 110.263 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 tp -148.4 48.59 1.03 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.452 -0.78 . . . . 0.0 109.931 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -159.31 50.13 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.391 -0.818 . . . . 0.0 110.054 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.483 ' HB ' ' CZ ' ' A' ' 97' ' ' ARG . 13.2 p -122.7 168.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.512 -0.742 . . . . 0.0 110.178 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -132.87 166.85 21.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 109.256 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 104' ' ' TRP . 4.9 t0 -70.22 71.94 0.44 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.889 . . . . 0.0 109.824 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.447 ' HB1' ' CE3' ' A' ' 104' ' ' TRP . . . 60.84 -79.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.642 -0.661 . . . . 0.0 110.051 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.447 ' CE3' ' HB1' ' A' ' 103' ' ' ALA . 9.3 p90 -133.64 26.81 4.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 109.478 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.65 -139.38 7.81 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.636 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -168.95 2.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.532 -0.981 . . . . 0.0 111.046 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -119.17 176.41 1.73 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.653 -0.655 . . . . 0.0 109.864 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 46.0 Cg_endo -71.29 -27.31 19.76 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.542 1.285 . . . . 0.0 110.263 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.5 p -78.05 -37.81 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 110.337 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.45 -42.58 87.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -0.831 . . . . 0.0 110.237 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.76 -36.15 76.06 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.332 -0.855 . . . . 0.0 110.164 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.406 ' CB ' ' CG2' ' A' ' 120' ' ' ILE . . . -61.32 -59.9 4.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.381 -0.825 . . . . 0.0 110.028 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -52.29 -27.18 14.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.465 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.13 -42.96 96.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.352 -0.843 . . . . 0.0 110.175 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.425 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -80.98 -32.4 34.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.867 . . . . 0.0 110.262 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.22 29.16 2.01 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.471 ' CE1' ' N ' ' A' ' 83' ' ' GLY . 29.9 m170 -90.85 72.62 6.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -1.091 . . . . 0.0 109.984 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -58.75 -28.25 65.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.387 -0.82 . . . . 0.0 110.386 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -74.88 -41.01 60.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.311 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.406 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 1.9 tt -79.18 -34.02 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.962 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.0 -29.06 69.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.84 . . . . 0.0 109.842 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -73.26 -53.08 11.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -62.07 -30.13 70.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 110.106 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 36.4 mt -71.15 -71.65 0.25 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.442 -0.786 . . . . 0.0 110.556 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -53.1 -28.49 25.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.268 -0.895 . . . . 0.0 110.235 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.92 -36.15 83.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.293 -0.879 . . . . 0.0 109.68 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.24 23.81 10.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 110.084 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.4 m . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 110.327 -179.924 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.9 t0 . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 121.028 0.442 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.28 29.1 0.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 110.386 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.2 -34.24 53.08 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.441 ' CD1' HD21 ' A' ' 57' ' ' LEU . 4.0 pp -53.47 -28.39 30.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.623 -0.928 . . . . 0.0 110.049 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.411 ' N ' ' CD1' ' A' ' 10' ' ' LEU . . . -81.45 -43.81 18.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.445 -0.784 . . . . 0.0 110.209 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.1 p -59.11 -57.73 11.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.332 -0.855 . . . . 0.0 109.899 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.5 -34.78 69.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.3 -0.875 . . . . 0.0 109.787 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.404 ' CB ' HG13 ' A' ' 53' ' ' VAL . . . -64.05 -41.69 97.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.557 -0.714 . . . . 0.0 109.742 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.65 67.99 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.347 -0.845 . . . . 0.0 110.063 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -84.82 5.51 28.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.382 -0.824 . . . . 0.0 110.536 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.29 42.4 83.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -112.39 74.85 0.88 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.469 -1.019 . . . . 0.0 110.432 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.576 ' CG1' ' HB3' ' A' ' 52' ' ' GLN . 42.4 t -57.7 -38.41 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.286 -0.884 . . . . 0.0 109.568 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -57.52 -49.08 77.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.811 . . . . 0.0 110.193 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 m -67.18 -39.26 86.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.383 -0.823 . . . . 0.0 110.004 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.2 t -69.83 -29.85 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.434 -0.791 . . . . 0.0 109.757 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -68.38 -32.67 72.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.479 -0.763 . . . . 0.0 110.145 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -79.31 -52.73 7.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 0.0 110.579 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.0 -54.6 27.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.283 -0.886 . . . . 0.0 110.599 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.446 HD11 ' CE1' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -55.43 -61.63 2.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.232 -0.918 . . . . 0.0 110.432 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.22 -23.9 64.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.56 -61.79 1.68 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.238 -0.913 . . . . 0.0 110.297 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 176.48 50.03 0.06 OUTLIER Glycine 0 N--CA 1.48 1.632 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.58 135.38 43.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.287 -1.125 . . . . 0.0 110.241 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.0 140.03 97.98 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.801 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.17 -3.35 13.78 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.665 1.35 . . . . 0.0 111.049 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -130.84 17.39 5.17 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.008 -1.058 . . . . 0.0 111.108 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.32 93.46 0.14 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.06 -1.025 . . . . 0.0 109.6 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mt -51.9 172.36 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.322 -0.861 . . . . 0.0 110.867 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -103.02 -163.0 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.471 -0.768 . . . . 0.0 110.075 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -96.07 -20.48 18.63 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 110.418 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.72 33.3 1.67 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 109.781 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.41 26.01 21.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -102.56 163.02 12.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.437 -1.037 . . . . 0.0 110.194 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.461 ' CB ' ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -81.0 179.4 1.93 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.442 -0.786 . . . . 0.0 110.042 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 41' ' ' ARG . 42.4 Cg_endo -69.87 -25.63 27.87 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.593 1.312 . . . . 0.0 110.933 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.482 ' O ' ' CG ' ' A' ' 46' ' ' MET . 10.6 mt -102.34 -34.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.148 -0.97 . . . . 0.0 109.847 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -54.74 -17.72 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 110.783 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -115.27 26.37 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.095 -1.003 . . . . 0.0 110.575 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -95.73 32.07 1.92 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.187 -0.945 . . . . 0.0 110.2 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.416 ' CB ' ' O ' ' A' ' 46' ' ' MET . 3.4 tmm? 68.41 -7.4 0.69 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.469 -0.769 . . . . 0.0 111.102 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.438 ' CE ' ' HB3' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 46.9 27.28 0.69 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.003 -1.06 . . . . 0.0 110.716 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.461 ' HA2' ' CD2' ' A' ' 84' ' ' PHE . . . -130.67 13.45 5.6 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 p -143.78 90.34 2.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -1.145 . . . . 0.0 110.257 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.46 -26.31 12.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.918 . . . . 0.0 110.19 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.576 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 0.6 OUTLIER -55.13 -34.24 63.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.397 -0.815 . . . . 0.0 110.247 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.404 HG13 ' CB ' ' A' ' 14' ' ' ALA . 26.8 t -83.41 -33.06 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.466 -0.771 . . . . 0.0 110.465 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.527 ' CB ' ' CG2' ' A' ' 87' ' ' THR . . . -63.08 -52.34 63.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.194 -0.941 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.55 -34.03 77.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.429 -0.794 . . . . 0.0 110.564 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 tt -53.3 -63.58 1.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.288 -0.883 . . . . 0.0 110.736 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.445 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 1.8 mt -70.4 -33.76 71.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.373 -0.83 . . . . 0.0 110.654 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.414 HD23 ' CG1' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -58.14 -61.51 2.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.921 . . . . 0.0 110.409 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 pp -60.06 -25.1 65.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 110.448 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.446 ' CE1' HD11 ' A' ' 26' ' ' LEU . 2.9 m-70 -78.61 -63.55 1.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.848 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.85 38.16 0.04 OUTLIER Glycine 0 N--CA 1.484 1.844 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -71.02 -175.67 1.2 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.053 -1.263 . . . . 0.0 110.242 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -119.12 76.8 15.93 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.492 -0.755 . . . . 0.0 110.002 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HB2' ' CB ' ' A' ' 96' ' ' ALA . 47.5 Cg_endo -76.56 -5.72 16.34 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.86 1.453 . . . . 0.0 110.632 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.93 -51.95 2.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.316 -0.865 . . . . 0.0 110.049 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.24 134.73 39.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.366 -0.834 . . . . 0.0 110.445 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.51 -174.79 2.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.358 -0.839 . . . . 0.0 110.394 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -86.59 127.52 60.26 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.719 . . . . 0.0 109.994 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.31 -29.49 11.3 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.518 1.273 . . . . 0.0 110.57 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.62 80.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 0.0 110.411 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.535 ' O ' ' C ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -143.76 38.88 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.255 -0.903 . . . . 0.0 110.557 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.535 ' C ' ' O ' ' A' ' 71' ' ' THR . 1.6 mt 25.45 61.83 0.06 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.765 -0.584 . . . . 0.0 111.561 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.08 119.81 39.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.9 . . . . 0.0 110.468 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.426 ' HB2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -93.39 173.33 4.94 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.479 -0.763 . . . . 0.0 110.345 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.87 -22.26 23.65 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.835 1.439 . . . . 0.0 110.33 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 52.0 t -59.45 -39.0 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.322 -0.861 . . . . 0.0 109.981 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.451 ' CE1' ' HD3' ' A' ' 108' ' ' PRO . 73.5 m80 -64.1 -45.19 89.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 110.09 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.438 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -52.82 -65.7 0.51 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.447 -0.783 . . . . 0.0 110.429 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.68 -26.77 24.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.33 -0.856 . . . . 0.0 110.132 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.28 -43.05 29.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 0.0 109.754 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -61.32 -21.75 64.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 110.223 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.41 -32.47 12.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 0.0 109.735 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.82 24.9 24.18 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.461 ' CD2' ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -88.95 93.81 9.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -1.161 . . . . 0.0 109.993 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.43 ' CD2' ' HA ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -61.97 -34.71 76.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.526 -0.733 . . . . 0.0 110.798 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -58.67 -35.65 72.91 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.247 -0.908 . . . . 0.0 110.97 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.527 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -75.15 -41.03 59.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.007 -1.058 . . . . 0.0 110.228 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tp -55.3 -40.79 71.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.349 -0.845 . . . . 0.0 109.873 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.39 -45.72 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 109.373 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.414 ' CG1' HD23 ' A' ' 58' ' ' LEU . 88.1 t -53.72 -45.86 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.551 -0.718 . . . . 0.0 110.227 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 mp -64.78 -20.93 66.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.399 -0.813 . . . . 0.0 110.676 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -78.13 -62.78 1.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.196 -0.94 . . . . 0.0 110.715 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.1 -33.06 56.73 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.469 -0.769 . . . . 0.0 110.553 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.407 ' HB1' ' CD2' ' A' ' 58' ' ' LEU . . . -68.69 -34.89 76.44 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.284 -0.885 . . . . 0.0 110.216 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 111.15 45.79 0.85 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' A' ' 64' ' ' PRO . . . -97.9 138.62 34.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.403 -1.057 . . . . 0.0 110.321 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -73.0 151.84 41.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.405 -0.81 . . . . 0.0 110.225 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 128' ' ' THR . 0.7 OUTLIER -127.35 -8.15 5.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.395 -0.816 . . . . 0.0 110.843 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -92.73 39.94 1.04 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.207 -0.933 . . . . 0.0 110.807 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 74' ' ' ARG . 14.6 p -100.65 148.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -0.889 . . . . 0.0 110.039 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m -99.17 154.2 18.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.293 -0.879 . . . . 0.0 110.231 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 104' ' ' TRP . 27.1 p-10 -81.86 57.01 3.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 71' ' ' THR . . . 64.95 -67.9 0.11 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.598 -0.688 . . . . 0.0 110.586 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.44 ' N ' ' O ' ' A' ' 102' ' ' ASP . 1.7 m95 -59.37 -61.14 2.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 167.01 -28.89 0.18 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -56.5 124.05 16.88 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.252 -1.146 . . . . 0.0 110.43 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 82.3 mt -80.06 167.02 36.6 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.38 -0.825 . . . . 0.0 110.081 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.9 Cg_endo -69.65 -23.36 31.36 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.642 1.338 . . . . 0.0 110.378 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.4 p -75.41 -35.67 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.794 . . . . 0.0 109.956 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -42.1 84.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.492 -0.755 . . . . 0.0 109.705 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.06 -30.32 70.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.44 -0.788 . . . . 0.0 109.944 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.33 -73.38 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.503 -0.748 . . . . 0.0 109.954 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -53.37 -22.19 7.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.775 . . . . 0.0 110.949 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.49 -71.22 0.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 0.0 110.642 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -59.69 -94.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.284 -0.885 . . . . 0.0 110.711 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.45 30.63 0.95 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -110.56 79.11 1.17 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.375 -1.074 . . . . 0.0 109.7 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -79.31 -42.25 26.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.88 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 20.7 p-10 -59.37 -37.35 77.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.442 -0.786 . . . . 0.0 110.049 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.43 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 3.1 tt -80.48 -31.32 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 109.755 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.78 -54.17 39.33 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.922 0.868 . . . . 0.0 109.815 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.443 ' O ' ' CE1' ' A' ' 125' ' ' HIS . 8.3 ttt-85 -59.11 -52.96 63.48 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.866 -0.521 . . . . 0.0 110.347 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -61.07 -26.67 67.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.089 -1.007 . . . . 0.0 110.363 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mt -66.63 -60.07 3.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.667 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.475 ' HA ' ' CG2' ' A' ' 128' ' ' THR . 2.6 p-80 -54.95 -24.68 25.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.457 ' N ' ' CD2' ' A' ' 125' ' ' HIS . . . -77.13 -24.89 51.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 110.633 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -107.65 -23.96 11.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.297 -0.877 . . . . 0.0 110.995 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' ' 98' ' ' LEU . 10.0 t . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.144 -0.973 . . . . 0.0 110.959 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.207 0.527 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 58.35 19.59 6.51 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.398 -0.814 . . . . 0.0 110.508 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.97 -17.45 79.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.42 ' CD2' ' HB2' ' A' ' 26' ' ' LEU . 60.4 mt -78.9 -44.24 23.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.355 -1.085 . . . . 0.0 109.819 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.405 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . . . -62.31 -44.86 95.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.496 -0.752 . . . . 0.0 110.065 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 p -57.12 -55.51 33.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 109.94 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.96 72.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.898 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.18 -49.92 67.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.824 . . . . 0.0 110.141 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 45' ' ' VAL . . . -63.91 -23.97 67.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.353 -0.842 . . . . 0.0 110.147 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -91.52 3.48 54.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 0.0 110.636 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.61 45.97 72.6 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -110.96 66.12 0.62 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -1.084 . . . . 0.0 110.231 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.77 ' CG2' ' HB2' ' A' ' 52' ' ' GLN . 19.1 t -52.31 -34.63 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.324 -0.86 . . . . 0.0 110.113 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -65.55 -54.64 25.19 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.405 -0.809 . . . . 0.0 110.937 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.6 m -57.3 -34.94 69.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.235 -0.915 . . . . 0.0 110.941 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.404 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 58.9 t -73.59 -26.71 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.261 -0.9 . . . . 0.0 110.417 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.46 ' HA ' ' CD1' ' A' ' 56' ' ' LEU . 18.9 mmt180 -68.59 -45.75 71.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.202 -0.936 . . . . 0.0 110.476 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -73.81 -58.44 3.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.452 -0.78 . . . . 0.0 111.28 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.25 -53.49 55.41 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.252 -0.905 . . . . 0.0 111.328 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.442 ' HG ' ' CE1' ' A' ' 60' ' ' HIS . 0.4 OUTLIER -52.61 -61.29 2.38 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.134 -0.979 . . . . 0.0 111.147 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -65.49 -13.07 58.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -0.977 . . . . 0.0 110.688 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.28 -26.71 30.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -0.989 . . . . 0.0 110.743 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.07 -7.64 0.39 Allowed Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.326 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -50.95 142.46 11.84 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.842 -1.387 . . . . 0.0 110.77 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.83 125.33 91.21 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 110.21 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.65 -21.05 22.43 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.573 1.302 . . . . 0.0 110.765 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.37 26.31 10.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.262 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.37 135.16 44.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.313 -0.867 . . . . 0.0 110.156 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.0 mt -84.22 170.13 14.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.833 . . . . 0.0 110.149 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.405 ' ND2' ' CB ' ' A' ' 11' ' ' ALA . 2.5 t-20 -106.94 -168.47 1.41 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.417 -0.802 . . . . 0.0 110.167 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -77.92 -23.44 48.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.389 -0.819 . . . . 0.0 110.27 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -96.28 25.38 4.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.315 -0.865 . . . . 0.0 110.095 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.54 32.09 37.98 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.05 -156.57 0.55 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.446 -1.032 . . . . 0.0 110.283 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.574 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 28.0 mmt-85 -110.49 170.29 5.46 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 0.0 109.598 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 41.0 Cg_endo -68.01 -21.67 42.87 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.484 1.254 . . . . 0.0 110.334 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.545 ' O ' ' HG2' ' A' ' 46' ' ' MET . 73.4 mt -107.67 -44.1 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.272 -0.892 . . . . 0.0 109.703 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.58 -22.54 3.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.155 -0.966 . . . . 0.0 110.501 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 7.1 p -105.29 25.73 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 110.798 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.545 ' HG2' ' O ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -95.83 165.63 12.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -0.999 . . . . 0.0 109.891 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.5 tmm? -61.06 -13.17 15.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.275 -0.891 . . . . 0.0 110.677 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 23.0 mmt 55.3 23.23 5.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.256 -0.902 . . . . 0.0 110.327 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.37 -19.71 5.74 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.407 ' HB3' ' CG2' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -118.15 105.77 12.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -1.156 . . . . 0.0 110.341 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 86' ' ' ASP . . . -59.36 -22.42 61.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.872 . . . . 0.0 110.598 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.77 ' HB2' ' CG2' ' A' ' 19' ' ' VAL . 3.4 mm-40 -61.46 -18.16 57.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.424 ' CG2' ' CG2' ' A' ' 19' ' ' VAL . 88.4 t -86.26 -41.7 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.714 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.45 -25.31 61.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.502 -0.749 . . . . 0.0 110.166 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -79.03 -43.94 23.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.375 -0.828 . . . . 0.0 110.346 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -59.06 -63.06 1.44 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.372 -0.83 . . . . 0.0 110.481 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 mt -52.52 -48.76 65.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.445 -0.784 . . . . 0.0 110.679 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.11 -38.65 76.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.35 -0.844 . . . . 0.0 110.213 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.85 -33.69 76.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -0.834 . . . . 0.0 110.188 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.442 ' CE1' ' HG ' ' A' ' 26' ' ' LEU . 12.5 m170 -84.69 -63.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.013 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.26 54.38 0.03 OUTLIER Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.76 -158.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -1.115 . . . . 0.0 110.112 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -126.71 71.87 74.01 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.368 -0.833 . . . . 0.0 109.988 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -79.43 -21.36 8.93 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.809 1.426 . . . . 0.0 110.59 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -89.33 -52.55 4.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.857 . . . . 0.0 110.31 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 166.42 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.34 -0.85 . . . . 0.0 110.481 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.54 -167.75 2.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 0.0 110.198 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -86.77 127.23 60.89 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.094 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.76 -25.28 14.76 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.573 1.302 . . . . 0.0 110.378 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.66 -51.43 65.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.372 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.78 26.63 7.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 110.463 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 44.17 37.73 2.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.334 -0.854 . . . . 0.0 110.959 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.5 125.67 42.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.298 -0.876 . . . . 0.0 110.559 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.574 ' HD2' ' HB ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -94.4 -175.99 0.52 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 110.144 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 47.7 Cg_endo -75.81 -35.45 2.59 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.386 1.203 . . . . 0.0 111.622 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.574 ' HB ' ' HD2' ' A' ' 74' ' ' ARG . 93.5 t -52.92 -31.61 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.049 -1.032 . . . . 0.0 110.301 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CE1' ' HB3' ' A' ' 108' ' ' PRO . 14.8 m80 -62.29 -44.34 96.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 109.969 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.68 -49.23 66.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.386 -0.821 . . . . 0.0 110.082 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.89 -28.44 36.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.862 . . . . 0.0 110.109 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.01 -30.31 22.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.384 -0.823 . . . . 0.0 109.805 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.413 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 2.5 mmt85 -61.0 -24.62 66.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.462 -0.774 . . . . 0.0 110.235 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -100.58 -27.27 13.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 110.416 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.73 35.35 6.88 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -98.68 94.64 6.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.446 -1.032 . . . . 0.0 110.251 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.75 -25.67 68.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.356 -0.84 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.424 ' HB2' ' CD1' ' A' ' 84' ' ' PHE . 2.9 m-20 -61.66 -56.36 20.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.192 -0.942 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.1 m -57.6 -42.77 83.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.241 -0.912 . . . . 0.0 109.991 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.68 -44.42 85.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.772 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.84 -42.51 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 0.0 109.003 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.4 t -57.21 -46.18 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.647 -0.658 . . . . 0.0 109.981 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.8 -47.04 86.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.418 -0.801 . . . . 0.0 109.929 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.414 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 2.7 t-160 -66.34 -26.25 67.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 110.165 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -68.38 -30.67 69.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 110.267 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -114.47 41.84 2.23 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.361 -0.837 . . . . 0.0 110.406 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.33 109.97 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.01 105.46 3.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -1.085 . . . . 0.0 110.722 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.509 ' O ' ' NE ' ' A' ' 74' ' ' ARG . 0.3 OUTLIER -58.91 107.28 0.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.395 -0.816 . . . . 0.0 109.133 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.414 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 1.1 mt -104.14 23.62 12.73 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.166 -0.959 . . . . 0.0 110.347 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -126.95 17.64 7.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.852 . . . . 0.0 110.499 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 p -67.98 162.0 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 109.81 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.7 m -100.64 137.17 39.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 104' ' ' TRP . 13.0 t70 -73.71 60.69 0.71 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 110.294 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.431 ' HB3' ' CE3' ' A' ' 104' ' ' TRP . . . 58.17 -79.6 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.591 -0.693 . . . . 0.0 110.655 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.471 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.9 OUTLIER -53.76 -42.92 68.73 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.269 -0.894 . . . . 0.0 110.115 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 146.25 -18.94 1.72 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.28 123.98 15.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.209 -1.171 . . . . 0.0 110.518 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.419 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 22.1 mt -79.85 168.32 27.03 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.809 . . . . 0.0 109.891 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.0 Cg_endo -69.13 -25.51 31.45 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.684 1.36 . . . . 0.0 110.39 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 p -82.09 -23.13 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.0 110.14 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -67.07 -43.29 82.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.381 -0.824 . . . . 0.0 110.202 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.08 -31.66 69.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -0.829 . . . . 0.0 110.151 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.86 -65.26 0.7 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.415 -0.803 . . . . 0.0 110.109 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -51.94 -26.31 10.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.457 -0.777 . . . . 0.0 110.567 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -43.35 16.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.342 -0.848 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -77.21 -77.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.27 -0.894 . . . . 0.0 110.181 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 165.12 43.83 0.02 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.413 ' CE1' ' O ' ' A' ' 81' ' ' ARG . 24.1 m80 -117.5 60.14 0.77 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.331 -1.099 . . . . 0.0 109.782 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -50.41 -29.64 10.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.32 -0.863 . . . . 0.0 110.568 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -69.99 -39.13 76.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -35.08 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.264 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.73 -29.27 70.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 110.026 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -73.74 -55.19 6.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.326 -0.859 . . . . 0.0 110.044 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -36.38 83.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.317 -0.865 . . . . 0.0 110.09 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.03 -62.44 1.88 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.376 -0.828 . . . . 0.0 110.283 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -51.01 -26.27 5.87 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.339 -0.851 . . . . 0.0 110.315 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.17 -38.51 51.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 110.136 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -112.67 29.1 8.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.87 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 95.7 m . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 109.876 179.918 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 121.227 0.537 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -138.88 -48.64 0.5 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -0.959 . . . . 0.0 109.958 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.63 -22.02 58.78 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.407 ' CD1' ' CG1' ' A' ' 22' ' ' VAL . 27.3 tp -67.27 -49.62 63.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -1.023 . . . . 0.0 110.314 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.8 -49.55 24.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 110.62 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.8 p -58.15 -49.18 77.91 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.298 -0.876 . . . . 0.0 110.623 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.46 -38.41 84.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.204 -0.935 . . . . 0.0 110.184 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.94 71.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.35 -0.844 . . . . 0.0 110.033 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.35 -33.45 25.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.336 -0.853 . . . . 0.0 110.047 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -75.91 -24.9 55.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.168 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.98 45.12 1.8 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -119.86 96.84 5.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -1.069 . . . . 0.0 110.001 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.726 ' CG2' ' HB2' ' A' ' 52' ' ' GLN . 38.4 t -76.76 -39.32 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.473 -0.767 . . . . 0.0 110.163 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.78 -46.0 90.56 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.276 -0.89 . . . . 0.0 110.757 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.2 m -64.6 -42.28 95.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.344 -0.847 . . . . 0.0 110.577 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 10' ' ' LEU . 65.1 t -70.28 -45.24 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.284 -0.885 . . . . 0.0 110.501 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -59.29 -39.89 84.42 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.722 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.76 -44.2 61.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.365 -0.834 . . . . 0.0 110.783 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.62 -48.03 78.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.236 -0.915 . . . . 0.0 110.689 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.424 HD21 ' CG ' ' A' ' 60' ' ' HIS . 3.1 mt -54.11 -63.99 0.97 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.283 -0.886 . . . . 0.0 110.602 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -16.22 40.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 0.0 110.305 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.2 -37.91 21.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.873 . . . . 0.0 110.543 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.71 -23.63 0.09 OUTLIER Glycine 0 N--CA 1.484 1.843 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.745 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -48.05 124.82 8.12 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.092 -1.24 . . . . 0.0 110.997 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.37 126.92 70.51 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 109.955 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.53 -9.72 20.13 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.606 1.319 . . . . 0.0 110.864 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.12 29.55 7.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.118 -0.989 . . . . 0.0 110.257 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.17 103.48 9.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 0.0 110.26 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pp -84.53 145.65 27.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -104.42 -154.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.424 -0.797 . . . . 0.0 109.814 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 38' ' ' PHE . 2.0 ptp180 -57.95 -171.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 110.252 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER 66.66 1.94 2.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.438 -0.789 . . . . 0.0 111.268 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 45.85 31.98 4.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.77 -168.54 1.54 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -1.15 . . . . 0.0 110.662 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.67 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -118.27 177.67 1.24 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 0.0 109.391 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 43.4 Cg_endo -70.53 -19.29 32.62 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.383 1.202 . . . . 0.0 110.847 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.5 mt -115.01 -34.83 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.134 -0.979 . . . . 0.0 110.001 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -53.43 -29.11 33.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.066 -1.021 . . . . 0.0 110.144 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -92.85 -2.76 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.407 -0.808 . . . . 0.0 110.339 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.411 ' HG3' ' CG1' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -56.05 154.54 7.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.398 -0.814 . . . . 0.0 110.345 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -70.97 -6.9 42.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 110.149 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 23.4 mmt 53.59 25.25 4.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.9 . . . . 0.0 110.411 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -118.03 -11.7 8.16 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 m -129.51 113.45 14.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -1.163 . . . . 0.0 110.296 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.53 -13.9 54.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.429 -0.794 . . . . 0.0 110.598 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.726 ' HB2' ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -73.08 -22.93 60.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.216 -0.928 . . . . 0.0 109.821 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.418 ' CG2' HG22 ' A' ' 19' ' ' VAL . 22.0 t -84.2 -36.84 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.149 -0.969 . . . . 0.0 110.188 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.35 -57.14 5.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.421 -0.799 . . . . 0.0 110.299 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -59.32 -45.82 90.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.439 -0.788 . . . . 0.0 110.474 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 59' ' ' LEU . 52.1 tp -52.63 -52.63 54.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.371 -0.83 . . . . 0.0 110.666 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.6 mt -69.89 -30.39 67.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.262 -0.899 . . . . 0.0 110.854 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.422 ' CD1' HG11 ' A' ' 90' ' ' VAL . 1.1 tt -75.72 -55.23 5.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.178 -0.951 . . . . 0.0 110.944 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.415 ' CD1' ' CD2' ' A' ' 60' ' ' HIS . 3.1 pp -54.07 -28.5 39.3 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.136 -0.978 . . . . 0.0 110.07 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.424 ' CG ' HD21 ' A' ' 26' ' ' LEU . 3.0 m-70 -75.61 -56.87 4.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.359 -0.838 . . . . 0.0 109.821 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.49 44.61 0.02 OUTLIER Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.27 -169.55 1.21 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.335 -1.097 . . . . 0.0 110.62 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -115.38 80.83 7.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.77 -27.0 9.19 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.854 1.45 . . . . 0.0 110.325 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -93.08 -41.44 9.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 110.081 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 151.37 7.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.273 -0.892 . . . . 0.0 110.277 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HB1' ' NE ' ' A' ' 74' ' ' ARG . . . -143.87 -172.72 3.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.416 -0.802 . . . . 0.0 110.565 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 15.5 t0 -89.69 125.07 62.34 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.33 -21.55 19.8 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.484 1.255 . . . . 0.0 110.62 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.24 -20.89 65.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 110.678 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -158.42 22.03 0.23 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.027 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.4 mt 44.05 65.29 1.06 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.306 -0.871 . . . . 0.0 110.403 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -119.21 103.23 9.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.092 -1.005 . . . . 0.0 111.156 -178.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.468 ' CG ' ' HD2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -75.29 169.65 19.4 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.728 . . . . 0.0 109.197 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 74' ' ' ARG . 46.7 Cg_endo -74.49 -4.34 15.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.458 1.241 . . . . 0.0 110.904 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.84 -35.39 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.211 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -62.16 -43.17 99.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 110.331 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -56.33 -57.98 9.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.477 -0.764 . . . . 0.0 110.438 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.87 -28.25 65.95 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.284 -0.885 . . . . 0.0 109.876 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.94 -27.9 39.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 110.032 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -71.9 -23.42 61.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.826 . . . . 0.0 110.367 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -97.08 -44.52 6.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.368 -0.832 . . . . 0.0 110.227 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.85 29.62 3.03 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.458 ' CZ ' ' CA ' ' A' ' 84' ' ' PHE . 4.3 t80 -93.61 91.8 7.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.43 -1.041 . . . . 0.0 110.224 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.22 -27.85 69.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.333 -0.855 . . . . 0.0 109.863 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -59.07 -54.44 47.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.397 -0.815 . . . . 0.0 110.348 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.9 m -61.46 -35.19 76.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.326 -0.859 . . . . 0.0 109.962 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.402 ' CD2' ' HB3' ' A' ' 123' ' ' TYR . 5.7 tp -59.53 -51.97 67.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.212 -0.93 . . . . 0.0 109.776 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.78 -45.01 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 109.269 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.422 HG11 ' CD1' ' A' ' 58' ' ' LEU . 96.4 t -50.48 -46.47 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.614 -0.679 . . . . 0.0 110.452 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 mp -65.01 -57.35 8.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 110.088 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.402 ' CE1' ' HB1' ' A' ' 127' ' ' ALA . 4.5 t-160 -63.68 -17.43 62.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 110.36 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -87.78 -13.88 41.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 0.0 110.615 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -133.46 49.57 2.28 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.186 -0.946 . . . . 0.0 110.512 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.64 108.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -168.63 104.98 0.43 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -1.101 . . . . 0.0 110.248 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -68.04 108.7 3.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.418 -0.802 . . . . 0.0 110.071 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 mp -93.18 -21.58 19.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.313 -0.867 . . . . 0.0 110.449 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -70.4 72.71 0.49 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.447 HG23 ' NE ' ' A' ' 74' ' ' ARG . 7.5 p -143.37 161.18 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -0.86 . . . . 0.0 110.341 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 13.3 p -128.6 147.33 50.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.51 -0.744 . . . . 0.0 109.422 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 104' ' ' TRP . 5.1 p-10 -69.86 65.3 0.23 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.254 -0.904 . . . . 0.0 110.607 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 56.66 -81.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.688 -0.632 . . . . 0.0 111.097 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.467 ' N ' ' O ' ' A' ' 102' ' ' ASP . 8.2 m-90 -91.52 43.98 1.16 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.265 -0.897 . . . . 0.0 110.359 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.54 -162.62 10.15 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.506 ' O ' ' CD1' ' A' ' 107' ' ' LEU . 10.5 mtm180 -120.79 -51.45 2.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.395 -1.062 . . . . 0.0 110.259 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.77 ' HG ' ' HD2' ' A' ' 108' ' ' PRO . 2.0 tp -174.13 162.72 2.91 Favored Pre-proline 0 N--CA 1.497 1.884 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.77 ' HD2' ' HG ' ' A' ' 107' ' ' LEU . 42.8 Cg_endo -70.39 -31.54 17.53 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.026 1.014 . . . . 0.0 110.24 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.05 -21.03 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 109.648 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -77.56 -45.29 25.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.383 -0.823 . . . . 0.0 109.621 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.59 -26.85 62.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 117' ' ' HIS . . . -78.0 -50.13 12.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.507 -0.746 . . . . 0.0 109.962 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -52.77 -23.28 6.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.478 -0.763 . . . . 0.0 110.898 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -94.63 -54.12 3.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.262 -0.899 . . . . 0.0 110.667 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -59.73 -95.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.254 -0.904 . . . . 0.0 110.435 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -170.29 31.79 0.15 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.412 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 9.0 m-70 -117.03 79.47 1.34 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -1.035 . . . . 0.0 109.536 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 30.0 mmt85 -81.32 -40.54 23.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.386 -0.821 . . . . 0.0 110.167 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.4 -54.45 43.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.307 -0.871 . . . . 0.0 109.702 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 121' ' ' ALA . 10.0 tt -60.13 -34.75 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.468 -0.77 . . . . 0.0 109.359 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.404 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -61.7 -39.42 91.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.658 -0.651 . . . . 0.0 109.799 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -56.17 -53.21 59.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.392 -0.817 . . . . 0.0 109.571 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.402 ' HB3' ' CD2' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -58.71 -45.19 90.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.357 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 128' ' ' THR . 78.3 mt -55.9 -48.53 75.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.435 -0.79 . . . . 0.0 109.928 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -53.5 -27.33 24.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.295 -0.878 . . . . 0.0 110.191 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.19 -38.69 15.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.316 -0.865 . . . . 0.0 110.467 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.402 ' HB1' ' CE1' ' A' ' 92' ' ' HIS . . . -98.02 10.62 39.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.304 -0.872 . . . . 0.0 110.783 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 124' ' ' LEU . 7.4 m . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 110.365 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 121.086 0.47 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.8 -22.07 1.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 110.835 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -53.91 -32.58 48.9 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.23 -27.69 68.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.444 -1.033 . . . . 0.0 110.09 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.4 -50.7 8.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.412 -0.805 . . . . 0.0 110.257 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.2 p -63.18 -50.17 71.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.421 -0.8 . . . . 0.0 110.08 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.5 -40.8 83.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.342 -0.849 . . . . 0.0 109.769 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.01 -38.93 87.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.038 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 -32.6 71.87 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.309 -0.869 . . . . 0.0 110.168 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.87 15.43 11.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.394 -0.816 . . . . 0.0 110.543 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.47 52.97 49.3 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -119.67 72.26 0.91 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -1.102 . . . . 0.0 110.536 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' A' ' 52' ' ' GLN . 58.0 t -56.96 -35.69 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.048 -1.032 . . . . 0.0 109.496 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -59.62 -54.95 40.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.557 -0.715 . . . . 0.0 109.988 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 84.0 m -56.92 -38.3 72.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.438 -0.789 . . . . 0.0 110.129 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.76 -22.05 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 110.475 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.466 ' HA ' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -62.65 -45.87 90.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.163 -0.961 . . . . 0.0 110.422 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -76.41 -51.22 12.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.46 -0.775 . . . . 0.0 111.408 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.402 ' C ' ' HB1' ' A' ' 30' ' ' ALA . 4.0 mt -51.2 -62.06 1.85 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.989 . . . . 0.0 111.227 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 2.0 mt -53.56 -46.82 70.38 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.15 -0.969 . . . . 0.0 111.365 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.66 9.34 7.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.06 -1.025 . . . . 0.0 110.962 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -114.47 -31.33 6.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.68 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.35 -27.81 0.08 OUTLIER Glycine 0 N--CA 1.484 1.849 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.598 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HB1' ' C ' ' A' ' 25' ' ' LEU . . . -48.22 128.65 14.5 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.136 -1.214 . . . . 0.0 110.758 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.22 145.36 82.97 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.397 -0.814 . . . . 0.0 110.301 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.98 -25.97 8.34 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.753 1.396 . . . . 0.0 110.784 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -114.44 32.38 5.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.324 -0.86 . . . . 0.0 110.403 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.8 96.87 10.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.354 -0.841 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -71.62 157.69 37.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.32 -0.862 . . . . 0.0 110.083 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.469 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 47.7 p30 -112.9 173.83 6.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.121 -0.987 . . . . 0.0 110.97 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -49.73 -26.9 4.2 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.368 -0.832 . . . . 0.0 110.608 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -11.93 60.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.28 -0.887 . . . . 0.0 109.887 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.21 25.61 18.86 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -93.99 1.2 56.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -1.014 . . . . 0.0 110.227 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 55.89 171.45 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.25 -0.906 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.493 ' O ' ' HB ' ' A' ' 43' ' ' ILE . 45.7 Cg_endo -72.65 169.44 21.89 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.534 1.281 . . . . 0.0 110.724 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.523 ' HA ' ' HG2' ' A' ' 46' ' ' MET . 30.7 mt 62.95 -60.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.821 -0.549 . . . . 0.0 111.017 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -43.12 -29.2 0.35 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.879 -1.138 . . . . 0.0 110.793 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.79 35.55 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 0.0 109.942 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.523 ' HG2' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -110.46 171.86 7.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.256 -0.903 . . . . 0.0 110.267 -179.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 8.5 ttp -73.45 98.91 2.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.319 -0.863 . . . . 0.0 108.685 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.488 ' O ' ' CD2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -61.73 -6.16 2.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 111.138 -179.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.5 20.78 32.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.9 t -154.06 109.05 3.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -1.129 . . . . 0.0 110.227 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.25 -29.54 69.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.404 -0.81 . . . . 0.0 110.033 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.475 ' HB3' ' CG2' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -51.35 -32.88 27.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.543 -0.723 . . . . 0.0 110.297 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.2 t -75.17 -47.94 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.359 -0.838 . . . . 0.0 110.053 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.423 ' CB ' ' CG2' ' A' ' 87' ' ' THR . . . -70.56 -23.44 62.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.399 -0.813 . . . . 0.0 110.158 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.71 -53.1 37.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.361 -0.837 . . . . 0.0 110.689 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.466 ' CD1' ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -61.58 -57.11 13.37 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.909 . . . . 0.0 110.647 -179.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -47.36 -50.37 22.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 110.97 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.5 tp -70.68 -24.7 62.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.406 -0.809 . . . . 0.0 110.544 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.1 tp -67.67 -41.28 83.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 109.982 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.424 ' CE1' ' HB3' ' A' ' 26' ' ' LEU . 12.0 m170 -78.91 -30.89 45.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.348 -0.845 . . . . 0.0 109.864 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.42 54.89 0.07 OUTLIER Glycine 0 N--CA 1.482 1.758 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.83 -168.3 0.19 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.273 -1.133 . . . . 0.0 110.051 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -117.21 78.52 10.36 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.853 . . . . 0.0 110.007 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.78 -27.47 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.719 1.378 . . . . 0.0 110.417 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -87.55 -59.27 2.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.433 -0.792 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.1 168.59 0.13 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.308 -0.87 . . . . 0.0 110.444 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.411 ' CB ' ' HD2' ' A' ' 74' ' ' ARG . . . -167.93 -158.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.875 . . . . 0.0 110.734 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -79.7 123.85 83.81 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.499 -0.75 . . . . 0.0 110.292 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.39 -24.11 14.54 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.549 1.289 . . . . 0.0 110.401 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.39 -46.24 86.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -0.892 . . . . 0.0 110.424 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.604 ' O ' ' C ' ' A' ' 72' ' ' LEU . 41.9 p -146.65 68.69 1.17 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 110.355 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.604 ' C ' ' O ' ' A' ' 71' ' ' THR . 13.9 mt 5.41 86.75 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.933 -0.479 . . . . 0.0 112.175 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.05 83.57 2.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 110.363 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.419 ' HD3' ' CG2' ' A' ' 100' ' ' VAL . 5.2 mpt_? -61.51 161.31 20.11 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.481 -0.762 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.36 -18.74 29.68 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.855 1.45 . . . . 0.0 110.422 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.88 -32.13 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.35 -0.844 . . . . 0.0 109.997 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -64.63 -41.72 95.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 110.34 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -70.31 -48.44 56.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.355 -0.841 . . . . 0.0 110.416 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.36 -29.18 14.58 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.293 -0.879 . . . . 0.0 110.448 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.453 ' CB ' ' CG2' ' A' ' 120' ' ' ILE . . . -96.55 -27.92 14.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.4 -0.812 . . . . 0.0 109.796 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -53.47 -28.43 30.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.402 -0.811 . . . . 0.0 109.765 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -99.5 -28.44 13.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.814 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.69 44.92 2.03 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 48' ' ' MET . 12.7 t80 -108.0 96.43 6.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.368 -1.078 . . . . 0.0 110.046 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.413 HD21 ' CD1' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -72.25 -24.29 61.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.516 -0.74 . . . . 0.0 110.663 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . 63.9 m-20 -59.67 -54.35 47.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.407 -0.808 . . . . 0.0 110.499 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.423 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 90.9 m -61.2 -36.75 80.72 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.094 -1.004 . . . . 0.0 110.157 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.429 HD23 ' CD1' ' A' ' 123' ' ' TYR . 0.7 OUTLIER -57.54 -48.79 78.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.318 -0.864 . . . . 0.0 110.252 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.66 -50.95 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 109.914 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 85.1 t -54.27 -45.57 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.838 . . . . 0.0 110.221 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.23 -56.06 26.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.39 -0.819 . . . . 0.0 110.35 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -64.32 -23.32 67.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.446 -0.784 . . . . 0.0 110.657 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -78.77 -33.75 46.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.202 -0.936 . . . . 0.0 110.575 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.12 39.69 1.22 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.322 -0.862 . . . . 0.0 111.012 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.55 108.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -168.31 132.45 1.62 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.532 -0.981 . . . . 0.0 110.05 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.55 140.01 42.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.242 -0.911 . . . . 0.0 110.071 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.416 HD11 ' N ' ' A' ' 98' ' ' LEU . 2.4 mp -128.31 19.49 6.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.315 -0.866 . . . . 0.0 110.48 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -123.29 55.87 1.2 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.151 -0.968 . . . . 0.0 110.421 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.419 ' CG2' ' HD3' ' A' ' 74' ' ' ARG . 12.6 p -112.76 164.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.383 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 98.8 m -106.47 150.88 25.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.474 -0.767 . . . . 0.0 109.802 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 104' ' ' TRP . 22.6 t70 -78.89 58.87 2.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.324 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.447 ' CA ' ' HB2' ' A' ' 72' ' ' LEU . . . 64.69 -71.97 0.07 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.519 -0.738 . . . . 0.0 110.719 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.431 ' N ' ' O ' ' A' ' 102' ' ' ASP . 2.1 m95 -65.49 -56.09 14.28 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.413 -0.804 . . . . 0.0 110.443 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.63 -28.15 0.14 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.01 105.79 0.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.237 -1.155 . . . . 0.0 110.423 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.62 170.64 13.4 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.277 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.3 -43.19 0.74 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.738 1.388 . . . . 0.0 110.425 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.97 -36.02 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.35 -0.844 . . . . 0.0 110.115 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.06 -45.8 80.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.441 -0.787 . . . . 0.0 110.187 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 tt -60.84 -27.74 68.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.222 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.3 -63.98 0.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 0.0 110.137 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -53.99 -23.63 13.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.92 -40.66 78.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.676 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.402 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 0.9 OUTLIER -91.29 5.32 49.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.228 -0.92 . . . . 0.0 110.77 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.63 37.06 8.92 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.445 ' HB3' ' CG1' ' A' ' 120' ' ' ILE . 23.9 m-70 -113.09 55.34 0.7 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -1.102 . . . . 0.0 109.791 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.96 -30.5 24.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.435 -0.791 . . . . 0.0 109.988 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -62.39 -40.62 97.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.735 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.453 ' CG2' ' CB ' ' A' ' 80' ' ' ALA . 4.1 mm -75.87 -36.28 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.509 -0.744 . . . . 0.0 109.601 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.33 -59.11 4.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 111.178 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -53.99 -41.27 67.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.007 -1.058 . . . . 0.0 110.133 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.429 ' CD1' HD23 ' A' ' 88' ' ' LEU . 11.7 t80 -68.86 -42.48 76.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.227 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 128' ' ' THR . 21.2 mt -66.24 -47.56 73.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.475 -0.766 . . . . 0.0 109.741 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -50.24 -32.11 15.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.411 -0.806 . . . . 0.0 110.333 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.49 -27.0 46.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.737 . . . . 0.0 110.293 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.73 -11.45 18.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.342 -0.849 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 124' ' ' LEU . 73.2 p . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 110.48 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.135 0.493 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.45 -19.53 62.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.761 . . . . 0.0 110.048 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.34 -25.95 55.57 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.15 -37.41 87.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.404 -1.057 . . . . 0.0 110.178 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.28 -49.03 14.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.286 -0.884 . . . . 0.0 110.107 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.9 p -56.39 -54.93 39.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.419 -0.801 . . . . 0.0 110.267 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.55 74.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.0 110.071 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.7 -43.75 58.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 110.134 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' HA ' ' N ' ' A' ' 47' ' ' MET . . . -61.44 -28.53 69.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.386 -0.821 . . . . 0.0 110.189 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -72.84 -27.77 62.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.409 -0.807 . . . . 0.0 110.159 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.34 28.04 4.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -106.65 143.0 35.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.379 -1.071 . . . . 0.0 110.483 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.639 ' CG2' ' HB2' ' A' ' 52' ' ' GLN . 95.0 t -109.53 -54.42 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.442 -0.787 . . . . 0.0 109.9 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -54.9 -32.54 61.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.51 -0.744 . . . . 0.0 110.418 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 m -62.07 -60.89 2.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 110.292 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.49 -27.51 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.27 -0.894 . . . . 0.0 110.146 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -43.44 82.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 110.161 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -63.31 -38.47 91.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.587 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.17 -44.68 68.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.0 110.619 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 14.2 mt -65.88 -57.0 8.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.311 -0.868 . . . . 0.0 110.481 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.84 -25.29 18.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.233 -0.917 . . . . 0.0 110.097 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.55 -67.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 110.046 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.88 47.21 0.06 OUTLIER Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.93 169.79 12.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -1.143 . . . . 0.0 110.175 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -89.85 125.37 61.09 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 110.04 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.95 -17.46 25.18 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.603 1.318 . . . . 0.0 110.649 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.32 39.86 3.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 110.062 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.91 109.79 5.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.403 -0.81 . . . . 0.0 110.224 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -72.83 99.26 2.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.309 -0.87 . . . . 0.0 109.744 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -54.82 -179.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.468 -0.77 . . . . 0.0 110.439 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -93.94 22.7 5.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.894 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 64.8 m-85 -111.8 21.57 15.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.202 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.74 26.9 26.47 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -131.2 -168.71 2.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.381 -1.07 . . . . 0.0 110.393 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.638 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.2 mmt180 -104.16 176.19 1.88 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.47 -0.769 . . . . 0.0 109.421 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.638 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 42.9 Cg_endo -69.76 -19.49 36.08 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.273 1.144 . . . . 0.0 110.648 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.435 ' O ' ' HG2' ' A' ' 46' ' ' MET . 44.7 mt -104.17 -27.94 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 109.775 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.32 -19.68 56.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.094 -1.004 . . . . 0.0 109.875 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 p -126.75 35.7 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.232 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.473 ' O ' ' CB ' ' A' ' 47' ' ' MET . 0.2 OUTLIER -96.16 31.59 2.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.259 -0.9 . . . . 0.0 110.298 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' MET . . . . . 0.473 ' CB ' ' O ' ' A' ' 46' ' ' MET . 4.8 tmm? 72.15 -18.08 0.34 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.557 -0.714 . . . . 0.0 111.208 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.418 ' H ' ' C ' ' A' ' 46' ' ' MET . 0.0 OUTLIER 50.43 26.2 2.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.019 -1.05 . . . . 0.0 110.679 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -125.32 28.88 4.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.11 100.87 0.75 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.318 -1.107 . . . . 0.0 110.312 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.52 -26.96 65.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.301 -0.874 . . . . 0.0 110.063 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.639 ' HB2' ' CG2' ' A' ' 19' ' ' VAL . 5.7 mm-40 -55.04 -29.39 57.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.488 -0.757 . . . . 0.0 110.591 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -88.24 -33.16 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 109.932 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.72 94.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.323 -0.86 . . . . 0.0 110.115 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -80.08 -38.68 31.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.341 -0.849 . . . . 0.0 110.559 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 37.5 tp -53.98 -58.04 8.76 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.295 -0.878 . . . . 0.0 110.32 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.2 mt -67.15 -28.04 67.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.958 . . . . 0.0 110.21 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.411 ' CD2' ' CB ' ' A' ' 94' ' ' ALA . 1.3 tp -66.92 -64.96 0.74 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.332 -0.855 . . . . 0.0 110.637 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 56' ' ' LEU . 3.9 pp -49.91 -27.78 5.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.266 -0.896 . . . . 0.0 110.315 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 26' ' ' LEU . 4.3 m80 -77.22 -62.81 1.53 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -0.855 . . . . 0.0 109.788 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 165.56 41.71 0.02 OUTLIER Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.17 -170.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.312 -1.111 . . . . 0.0 110.329 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -125.28 73.73 67.3 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.461 -0.774 . . . . 0.0 110.282 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.848 1.446 . . . . 0.0 110.601 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -89.93 -50.01 6.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.931 . . . . 0.0 110.725 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.21 172.24 0.22 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.173 -0.954 . . . . 0.0 110.459 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.451 ' CB ' ' HG2' ' A' ' 74' ' ' ARG . . . -156.76 -178.14 7.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.483 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 4.4 t0 -89.59 116.67 66.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 110.036 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.89 -17.18 32.63 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.61 1.321 . . . . 0.0 110.363 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.26 -24.12 63.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 110.686 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 m -150.73 21.48 0.8 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.25 -0.906 . . . . 0.0 110.599 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.9 mt 49.23 27.64 1.92 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.176 -0.952 . . . . 0.0 110.385 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -84.79 121.9 28.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.422 -0.799 . . . . 0.0 110.722 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.452 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 2.2 mtt180 -94.79 173.59 4.35 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 110.003 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 42.1 Cg_endo -68.39 -17.55 44.13 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.654 1.344 . . . . 0.0 110.23 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.1 t -69.96 -32.33 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.363 -0.836 . . . . 0.0 109.605 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.418 ' CG ' ' HB3' ' A' ' 108' ' ' PRO . 60.7 m80 -67.97 -43.73 78.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.477 -0.764 . . . . 0.0 110.082 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.415 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 0.6 OUTLIER -59.73 -60.63 3.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 0.0 109.648 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.84 -24.34 8.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.478 -0.764 . . . . 0.0 109.624 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.413 ' HA ' HD11 ' A' ' 120' ' ' ILE . . . -83.56 -30.11 27.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.523 -0.736 . . . . 0.0 109.613 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -57.35 -35.59 70.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.416 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 8.6 mp0 -98.01 -15.65 19.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.494 -0.754 . . . . 0.0 110.291 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 117' ' ' HIS . . . 76.71 49.33 7.99 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.14 88.42 3.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.378 -1.072 . . . . 0.0 110.037 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 mt -60.09 -31.65 70.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.398 -0.814 . . . . 0.0 110.47 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -56.88 -48.17 78.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 97.7 m -68.64 -32.87 73.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 109.814 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mp -57.8 -44.06 86.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.343 -0.848 . . . . 0.0 109.821 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 t -60.89 -54.29 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.448 -0.783 . . . . 0.0 109.439 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.405 ' CG1' ' CD2' ' A' ' 58' ' ' LEU . 96.9 t -44.8 -45.91 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.714 -0.616 . . . . 0.0 110.807 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -54.07 24.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 110.512 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -64.59 -46.83 81.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.331 -0.855 . . . . 0.0 110.996 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -10.05 55.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.178 -0.951 . . . . 0.0 110.922 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.411 ' CB ' ' CD2' ' A' ' 58' ' ' LEU . . . -120.02 26.71 9.11 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.156 -0.965 . . . . 0.0 110.447 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.77 107.18 0.25 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -170.54 114.99 0.47 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.328 -1.101 . . . . 0.0 110.143 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' ' 74' ' ' ARG . 6.4 ttt85 -69.78 132.89 46.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -0.828 . . . . 0.0 110.082 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.4 mp -119.8 26.83 9.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.418 -0.801 . . . . 0.0 110.191 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -115.54 53.03 0.85 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 110.287 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.4 p -123.06 153.75 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 110.103 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 78.2 m -109.48 147.47 32.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 0.0 109.924 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.407 ' O ' ' O ' ' A' ' 103' ' ' ALA . 6.6 p-10 -70.75 67.25 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 0.0 110.325 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.494 ' O ' ' CG ' ' A' ' 104' ' ' TRP . . . 57.48 111.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.424 -0.797 . . . . 0.0 110.481 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.494 ' CG ' ' O ' ' A' ' 103' ' ' ALA . 38.4 p90 35.64 34.96 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.76 -0.588 . . . . 0.0 111.432 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -122.84 -126.9 3.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.38 179.01 6.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -1.09 . . . . 0.0 110.269 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.486 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 96.9 mt -62.85 166.72 7.14 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.477 -0.764 . . . . 0.0 110.013 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.7 Cg_endo -69.94 -16.91 36.99 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.67 1.353 . . . . 0.0 110.536 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.428 HG22 ' CG ' ' A' ' 125' ' ' HIS . 11.6 p -61.64 -35.21 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.218 -0.926 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -69.3 -41.74 76.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 110.153 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.01 -31.15 66.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.92 -67.72 0.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.843 . . . . 0.0 110.225 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -25.72 20.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.85 -27.12 60.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.358 -0.839 . . . . 0.0 110.53 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -95.29 -16.02 22.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.667 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 125.28 -13.99 7.4 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.44 ' HB3' ' CG2' ' A' ' 120' ' ' ILE . 24.0 m-70 -75.87 96.87 3.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -1.196 . . . . 0.0 109.594 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' A' ' 119' ' ' ASP . 2.7 ptm180 -91.38 -41.82 10.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.923 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 118' ' ' ARG . 74.4 m-20 -63.29 -38.85 92.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -0.919 . . . . 0.0 109.634 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -65.63 -37.24 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.567 -0.708 . . . . 0.0 109.92 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.435 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -60.66 -37.0 80.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.453 -0.779 . . . . 0.0 109.9 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -51.15 70.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.408 -0.807 . . . . 0.0 109.759 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -60.28 -28.24 67.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.39 -0.819 . . . . 0.0 110.066 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.9 mt -85.59 -38.1 18.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 110.266 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.428 ' CG ' HG22 ' A' ' 109' ' ' VAL . 18.7 m-70 -54.62 -29.3 51.6 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.215 -0.928 . . . . 0.0 110.355 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.86 -20.63 16.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 110.312 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -92.68 -26.85 17.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 0.0 110.582 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.2 p . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.319 -0.863 . . . . 0.0 110.378 -179.837 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.319 0.581 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.46 -21.7 61.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.399 -0.813 . . . . 0.0 110.321 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.423 ' HA2' ' CG2' ' A' ' 12' ' ' THR . . . -57.65 -25.21 55.19 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.5 tp -75.92 -38.52 57.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -1.071 . . . . 0.0 110.506 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.17 -38.09 22.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.091 -1.005 . . . . 0.0 111.041 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.423 ' CG2' ' HA2' ' A' ' 9' ' ' GLY . 15.2 t -61.81 -41.11 97.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.144 -0.972 . . . . 0.0 110.487 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 18' ' ' GLN . . . -68.15 -50.56 53.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.175 -0.953 . . . . 0.0 109.534 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.57 -45.88 66.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.91 . . . . 0.0 110.563 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.4 -18.02 62.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.422 -0.799 . . . . 0.0 110.648 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -97.15 26.03 5.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 0.0 110.587 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 56.93 37.85 81.2 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.62 ' HB3' ' OG1' ' A' ' 21' ' ' THR . 62.6 mm-40 -112.96 93.87 4.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.42 -1.047 . . . . 0.0 110.271 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 52' ' ' GLN . 11.3 t -82.78 -59.31 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.215 -0.928 . . . . 0.0 110.47 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -50.23 -48.99 54.28 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.62 ' OG1' ' HB3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -53.88 -34.57 59.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.518 -0.739 . . . . 0.0 110.362 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -81.12 -30.15 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.779 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -58.9 -37.56 76.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.296 -0.877 . . . . 0.0 110.108 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -79.28 -51.42 9.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 110.42 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.73 -53.93 45.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 0.0 110.672 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.5 mt -56.56 -59.88 4.35 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.247 -0.908 . . . . 0.0 110.404 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.67 -24.15 65.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.369 -0.832 . . . . 0.0 110.266 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.43 -64.93 0.92 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.35 48.69 0.07 OUTLIER Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.4 172.24 9.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -1.088 . . . . 0.0 110.22 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -110.82 102.75 53.25 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 0.0 110.239 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.3 -15.08 31.55 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.655 1.345 . . . . 0.0 110.64 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -109.31 26.83 10.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.909 . . . . 0.0 110.163 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.63 102.62 14.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.365 -0.835 . . . . 0.0 110.405 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 25.7 mt -65.82 123.08 18.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.355 -0.841 . . . . 0.0 110.076 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -62.48 175.64 0.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.395 -0.815 . . . . 0.0 109.886 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -6.12 45.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.305 -0.872 . . . . 0.0 110.459 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -93.3 17.59 10.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.173 -0.955 . . . . 0.0 110.084 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.98 24.0 18.27 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -110.15 155.85 21.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.387 -1.066 . . . . 0.0 109.836 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.55 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.9 mmp_? -73.61 168.86 21.65 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.387 -0.821 . . . . 0.0 109.524 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 41.0 Cg_endo -68.03 -14.98 42.48 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.454 1.239 . . . . 0.0 110.173 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.476 ' HA ' ' HG2' ' A' ' 46' ' ' MET . 58.0 mt -107.95 -17.94 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.85 . . . . 0.0 109.87 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -69.12 -20.93 64.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 110.15 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.59 -17.0 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.355 -0.841 . . . . 0.0 110.399 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.476 ' HG2' ' HA ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -55.92 164.49 1.17 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.195 -0.941 . . . . 0.0 110.31 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -63.14 89.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.171 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.442 ' HG3' ' HA ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -49.82 -19.93 0.76 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.47 -0.768 . . . . 0.0 111.28 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.439 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . -86.66 20.44 23.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.43 ' HB3' HG23 ' A' ' 53' ' ' VAL . 21.2 t -140.67 118.62 11.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.007 -1.29 . . . . 0.0 110.375 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.76 -26.25 59.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.924 . . . . 0.0 109.647 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.526 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 11.7 mt-30 -53.44 -27.35 24.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.525 -0.735 . . . . 0.0 110.644 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 50' ' ' SER . 0.0 OUTLIER -90.05 -48.3 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 110.186 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.05 -35.11 64.14 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.297 -0.877 . . . . 0.0 110.368 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -78.03 -48.24 16.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.361 -0.837 . . . . 0.0 110.635 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.83 -65.54 0.54 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.201 -0.937 . . . . 0.0 110.761 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.95 -47.01 61.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.458 -0.776 . . . . 0.0 110.823 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.3 -43.5 74.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.3 tp -60.4 -25.61 66.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -95.98 24.68 5.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.201 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.55 54.41 37.94 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.28 -146.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -1.083 . . . . 0.0 109.464 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.63 70.7 77.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.004 -1.06 . . . . 0.0 110.048 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -81.57 -24.1 4.51 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.806 1.424 . . . . 0.0 110.134 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -95.75 -29.13 14.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 110.358 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -64.39 139.58 58.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 110.375 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.51 175.12 8.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.335 -0.853 . . . . 0.0 110.5 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.491 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 8.6 t70 -76.95 137.18 65.92 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.753 . . . . 0.0 109.84 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.06 -28.35 3.92 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.519 1.273 . . . . 0.0 111.106 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.49 -22.69 58.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.133 -0.979 . . . . 0.0 110.686 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 72' ' ' LEU . 3.5 m -144.25 19.57 1.74 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 111.13 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 71' ' ' THR . 4.9 mt 40.25 36.68 0.35 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.313 -0.867 . . . . 0.0 110.861 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -87.3 126.16 34.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.405 -0.809 . . . . 0.0 110.851 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.495 ' HB2' ' CG1' ' A' ' 100' ' ' VAL . 0.2 OUTLIER -92.62 173.25 5.23 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.557 -0.714 . . . . 0.0 110.178 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.09 -18.72 16.25 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.663 1.349 . . . . 0.0 110.348 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.89 -32.79 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.33 -0.856 . . . . 0.0 109.939 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.41 ' CE1' ' HD3' ' A' ' 108' ' ' PRO . 68.8 m80 -60.92 -46.15 91.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.04 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.403 ' CB ' ' CE ' ' A' ' 48' ' ' MET . 1.2 m-20 -60.21 -57.1 14.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.3 -0.875 . . . . 0.0 110.037 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HA ' ' HG3' ' A' ' 48' ' ' MET . . . -51.64 -30.53 21.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.357 -0.84 . . . . 0.0 109.818 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.16 -23.55 30.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.562 -0.711 . . . . 0.0 109.749 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.448 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -60.38 -35.58 76.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.457 -0.777 . . . . 0.0 110.122 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -94.76 -19.5 20.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.34 -0.85 . . . . 0.0 110.463 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.23 30.63 13.55 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.439 ' CE2' ' HA2' ' A' ' 49' ' ' GLY . 18.0 t80 -97.65 92.01 5.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -1.004 . . . . 0.0 110.092 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.63 -22.45 66.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.273 -0.892 . . . . 0.0 110.349 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -57.47 -41.14 80.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.397 -0.814 . . . . 0.0 110.392 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.416 HG21 ' CE ' ' A' ' 46' ' ' MET . 74.8 m -72.86 -36.38 67.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.349 -0.844 . . . . 0.0 109.96 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.4 mp -62.52 -42.26 99.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 109.769 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.6 t -61.31 -44.59 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.448 -0.783 . . . . 0.0 109.332 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.1 t -55.49 -44.29 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.444 -0.785 . . . . 0.0 109.857 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.5 mp -62.52 -45.95 90.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.428 -0.795 . . . . 0.0 109.744 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -70.97 -15.91 62.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.0 110.254 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -74.61 -71.64 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.349 -0.844 . . . . 0.0 110.136 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.78 -78.47 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.331 -0.855 . . . . 0.0 110.286 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.06 107.61 0.26 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -160.68 119.36 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -1.046 . . . . 0.0 109.834 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -60.43 126.59 28.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.263 -0.898 . . . . 0.0 110.379 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.51 64.64 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 110.283 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -171.29 61.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -0.859 . . . . 0.0 110.053 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.495 ' CG1' ' HB2' ' A' ' 74' ' ' ARG . 7.3 p -131.86 173.13 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 110.065 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -135.1 160.87 36.98 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 104' ' ' TRP . 29.5 m-20 -68.76 71.91 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.709 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 101' ' ' CYS . . . 56.49 -80.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.64 -0.663 . . . . 0.0 110.113 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.503 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -126.78 32.69 5.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -115.46 -142.15 7.59 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.388 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.408 ' HB3' ' CB ' ' A' ' 110' ' ' ASP . 5.4 mtt85 -98.06 159.13 15.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -1.024 . . . . 0.0 110.787 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -78.99 175.64 4.53 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.604 -0.685 . . . . 0.0 109.618 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 40.8 Cg_endo -66.12 -16.87 53.7 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.385 1.203 . . . . 0.0 110.174 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.43 HG21 ' CG ' ' A' ' 125' ' ' HIS . 9.7 p -91.69 -34.9 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.873 . . . . 0.0 109.796 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.408 ' CB ' ' HB3' ' A' ' 106' ' ' ARG . 10.0 m-20 -66.91 -41.65 86.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -0.8 . . . . 0.0 109.954 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.426 HD22 ' HG2' ' A' ' 81' ' ' ARG . 5.8 tt -57.04 -31.02 64.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.419 -0.801 . . . . 0.0 109.951 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.85 -36.85 23.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.532 -0.73 . . . . 0.0 109.979 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -54.99 -26.21 35.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 0.0 110.644 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -91.88 -47.28 7.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.377 -0.827 . . . . 0.0 110.72 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.422 ' HG2' ' CE1' ' A' ' 117' ' ' HIS . 52.6 tp60 -66.4 -100.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.913 . . . . 0.0 110.547 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.12 24.7 0.2 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.523 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.448 ' CE1' ' O ' ' A' ' 81' ' ' ARG . 1.6 m170 -100.51 86.2 3.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.0 -1.294 . . . . 0.0 109.386 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 122' ' ' ARG . 2.6 mpt_? -80.72 -57.93 3.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.415 -0.803 . . . . 0.0 110.71 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -45.76 -46.84 15.42 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.627 -0.671 . . . . 0.0 110.894 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 121' ' ' ALA . 2.7 tt -65.41 -37.44 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 0.0 109.644 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -61.82 -39.7 92.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 110.0 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 11.5 mmt180 -63.8 -41.37 97.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -74.34 -30.64 62.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.548 -0.72 . . . . 0.0 109.587 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.4 mt -72.89 -59.55 2.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.522 -0.737 . . . . 0.0 109.972 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.43 ' CG ' HG21 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -56.06 -28.57 58.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.38 -0.825 . . . . 0.0 110.096 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.82 -33.77 71.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.429 -0.794 . . . . 0.0 110.243 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.81 -22.41 15.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.398 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.2 p . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 0.0 110.354 -179.946 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.236 0.541 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.51 50.74 1.0 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' A' ' 25' ' ' LEU . . . -55.08 -27.76 46.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.404 HD21 ' CD2' ' A' ' 26' ' ' LEU . 3.9 pp -57.96 -33.6 69.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.503 -0.998 . . . . 0.0 109.866 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.49 -39.28 53.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.381 -0.824 . . . . 0.0 109.733 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.7 m -62.36 -54.46 40.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.406 -0.809 . . . . 0.0 109.785 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 16' ' ' ARG . . . -64.13 -32.33 73.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 0.0 109.783 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB2' ' CB ' ' A' ' 46' ' ' MET . . . -67.19 -32.68 73.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.206 -0.934 . . . . 0.0 109.494 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.87 -27.02 63.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 110.02 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 19.2 ptt180 -100.17 20.25 14.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.33 -0.856 . . . . 0.0 110.411 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 62.5 83.0 0.07 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -151.74 71.25 0.97 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 110.174 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.601 ' CG1' ' HB3' ' A' ' 52' ' ' GLN . 24.8 t -57.0 -43.01 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.236 -0.915 . . . . 0.0 109.889 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -56.89 -52.61 64.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.343 -0.848 . . . . 0.0 110.541 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -41.44 96.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.359 -0.838 . . . . 0.0 110.249 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.24 -38.28 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.45 -0.781 . . . . 0.0 110.024 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.8 mmm-85 -69.5 -24.56 63.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 110.148 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -79.31 -53.6 6.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.836 . . . . 0.0 110.464 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.4 ' CD1' ' HA3' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -59.58 -44.07 93.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.347 -0.846 . . . . 0.0 110.484 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.43 HD11 ' CG ' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -57.24 -53.33 59.35 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.18 -0.95 . . . . 0.0 110.245 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -75.35 -5.56 45.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.427 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.1 -39.05 19.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.139 -0.975 . . . . 0.0 110.431 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.98 -20.19 0.14 Allowed Glycine 0 N--CA 1.484 1.881 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.642 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.46 136.27 10.01 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.151 -1.205 . . . . 0.0 111.009 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.574 ' OD2' ' CB ' ' A' ' 34' ' ' ALA . 10.4 p-10 -78.19 150.59 77.61 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 110.203 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.73 4.45 6.91 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.852 1.448 . . . . 0.0 111.051 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -136.35 43.25 2.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.036 -1.04 . . . . 0.0 110.917 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.574 ' CB ' ' OD2' ' A' ' 31' ' ' ASP . . . -109.72 104.69 13.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.61 138.76 45.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.201 -0.937 . . . . 0.0 110.253 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -107.7 82.72 1.69 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.471 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 52.02 -171.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.313 -0.867 . . . . 0.0 110.862 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 39' ' ' GLY . 80.2 m-85 55.56 13.28 0.94 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.571 -0.705 . . . . 0.0 110.924 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' PHE . . . 38.54 35.31 0.31 Allowed Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -107.11 -164.68 1.0 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -1.041 . . . . 0.0 110.478 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.632 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.8 mmp_? -116.71 176.64 1.47 Allowed Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.632 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 43.1 Cg_endo -72.07 -19.78 26.02 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.31 1.163 . . . . 0.0 110.2 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' ' 46' ' ' MET . 25.4 mt -104.27 -27.44 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -74.47 -4.26 35.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.536 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.4 p -115.03 -17.95 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.084 -1.01 . . . . 0.0 110.748 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -64.34 164.82 10.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.966 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.67 -16.92 4.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.375 -0.828 . . . . 0.0 110.545 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . 0.441 ' CG ' ' HA ' ' A' ' 79' ' ' ALA . 45.3 tpp 58.93 24.66 12.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.294 -0.878 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.23 20.54 5.59 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 m -149.13 96.26 2.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 110.04 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.49 -26.76 13.86 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.274 -0.891 . . . . 0.0 110.296 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.601 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 6.0 mt-30 -53.28 -34.8 58.76 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.404 HG12 ' CB ' ' A' ' 14' ' ' ALA . 60.3 t -84.13 -38.47 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 110.223 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.404 ' CB ' ' CG2' ' A' ' 87' ' ' THR . . . -68.18 -33.18 73.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.415 -0.803 . . . . 0.0 110.553 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -76.6 -39.98 50.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.966 . . . . 0.0 110.659 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.5 tp -56.2 -63.03 1.32 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.284 -0.885 . . . . 0.0 110.732 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mt -59.78 -30.31 68.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.254 -0.904 . . . . 0.0 110.84 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.405 ' CD2' ' CG1' ' A' ' 90' ' ' VAL . 2.7 tp -60.13 -67.51 0.38 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.13 -0.981 . . . . 0.0 110.99 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pp -51.85 -25.28 7.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.247 -0.908 . . . . 0.0 110.7 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.43 ' CG ' HD11 ' A' ' 26' ' ' LEU . 12.7 m80 -80.88 -67.3 0.79 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.179 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.52 40.9 0.04 OUTLIER Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.67 -164.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.314 -1.109 . . . . 0.0 110.13 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.59 74.43 74.63 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.959 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.89 -32.61 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.901 1.474 . . . . 0.0 110.158 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -95.6 -30.18 13.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.388 -0.82 . . . . 0.0 110.012 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 171.08 2.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.438 -0.789 . . . . 0.0 110.139 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.46 -179.51 3.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.421 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 72' ' ' LEU . 21.8 t0 -78.69 131.44 67.71 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.396 -0.815 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.67 -23.16 11.39 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.544 1.286 . . . . 0.0 110.398 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.83 -29.41 62.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 0.0 110.59 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.427 ' O ' ' CB ' ' A' ' 103' ' ' ALA . 7.8 m -138.92 17.32 2.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.907 . . . . 0.0 110.665 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER 42.38 29.47 0.15 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.317 -0.864 . . . . 0.0 110.794 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.31 134.84 45.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 110.556 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.406 ' HG3' ' CG1' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -107.72 165.17 13.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 110.324 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.37 -24.68 22.5 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.698 1.367 . . . . 0.0 110.322 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.7 -29.14 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.353 -0.842 . . . . 0.0 110.007 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.447 ' CE1' ' HD3' ' A' ' 108' ' ' PRO . 33.4 m80 -68.65 -34.33 75.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.344 -0.848 . . . . 0.0 110.126 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.417 ' HB3' ' HE3' ' A' ' 48' ' ' MET . 43.4 m-20 -77.82 -56.5 4.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.409 -0.807 . . . . 0.0 110.239 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.441 ' HA ' ' CG ' ' A' ' 48' ' ' MET . . . -52.65 -26.6 14.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.093 -1.004 . . . . 0.0 109.888 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.436 ' O ' ' CD2' ' A' ' 117' ' ' HIS . . . -85.3 -21.31 29.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.435 -0.791 . . . . 0.0 109.566 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -76.44 -17.25 59.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.429 -0.794 . . . . 0.0 110.341 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.402 ' C ' ' CE1' ' A' ' 117' ' ' HIS . 30.6 mm-40 -100.84 -34.54 9.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.18 -0.95 . . . . 0.0 110.323 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.9 34.18 4.42 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.2 105.61 15.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -1.091 . . . . 0.0 110.123 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.6 -21.98 51.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.466 -0.772 . . . . 0.0 110.256 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.0 -48.71 64.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.361 -0.837 . . . . 0.0 110.565 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.404 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 97.8 m -65.3 -33.98 77.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.14 -0.975 . . . . 0.0 110.071 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 -48.53 80.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.226 -0.921 . . . . 0.0 109.857 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.6 t -60.06 -40.7 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 109.527 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.405 ' CG1' ' CD2' ' A' ' 58' ' ' LEU . 91.3 t -53.82 -53.79 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.446 -0.784 . . . . 0.0 110.234 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mp -52.74 -52.01 58.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.387 -0.821 . . . . 0.0 110.581 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -60.99 -24.69 66.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.254 -0.904 . . . . 0.0 110.177 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.42 -22.88 60.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.407 -0.808 . . . . 0.0 110.338 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -121.46 35.05 4.99 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.278 -0.889 . . . . 0.0 110.616 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.59 114.05 0.14 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -155.6 131.56 9.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -1.099 . . . . 0.0 110.034 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 141.47 38.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 109.951 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.59 11.09 4.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -0.816 . . . . 0.0 110.307 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -110.73 22.92 14.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 110.019 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.406 ' CG1' ' HG3' ' A' ' 74' ' ' ARG . 9.5 p -91.56 144.93 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.451 -0.78 . . . . 0.0 109.932 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 53.4 m -115.17 41.96 2.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 110.383 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 104' ' ' TRP . 32.0 t0 52.64 69.47 0.68 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.351 -0.843 . . . . 0.0 110.36 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 71' ' ' THR . . . 62.89 -77.93 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.519 -0.738 . . . . 0.0 110.254 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -155.5 45.92 0.48 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.356 -0.84 . . . . 0.0 109.801 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -129.42 -118.09 2.03 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -95.83 -178.36 4.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -1.102 . . . . 0.0 110.665 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.493 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 3.7 mp -105.14 173.65 3.16 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.498 -0.752 . . . . 0.0 109.942 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 41.6 Cg_endo -67.83 -20.12 46.02 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.551 1.29 . . . . 0.0 110.274 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.4 p -83.28 -23.56 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 110.189 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -62.32 -28.34 69.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.225 -0.922 . . . . 0.0 110.266 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 4.4 mm? -58.32 -68.55 0.24 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.308 -0.87 . . . . 0.0 109.941 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.54 98.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.871 . . . . 0.0 109.725 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -48.98 -31.99 8.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.513 -0.742 . . . . 0.0 109.51 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 115' ' ' GLN . 10.8 tt0 -66.97 -62.94 1.18 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.608 -0.683 . . . . 0.0 109.212 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER 172.46 113.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.541 -0.724 . . . . 0.0 110.221 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.43 -53.19 0.42 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.628 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.436 ' CD2' ' O ' ' A' ' 80' ' ' ALA . 1.2 m-70 -138.86 75.78 1.54 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.176 -1.19 . . . . 0.0 110.566 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -61.41 -22.78 65.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 0.0 109.979 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -72.87 -42.21 63.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.401 -0.812 . . . . 0.0 110.451 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 80' ' ' ALA . 0.6 OUTLIER -61.87 -30.75 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.917 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 125' ' ' HIS . . . -65.1 -52.61 54.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.421 -0.8 . . . . 0.0 109.644 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -45.81 -46.38 15.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.285 -0.884 . . . . 0.0 110.662 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -81.77 -56.74 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 111.057 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 125' ' ' HIS . 0.3 OUTLIER -59.51 -39.65 84.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.034 . . . . 0.0 111.158 -178.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.519 ' CD2' ' C ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -67.81 -39.76 83.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.747 -1.22 . . . . 0.0 109.461 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . 0.449 ' N ' ' CD2' ' A' ' 125' ' ' HIS . . . -54.23 -27.94 37.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.412 -0.805 . . . . 0.0 109.548 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -90.86 -16.8 27.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.595 -0.69 . . . . 0.0 110.411 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 124' ' ' LEU . 29.1 p . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.194 -0.941 . . . . 0.0 109.71 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.236 0.541 . . . . 3.36 109.873 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.34 18.24 12.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 3.58 110.236 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.96 -37.35 92.08 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.385 -1.486 . . . . 2.79 109.385 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.93 -27.25 66.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.384 -1.068 . . . . 2.88 110.154 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.47 -47.08 14.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.45 -0.781 . . . . 2.34 110.0 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.8 p -62.17 -51.2 68.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.373 -0.83 . . . . 2.55 109.837 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.53 -34.01 72.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.377 -0.827 . . . . 2.01 109.791 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.07 -36.18 66.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.536 -0.728 . . . . 1.66 109.91 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 46' ' ' MET . . . -60.75 -27.07 67.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.421 -0.799 . . . . 2.08 110.066 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -93.52 -17.51 23.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.372 -0.83 . . . . 5.69 110.321 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.17 54.04 1.31 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.518 -1.433 . . . . 1.44 109.518 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -124.92 79.42 1.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -1.118 . . . . 3.26 110.521 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.669 ' CG2' ' HB3' ' A' ' 52' ' ' GLN . 84.5 t -61.71 -38.84 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.222 -0.924 . . . . 1.8 109.66 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.78 -44.57 90.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.348 -0.845 . . . . 2.51 110.346 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 m -64.35 -42.68 96.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.869 . . . . 2.25 109.974 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.66 -25.77 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.429 -0.794 . . . . 2.02 110.198 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.418 ' HG2' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -64.26 -51.31 64.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.317 -0.864 . . . . 2.38 110.464 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.82 -21.06 60.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.275 -0.89 . . . . 5.21 110.599 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.26 -63.61 1.08 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.202 -0.936 . . . . 3.0 110.551 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 10.2 mt -56.83 -46.37 81.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.289 -0.882 . . . . 3.45 110.646 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.36 -35.24 75.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.38 -0.825 . . . . 3.3 110.375 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.08 -65.8 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.362 -0.836 . . . . 2.66 110.134 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.99 57.33 0.07 OUTLIER Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.563 -1.415 . . . . 3.23 109.563 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.01 133.93 52.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -1.114 . . . . 2.91 110.168 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -69.57 127.65 92.58 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 3.66 109.996 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.86 -17.32 25.61 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.592 1.312 . . . . 2.35 110.547 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -107.93 29.03 7.64 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -0.906 . . . . 2.17 110.227 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.22 106.2 13.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.363 -0.836 . . . . 2.69 110.153 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -65.3 164.92 12.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.384 -0.822 . . . . 3.46 110.386 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -107.69 -170.0 1.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 3.25 110.14 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -81.77 -18.58 43.66 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.397 -0.814 . . . . 4.9 110.341 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -91.46 18.46 7.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.311 -0.868 . . . . 3.9 110.43 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.07 37.4 45.62 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.836 -1.306 . . . . 2.3 109.836 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.05 162.94 17.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.37 -1.077 . . . . 3.25 110.325 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.601 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.2 mmp_? -77.08 170.76 14.77 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.503 -0.748 . . . . 2.55 109.516 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 41.1 Cg_endo -67.58 -13.1 37.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.478 1.252 . . . . 1.72 110.52 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.4 HG23 ' HE2' ' A' ' 46' ' ' MET . 74.2 mt -109.92 -17.86 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -0.918 . . . . 1.87 109.862 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.81 -4.97 49.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.218 -0.926 . . . . 2.69 110.282 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.2 p -120.36 -6.43 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.251 -0.906 . . . . 2.0 110.903 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -69.41 162.42 27.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.024 -1.047 . . . . 1.8 110.174 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -54.67 -19.62 6.53 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.344 -0.847 . . . . 2.26 110.865 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.96 19.68 10.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.29 -0.881 . . . . 1.43 110.156 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.418 ' HA2' ' CD2' ' A' ' 84' ' ' PHE . . . -124.81 24.39 6.07 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.369 -1.492 . . . . 1.25 109.369 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.9 t -154.59 106.84 2.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -1.083 . . . . 1.93 110.071 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.88 -25.68 63.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.419 -0.801 . . . . 1.66 110.348 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.669 ' HB3' ' CG2' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -58.08 -29.54 65.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.269 -0.895 . . . . 3.15 110.185 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.403 ' CG2' ' CG2' ' A' ' 19' ' ' VAL . 34.6 t -84.19 -47.93 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.396 -0.815 . . . . 1.81 110.504 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.15 83.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.31 -0.869 . . . . 1.64 110.661 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -74.93 -33.76 62.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 2.74 110.457 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.418 HD12 ' HG2' ' A' ' 23' ' ' ARG . 1.9 tt -57.22 -64.31 0.93 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.294 -0.879 . . . . 2.59 110.725 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 mt -61.41 -40.24 93.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.353 -0.842 . . . . 2.34 110.9 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.47 -57.46 12.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 2.73 110.745 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -53.49 -26.35 20.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.287 -0.883 . . . . 2.78 110.236 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.413 ' CE1' ' HB3' ' A' ' 26' ' ' LEU . 3.1 m170 -84.2 -73.9 0.4 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 2.98 110.054 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.16 50.11 0.05 OUTLIER Glycine 0 N--CA 1.483 1.831 0 N-CA-C 109.741 -1.343 . . . . 1.62 109.741 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.8 -162.11 0.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -1.109 . . . . 1.95 110.177 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.91 76.83 39.63 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 2.16 110.183 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.75 -24.44 8.69 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.775 1.408 . . . . 1.35 110.573 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -92.84 -50.01 5.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 3.1 110.4 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.07 120.85 6.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.244 -0.91 . . . . 1.88 110.449 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.36 -179.44 3.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.396 -0.815 . . . . 2.11 110.329 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -76.95 125.59 86.71 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 2.51 110.003 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.78 -13.0 24.41 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.495 1.26 . . . . 2.53 110.727 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.0 -30.86 44.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.958 . . . . 3.02 110.557 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 m -142.66 17.15 2.0 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 3.31 110.567 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.98 32.08 7.05 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.288 -0.883 . . . . 2.76 110.506 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.7 121.47 28.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.389 -0.819 . . . . 2.11 110.379 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.412 ' HB2' ' CG1' ' A' ' 100' ' ' VAL . 1.0 OUTLIER -93.1 172.65 5.78 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.775 . . . . 2.97 110.161 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.13 -9.38 24.4 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.719 1.379 . . . . 1.08 110.772 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.83 -23.94 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.178 -0.951 . . . . 1.2 110.141 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -72.03 -52.14 18.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.311 -0.868 . . . . 0.95 110.476 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -58.44 -47.48 83.83 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.282 -0.886 . . . . 1.76 110.418 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.62 -26.36 66.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -0.853 . . . . 1.0 110.211 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.7 -21.33 25.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.352 -0.843 . . . . 1.48 110.442 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 -72.6 -30.83 64.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.256 -0.903 . . . . 3.61 110.344 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.404 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 1.3 mm-40 -86.61 -36.11 19.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.872 . . . . 2.1 110.211 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.37 46.06 1.9 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.699 -1.361 . . . . 1.17 109.699 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.418 ' CD2' ' HA2' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -115.13 103.15 10.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.366 -1.079 . . . . 2.48 109.923 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mt -75.24 -22.62 57.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.847 . . . . 2.56 110.368 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.97 -43.31 95.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 1.68 110.114 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 63.7 m -73.24 -39.55 65.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.326 -0.859 . . . . 1.38 109.889 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.47 -46.51 76.83 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.393 -0.817 . . . . 1.75 109.952 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.18 -41.15 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.402 -0.811 . . . . 1.84 109.539 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.2 t -57.2 -47.9 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.596 -0.69 . . . . 1.67 110.276 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.11 -52.5 65.3 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.39 -0.819 . . . . 1.49 110.303 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -60.01 -27.2 66.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.514 -0.741 . . . . 1.94 110.323 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -67.8 -69.03 0.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 3.72 110.265 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.65 -28.19 45.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 1.91 110.669 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.17 87.86 1.21 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.564 -1.415 . . . . 1.92 109.564 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.33 134.43 37.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -1.118 . . . . 1.55 110.313 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -71.43 143.05 50.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.802 . . . . 4.14 110.103 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mp -123.37 -2.78 8.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 2.1 110.823 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -93.69 69.97 4.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.122 -0.986 . . . . 2.12 110.151 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.412 ' CG1' ' HB2' ' A' ' 74' ' ' ARG . 12.2 p -135.27 151.23 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.433 -0.792 . . . . 1.79 110.156 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' CYS . . . . . 0.401 ' O ' ' N ' ' A' ' 103' ' ' ALA . 12.3 m -116.22 159.17 22.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.243 -0.911 . . . . 2.38 109.404 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -68.55 74.54 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 2.65 109.755 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.43 ' HB3' ' CE3' ' A' ' 104' ' ' TRP . . . 61.16 -79.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.635 -0.666 . . . . 2.58 110.047 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.448 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.2 p90 -128.41 37.96 4.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 4.46 109.859 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -120.49 -141.25 6.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.99 -1.244 . . . . 2.7 109.99 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -101.74 -164.95 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.4 -1.059 . . . . 5.24 110.48 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -96.18 174.27 3.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.725 . . . . 2.54 110.035 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.8 Cg_endo -68.16 -22.39 40.85 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.697 1.367 . . . . 1.02 110.254 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.73 -27.31 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 1.77 110.042 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -80.26 -38.93 29.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.836 . . . . 2.42 110.095 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.48 -26.83 65.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.399 -0.813 . . . . 2.48 109.918 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.04 -54.26 6.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.51 -0.744 . . . . 1.82 109.971 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -53.09 -25.79 14.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.395 -0.816 . . . . 3.39 110.573 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -79.05 -54.98 5.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 3.16 110.235 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.38 -67.33 0.43 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.399 -0.813 . . . . 4.58 110.052 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 157.6 47.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.595 -1.402 . . . . 2.69 109.595 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' HIS . . . . . 0.404 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 70.1 m-70 -122.23 64.63 0.93 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.361 -1.082 . . . . 2.8 109.999 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -35.43 67.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.283 -0.886 . . . . 5.16 110.158 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -61.9 -48.5 80.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.379 -0.825 . . . . 2.51 110.218 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.62 -25.38 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.397 -0.815 . . . . 1.97 110.347 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.0 -45.41 67.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.395 -0.816 . . . . 2.14 110.119 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.5 mtp85 -59.56 -53.54 56.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.357 -0.839 . . . . 4.59 110.126 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -60.52 -35.91 77.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.343 -0.848 . . . . 2.42 110.058 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 34.3 mt -72.6 -41.06 66.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.453 -0.78 . . . . 1.9 110.172 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -59.73 -22.53 62.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.401 -0.812 . . . . 4.51 110.327 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -86.47 -30.86 21.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.878 . . . . 2.64 110.308 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -96.84 -21.04 17.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.278 -0.888 . . . . 1.93 110.633 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.4 p . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 2.39 110.458 -179.74 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 46.4 t -71.27 146.19 91.82 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.341 -1.094 . . . . 0.0 109.805 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.96 144.49 30.46 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.614 1.323 . . . . 0.0 110.652 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -176.79 174.09 46.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' ILE . . . . . 0.502 ' CG2' ' CD2' ' A' ' 0' ' ' HIS . 5.5 tp -173.42 153.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.118 -1.225 . . . . 0.0 111.175 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . 0.502 ' CD2' ' CG2' ' A' ' -1' ' ' ILE . 26.2 p80 40.52 108.21 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 122.099 0.952 . . . . 0.0 113.207 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.4 mmt 55.21 -163.19 0.14 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.489 -0.757 . . . . 0.0 111.673 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.5 tp -159.16 -55.23 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.698 -0.626 . . . . 0.0 110.309 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 152.27 167.0 14.72 Favored Glycine 0 N--CA 1.498 2.824 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.25 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.64 139.94 2.76 Favored Glycine 0 N--CA 1.498 2.798 0 O-C-N 121.291 -1.123 . . . . 0.0 110.434 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -120.69 -167.1 1.42 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.444 -1.033 . . . . 0.0 109.69 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.273 58.9 m -169.18 178.63 4.3 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 123.881 1.8 . . . . 0.0 114.733 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.743 ' O ' HD13 ' A' ' 25' ' ' LEU . 6.4 p-10 -115.09 49.23 1.07 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 171.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.501 ' HB2' ' HB1' ' A' ' 34' ' ' ALA . . . -115.47 5.45 14.49 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.239 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.82 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -41.22 -33.58 0.81 Allowed Glycine 0 N--CA 1.499 2.844 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.596 ' HA ' ' HA ' ' A' ' 22' ' ' VAL . 4.2 pp -53.66 -29.1 36.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.755 -0.85 . . . . 0.0 109.803 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.439 ' N ' HD12 ' A' ' 10' ' ' LEU . . . -88.06 -60.23 2.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.366 -0.834 . . . . 0.0 109.995 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.1 p -53.46 -47.67 69.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.444 -0.785 . . . . 0.0 110.525 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.506 ' CB ' ' HB ' ' A' ' 21' ' ' THR . . . -67.73 -38.69 83.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 109.778 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 46' ' ' MET . . . -56.54 -52.88 63.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.413 -0.805 . . . . 0.0 109.706 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.46 -30.4 40.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.891 . . . . 0.0 109.078 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -90.51 8.88 31.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.64 -0.662 . . . . 0.0 110.084 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.0 58.64 7.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -131.92 81.07 1.95 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -1.133 . . . . 0.0 111.008 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.597 ' CG2' ' HB3' ' A' ' 52' ' ' GLN . 61.1 t -68.67 -29.39 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.065 -1.022 . . . . 0.0 109.217 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -61.8 -42.97 99.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.312 -0.868 . . . . 0.0 109.423 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.506 ' HB ' ' CB ' ' A' ' 13' ' ' ALA . 1.8 m -69.08 -41.25 77.76 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.596 ' HA ' ' HA ' ' A' ' 10' ' ' LEU . 21.6 t -61.61 -34.32 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.496 ' HG2' HD12 ' A' ' 56' ' ' LEU . 1.6 mmt180 -70.24 -33.73 71.99 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.41 -53.42 8.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.67 -0.643 . . . . 0.0 111.092 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.82 ' HG ' ' N ' ' A' ' 9' ' ' GLY . 2.9 tm? -55.91 -25.36 42.64 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.008 -1.058 . . . . 0.0 109.145 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.34 -68.82 0.78 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.053 -1.03 . . . . 0.0 111.713 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -50.54 -17.9 0.58 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.29 -0.881 . . . . 0.0 111.535 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.4 2.98 10.0 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.983 -1.073 . . . . 0.0 110.951 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.35 72.93 1.26 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -132.69 -166.49 1.75 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.412 -1.051 . . . . 0.0 111.42 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.13 140.76 21.55 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.675 -0.64 . . . . 0.0 109.609 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.43 5.36 3.75 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.48 1.253 . . . . 0.0 111.277 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -134.18 42.62 2.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.859 -1.15 . . . . 0.0 111.254 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 8' ' ' ALA . . . -69.36 79.3 0.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.96 -1.087 . . . . 0.0 109.186 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mt -49.5 158.58 0.41 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.532 -0.73 . . . . 0.0 111.397 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -121.26 159.14 26.59 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -22.79 13.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.153 -0.967 . . . . 0.0 110.566 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -77.3 -9.78 59.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 110.356 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.72 28.79 31.49 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 44' ' ' GLN . 13.4 mtm180 -101.77 37.96 1.72 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -1.079 . . . . 0.0 110.084 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.89 177.27 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.312 -0.867 . . . . 0.0 110.674 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -81.53 -24.78 4.12 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.608 1.32 . . . . 0.0 110.816 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.0 mt -102.39 -40.9 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.158 -0.963 . . . . 0.0 110.884 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.43 ' CB ' ' O ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -52.19 -20.68 2.74 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.029 -1.045 . . . . 0.0 110.777 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 p -113.92 44.5 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.932 . . . . 0.0 110.85 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.45 ' HA ' ' HB2' ' A' ' 14' ' ' ALA . 16.6 ptt? -111.8 26.58 10.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.032 -1.042 . . . . 0.0 110.163 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.41 ' CB ' ' O ' ' A' ' 46' ' ' MET . 3.5 tmm? 67.86 -2.39 1.43 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.583 -0.698 . . . . 0.0 111.086 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.424 ' O ' ' CZ ' ' A' ' 84' ' ' PHE . 14.3 mmt 42.35 31.23 0.25 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.211 -0.931 . . . . 0.0 110.988 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -125.01 -3.36 7.55 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.7 p -133.35 99.69 4.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.993 -1.298 . . . . 0.0 110.695 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.0 67.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.302 -0.874 . . . . 0.0 109.824 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.597 ' HB3' ' CG2' ' A' ' 19' ' ' VAL . 8.3 tp60 -52.01 -27.78 14.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.428 -0.795 . . . . 0.0 110.043 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.406 ' CG2' ' CG2' ' A' ' 19' ' ' VAL . 19.3 t -87.68 -36.46 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.828 . . . . 0.0 109.489 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.8 -40.16 91.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.428 -0.795 . . . . 0.0 110.424 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.17 -39.95 53.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.0 110.614 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.496 HD12 ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -49.43 -64.59 0.76 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.335 -0.853 . . . . 0.0 111.54 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.434 HD23 HD22 ' A' ' 10' ' ' LEU . 3.2 mt -67.25 -38.12 84.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.106 -0.996 . . . . 0.0 111.152 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.44 ' CD2' ' CG1' ' A' ' 90' ' ' VAL . 1.1 tp -52.79 -66.74 0.33 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.019 -1.051 . . . . 0.0 110.532 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 56' ' ' LEU . 4.0 pp -52.23 -27.57 15.3 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.283 -0.886 . . . . 0.0 110.004 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.41 ' N ' HD11 ' A' ' 59' ' ' LEU . 3.3 m80 -77.24 -68.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.368 -0.833 . . . . 0.0 110.073 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.25 38.34 0.03 OUTLIER Glycine 0 N--CA 1.484 1.842 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.16 -166.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.204 -1.174 . . . . 0.0 110.422 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -121.74 75.26 36.34 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 110.057 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -77.89 -21.35 11.07 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.831 1.437 . . . . 0.0 110.54 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -95.53 -47.69 6.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 110.457 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.58 172.96 0.44 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.276 -0.89 . . . . 0.0 110.22 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.27 -176.67 2.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.492 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.41 123.21 86.87 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.425 -0.797 . . . . 0.0 109.95 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.31 -13.98 20.61 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.681 1.358 . . . . 0.0 110.97 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.49 -20.95 56.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.197 -0.939 . . . . 0.0 110.85 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.432 ' O ' ' CB ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -155.03 27.15 0.42 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.082 -1.011 . . . . 0.0 110.877 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.527 ' HB2' ' H ' ' A' ' 103' ' ' ALA . 86.1 mt 43.14 45.11 4.62 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.277 -0.89 . . . . 0.0 111.417 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.39 103.48 15.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.223 -0.923 . . . . 0.0 110.56 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.473 ' CG ' ' HD2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -85.54 179.38 1.89 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.849 . . . . 0.0 110.106 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 74' ' ' ARG . 48.8 Cg_endo -78.68 -18.29 12.01 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.544 1.286 . . . . 0.0 110.603 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 75.8 t -67.94 -36.31 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 110.107 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.457 ' CD2' ' HB2' ' A' ' 102' ' ' ASP . 74.7 m80 -68.4 -39.62 81.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.29 -0.881 . . . . 0.0 110.4 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.408 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 0.7 OUTLIER -57.67 -55.41 35.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.352 -0.843 . . . . 0.0 110.062 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.91 -18.47 63.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.082 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.415 ' HA ' ' CD1' ' A' ' 120' ' ' ILE . . . -82.27 -44.15 16.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.389 -0.819 . . . . 0.0 110.571 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.437 ' HG3' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -64.59 -20.57 66.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.186 -0.946 . . . . 0.0 110.126 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.437 ' N ' ' HG3' ' A' ' 81' ' ' ARG . 2.2 mm-40 -97.02 -48.04 5.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.017 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.49 14.43 10.57 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.424 ' CZ ' ' O ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -78.66 80.05 5.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.124 -1.221 . . . . 0.0 109.804 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.07 -23.66 63.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.448 -0.783 . . . . 0.0 110.431 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -61.54 -52.54 64.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.221 -0.924 . . . . 0.0 110.088 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.407 ' CG2' ' HE1' ' A' ' 46' ' ' MET . 37.6 m -58.59 -34.97 71.68 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.257 -0.902 . . . . 0.0 109.933 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.5 mp -57.4 -46.82 83.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 71.4 t -57.35 -46.94 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.451 -0.781 . . . . 0.0 109.288 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.44 ' CG1' ' CD2' ' A' ' 58' ' ' LEU . 49.4 t -50.77 -55.4 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.526 -0.734 . . . . 0.0 110.358 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.62 -63.11 1.23 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.233 -0.917 . . . . 0.0 110.161 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -61.28 -21.72 64.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 0.0 110.133 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 48.4 ttt180 -77.91 -8.94 58.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.304 -0.873 . . . . 0.0 110.378 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -135.2 33.93 3.07 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.291 -0.881 . . . . 0.0 110.43 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.51 90.49 0.08 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -120.75 154.98 34.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -1.065 . . . . 0.0 110.316 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.56 75.15 7.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 110.209 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 mt -83.81 68.63 10.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -170.06 44.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.393 -0.817 . . . . 0.0 109.725 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.461 ' CG1' ' HB2' ' A' ' 74' ' ' ARG . 7.8 p -124.5 171.21 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -121.81 136.71 54.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 109.281 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.457 ' HB2' ' CD2' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -69.37 73.91 0.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.845 . . . . 0.0 109.361 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.527 ' H ' ' HB2' ' A' ' 72' ' ' LEU . . . 66.83 -69.07 0.13 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.344 0.592 . . . . 0.0 109.774 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.421 ' N ' ' O ' ' A' ' 102' ' ' ASP . 1.8 m-90 -140.88 35.5 1.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.482 -0.761 . . . . 0.0 109.379 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 107' ' ' LEU . . . -107.38 24.54 24.11 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.388 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 101' ' ' CYS . 21.8 mtm180 59.52 -73.16 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.408 -1.054 . . . . 0.0 110.78 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 105' ' ' GLY . 0.7 OUTLIER -155.84 167.99 13.15 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 110.022 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.457 ' HA ' ' CD2' ' A' ' 77' ' ' HIS . 46.3 Cg_endo -70.82 -31.49 15.72 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.648 1.341 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.64 -38.99 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.885 . . . . 0.0 110.042 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -66.09 -50.76 62.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.357 -0.839 . . . . 0.0 110.065 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.54 -29.12 58.36 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.376 -0.828 . . . . 0.0 110.288 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.71 -75.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.421 -0.799 . . . . 0.0 110.216 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -52.73 -27.2 16.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.284 -0.885 . . . . 0.0 110.779 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -58.71 -50.48 73.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.321 -0.862 . . . . 0.0 110.685 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -78.02 -76.65 0.18 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.347 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -167.72 34.81 0.21 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -122.77 79.37 1.63 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.333 -1.098 . . . . 0.0 109.925 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.9 mtp85 -81.22 -40.05 24.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.61 -43.44 80.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.315 -0.865 . . . . 0.0 110.273 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.476 HG21 HD11 ' A' ' 120' ' ' ILE . 17.0 tt -76.64 -38.42 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.982 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -58.64 -44.78 90.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.559 -0.713 . . . . 0.0 110.006 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -61.99 -45.2 94.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.352 -0.842 . . . . 0.0 110.012 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -64.53 -37.12 86.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.956 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 12.1 mt -61.34 -58.94 6.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.858 . . . . 0.0 110.196 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.22 -24.27 10.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.347 -0.846 . . . . 0.0 110.489 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.2 -11.18 44.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.476 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.73 12.08 6.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.967 . . . . 0.0 110.681 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 11.9 t -118.61 -23.64 7.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.143 -0.973 . . . . 0.0 110.324 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.19 114.87 0.29 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.9 t0 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.363 -1.08 . . . . 0.0 110.508 -179.826 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 1.1 t 62.24 152.49 0.11 Allowed Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.368 -1.077 . . . . 0.0 110.218 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.98 160.21 46.33 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.675 1.355 . . . . 0.0 110.54 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -78.19 102.33 1.81 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' ILE . . . . . 0.414 HD12 HG23 ' A' ' -1' ' ' ILE . 0.3 OUTLIER -80.59 -19.36 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -1.104 . . . . 0.0 110.359 -179.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . 0.411 ' O ' ' O ' ' A' ' 1' ' ' MET . 79.5 t60 54.91 97.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.182 -0.949 . . . . 0.0 110.593 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' O ' ' A' ' 0' ' ' HIS . 10.5 tmm? 58.25 119.3 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.539 -0.725 . . . . 0.0 110.937 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp -75.71 164.83 25.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.922 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.44 -26.84 64.87 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 122.1 -143.13 15.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.8 p -105.81 41.3 1.41 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.376 -1.073 . . . . 0.0 110.307 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.8 m -62.41 -84.52 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 109.941 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 54.89 14.69 0.95 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.172 -0.955 . . . . 0.0 110.894 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -124.59 -21.88 4.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.925 -1.11 . . . . 0.0 110.603 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.92 -29.21 50.54 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.1 tp -56.78 -53.72 54.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.367 -1.078 . . . . 0.0 110.545 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.69 -52.19 53.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.338 -0.851 . . . . 0.0 110.47 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 p -59.15 -46.67 87.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.351 -0.843 . . . . 0.0 110.452 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -36.65 76.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 109.926 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.92 -31.71 63.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.903 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.72 -28.69 62.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.392 -0.817 . . . . 0.0 110.017 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -90.44 11.16 22.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.35 -0.844 . . . . 0.0 110.323 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.11 58.5 13.27 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 88.0 mm-40 -126.66 81.88 2.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 110.379 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.614 ' CG1' ' HB3' ' A' ' 52' ' ' GLN . 53.8 t -60.43 -50.65 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.142 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -51.66 -51.66 54.05 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.283 -0.885 . . . . 0.0 110.55 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.0 m -61.82 -42.7 99.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.244 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 97.7 t -67.6 -38.22 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.355 -0.841 . . . . 0.0 110.207 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.408 ' HG3' HD11 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -69.65 -31.23 69.19 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.309 -0.869 . . . . 0.0 110.217 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -80.48 -51.13 9.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 110.695 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.35 -60.92 3.05 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.254 -0.903 . . . . 0.0 110.483 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 tt -53.28 -43.68 67.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.215 -0.928 . . . . 0.0 110.588 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -78.1 1.51 20.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.533 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -105.84 -29.33 10.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 110.3 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.75 -26.87 0.1 Allowed Glycine 0 N--CA 1.484 1.858 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.456 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -48.56 135.25 14.68 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.199 -1.177 . . . . 0.0 110.9 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -87.96 141.43 31.44 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.0 110.164 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.72 -28.35 11.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.663 1.349 . . . . 0.0 110.544 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -92.48 18.83 7.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 110.433 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.33 142.41 31.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -0.922 . . . . 0.0 110.205 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 14.8 mt -99.47 153.84 18.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.364 -0.835 . . . . 0.0 110.196 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -102.08 30.9 4.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.331 -0.855 . . . . 0.0 110.206 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 54.77 24.67 5.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.363 -0.835 . . . . 0.0 110.496 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.09 2.7 9.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.315 -0.866 . . . . 0.0 110.587 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 54.04 27.31 37.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.445 ' O ' ' CB ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -120.17 18.1 12.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.334 -1.098 . . . . 0.0 110.38 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.443 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 21.1 mmt-85 53.73 175.63 0.03 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.168 -0.958 . . . . 0.0 110.314 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 51.3 Cg_endo -85.17 -0.05 8.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.54 1.284 . . . . 0.0 111.154 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 50.7 mm -114.29 -41.39 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.987 -1.071 . . . . 0.0 110.628 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.445 ' CB ' ' O ' ' A' ' 40' ' ' ARG . 2.9 tt0 -57.58 -41.49 81.24 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.157 -0.965 . . . . 0.0 109.927 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.5 p -75.74 -11.86 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 0.0 110.288 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 2.3 ttm -51.34 150.07 3.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.337 -0.852 . . . . 0.0 110.431 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -62.42 -15.76 51.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 110.265 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.44 26.27 8.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.216 -0.927 . . . . 0.0 110.192 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.14 19.37 5.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.487 ' N ' ' CZ ' ' A' ' 84' ' ' PHE . 19.8 t -157.84 101.83 1.81 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -1.024 . . . . 0.0 110.243 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -57.82 -26.93 62.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.614 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 1.1 mp0 -54.82 -34.06 62.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.399 -0.813 . . . . 0.0 110.556 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 89.1 t -76.26 -62.76 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -0.865 . . . . 0.0 110.322 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.407 ' CB ' ' CG2' ' A' ' 87' ' ' THR . . . -47.71 -27.6 2.05 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.393 -0.817 . . . . 0.0 110.894 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -70.9 -56.05 7.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.406 -0.809 . . . . 0.0 110.452 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.408 HD11 ' HG3' ' A' ' 23' ' ' ARG . 15.4 tp -52.36 -56.28 15.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.331 -0.856 . . . . 0.0 110.681 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 42' ' ' PRO . 3.2 mp -52.13 -53.92 36.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.326 -0.859 . . . . 0.0 110.731 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -28.19 69.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.31 -0.869 . . . . 0.0 110.375 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.0 tp -69.83 -38.18 76.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 110.222 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -83.97 -20.35 33.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.398 -0.814 . . . . 0.0 110.297 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.54 53.54 0.72 Allowed Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.09 -147.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.269 -1.136 . . . . 0.0 109.803 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -125.81 70.69 66.61 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.09 -1.006 . . . . 0.0 110.365 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -82.36 -28.36 1.9 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.799 1.421 . . . . 0.0 110.042 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -79.65 -34.98 39.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.41 -0.806 . . . . 0.0 110.255 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 129.49 41.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 110.298 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -118.06 162.69 17.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -0.862 . . . . 0.0 110.24 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -69.34 124.21 89.98 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.0 109.903 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.89 -23.41 16.4 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.592 1.311 . . . . 0.0 110.556 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.35 -33.21 75.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 0.0 110.512 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.63 24.7 1.22 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.26 49.87 9.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.373 -0.829 . . . . 0.0 110.863 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.48 131.8 45.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 0.0 110.36 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.431 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 9.8 mtp180 -101.54 165.89 13.25 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.479 -0.763 . . . . 0.0 110.166 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 43.1 Cg_endo -69.11 -11.7 32.33 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.66 1.347 . . . . 0.0 110.803 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.4 t -67.09 -28.29 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.903 . . . . 0.0 109.948 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.429 ' CE1' ' HD3' ' A' ' 108' ' ' PRO . 72.1 m80 -67.75 -53.23 28.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 110.252 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.439 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 4.3 m-20 -51.84 -57.09 10.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.53 -0.731 . . . . 0.0 110.858 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.39 -16.05 59.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.314 -0.866 . . . . 0.0 110.693 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.53 -37.08 13.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.162 -0.961 . . . . 0.0 110.53 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.439 ' HG2' ' HA ' ' A' ' 78' ' ' ASP . 14.9 ptt180 -70.76 -18.67 62.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.327 -0.858 . . . . 0.0 110.826 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.95 11.17 38.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.707 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.471 ' N ' ' CE1' ' A' ' 117' ' ' HIS . . . 56.89 42.15 92.1 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.487 ' CZ ' ' N ' ' A' ' 50' ' ' SER . 0.7 OUTLIER -110.81 98.39 7.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.485 -1.009 . . . . 0.0 110.147 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.15 -34.05 24.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 0.0 110.35 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 14.5 p30 -51.07 -44.43 61.16 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.244 -0.91 . . . . 0.0 110.599 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.429 ' N ' ' OD1' ' A' ' 86' ' ' ASP . 45.1 m -76.21 -31.77 58.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 109.456 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 8.2 tp -60.48 -37.59 81.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.466 -0.771 . . . . 0.0 109.429 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.3 t -68.22 -44.04 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.507 -0.746 . . . . 0.0 109.325 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.77 -41.64 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.46 -0.775 . . . . 0.0 110.172 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 mt -60.03 -52.03 67.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.438 -0.789 . . . . 0.0 109.984 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -72.09 -29.4 64.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 0.0 109.762 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -68.01 -57.76 5.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.439 -0.788 . . . . 0.0 109.89 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -70.49 -61.85 1.61 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.412 -0.805 . . . . 0.0 110.365 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 170.86 105.92 0.19 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -168.04 133.42 1.86 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.275 -1.132 . . . . 0.0 110.245 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.483 ' CZ ' ' HB ' ' A' ' 100' ' ' VAL . 3.7 ttp180 -65.75 163.43 16.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 0.0 110.263 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 tp -148.4 48.59 1.03 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.452 -0.78 . . . . 0.0 109.931 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -159.31 50.13 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.391 -0.818 . . . . 0.0 110.054 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.483 ' HB ' ' CZ ' ' A' ' 97' ' ' ARG . 13.2 p -122.7 168.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.512 -0.742 . . . . 0.0 110.178 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -132.87 166.85 21.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 109.256 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 104' ' ' TRP . 4.9 t0 -70.22 71.94 0.44 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.889 . . . . 0.0 109.824 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.447 ' HB1' ' CE3' ' A' ' 104' ' ' TRP . . . 60.84 -79.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.642 -0.661 . . . . 0.0 110.051 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.447 ' CE3' ' HB1' ' A' ' 103' ' ' ALA . 9.3 p90 -133.64 26.81 4.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 109.478 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.65 -139.38 7.81 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.636 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -168.95 2.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.532 -0.981 . . . . 0.0 111.046 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 0.3 OUTLIER -119.17 176.41 1.73 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.653 -0.655 . . . . 0.0 109.864 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 46.0 Cg_endo -71.29 -27.31 19.76 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.542 1.285 . . . . 0.0 110.263 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 12.5 p -78.05 -37.81 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 110.337 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -66.45 -42.58 87.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -0.831 . . . . 0.0 110.237 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.76 -36.15 76.06 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.332 -0.855 . . . . 0.0 110.164 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.406 ' CB ' ' CG2' ' A' ' 120' ' ' ILE . . . -61.32 -59.9 4.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.381 -0.825 . . . . 0.0 110.028 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -52.29 -27.18 14.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.465 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.13 -42.96 96.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.352 -0.843 . . . . 0.0 110.175 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.425 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -80.98 -32.4 34.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.867 . . . . 0.0 110.262 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.22 29.16 2.01 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.471 ' CE1' ' N ' ' A' ' 83' ' ' GLY . 29.9 m170 -90.85 72.62 6.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -1.091 . . . . 0.0 109.984 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -58.75 -28.25 65.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.387 -0.82 . . . . 0.0 110.386 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -74.88 -41.01 60.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.311 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.406 ' CG2' ' CB ' ' A' ' 112' ' ' ALA . 1.9 tt -79.18 -34.02 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.962 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.0 -29.06 69.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.84 . . . . 0.0 109.842 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -73.26 -53.08 11.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -62.07 -30.13 70.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 110.106 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 36.4 mt -71.15 -71.65 0.25 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.442 -0.786 . . . . 0.0 110.556 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -53.1 -28.49 25.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.268 -0.895 . . . . 0.0 110.235 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.92 -36.15 83.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.293 -0.879 . . . . 0.0 109.68 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.24 23.81 10.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 110.084 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 89.4 m -131.64 -43.68 1.0 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 110.327 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -108.57 6.31 33.53 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.1 -1.235 . . . . 0.0 110.596 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 47.5 t 51.93 71.52 1.46 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.375 -1.074 . . . . 0.0 110.428 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.94 172.04 15.42 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.744 1.392 . . . . 0.0 110.447 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . 84.24 -0.19 89.4 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' ILE . . . . . . . . . . . . . 10.7 tp -66.84 160.64 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.138 -1.213 . . . . 0.0 110.215 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -103.65 -19.8 14.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.325 -0.859 . . . . 0.0 110.909 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -149.82 0.27 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.825 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.2 mt -78.08 -155.9 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.227 -0.92 . . . . 0.0 110.426 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.63 -100.05 0.56 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.66 162.19 1.66 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.7 p -166.61 -68.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.082 -1.246 . . . . 0.0 111.255 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -61.57 -80.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.425 -0.797 . . . . 0.0 111.183 -178.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.9 t0 54.38 -81.28 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.202 -0.936 . . . . 0.0 109.999 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 6' ' ' SER . . . -87.28 29.1 0.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 110.386 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.2 -34.24 53.08 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.441 ' CD1' HD21 ' A' ' 57' ' ' LEU . 4.0 pp -53.47 -28.39 30.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.623 -0.928 . . . . 0.0 110.049 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.411 ' N ' ' CD1' ' A' ' 10' ' ' LEU . . . -81.45 -43.81 18.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.445 -0.784 . . . . 0.0 110.209 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.1 p -59.11 -57.73 11.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.332 -0.855 . . . . 0.0 109.899 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.5 -34.78 69.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.3 -0.875 . . . . 0.0 109.787 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.404 ' CB ' HG13 ' A' ' 53' ' ' VAL . . . -64.05 -41.69 97.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.557 -0.714 . . . . 0.0 109.742 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.92 -30.65 67.99 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.347 -0.845 . . . . 0.0 110.063 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -84.82 5.51 28.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.382 -0.824 . . . . 0.0 110.536 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.29 42.4 83.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -112.39 74.85 0.88 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.469 -1.019 . . . . 0.0 110.432 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.576 ' CG1' ' HB3' ' A' ' 52' ' ' GLN . 42.4 t -57.7 -38.41 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.286 -0.884 . . . . 0.0 109.568 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -57.52 -49.08 77.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.811 . . . . 0.0 110.193 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 m -67.18 -39.26 86.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.383 -0.823 . . . . 0.0 110.004 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.2 t -69.83 -29.85 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.434 -0.791 . . . . 0.0 109.757 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 mmt180 -68.38 -32.67 72.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.479 -0.763 . . . . 0.0 110.145 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -79.31 -52.73 7.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 0.0 110.579 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.0 -54.6 27.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.283 -0.886 . . . . 0.0 110.599 -179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.446 HD11 ' CE1' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -55.43 -61.63 2.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.232 -0.918 . . . . 0.0 110.432 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.22 -23.9 64.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -72.56 -61.79 1.68 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.238 -0.913 . . . . 0.0 110.297 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 176.48 50.03 0.06 OUTLIER Glycine 0 N--CA 1.48 1.632 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.58 135.38 43.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.287 -1.125 . . . . 0.0 110.241 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -65.0 140.03 97.98 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.801 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.17 -3.35 13.78 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.665 1.35 . . . . 0.0 111.049 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -130.84 17.39 5.17 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.008 -1.058 . . . . 0.0 111.108 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.32 93.46 0.14 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.06 -1.025 . . . . 0.0 109.6 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mt -51.9 172.36 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.322 -0.861 . . . . 0.0 110.867 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -103.02 -163.0 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.471 -0.768 . . . . 0.0 110.075 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -96.07 -20.48 18.63 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 110.418 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.72 33.3 1.67 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 109.781 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.41 26.01 21.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -102.56 163.02 12.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.437 -1.037 . . . . 0.0 110.194 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.461 ' CB ' ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -81.0 179.4 1.93 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.442 -0.786 . . . . 0.0 110.042 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 41' ' ' ARG . 42.4 Cg_endo -69.87 -25.63 27.87 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.593 1.312 . . . . 0.0 110.933 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.482 ' O ' ' CG ' ' A' ' 46' ' ' MET . 10.6 mt -102.34 -34.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.148 -0.97 . . . . 0.0 109.847 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -54.74 -17.72 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 110.783 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.7 p -115.27 26.37 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.095 -1.003 . . . . 0.0 110.575 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.482 ' CG ' ' O ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -95.73 32.07 1.92 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.187 -0.945 . . . . 0.0 110.2 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.416 ' CB ' ' O ' ' A' ' 46' ' ' MET . 3.4 tmm? 68.41 -7.4 0.69 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.469 -0.769 . . . . 0.0 111.102 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.438 ' CE ' ' HB3' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 46.9 27.28 0.69 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.003 -1.06 . . . . 0.0 110.716 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.461 ' HA2' ' CD2' ' A' ' 84' ' ' PHE . . . -130.67 13.45 5.6 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 p -143.78 90.34 2.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -1.145 . . . . 0.0 110.257 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.46 -26.31 12.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.918 . . . . 0.0 110.19 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.576 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 0.6 OUTLIER -55.13 -34.24 63.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.397 -0.815 . . . . 0.0 110.247 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.404 HG13 ' CB ' ' A' ' 14' ' ' ALA . 26.8 t -83.41 -33.06 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.466 -0.771 . . . . 0.0 110.465 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.527 ' CB ' ' CG2' ' A' ' 87' ' ' THR . . . -63.08 -52.34 63.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.194 -0.941 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -66.55 -34.03 77.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.429 -0.794 . . . . 0.0 110.564 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.6 tt -53.3 -63.58 1.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.288 -0.883 . . . . 0.0 110.736 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.445 ' HB3' ' HB1' ' A' ' 62' ' ' ALA . 1.8 mt -70.4 -33.76 71.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.373 -0.83 . . . . 0.0 110.654 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.414 HD23 ' CG1' ' A' ' 90' ' ' VAL . 0.6 OUTLIER -58.14 -61.51 2.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.921 . . . . 0.0 110.409 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 pp -60.06 -25.1 65.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 110.448 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.446 ' CE1' HD11 ' A' ' 26' ' ' LEU . 2.9 m-70 -78.61 -63.55 1.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.848 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.85 38.16 0.04 OUTLIER Glycine 0 N--CA 1.484 1.844 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.445 ' HB1' ' HB3' ' A' ' 57' ' ' LEU . . . -71.02 -175.67 1.2 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.053 -1.263 . . . . 0.0 110.242 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -119.12 76.8 15.93 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.492 -0.755 . . . . 0.0 110.002 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.419 ' HB2' ' CB ' ' A' ' 96' ' ' ALA . 47.5 Cg_endo -76.56 -5.72 16.34 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.86 1.453 . . . . 0.0 110.632 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.93 -51.95 2.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.316 -0.865 . . . . 0.0 110.049 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.24 134.73 39.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.366 -0.834 . . . . 0.0 110.445 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -119.51 -174.79 2.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.358 -0.839 . . . . 0.0 110.394 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -86.59 127.52 60.26 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.719 . . . . 0.0 109.994 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.31 -29.49 11.3 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.518 1.273 . . . . 0.0 110.57 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.62 80.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 0.0 110.411 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.535 ' O ' ' C ' ' A' ' 72' ' ' LEU . 0.8 OUTLIER -143.76 38.88 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.255 -0.903 . . . . 0.0 110.557 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.535 ' C ' ' O ' ' A' ' 71' ' ' THR . 1.6 mt 25.45 61.83 0.06 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.765 -0.584 . . . . 0.0 111.561 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.08 119.81 39.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.9 . . . . 0.0 110.468 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.426 ' HB2' HG12 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -93.39 173.33 4.94 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.479 -0.763 . . . . 0.0 110.345 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.87 -22.26 23.65 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.835 1.439 . . . . 0.0 110.33 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 52.0 t -59.45 -39.0 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.322 -0.861 . . . . 0.0 109.981 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.451 ' CE1' ' HD3' ' A' ' 108' ' ' PRO . 73.5 m80 -64.1 -45.19 89.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 110.09 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.438 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -52.82 -65.7 0.51 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.447 -0.783 . . . . 0.0 110.429 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.68 -26.77 24.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.33 -0.856 . . . . 0.0 110.132 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -78.28 -43.05 29.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 0.0 109.754 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -61.32 -21.75 64.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 110.223 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.41 -32.47 12.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 0.0 109.735 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.82 24.9 24.18 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.461 ' CD2' ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -88.95 93.81 9.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -1.161 . . . . 0.0 109.993 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.43 ' CD2' ' HA ' ' A' ' 120' ' ' ILE . 0.1 OUTLIER -61.97 -34.71 76.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.526 -0.733 . . . . 0.0 110.798 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -58.67 -35.65 72.91 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.247 -0.908 . . . . 0.0 110.97 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.527 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -75.15 -41.03 59.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.007 -1.058 . . . . 0.0 110.228 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.4 tp -55.3 -40.79 71.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.349 -0.845 . . . . 0.0 109.873 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.39 -45.72 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 109.373 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.414 ' CG1' HD23 ' A' ' 58' ' ' LEU . 88.1 t -53.72 -45.86 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.551 -0.718 . . . . 0.0 110.227 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 mp -64.78 -20.93 66.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.399 -0.813 . . . . 0.0 110.676 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -78.13 -62.78 1.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.196 -0.94 . . . . 0.0 110.715 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -54.1 -33.06 56.73 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.469 -0.769 . . . . 0.0 110.553 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.407 ' HB1' ' CD2' ' A' ' 58' ' ' LEU . . . -68.69 -34.89 76.44 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.284 -0.885 . . . . 0.0 110.216 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 111.15 45.79 0.85 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.419 ' CB ' ' HB2' ' A' ' 64' ' ' PRO . . . -97.9 138.62 34.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.403 -1.057 . . . . 0.0 110.321 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -73.0 151.84 41.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.405 -0.81 . . . . 0.0 110.225 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.552 ' HB3' ' HB ' ' A' ' 128' ' ' THR . 0.7 OUTLIER -127.35 -8.15 5.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.395 -0.816 . . . . 0.0 110.843 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -92.73 39.94 1.04 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.207 -0.933 . . . . 0.0 110.807 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 74' ' ' ARG . 14.6 p -100.65 148.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -0.889 . . . . 0.0 110.039 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m -99.17 154.2 18.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.293 -0.879 . . . . 0.0 110.231 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 104' ' ' TRP . 27.1 p-10 -81.86 57.01 3.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 71' ' ' THR . . . 64.95 -67.9 0.11 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.598 -0.688 . . . . 0.0 110.586 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.44 ' N ' ' O ' ' A' ' 102' ' ' ASP . 1.7 m95 -59.37 -61.14 2.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 167.01 -28.89 0.18 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -56.5 124.05 16.88 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.252 -1.146 . . . . 0.0 110.43 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 82.3 mt -80.06 167.02 36.6 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.38 -0.825 . . . . 0.0 110.081 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.9 Cg_endo -69.65 -23.36 31.36 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.642 1.338 . . . . 0.0 110.378 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.4 p -75.41 -35.67 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.794 . . . . 0.0 109.956 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -67.15 -42.1 84.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.492 -0.755 . . . . 0.0 109.705 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.06 -30.32 70.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.44 -0.788 . . . . 0.0 109.944 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.33 -73.38 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.503 -0.748 . . . . 0.0 109.954 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -53.37 -22.19 7.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.775 . . . . 0.0 110.949 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.49 -71.22 0.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 0.0 110.642 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -59.69 -94.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.284 -0.885 . . . . 0.0 110.711 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.45 30.63 0.95 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -110.56 79.11 1.17 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.375 -1.074 . . . . 0.0 109.7 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -79.31 -42.25 26.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.88 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.435 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 20.7 p-10 -59.37 -37.35 77.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.442 -0.786 . . . . 0.0 110.049 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.43 ' HA ' ' CD2' ' A' ' 85' ' ' LEU . 3.1 tt -80.48 -31.32 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 109.755 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.78 -54.17 39.33 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.922 0.868 . . . . 0.0 109.815 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.443 ' O ' ' CE1' ' A' ' 125' ' ' HIS . 8.3 ttt-85 -59.11 -52.96 63.48 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.866 -0.521 . . . . 0.0 110.347 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -61.07 -26.67 67.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.089 -1.007 . . . . 0.0 110.363 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.1 mt -66.63 -60.07 3.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.667 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.475 ' HA ' ' CG2' ' A' ' 128' ' ' THR . 2.6 p-80 -54.95 -24.68 25.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.457 ' N ' ' CD2' ' A' ' 125' ' ' HIS . . . -77.13 -24.89 51.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 110.633 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -107.65 -23.96 11.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.297 -0.877 . . . . 0.0 110.995 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' ' 98' ' ' LEU . 10.0 t -92.12 15.64 13.04 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.144 -0.973 . . . . 0.0 110.959 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.1 -67.36 0.03 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.41 -1.053 . . . . 0.0 110.489 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 26.3 t -91.35 150.84 42.08 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.313 -1.11 . . . . 0.0 110.121 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.02 -37.51 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.786 1.414 . . . . 0.0 110.381 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . 90.94 63.55 1.2 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 0' ' ' HIS . 2.3 tp -159.77 -47.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -1.13 . . . . 0.0 110.158 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . 0.417 ' HB2' ' O ' ' A' ' -1' ' ' ILE . 64.4 t-80 -177.2 137.09 0.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.208 -0.932 . . . . 0.0 110.337 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -170.52 149.1 3.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.286 -0.884 . . . . 0.0 110.213 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 6.4 mp -75.67 158.18 32.69 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.267 -0.896 . . . . 0.0 110.157 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.24 113.31 3.81 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.71 69.22 0.41 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 p -61.86 -168.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.36 -1.082 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.5 m -94.74 123.89 38.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.409 -0.807 . . . . 0.0 110.225 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -120.73 174.89 6.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 0.0 110.172 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 58.35 19.59 6.51 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.398 -0.814 . . . . 0.0 110.508 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.97 -17.45 79.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.42 ' CD2' ' HB2' ' A' ' 26' ' ' LEU . 60.4 mt -78.9 -44.24 23.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.355 -1.085 . . . . 0.0 109.819 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.405 ' CB ' ' ND2' ' A' ' 36' ' ' ASN . . . -62.31 -44.86 95.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.496 -0.752 . . . . 0.0 110.065 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 p -57.12 -55.51 33.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 109.94 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.96 72.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.898 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.18 -49.92 67.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.824 . . . . 0.0 110.141 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 45' ' ' VAL . . . -63.91 -23.97 67.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.353 -0.842 . . . . 0.0 110.147 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -91.52 3.48 54.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 0.0 110.636 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.61 45.97 72.6 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -110.96 66.12 0.62 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -1.084 . . . . 0.0 110.231 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.77 ' CG2' ' HB2' ' A' ' 52' ' ' GLN . 19.1 t -52.31 -34.63 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.324 -0.86 . . . . 0.0 110.113 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -65.55 -54.64 25.19 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.405 -0.809 . . . . 0.0 110.937 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.6 m -57.3 -34.94 69.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.235 -0.915 . . . . 0.0 110.941 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.404 ' O ' ' CB ' ' A' ' 26' ' ' LEU . 58.9 t -73.59 -26.71 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.261 -0.9 . . . . 0.0 110.417 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.46 ' HA ' ' CD1' ' A' ' 56' ' ' LEU . 18.9 mmt180 -68.59 -45.75 71.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.202 -0.936 . . . . 0.0 110.476 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -73.81 -58.44 3.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.452 -0.78 . . . . 0.0 111.28 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.25 -53.49 55.41 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.252 -0.905 . . . . 0.0 111.328 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.442 ' HG ' ' CE1' ' A' ' 60' ' ' HIS . 0.4 OUTLIER -52.61 -61.29 2.38 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.134 -0.979 . . . . 0.0 111.147 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -65.49 -13.07 58.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -0.977 . . . . 0.0 110.688 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -83.28 -26.71 30.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -0.989 . . . . 0.0 110.743 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.07 -7.64 0.39 Allowed Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.326 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -50.95 142.46 11.84 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.842 -1.387 . . . . 0.0 110.77 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.83 125.33 91.21 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 110.21 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.65 -21.05 22.43 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.573 1.302 . . . . 0.0 110.765 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.37 26.31 10.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.262 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.37 135.16 44.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.313 -0.867 . . . . 0.0 110.156 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.0 mt -84.22 170.13 14.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.833 . . . . 0.0 110.149 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.405 ' ND2' ' CB ' ' A' ' 11' ' ' ALA . 2.5 t-20 -106.94 -168.47 1.41 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.417 -0.802 . . . . 0.0 110.167 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -77.92 -23.44 48.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.389 -0.819 . . . . 0.0 110.27 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -96.28 25.38 4.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.315 -0.865 . . . . 0.0 110.095 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.54 32.09 37.98 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.05 -156.57 0.55 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.446 -1.032 . . . . 0.0 110.283 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.574 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 28.0 mmt-85 -110.49 170.29 5.46 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 0.0 109.598 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 41.0 Cg_endo -68.01 -21.67 42.87 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.484 1.254 . . . . 0.0 110.334 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.545 ' O ' ' HG2' ' A' ' 46' ' ' MET . 73.4 mt -107.67 -44.1 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.272 -0.892 . . . . 0.0 109.703 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.58 -22.54 3.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.155 -0.966 . . . . 0.0 110.501 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 7.1 p -105.29 25.73 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 110.798 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.545 ' HG2' ' O ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -95.83 165.63 12.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -0.999 . . . . 0.0 109.891 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.5 tmm? -61.06 -13.17 15.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.275 -0.891 . . . . 0.0 110.677 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 23.0 mmt 55.3 23.23 5.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.256 -0.902 . . . . 0.0 110.327 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.37 -19.71 5.74 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.407 ' HB3' ' CG2' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -118.15 105.77 12.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -1.156 . . . . 0.0 110.341 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 86' ' ' ASP . . . -59.36 -22.42 61.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.872 . . . . 0.0 110.598 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.77 ' HB2' ' CG2' ' A' ' 19' ' ' VAL . 3.4 mm-40 -61.46 -18.16 57.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.424 ' CG2' ' CG2' ' A' ' 19' ' ' VAL . 88.4 t -86.26 -41.7 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.714 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.45 -25.31 61.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.502 -0.749 . . . . 0.0 110.166 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -79.03 -43.94 23.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.375 -0.828 . . . . 0.0 110.346 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -59.06 -63.06 1.44 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.372 -0.83 . . . . 0.0 110.481 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.0 mt -52.52 -48.76 65.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.445 -0.784 . . . . 0.0 110.679 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.11 -38.65 76.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.35 -0.844 . . . . 0.0 110.213 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.85 -33.69 76.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -0.834 . . . . 0.0 110.188 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.442 ' CE1' ' HG ' ' A' ' 26' ' ' LEU . 12.5 m170 -84.69 -63.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.013 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.26 54.38 0.03 OUTLIER Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.76 -158.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -1.115 . . . . 0.0 110.112 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -126.71 71.87 74.01 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.368 -0.833 . . . . 0.0 109.988 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -79.43 -21.36 8.93 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.809 1.426 . . . . 0.0 110.59 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -89.33 -52.55 4.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.857 . . . . 0.0 110.31 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 166.42 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.34 -0.85 . . . . 0.0 110.481 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.54 -167.75 2.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 0.0 110.198 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -86.77 127.23 60.89 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.094 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.76 -25.28 14.76 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.573 1.302 . . . . 0.0 110.378 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.66 -51.43 65.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.372 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.78 26.63 7.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 110.463 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 44.17 37.73 2.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.334 -0.854 . . . . 0.0 110.959 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.5 125.67 42.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.298 -0.876 . . . . 0.0 110.559 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.574 ' HD2' ' HB ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -94.4 -175.99 0.52 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 110.144 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 47.7 Cg_endo -75.81 -35.45 2.59 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.386 1.203 . . . . 0.0 111.622 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.574 ' HB ' ' HD2' ' A' ' 74' ' ' ARG . 93.5 t -52.92 -31.61 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.049 -1.032 . . . . 0.0 110.301 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.417 ' CE1' ' HB3' ' A' ' 108' ' ' PRO . 14.8 m80 -62.29 -44.34 96.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 109.969 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.68 -49.23 66.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.386 -0.821 . . . . 0.0 110.082 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.89 -28.44 36.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.862 . . . . 0.0 110.109 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.01 -30.31 22.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.384 -0.823 . . . . 0.0 109.805 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.413 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 2.5 mmt85 -61.0 -24.62 66.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.462 -0.774 . . . . 0.0 110.235 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -100.58 -27.27 13.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 110.416 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.73 35.35 6.88 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -98.68 94.64 6.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.446 -1.032 . . . . 0.0 110.251 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.75 -25.67 68.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.356 -0.84 . . . . 0.0 110.524 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.424 ' HB2' ' CD1' ' A' ' 84' ' ' PHE . 2.9 m-20 -61.66 -56.36 20.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.192 -0.942 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.1 m -57.6 -42.77 83.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.241 -0.912 . . . . 0.0 109.991 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.68 -44.42 85.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.772 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.84 -42.51 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 0.0 109.003 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.4 t -57.21 -46.18 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.647 -0.658 . . . . 0.0 109.981 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.6 mp -61.8 -47.04 86.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.418 -0.801 . . . . 0.0 109.929 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.414 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 2.7 t-160 -66.34 -26.25 67.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 110.165 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -68.38 -30.67 69.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 110.267 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -114.47 41.84 2.23 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.361 -0.837 . . . . 0.0 110.406 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.33 109.97 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -149.01 105.46 3.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -1.085 . . . . 0.0 110.722 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.509 ' O ' ' NE ' ' A' ' 74' ' ' ARG . 0.3 OUTLIER -58.91 107.28 0.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.395 -0.816 . . . . 0.0 109.133 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.414 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 1.1 mt -104.14 23.62 12.73 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.166 -0.959 . . . . 0.0 110.347 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -126.95 17.64 7.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.852 . . . . 0.0 110.499 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.4 p -67.98 162.0 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 109.81 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.7 m -100.64 137.17 39.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 104' ' ' TRP . 13.0 t70 -73.71 60.69 0.71 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 110.294 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.431 ' HB3' ' CE3' ' A' ' 104' ' ' TRP . . . 58.17 -79.6 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.591 -0.693 . . . . 0.0 110.655 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.471 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.9 OUTLIER -53.76 -42.92 68.73 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.269 -0.894 . . . . 0.0 110.115 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 146.25 -18.94 1.72 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.28 123.98 15.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.209 -1.171 . . . . 0.0 110.518 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.419 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 22.1 mt -79.85 168.32 27.03 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.809 . . . . 0.0 109.891 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.0 Cg_endo -69.13 -25.51 31.45 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.684 1.36 . . . . 0.0 110.39 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 10.8 p -82.09 -23.13 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.0 110.14 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -67.07 -43.29 82.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.381 -0.824 . . . . 0.0 110.202 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.08 -31.66 69.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -0.829 . . . . 0.0 110.151 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.86 -65.26 0.7 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.415 -0.803 . . . . 0.0 110.109 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -51.94 -26.31 10.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.457 -0.777 . . . . 0.0 110.567 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -43.35 16.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.342 -0.848 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -77.21 -77.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.27 -0.894 . . . . 0.0 110.181 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 165.12 43.83 0.02 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.413 ' CE1' ' O ' ' A' ' 81' ' ' ARG . 24.1 m80 -117.5 60.14 0.77 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.331 -1.099 . . . . 0.0 109.782 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -50.41 -29.64 10.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.32 -0.863 . . . . 0.0 110.568 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -69.99 -39.13 76.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -35.08 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.264 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.73 -29.27 70.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 110.026 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -73.74 -55.19 6.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.326 -0.859 . . . . 0.0 110.044 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -36.38 83.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.317 -0.865 . . . . 0.0 110.09 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.03 -62.44 1.88 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.376 -0.828 . . . . 0.0 110.283 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -51.01 -26.27 5.87 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.339 -0.851 . . . . 0.0 110.315 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.17 -38.51 51.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 110.136 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -112.67 29.1 8.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.87 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 95.7 m -134.35 44.68 2.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 109.876 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.32 30.53 10.74 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.9 t0 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.351 -1.088 . . . . 0.0 110.571 -179.883 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' SER . . . . . 0.444 ' N ' ' HD2' ' A' ' -3' ' ' PRO . 0.5 OUTLIER -70.41 -56.39 6.69 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.325 -1.103 . . . . 0.0 110.349 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' -4' ' ' SER . 47.2 Cg_endo -72.77 90.45 0.83 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.456 1.24 . . . . 0.0 110.4 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . 168.11 171.24 33.81 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' ILE . . . . . 0.407 HG13 ' N ' ' A' ' 0' ' ' HIS . 4.2 pt -113.1 -20.6 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.269 -1.136 . . . . 0.0 110.434 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . 0.407 ' N ' HG13 ' A' ' -1' ' ' ILE . 6.8 t60 -65.15 121.91 15.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.2 -0.938 . . . . 0.0 110.166 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ptp -102.12 -22.92 14.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.385 -0.822 . . . . 0.0 110.33 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.406 ' O ' ' CD2' ' A' ' 0' ' ' HIS . 0.9 OUTLIER -100.28 142.95 31.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.329 -0.857 . . . . 0.0 110.261 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.12 167.82 14.71 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.33 -12.33 8.24 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' A' ' 6' ' ' SER . 16.4 m -101.92 154.76 18.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.21 -1.17 . . . . 0.0 110.291 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 5' ' ' SER . 82.1 p 45.17 -168.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.764 -0.585 . . . . 0.0 110.947 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 47.38 22.07 0.25 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.474 -0.767 . . . . 0.0 110.955 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -138.88 -48.64 0.5 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -0.959 . . . . 0.0 109.958 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.63 -22.02 58.78 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.407 ' CD1' ' CG1' ' A' ' 22' ' ' VAL . 27.3 tp -67.27 -49.62 63.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -1.023 . . . . 0.0 110.314 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.8 -49.55 24.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 110.62 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.8 p -58.15 -49.18 77.91 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.298 -0.876 . . . . 0.0 110.623 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.46 -38.41 84.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.204 -0.935 . . . . 0.0 110.184 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.96 -29.94 71.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.35 -0.844 . . . . 0.0 110.033 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.35 -33.45 25.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.336 -0.853 . . . . 0.0 110.047 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -75.91 -24.9 55.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.168 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.98 45.12 1.8 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -119.86 96.84 5.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -1.069 . . . . 0.0 110.001 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.726 ' CG2' ' HB2' ' A' ' 52' ' ' GLN . 38.4 t -76.76 -39.32 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.473 -0.767 . . . . 0.0 110.163 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.78 -46.0 90.56 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.276 -0.89 . . . . 0.0 110.757 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.2 m -64.6 -42.28 95.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.344 -0.847 . . . . 0.0 110.577 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.407 ' CG1' ' CD1' ' A' ' 10' ' ' LEU . 65.1 t -70.28 -45.24 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.284 -0.885 . . . . 0.0 110.501 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -59.29 -39.89 84.42 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.722 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -72.76 -44.2 61.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.365 -0.834 . . . . 0.0 110.783 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.62 -48.03 78.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.236 -0.915 . . . . 0.0 110.689 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.424 HD21 ' CG ' ' A' ' 60' ' ' HIS . 3.1 mt -54.11 -63.99 0.97 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.283 -0.886 . . . . 0.0 110.602 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -16.22 40.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 0.0 110.305 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.2 -37.91 21.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.873 . . . . 0.0 110.543 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.71 -23.63 0.09 OUTLIER Glycine 0 N--CA 1.484 1.843 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.745 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -48.05 124.82 8.12 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.092 -1.24 . . . . 0.0 110.997 -179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.37 126.92 70.51 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 109.955 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.53 -9.72 20.13 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.606 1.319 . . . . 0.0 110.864 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.12 29.55 7.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.118 -0.989 . . . . 0.0 110.257 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.17 103.48 9.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 0.0 110.26 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pp -84.53 145.65 27.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -104.42 -154.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.424 -0.797 . . . . 0.0 109.814 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 38' ' ' PHE . 2.0 ptp180 -57.95 -171.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 110.252 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER 66.66 1.94 2.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.438 -0.789 . . . . 0.0 111.268 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 45.85 31.98 4.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.77 -168.54 1.54 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -1.15 . . . . 0.0 110.662 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.67 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -118.27 177.67 1.24 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 0.0 109.391 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 43.4 Cg_endo -70.53 -19.29 32.62 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.383 1.202 . . . . 0.0 110.847 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 53.5 mt -115.01 -34.83 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.134 -0.979 . . . . 0.0 110.001 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -53.43 -29.11 33.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.066 -1.021 . . . . 0.0 110.144 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.8 p -92.85 -2.76 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.407 -0.808 . . . . 0.0 110.339 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.411 ' HG3' ' CG1' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -56.05 154.54 7.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.398 -0.814 . . . . 0.0 110.345 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -70.97 -6.9 42.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 110.149 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 23.4 mmt 53.59 25.25 4.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.9 . . . . 0.0 110.411 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -118.03 -11.7 8.16 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 m -129.51 113.45 14.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -1.163 . . . . 0.0 110.296 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -64.53 -13.9 54.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.429 -0.794 . . . . 0.0 110.598 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.726 ' HB2' ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -73.08 -22.93 60.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.216 -0.928 . . . . 0.0 109.821 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.418 ' CG2' HG22 ' A' ' 19' ' ' VAL . 22.0 t -84.2 -36.84 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.149 -0.969 . . . . 0.0 110.188 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.35 -57.14 5.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.421 -0.799 . . . . 0.0 110.299 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -59.32 -45.82 90.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.439 -0.788 . . . . 0.0 110.474 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 59' ' ' LEU . 52.1 tp -52.63 -52.63 54.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.371 -0.83 . . . . 0.0 110.666 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.6 mt -69.89 -30.39 67.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.262 -0.899 . . . . 0.0 110.854 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.422 ' CD1' HG11 ' A' ' 90' ' ' VAL . 1.1 tt -75.72 -55.23 5.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.178 -0.951 . . . . 0.0 110.944 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.415 ' CD1' ' CD2' ' A' ' 60' ' ' HIS . 3.1 pp -54.07 -28.5 39.3 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.136 -0.978 . . . . 0.0 110.07 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.424 ' CG ' HD21 ' A' ' 26' ' ' LEU . 3.0 m-70 -75.61 -56.87 4.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.359 -0.838 . . . . 0.0 109.821 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.49 44.61 0.02 OUTLIER Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -76.27 -169.55 1.21 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.335 -1.097 . . . . 0.0 110.62 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -115.38 80.83 7.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.77 -27.0 9.19 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.854 1.45 . . . . 0.0 110.325 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -93.08 -41.44 9.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 110.081 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 151.37 7.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.273 -0.892 . . . . 0.0 110.277 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.402 ' HB1' ' NE ' ' A' ' 74' ' ' ARG . . . -143.87 -172.72 3.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.416 -0.802 . . . . 0.0 110.565 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 15.5 t0 -89.69 125.07 62.34 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.33 -21.55 19.8 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.484 1.255 . . . . 0.0 110.62 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.24 -20.89 65.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 110.678 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.3 t -158.42 22.03 0.23 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.027 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.4 mt 44.05 65.29 1.06 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.306 -0.871 . . . . 0.0 110.403 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -119.21 103.23 9.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.092 -1.005 . . . . 0.0 111.156 -178.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.468 ' CG ' ' HD2' ' A' ' 75' ' ' PRO . 0.1 OUTLIER -75.29 169.65 19.4 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.728 . . . . 0.0 109.197 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 74' ' ' ARG . 46.7 Cg_endo -74.49 -4.34 15.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.458 1.241 . . . . 0.0 110.904 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 62.6 t -71.84 -35.39 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.211 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -62.16 -43.17 99.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 110.331 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -56.33 -57.98 9.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.477 -0.764 . . . . 0.0 110.438 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.87 -28.25 65.95 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.284 -0.885 . . . . 0.0 109.876 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -79.94 -27.9 39.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 110.032 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -71.9 -23.42 61.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.826 . . . . 0.0 110.367 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -97.08 -44.52 6.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.368 -0.832 . . . . 0.0 110.227 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.85 29.62 3.03 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.458 ' CZ ' ' CA ' ' A' ' 84' ' ' PHE . 4.3 t80 -93.61 91.8 7.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.43 -1.041 . . . . 0.0 110.224 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mt -62.22 -27.85 69.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.333 -0.855 . . . . 0.0 109.863 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -59.07 -54.44 47.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.397 -0.815 . . . . 0.0 110.348 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 29.9 m -61.46 -35.19 76.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.326 -0.859 . . . . 0.0 109.962 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.402 ' CD2' ' HB3' ' A' ' 123' ' ' TYR . 5.7 tp -59.53 -51.97 67.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.212 -0.93 . . . . 0.0 109.776 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.78 -45.01 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 109.269 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.422 HG11 ' CD1' ' A' ' 58' ' ' LEU . 96.4 t -50.48 -46.47 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.614 -0.679 . . . . 0.0 110.452 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.3 mp -65.01 -57.35 8.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 110.088 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.402 ' CE1' ' HB1' ' A' ' 127' ' ' ALA . 4.5 t-160 -63.68 -17.43 62.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 110.36 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -87.78 -13.88 41.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 0.0 110.615 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -133.46 49.57 2.28 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.186 -0.946 . . . . 0.0 110.512 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.64 108.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -168.63 104.98 0.43 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -1.101 . . . . 0.0 110.248 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -68.04 108.7 3.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.418 -0.802 . . . . 0.0 110.071 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 mp -93.18 -21.58 19.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.313 -0.867 . . . . 0.0 110.449 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -70.4 72.71 0.49 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.447 HG23 ' NE ' ' A' ' 74' ' ' ARG . 7.5 p -143.37 161.18 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -0.86 . . . . 0.0 110.341 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 13.3 p -128.6 147.33 50.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.51 -0.744 . . . . 0.0 109.422 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 104' ' ' TRP . 5.1 p-10 -69.86 65.3 0.23 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.254 -0.904 . . . . 0.0 110.607 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 56.66 -81.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.688 -0.632 . . . . 0.0 111.097 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.467 ' N ' ' O ' ' A' ' 102' ' ' ASP . 8.2 m-90 -91.52 43.98 1.16 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.265 -0.897 . . . . 0.0 110.359 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.54 -162.62 10.15 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.506 ' O ' ' CD1' ' A' ' 107' ' ' LEU . 10.5 mtm180 -120.79 -51.45 2.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.395 -1.062 . . . . 0.0 110.259 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.77 ' HG ' ' HD2' ' A' ' 108' ' ' PRO . 2.0 tp -174.13 162.72 2.91 Favored Pre-proline 0 N--CA 1.497 1.884 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.77 ' HD2' ' HG ' ' A' ' 107' ' ' LEU . 42.8 Cg_endo -70.39 -31.54 17.53 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.026 1.014 . . . . 0.0 110.24 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 7.4 p -62.05 -21.03 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 109.648 179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -77.56 -45.29 25.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.383 -0.823 . . . . 0.0 109.621 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.59 -26.85 62.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 117' ' ' HIS . . . -78.0 -50.13 12.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.507 -0.746 . . . . 0.0 109.962 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -52.77 -23.28 6.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.478 -0.763 . . . . 0.0 110.898 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -94.63 -54.12 3.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.262 -0.899 . . . . 0.0 110.667 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -59.73 -95.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.254 -0.904 . . . . 0.0 110.435 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -170.29 31.79 0.15 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.412 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 9.0 m-70 -117.03 79.47 1.34 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -1.035 . . . . 0.0 109.536 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 30.0 mmt85 -81.32 -40.54 23.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.386 -0.821 . . . . 0.0 110.167 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.4 -54.45 43.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.307 -0.871 . . . . 0.0 109.702 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 121' ' ' ALA . 10.0 tt -60.13 -34.75 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.468 -0.77 . . . . 0.0 109.359 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.404 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -61.7 -39.42 91.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.658 -0.651 . . . . 0.0 109.799 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -56.17 -53.21 59.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.392 -0.817 . . . . 0.0 109.571 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.402 ' HB3' ' CD2' ' A' ' 88' ' ' LEU . 0.2 OUTLIER -58.71 -45.19 90.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.357 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 128' ' ' THR . 78.3 mt -55.9 -48.53 75.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.435 -0.79 . . . . 0.0 109.928 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -53.5 -27.33 24.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.295 -0.878 . . . . 0.0 110.191 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.19 -38.69 15.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.316 -0.865 . . . . 0.0 110.467 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.402 ' HB1' ' CE1' ' A' ' 92' ' ' HIS . . . -98.02 10.62 39.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.304 -0.872 . . . . 0.0 110.783 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 124' ' ' LEU . 7.4 m -133.39 -52.02 0.88 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 110.365 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.95 101.37 1.23 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.294 -1.121 . . . . 0.0 110.673 -179.837 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 11.5 t 52.17 92.29 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.284 -1.127 . . . . 0.0 110.617 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.43 -24.41 19.26 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.685 1.36 . . . . 0.0 110.29 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . 77.19 76.97 0.83 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' ILE . . . . . . . . . . . . . 4.3 tp -153.05 -42.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -1.102 . . . . 0.0 110.372 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -110.25 163.69 13.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.178 -0.951 . . . . 0.0 110.344 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 tpt -107.32 120.84 43.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.81 . . . . 0.0 110.331 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp -109.57 26.47 10.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.516 -0.74 . . . . 0.0 109.921 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.23 -28.73 21.9 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.6 91.73 0.1 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.9 m -78.51 84.0 4.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.318 -1.107 . . . . 0.0 110.073 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.3 m -68.39 -83.58 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.269 -0.895 . . . . 0.0 110.348 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 49.77 23.96 1.14 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.055 -1.028 . . . . 0.0 110.638 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.8 -22.07 1.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 110.835 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -53.91 -32.58 48.9 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.23 -27.69 68.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.444 -1.033 . . . . 0.0 110.09 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.4 -50.7 8.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.412 -0.805 . . . . 0.0 110.257 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.2 p -63.18 -50.17 71.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.421 -0.8 . . . . 0.0 110.08 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.5 -40.8 83.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.342 -0.849 . . . . 0.0 109.769 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.01 -38.93 87.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.038 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.73 -32.6 71.87 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.309 -0.869 . . . . 0.0 110.168 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.87 15.43 11.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.394 -0.816 . . . . 0.0 110.543 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.47 52.97 49.3 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -119.67 72.26 0.91 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -1.102 . . . . 0.0 110.536 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' A' ' 52' ' ' GLN . 58.0 t -56.96 -35.69 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.048 -1.032 . . . . 0.0 109.496 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -59.62 -54.95 40.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.557 -0.715 . . . . 0.0 109.988 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 84.0 m -56.92 -38.3 72.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.438 -0.789 . . . . 0.0 110.129 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 57.7 t -79.76 -22.05 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 110.475 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.466 ' HA ' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -62.65 -45.87 90.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.163 -0.961 . . . . 0.0 110.422 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -76.41 -51.22 12.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.46 -0.775 . . . . 0.0 111.408 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.402 ' C ' ' HB1' ' A' ' 30' ' ' ALA . 4.0 mt -51.2 -62.06 1.85 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.989 . . . . 0.0 111.227 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.424 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 2.0 mt -53.56 -46.82 70.38 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.15 -0.969 . . . . 0.0 111.365 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.66 9.34 7.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.06 -1.025 . . . . 0.0 110.962 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -114.47 -31.33 6.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.68 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.35 -27.81 0.08 OUTLIER Glycine 0 N--CA 1.484 1.849 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.598 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.402 ' HB1' ' C ' ' A' ' 25' ' ' LEU . . . -48.22 128.65 14.5 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.136 -1.214 . . . . 0.0 110.758 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.22 145.36 82.97 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.397 -0.814 . . . . 0.0 110.301 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -76.98 -25.97 8.34 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.753 1.396 . . . . 0.0 110.784 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -114.44 32.38 5.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.324 -0.86 . . . . 0.0 110.403 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.8 96.87 10.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.354 -0.841 . . . . 0.0 110.281 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.487 HD12 ' N ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -71.62 157.69 37.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.32 -0.862 . . . . 0.0 110.083 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.469 ' O ' ' CD2' ' A' ' 35' ' ' LEU . 47.7 p30 -112.9 173.83 6.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.121 -0.987 . . . . 0.0 110.97 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -49.73 -26.9 4.2 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.368 -0.832 . . . . 0.0 110.608 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -11.93 60.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.28 -0.887 . . . . 0.0 109.887 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.21 25.61 18.86 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.8 ttt180 -93.99 1.2 56.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -1.014 . . . . 0.0 110.227 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 55.89 171.45 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.25 -0.906 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.493 ' O ' ' HB ' ' A' ' 43' ' ' ILE . 45.7 Cg_endo -72.65 169.44 21.89 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.534 1.281 . . . . 0.0 110.724 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.523 ' HA ' ' HG2' ' A' ' 46' ' ' MET . 30.7 mt 62.95 -60.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.821 -0.549 . . . . 0.0 111.017 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -43.12 -29.2 0.35 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.879 -1.138 . . . . 0.0 110.793 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 p -113.79 35.55 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 0.0 109.942 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.523 ' HG2' ' HA ' ' A' ' 43' ' ' ILE . 0.4 OUTLIER -110.46 171.86 7.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.256 -0.903 . . . . 0.0 110.267 -179.805 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 8.5 ttp -73.45 98.91 2.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.319 -0.863 . . . . 0.0 108.685 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.488 ' O ' ' CD2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -61.73 -6.16 2.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 111.138 -179.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.5 20.78 32.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.9 t -154.06 109.05 3.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -1.129 . . . . 0.0 110.227 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.25 -29.54 69.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.404 -0.81 . . . . 0.0 110.033 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.475 ' HB3' ' CG2' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -51.35 -32.88 27.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.543 -0.723 . . . . 0.0 110.297 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.2 t -75.17 -47.94 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.359 -0.838 . . . . 0.0 110.053 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.423 ' CB ' ' CG2' ' A' ' 87' ' ' THR . . . -70.56 -23.44 62.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.399 -0.813 . . . . 0.0 110.158 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -66.71 -53.1 37.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.361 -0.837 . . . . 0.0 110.689 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.466 ' CD1' ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -61.58 -57.11 13.37 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.909 . . . . 0.0 110.647 -179.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -47.36 -50.37 22.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 110.97 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.5 tp -70.68 -24.7 62.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.406 -0.809 . . . . 0.0 110.544 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.1 tp -67.67 -41.28 83.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 109.982 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.424 ' CE1' ' HB3' ' A' ' 26' ' ' LEU . 12.0 m170 -78.91 -30.89 45.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.348 -0.845 . . . . 0.0 109.864 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.42 54.89 0.07 OUTLIER Glycine 0 N--CA 1.482 1.758 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.83 -168.3 0.19 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.273 -1.133 . . . . 0.0 110.051 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -117.21 78.52 10.36 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.853 . . . . 0.0 110.007 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.78 -27.47 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.719 1.378 . . . . 0.0 110.417 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -87.55 -59.27 2.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.433 -0.792 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.1 168.59 0.13 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.308 -0.87 . . . . 0.0 110.444 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.411 ' CB ' ' HD2' ' A' ' 74' ' ' ARG . . . -167.93 -158.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.875 . . . . 0.0 110.734 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -79.7 123.85 83.81 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.499 -0.75 . . . . 0.0 110.292 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.39 -24.11 14.54 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.549 1.289 . . . . 0.0 110.401 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.39 -46.24 86.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -0.892 . . . . 0.0 110.424 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.604 ' O ' ' C ' ' A' ' 72' ' ' LEU . 41.9 p -146.65 68.69 1.17 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 110.355 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.604 ' C ' ' O ' ' A' ' 71' ' ' THR . 13.9 mt 5.41 86.75 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.933 -0.479 . . . . 0.0 112.175 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.05 83.57 2.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 110.363 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.419 ' HD3' ' CG2' ' A' ' 100' ' ' VAL . 5.2 mpt_? -61.51 161.31 20.11 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.481 -0.762 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.36 -18.74 29.68 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.855 1.45 . . . . 0.0 110.422 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.88 -32.13 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.35 -0.844 . . . . 0.0 109.997 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 64.0 m80 -64.63 -41.72 95.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 110.34 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -70.31 -48.44 56.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.355 -0.841 . . . . 0.0 110.416 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.36 -29.18 14.58 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.293 -0.879 . . . . 0.0 110.448 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.453 ' CB ' ' CG2' ' A' ' 120' ' ' ILE . . . -96.55 -27.92 14.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.4 -0.812 . . . . 0.0 109.796 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -53.47 -28.43 30.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.402 -0.811 . . . . 0.0 109.765 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -99.5 -28.44 13.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.814 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.69 44.92 2.03 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 48' ' ' MET . 12.7 t80 -108.0 96.43 6.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.368 -1.078 . . . . 0.0 110.046 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.413 HD21 ' CD1' ' A' ' 120' ' ' ILE . 0.2 OUTLIER -72.25 -24.29 61.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.516 -0.74 . . . . 0.0 110.663 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . 63.9 m-20 -59.67 -54.35 47.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.407 -0.808 . . . . 0.0 110.499 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.423 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 90.9 m -61.2 -36.75 80.72 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.094 -1.004 . . . . 0.0 110.157 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.429 HD23 ' CD1' ' A' ' 123' ' ' TYR . 0.7 OUTLIER -57.54 -48.79 78.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.318 -0.864 . . . . 0.0 110.252 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 96.0 t -59.66 -50.95 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 109.914 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 85.1 t -54.27 -45.57 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.838 . . . . 0.0 110.221 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.23 -56.06 26.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.39 -0.819 . . . . 0.0 110.35 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -64.32 -23.32 67.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.446 -0.784 . . . . 0.0 110.657 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -78.77 -33.75 46.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.202 -0.936 . . . . 0.0 110.575 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -98.12 39.69 1.22 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.322 -0.862 . . . . 0.0 111.012 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.55 108.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -168.31 132.45 1.62 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.532 -0.981 . . . . 0.0 110.05 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.55 140.01 42.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.242 -0.911 . . . . 0.0 110.071 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.416 HD11 ' N ' ' A' ' 98' ' ' LEU . 2.4 mp -128.31 19.49 6.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.315 -0.866 . . . . 0.0 110.48 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -123.29 55.87 1.2 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.151 -0.968 . . . . 0.0 110.421 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.419 ' CG2' ' HD3' ' A' ' 74' ' ' ARG . 12.6 p -112.76 164.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.383 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 98.8 m -106.47 150.88 25.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.474 -0.767 . . . . 0.0 109.802 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 104' ' ' TRP . 22.6 t70 -78.89 58.87 2.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.324 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.447 ' CA ' ' HB2' ' A' ' 72' ' ' LEU . . . 64.69 -71.97 0.07 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.519 -0.738 . . . . 0.0 110.719 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.431 ' N ' ' O ' ' A' ' 102' ' ' ASP . 2.1 m95 -65.49 -56.09 14.28 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.413 -0.804 . . . . 0.0 110.443 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 168.63 -28.15 0.14 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.01 105.79 0.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.237 -1.155 . . . . 0.0 110.423 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.62 170.64 13.4 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.277 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.3 -43.19 0.74 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.738 1.388 . . . . 0.0 110.425 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 9.9 p -58.97 -36.02 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.35 -0.844 . . . . 0.0 110.115 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -66.06 -45.8 80.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.441 -0.787 . . . . 0.0 110.187 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.0 tt -60.84 -27.74 68.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.222 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.3 -63.98 0.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 0.0 110.137 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -53.99 -23.63 13.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.92 -40.66 78.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.676 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.402 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 0.9 OUTLIER -91.29 5.32 49.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.228 -0.92 . . . . 0.0 110.77 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.63 37.06 8.92 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.445 ' HB3' ' CG1' ' A' ' 120' ' ' ILE . 23.9 m-70 -113.09 55.34 0.7 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -1.102 . . . . 0.0 109.791 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.96 -30.5 24.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.435 -0.791 . . . . 0.0 109.988 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -62.39 -40.62 97.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.735 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.453 ' CG2' ' CB ' ' A' ' 80' ' ' ALA . 4.1 mm -75.87 -36.28 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.509 -0.744 . . . . 0.0 109.601 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.33 -59.11 4.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 111.178 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -53.99 -41.27 67.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.007 -1.058 . . . . 0.0 110.133 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.429 ' CD1' HD23 ' A' ' 88' ' ' LEU . 11.7 t80 -68.86 -42.48 76.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.227 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 128' ' ' THR . 21.2 mt -66.24 -47.56 73.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.475 -0.766 . . . . 0.0 109.741 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -50.24 -32.11 15.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.411 -0.806 . . . . 0.0 110.333 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.49 -27.0 46.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.737 . . . . 0.0 110.293 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.73 -11.45 18.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.342 -0.849 . . . . 0.0 110.85 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 124' ' ' LEU . 73.2 p -90.16 -29.79 18.04 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 110.48 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.88 -98.57 0.01 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 . . . . . 0 C--N 1.307 -1.249 0 O-C-N 121.41 -1.053 . . . . 0.0 110.254 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 7.5 t -78.73 138.51 58.11 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.345 -1.091 . . . . 0.0 110.192 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -72.94 -35.29 5.6 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.683 1.359 . . . . 0.0 110.427 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . 123.36 118.27 2.41 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' ILE . . . . . . . . . . . . . 1.3 pp -64.47 -153.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.339 -1.095 . . . . 0.0 110.078 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . 0.463 ' O ' ' C ' ' A' ' 1' ' ' MET . 57.7 m80 -52.14 -75.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.171 -0.956 . . . . 0.0 110.731 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.463 ' C ' ' O ' ' A' ' 0' ' ' HIS . 9.8 ptp 32.07 87.95 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.422 0.63 . . . . 0.0 111.64 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.417 ' CD2' ' N ' ' A' ' 2' ' ' LEU . 4.4 mm? -63.44 100.09 0.24 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 0.0 110.241 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.8 147.86 17.98 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.58 159.94 0.18 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.4 p -168.83 108.13 0.47 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -1.141 . . . . 0.0 110.506 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.68 -27.64 40.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.492 -0.755 . . . . 0.0 109.896 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -59.35 -36.92 76.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.322 -0.861 . . . . 0.0 110.019 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.45 -19.53 62.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.761 . . . . 0.0 110.048 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.34 -25.95 55.57 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 80.7 mt -64.15 -37.41 87.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.404 -1.057 . . . . 0.0 110.178 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.28 -49.03 14.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.286 -0.884 . . . . 0.0 110.107 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.9 p -56.39 -54.93 39.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.419 -0.801 . . . . 0.0 110.267 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.55 74.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.0 110.071 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.7 -43.75 58.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 110.134 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' HA ' ' N ' ' A' ' 47' ' ' MET . . . -61.44 -28.53 69.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.386 -0.821 . . . . 0.0 110.189 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -72.84 -27.77 62.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.409 -0.807 . . . . 0.0 110.159 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.34 28.04 4.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -106.65 143.0 35.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.379 -1.071 . . . . 0.0 110.483 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.639 ' CG2' ' HB2' ' A' ' 52' ' ' GLN . 95.0 t -109.53 -54.42 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.442 -0.787 . . . . 0.0 109.9 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -54.9 -32.54 61.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.51 -0.744 . . . . 0.0 110.418 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 m -62.07 -60.89 2.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 110.292 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.3 t -61.49 -27.51 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.27 -0.894 . . . . 0.0 110.146 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.1 -43.44 82.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 110.161 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -63.31 -38.47 91.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.587 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.17 -44.68 68.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.0 110.619 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.426 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 14.2 mt -65.88 -57.0 8.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.311 -0.868 . . . . 0.0 110.481 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.84 -25.29 18.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.233 -0.917 . . . . 0.0 110.097 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.55 -67.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 110.046 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.88 47.21 0.06 OUTLIER Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -85.93 169.79 12.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -1.143 . . . . 0.0 110.175 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -89.85 125.37 61.09 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 110.04 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.95 -17.46 25.18 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.603 1.318 . . . . 0.0 110.649 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.32 39.86 3.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 110.062 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.91 109.79 5.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.403 -0.81 . . . . 0.0 110.224 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -72.83 99.26 2.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.309 -0.87 . . . . 0.0 109.744 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -54.82 -179.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.468 -0.77 . . . . 0.0 110.439 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -93.94 22.7 5.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.894 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 64.8 m-85 -111.8 21.57 15.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.202 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.74 26.9 26.47 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -131.2 -168.71 2.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.381 -1.07 . . . . 0.0 110.393 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.638 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.2 mmt180 -104.16 176.19 1.88 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.47 -0.769 . . . . 0.0 109.421 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.638 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 42.9 Cg_endo -69.76 -19.49 36.08 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.273 1.144 . . . . 0.0 110.648 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.435 ' O ' ' HG2' ' A' ' 46' ' ' MET . 44.7 mt -104.17 -27.94 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 109.775 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.32 -19.68 56.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.094 -1.004 . . . . 0.0 109.875 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.4 p -126.75 35.7 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.232 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.473 ' O ' ' CB ' ' A' ' 47' ' ' MET . 0.2 OUTLIER -96.16 31.59 2.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.259 -0.9 . . . . 0.0 110.298 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' MET . . . . . 0.473 ' CB ' ' O ' ' A' ' 46' ' ' MET . 4.8 tmm? 72.15 -18.08 0.34 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.557 -0.714 . . . . 0.0 111.208 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.418 ' H ' ' C ' ' A' ' 46' ' ' MET . 0.0 OUTLIER 50.43 26.2 2.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.019 -1.05 . . . . 0.0 110.679 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -125.32 28.88 4.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.11 100.87 0.75 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.318 -1.107 . . . . 0.0 110.312 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.52 -26.96 65.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.301 -0.874 . . . . 0.0 110.063 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.639 ' HB2' ' CG2' ' A' ' 19' ' ' VAL . 5.7 mm-40 -55.04 -29.39 57.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.488 -0.757 . . . . 0.0 110.591 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.2 t -88.24 -33.16 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 109.932 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.72 94.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.323 -0.86 . . . . 0.0 110.115 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -80.08 -38.68 31.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.341 -0.849 . . . . 0.0 110.559 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.436 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 37.5 tp -53.98 -58.04 8.76 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.295 -0.878 . . . . 0.0 110.32 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 8.2 mt -67.15 -28.04 67.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.958 . . . . 0.0 110.21 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.411 ' CD2' ' CB ' ' A' ' 94' ' ' ALA . 1.3 tp -66.92 -64.96 0.74 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.332 -0.855 . . . . 0.0 110.637 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 56' ' ' LEU . 3.9 pp -49.91 -27.78 5.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.266 -0.896 . . . . 0.0 110.315 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.426 ' CE1' ' HB3' ' A' ' 26' ' ' LEU . 4.3 m80 -77.22 -62.81 1.53 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -0.855 . . . . 0.0 109.788 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 165.56 41.71 0.02 OUTLIER Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.17 -170.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.312 -1.111 . . . . 0.0 110.329 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -125.28 73.73 67.3 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.461 -0.774 . . . . 0.0 110.282 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.848 1.446 . . . . 0.0 110.601 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -89.93 -50.01 6.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.931 . . . . 0.0 110.725 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.21 172.24 0.22 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.173 -0.954 . . . . 0.0 110.459 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.451 ' CB ' ' HG2' ' A' ' 74' ' ' ARG . . . -156.76 -178.14 7.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.483 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.404 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 4.4 t0 -89.59 116.67 66.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 110.036 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.89 -17.18 32.63 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.61 1.321 . . . . 0.0 110.363 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.26 -24.12 63.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 110.686 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.1 m -150.73 21.48 0.8 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.25 -0.906 . . . . 0.0 110.599 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.9 mt 49.23 27.64 1.92 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.176 -0.952 . . . . 0.0 110.385 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.404 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -84.79 121.9 28.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.422 -0.799 . . . . 0.0 110.722 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.452 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 2.2 mtt180 -94.79 173.59 4.35 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 110.003 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 42.1 Cg_endo -68.39 -17.55 44.13 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.654 1.344 . . . . 0.0 110.23 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.1 t -69.96 -32.33 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.363 -0.836 . . . . 0.0 109.605 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.418 ' CG ' ' HB3' ' A' ' 108' ' ' PRO . 60.7 m80 -67.97 -43.73 78.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.477 -0.764 . . . . 0.0 110.082 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.415 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 0.6 OUTLIER -59.73 -60.63 3.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 0.0 109.648 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.84 -24.34 8.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.478 -0.764 . . . . 0.0 109.624 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.413 ' HA ' HD11 ' A' ' 120' ' ' ILE . . . -83.56 -30.11 27.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.523 -0.736 . . . . 0.0 109.613 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -57.35 -35.59 70.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 8.6 mp0 -98.01 -15.65 19.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.494 -0.754 . . . . 0.0 110.291 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 117' ' ' HIS . . . 76.71 49.33 7.99 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.14 88.42 3.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.378 -1.072 . . . . 0.0 110.037 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 mt -60.09 -31.65 70.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.398 -0.814 . . . . 0.0 110.47 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -56.88 -48.17 78.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 97.7 m -68.64 -32.87 73.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 109.814 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mp -57.8 -44.06 86.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.343 -0.848 . . . . 0.0 109.821 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 34.1 t -60.89 -54.29 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.448 -0.783 . . . . 0.0 109.439 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.405 ' CG1' ' CD2' ' A' ' 58' ' ' LEU . 96.9 t -44.8 -45.91 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.714 -0.616 . . . . 0.0 110.807 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -54.07 24.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 110.512 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -64.59 -46.83 81.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.331 -0.855 . . . . 0.0 110.996 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -69.19 -10.05 55.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.178 -0.951 . . . . 0.0 110.922 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.411 ' CB ' ' CD2' ' A' ' 58' ' ' LEU . . . -120.02 26.71 9.11 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.156 -0.965 . . . . 0.0 110.447 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.77 107.18 0.25 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -170.54 114.99 0.47 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.328 -1.101 . . . . 0.0 110.143 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.402 ' HB3' ' NH1' ' A' ' 74' ' ' ARG . 6.4 ttt85 -69.78 132.89 46.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -0.828 . . . . 0.0 110.082 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.4 mp -119.8 26.83 9.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.418 -0.801 . . . . 0.0 110.191 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -115.54 53.03 0.85 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 110.287 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 14.4 p -123.06 153.75 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 110.103 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 78.2 m -109.48 147.47 32.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 0.0 109.924 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.407 ' O ' ' O ' ' A' ' 103' ' ' ALA . 6.6 p-10 -70.75 67.25 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 0.0 110.325 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.494 ' O ' ' CG ' ' A' ' 104' ' ' TRP . . . 57.48 111.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.424 -0.797 . . . . 0.0 110.481 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.494 ' CG ' ' O ' ' A' ' 103' ' ' ALA . 38.4 p90 35.64 34.96 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.76 -0.588 . . . . 0.0 111.432 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -122.84 -126.9 3.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.38 179.01 6.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -1.09 . . . . 0.0 110.269 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.486 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 96.9 mt -62.85 166.72 7.14 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.477 -0.764 . . . . 0.0 110.013 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.7 Cg_endo -69.94 -16.91 36.99 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.67 1.353 . . . . 0.0 110.536 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.428 HG22 ' CG ' ' A' ' 125' ' ' HIS . 11.6 p -61.64 -35.21 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.218 -0.926 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -69.3 -41.74 76.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 110.153 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.01 -31.15 66.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.92 -67.72 0.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.843 . . . . 0.0 110.225 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -25.72 20.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.85 -27.12 60.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.358 -0.839 . . . . 0.0 110.53 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -95.29 -16.02 22.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.667 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 125.28 -13.99 7.4 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.44 ' HB3' ' CG2' ' A' ' 120' ' ' ILE . 24.0 m-70 -75.87 96.87 3.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -1.196 . . . . 0.0 109.594 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' A' ' 119' ' ' ASP . 2.7 ptm180 -91.38 -41.82 10.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.923 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 118' ' ' ARG . 74.4 m-20 -63.29 -38.85 92.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -0.919 . . . . 0.0 109.634 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.44 ' CG2' ' HB3' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -65.63 -37.24 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.567 -0.708 . . . . 0.0 109.92 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.435 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -60.66 -37.0 80.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.453 -0.779 . . . . 0.0 109.9 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -51.15 70.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.408 -0.807 . . . . 0.0 109.759 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 30.9 t80 -60.28 -28.24 67.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.39 -0.819 . . . . 0.0 110.066 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.9 mt -85.59 -38.1 18.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 110.266 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.428 ' CG ' HG22 ' A' ' 109' ' ' VAL . 18.7 m-70 -54.62 -29.3 51.6 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.215 -0.928 . . . . 0.0 110.355 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.86 -20.63 16.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 110.312 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -92.68 -26.85 17.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 0.0 110.582 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.2 p -98.51 15.71 24.09 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.319 -0.863 . . . . 0.0 110.378 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -107.73 -111.98 3.58 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 130' ' ' ASP . 21.2 p-10 . . . . . 0 N--CA 1.486 1.361 0 O-C-N 121.363 -1.081 . . . . 0.0 110.403 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 44.6 m -74.07 160.45 81.65 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.33 -1.1 . . . . 0.0 110.206 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.91 134.79 22.24 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.882 1.464 . . . . 0.0 110.456 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -141.13 53.43 0.66 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' ILE . . . . . . . . . . . . . 29.2 pt -110.95 34.01 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -1.116 . . . . 0.0 110.258 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -95.35 14.35 22.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.436 -0.79 . . . . 0.0 110.439 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttm 58.33 163.8 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.246 -0.909 . . . . 0.0 110.393 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.9 tp -154.66 96.52 1.89 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.22 -0.925 . . . . 0.0 110.153 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.67 -56.62 0.05 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.91 -26.72 74.01 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.6 p -88.7 -179.18 5.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -1.115 . . . . 0.0 110.179 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 55.71 22.9 5.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.379 -0.826 . . . . 0.0 110.439 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.62 -36.96 73.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.959 . . . . 0.0 109.967 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.46 -21.7 61.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.399 -0.813 . . . . 0.0 110.321 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.423 ' HA2' ' CG2' ' A' ' 12' ' ' THR . . . -57.65 -25.21 55.19 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.5 tp -75.92 -38.52 57.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -1.071 . . . . 0.0 110.506 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.17 -38.09 22.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.091 -1.005 . . . . 0.0 111.041 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.423 ' CG2' ' HA2' ' A' ' 9' ' ' GLY . 15.2 t -61.81 -41.11 97.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.144 -0.972 . . . . 0.0 110.487 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 18' ' ' GLN . . . -68.15 -50.56 53.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.175 -0.953 . . . . 0.0 109.534 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.57 -45.88 66.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.91 . . . . 0.0 110.563 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.4 -18.02 62.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.422 -0.799 . . . . 0.0 110.648 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -97.15 26.03 5.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 0.0 110.587 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 56.93 37.85 81.2 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.62 ' HB3' ' OG1' ' A' ' 21' ' ' THR . 62.6 mm-40 -112.96 93.87 4.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.42 -1.047 . . . . 0.0 110.271 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 52' ' ' GLN . 11.3 t -82.78 -59.31 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.215 -0.928 . . . . 0.0 110.47 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -50.23 -48.99 54.28 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.62 ' OG1' ' HB3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -53.88 -34.57 59.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.518 -0.739 . . . . 0.0 110.362 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 95.3 t -81.12 -30.15 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.779 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -58.9 -37.56 76.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.296 -0.877 . . . . 0.0 110.108 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -79.28 -51.42 9.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 110.42 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.73 -53.93 45.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 0.0 110.672 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.5 mt -56.56 -59.88 4.35 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.247 -0.908 . . . . 0.0 110.404 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.67 -24.15 65.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.369 -0.832 . . . . 0.0 110.266 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -74.43 -64.93 0.92 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.35 48.69 0.07 OUTLIER Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.4 172.24 9.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -1.088 . . . . 0.0 110.22 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -110.82 102.75 53.25 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 0.0 110.239 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.3 -15.08 31.55 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.655 1.345 . . . . 0.0 110.64 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -109.31 26.83 10.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.909 . . . . 0.0 110.163 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.63 102.62 14.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.365 -0.835 . . . . 0.0 110.405 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 25.7 mt -65.82 123.08 18.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.355 -0.841 . . . . 0.0 110.076 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -62.48 175.64 0.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.395 -0.815 . . . . 0.0 109.886 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -6.12 45.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.305 -0.872 . . . . 0.0 110.459 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -93.3 17.59 10.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.173 -0.955 . . . . 0.0 110.084 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.98 24.0 18.27 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -110.15 155.85 21.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.387 -1.066 . . . . 0.0 109.836 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.55 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.9 mmp_? -73.61 168.86 21.65 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.387 -0.821 . . . . 0.0 109.524 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 41.0 Cg_endo -68.03 -14.98 42.48 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.454 1.239 . . . . 0.0 110.173 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.476 ' HA ' ' HG2' ' A' ' 46' ' ' MET . 58.0 mt -107.95 -17.94 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.85 . . . . 0.0 109.87 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -69.12 -20.93 64.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 110.15 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.59 -17.0 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.355 -0.841 . . . . 0.0 110.399 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.476 ' HG2' ' HA ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -55.92 164.49 1.17 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.195 -0.941 . . . . 0.0 110.31 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -63.14 89.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.171 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.442 ' HG3' ' HA ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -49.82 -19.93 0.76 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.47 -0.768 . . . . 0.0 111.28 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.439 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . -86.66 20.44 23.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.43 ' HB3' HG23 ' A' ' 53' ' ' VAL . 21.2 t -140.67 118.62 11.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.007 -1.29 . . . . 0.0 110.375 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -74.76 -26.25 59.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.924 . . . . 0.0 109.647 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.526 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 11.7 mt-30 -53.44 -27.35 24.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.525 -0.735 . . . . 0.0 110.644 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.43 HG23 ' HB3' ' A' ' 50' ' ' SER . 0.0 OUTLIER -90.05 -48.3 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 110.186 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.05 -35.11 64.14 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.297 -0.877 . . . . 0.0 110.368 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -78.03 -48.24 16.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.361 -0.837 . . . . 0.0 110.635 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.83 -65.54 0.54 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.201 -0.937 . . . . 0.0 110.761 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.95 -47.01 61.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.458 -0.776 . . . . 0.0 110.823 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.3 -43.5 74.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.3 tp -60.4 -25.61 66.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -95.98 24.68 5.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.201 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.55 54.41 37.94 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.28 -146.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -1.083 . . . . 0.0 109.464 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.63 70.7 77.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.004 -1.06 . . . . 0.0 110.048 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -81.57 -24.1 4.51 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.806 1.424 . . . . 0.0 110.134 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -95.75 -29.13 14.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 110.358 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.44 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -64.39 139.58 58.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 110.375 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.51 175.12 8.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.335 -0.853 . . . . 0.0 110.5 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.491 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 8.6 t70 -76.95 137.18 65.92 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.753 . . . . 0.0 109.84 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.06 -28.35 3.92 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.519 1.273 . . . . 0.0 111.106 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.49 -22.69 58.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.133 -0.979 . . . . 0.0 110.686 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.42 ' O ' ' C ' ' A' ' 72' ' ' LEU . 3.5 m -144.25 19.57 1.74 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 111.13 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.42 ' C ' ' O ' ' A' ' 71' ' ' THR . 4.9 mt 40.25 36.68 0.35 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.313 -0.867 . . . . 0.0 110.861 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -87.3 126.16 34.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.405 -0.809 . . . . 0.0 110.851 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.495 ' HB2' ' CG1' ' A' ' 100' ' ' VAL . 0.2 OUTLIER -92.62 173.25 5.23 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.557 -0.714 . . . . 0.0 110.178 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.09 -18.72 16.25 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.663 1.349 . . . . 0.0 110.348 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.89 -32.79 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.33 -0.856 . . . . 0.0 109.939 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.41 ' CE1' ' HD3' ' A' ' 108' ' ' PRO . 68.8 m80 -60.92 -46.15 91.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.04 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.403 ' CB ' ' CE ' ' A' ' 48' ' ' MET . 1.2 m-20 -60.21 -57.1 14.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.3 -0.875 . . . . 0.0 110.037 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HA ' ' HG3' ' A' ' 48' ' ' MET . . . -51.64 -30.53 21.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.357 -0.84 . . . . 0.0 109.818 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.16 -23.55 30.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.562 -0.711 . . . . 0.0 109.749 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.448 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -60.38 -35.58 76.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.457 -0.777 . . . . 0.0 110.122 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -94.76 -19.5 20.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.34 -0.85 . . . . 0.0 110.463 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.23 30.63 13.55 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.439 ' CE2' ' HA2' ' A' ' 49' ' ' GLY . 18.0 t80 -97.65 92.01 5.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -1.004 . . . . 0.0 110.092 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.63 -22.45 66.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.273 -0.892 . . . . 0.0 110.349 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -57.47 -41.14 80.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.397 -0.814 . . . . 0.0 110.392 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.416 HG21 ' CE ' ' A' ' 46' ' ' MET . 74.8 m -72.86 -36.38 67.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.349 -0.844 . . . . 0.0 109.96 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.4 mp -62.52 -42.26 99.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 109.769 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.6 t -61.31 -44.59 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.448 -0.783 . . . . 0.0 109.332 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 65.1 t -55.49 -44.29 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.444 -0.785 . . . . 0.0 109.857 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 5.5 mp -62.52 -45.95 90.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.428 -0.795 . . . . 0.0 109.744 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -70.97 -15.91 62.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.0 110.254 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -74.61 -71.64 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.349 -0.844 . . . . 0.0 110.136 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -60.78 -78.47 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.331 -0.855 . . . . 0.0 110.286 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.06 107.61 0.26 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -160.68 119.36 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -1.046 . . . . 0.0 109.834 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -60.43 126.59 28.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.263 -0.898 . . . . 0.0 110.379 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.51 64.64 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 110.283 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -171.29 61.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -0.859 . . . . 0.0 110.053 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.495 ' CG1' ' HB2' ' A' ' 74' ' ' ARG . 7.3 p -131.86 173.13 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 110.065 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -135.1 160.87 36.98 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 104' ' ' TRP . 29.5 m-20 -68.76 71.91 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.709 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' A' ' 101' ' ' CYS . . . 56.49 -80.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.64 -0.663 . . . . 0.0 110.113 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.503 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -126.78 32.69 5.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -115.46 -142.15 7.59 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.388 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.408 ' HB3' ' CB ' ' A' ' 110' ' ' ASP . 5.4 mtt85 -98.06 159.13 15.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -1.024 . . . . 0.0 110.787 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.484 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -78.99 175.64 4.53 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.604 -0.685 . . . . 0.0 109.618 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 40.8 Cg_endo -66.12 -16.87 53.7 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.385 1.203 . . . . 0.0 110.174 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.43 HG21 ' CG ' ' A' ' 125' ' ' HIS . 9.7 p -91.69 -34.9 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.873 . . . . 0.0 109.796 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.408 ' CB ' ' HB3' ' A' ' 106' ' ' ARG . 10.0 m-20 -66.91 -41.65 86.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -0.8 . . . . 0.0 109.954 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.426 HD22 ' HG2' ' A' ' 81' ' ' ARG . 5.8 tt -57.04 -31.02 64.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.419 -0.801 . . . . 0.0 109.951 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -83.85 -36.85 23.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.532 -0.73 . . . . 0.0 109.979 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -54.99 -26.21 35.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 0.0 110.644 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -91.88 -47.28 7.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.377 -0.827 . . . . 0.0 110.72 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.422 ' HG2' ' CE1' ' A' ' 117' ' ' HIS . 52.6 tp60 -66.4 -100.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.913 . . . . 0.0 110.547 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.12 24.7 0.2 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.523 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.448 ' CE1' ' O ' ' A' ' 81' ' ' ARG . 1.6 m170 -100.51 86.2 3.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.0 -1.294 . . . . 0.0 109.386 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.408 ' O ' ' HG2' ' A' ' 122' ' ' ARG . 2.6 mpt_? -80.72 -57.93 3.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.415 -0.803 . . . . 0.0 110.71 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -45.76 -46.84 15.42 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.627 -0.671 . . . . 0.0 110.894 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 121' ' ' ALA . 2.7 tt -65.41 -37.44 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 0.0 109.644 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -61.82 -39.7 92.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 110.0 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 11.5 mmt180 -63.8 -41.37 97.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -74.34 -30.64 62.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.548 -0.72 . . . . 0.0 109.587 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 20.4 mt -72.89 -59.55 2.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.522 -0.737 . . . . 0.0 109.972 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.43 ' CG ' HG21 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -56.06 -28.57 58.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.38 -0.825 . . . . 0.0 110.096 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.82 -33.77 71.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.429 -0.794 . . . . 0.0 110.243 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.81 -22.41 15.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.398 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.2 p -93.99 16.1 15.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 0.0 110.354 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -83.15 67.34 3.76 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.629 -179.71 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' SER . . . . . 0.45 ' N ' ' HD2' ' A' ' -3' ' ' PRO . 1.2 t -64.89 -56.8 18.78 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.363 -1.081 . . . . 0.0 110.404 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' -4' ' ' SER . 47.2 Cg_endo -72.34 -32.27 10.49 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.472 1.249 . . . . 0.0 110.64 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -66.29 127.19 29.25 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' ILE . . . . . . . . . . . . . 13.4 pt -144.72 23.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.369 -1.077 . . . . 0.0 110.564 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -170.17 -141.62 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.923 . . . . 0.0 110.438 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.92 175.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.236 -0.915 . . . . 0.0 111.17 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.0 tt -154.16 87.42 1.19 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.508 -0.745 . . . . 0.0 109.991 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.45 -160.37 36.29 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.82 -101.84 2.48 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.6 p -135.22 -78.14 0.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -1.127 . . . . 0.0 110.626 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.8 m -125.57 95.49 4.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.201 -0.937 . . . . 0.0 110.695 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.88 -17.93 51.95 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.358 -0.839 . . . . 0.0 110.01 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -148.51 50.74 1.0 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.4 ' HA3' ' CD1' ' A' ' 25' ' ' LEU . . . -55.08 -27.76 46.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.404 HD21 ' CD2' ' A' ' 26' ' ' LEU . 3.9 pp -57.96 -33.6 69.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.503 -0.998 . . . . 0.0 109.866 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.49 -39.28 53.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.381 -0.824 . . . . 0.0 109.733 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.7 m -62.36 -54.46 40.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.406 -0.809 . . . . 0.0 109.785 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 16' ' ' ARG . . . -64.13 -32.33 73.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 0.0 109.783 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB2' ' CB ' ' A' ' 46' ' ' MET . . . -67.19 -32.68 73.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.206 -0.934 . . . . 0.0 109.494 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.87 -27.02 63.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 110.02 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 19.2 ptt180 -100.17 20.25 14.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.33 -0.856 . . . . 0.0 110.411 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 62.5 83.0 0.07 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 35.4 mm-40 -151.74 71.25 0.97 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 110.174 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.601 ' CG1' ' HB3' ' A' ' 52' ' ' GLN . 24.8 t -57.0 -43.01 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.236 -0.915 . . . . 0.0 109.889 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -56.89 -52.61 64.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.343 -0.848 . . . . 0.0 110.541 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -41.44 96.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.359 -0.838 . . . . 0.0 110.249 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.24 -38.28 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.45 -0.781 . . . . 0.0 110.024 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.8 mmm-85 -69.5 -24.56 63.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 110.148 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 89.8 mm-40 -79.31 -53.6 6.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.836 . . . . 0.0 110.464 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.4 ' CD1' ' HA3' ' A' ' 9' ' ' GLY . 0.4 OUTLIER -59.58 -44.07 93.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.347 -0.846 . . . . 0.0 110.484 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.43 HD11 ' CG ' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -57.24 -53.33 59.35 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.18 -0.95 . . . . 0.0 110.245 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -75.35 -5.56 45.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.427 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -84.1 -39.05 19.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.139 -0.975 . . . . 0.0 110.431 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.98 -20.19 0.14 Allowed Glycine 0 N--CA 1.484 1.881 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.642 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -47.46 136.27 10.01 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.151 -1.205 . . . . 0.0 111.009 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.574 ' OD2' ' CB ' ' A' ' 34' ' ' ALA . 10.4 p-10 -78.19 150.59 77.61 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 110.203 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.73 4.45 6.91 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.852 1.448 . . . . 0.0 111.051 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -136.35 43.25 2.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.036 -1.04 . . . . 0.0 110.917 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.574 ' CB ' ' OD2' ' A' ' 31' ' ' ASP . . . -109.72 104.69 13.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 pp -73.61 138.76 45.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.201 -0.937 . . . . 0.0 110.253 -179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -107.7 82.72 1.69 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.471 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 52.02 -171.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.313 -0.867 . . . . 0.0 110.862 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 39' ' ' GLY . 80.2 m-85 55.56 13.28 0.94 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.571 -0.705 . . . . 0.0 110.924 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' PHE . . . 38.54 35.31 0.31 Allowed Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -107.11 -164.68 1.0 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -1.041 . . . . 0.0 110.478 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.632 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.8 mmp_? -116.71 176.64 1.47 Allowed Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.632 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 43.1 Cg_endo -72.07 -19.78 26.02 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.31 1.163 . . . . 0.0 110.2 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.425 ' O ' ' HG2' ' A' ' 46' ' ' MET . 25.4 mt -104.27 -27.44 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -74.47 -4.26 35.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.536 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.4 p -115.03 -17.95 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.084 -1.01 . . . . 0.0 110.748 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -64.34 164.82 10.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.966 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.67 -16.92 4.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.375 -0.828 . . . . 0.0 110.545 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.441 ' CG ' ' HA ' ' A' ' 79' ' ' ALA . 45.3 tpp 58.93 24.66 12.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.294 -0.878 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.23 20.54 5.59 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 m -149.13 96.26 2.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 110.04 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.49 -26.76 13.86 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.274 -0.891 . . . . 0.0 110.296 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.601 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 6.0 mt-30 -53.28 -34.8 58.76 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.404 HG12 ' CB ' ' A' ' 14' ' ' ALA . 60.3 t -84.13 -38.47 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 110.223 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.404 ' CB ' ' CG2' ' A' ' 87' ' ' THR . . . -68.18 -33.18 73.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.415 -0.803 . . . . 0.0 110.553 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -76.6 -39.98 50.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.966 . . . . 0.0 110.659 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 46.5 tp -56.2 -63.03 1.32 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.284 -0.885 . . . . 0.0 110.732 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mt -59.78 -30.31 68.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.254 -0.904 . . . . 0.0 110.84 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.405 ' CD2' ' CG1' ' A' ' 90' ' ' VAL . 2.7 tp -60.13 -67.51 0.38 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.13 -0.981 . . . . 0.0 110.99 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.2 pp -51.85 -25.28 7.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.247 -0.908 . . . . 0.0 110.7 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.43 ' CG ' HD11 ' A' ' 26' ' ' LEU . 12.7 m80 -80.88 -67.3 0.79 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.179 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.52 40.9 0.04 OUTLIER Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.67 -164.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.314 -1.109 . . . . 0.0 110.13 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.59 74.43 74.63 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.959 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.89 -32.61 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.901 1.474 . . . . 0.0 110.158 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -95.6 -30.18 13.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.388 -0.82 . . . . 0.0 110.012 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 171.08 2.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.438 -0.789 . . . . 0.0 110.139 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -169.46 -179.51 3.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.421 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 72' ' ' LEU . 21.8 t0 -78.69 131.44 67.71 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.396 -0.815 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.67 -23.16 11.39 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.544 1.286 . . . . 0.0 110.398 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.83 -29.41 62.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 0.0 110.59 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.427 ' O ' ' CB ' ' A' ' 103' ' ' ALA . 7.8 m -138.92 17.32 2.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.907 . . . . 0.0 110.665 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER 42.38 29.47 0.15 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.317 -0.864 . . . . 0.0 110.794 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.31 134.84 45.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 110.556 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.406 ' HG3' ' CG1' ' A' ' 100' ' ' VAL . 0.1 OUTLIER -107.72 165.17 13.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 110.324 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.37 -24.68 22.5 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.698 1.367 . . . . 0.0 110.322 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.9 t -58.7 -29.14 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.353 -0.842 . . . . 0.0 110.007 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.447 ' CE1' ' HD3' ' A' ' 108' ' ' PRO . 33.4 m80 -68.65 -34.33 75.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.344 -0.848 . . . . 0.0 110.126 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.417 ' HB3' ' HE3' ' A' ' 48' ' ' MET . 43.4 m-20 -77.82 -56.5 4.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.409 -0.807 . . . . 0.0 110.239 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.441 ' HA ' ' CG ' ' A' ' 48' ' ' MET . . . -52.65 -26.6 14.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.093 -1.004 . . . . 0.0 109.888 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.436 ' O ' ' CD2' ' A' ' 117' ' ' HIS . . . -85.3 -21.31 29.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.435 -0.791 . . . . 0.0 109.566 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -76.44 -17.25 59.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.429 -0.794 . . . . 0.0 110.341 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.402 ' C ' ' CE1' ' A' ' 117' ' ' HIS . 30.6 mm-40 -100.84 -34.54 9.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.18 -0.95 . . . . 0.0 110.323 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.9 34.18 4.42 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.2 105.61 15.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -1.091 . . . . 0.0 110.123 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -77.6 -21.98 51.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.466 -0.772 . . . . 0.0 110.256 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -68.0 -48.71 64.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.361 -0.837 . . . . 0.0 110.565 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.404 ' CG2' ' CB ' ' A' ' 54' ' ' ALA . 97.8 m -65.3 -33.98 77.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.14 -0.975 . . . . 0.0 110.071 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.87 -48.53 80.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.226 -0.921 . . . . 0.0 109.857 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 67.6 t -60.06 -40.7 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 109.527 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.405 ' CG1' ' CD2' ' A' ' 58' ' ' LEU . 91.3 t -53.82 -53.79 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.446 -0.784 . . . . 0.0 110.234 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mp -52.74 -52.01 58.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.387 -0.821 . . . . 0.0 110.581 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -60.99 -24.69 66.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.254 -0.904 . . . . 0.0 110.177 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.42 -22.88 60.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.407 -0.808 . . . . 0.0 110.338 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -121.46 35.05 4.99 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.278 -0.889 . . . . 0.0 110.616 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.59 114.05 0.14 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -155.6 131.56 9.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -1.099 . . . . 0.0 110.034 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 141.47 38.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 109.951 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -133.59 11.09 4.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -0.816 . . . . 0.0 110.307 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -110.73 22.92 14.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 110.019 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.406 ' CG1' ' HG3' ' A' ' 74' ' ' ARG . 9.5 p -91.56 144.93 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.451 -0.78 . . . . 0.0 109.932 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 53.4 m -115.17 41.96 2.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 110.383 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 104' ' ' TRP . 32.0 t0 52.64 69.47 0.68 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.351 -0.843 . . . . 0.0 110.36 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.427 ' CB ' ' O ' ' A' ' 71' ' ' THR . . . 62.89 -77.93 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.519 -0.738 . . . . 0.0 110.254 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -155.5 45.92 0.48 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.356 -0.84 . . . . 0.0 109.801 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -129.42 -118.09 2.03 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -95.83 -178.36 4.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -1.102 . . . . 0.0 110.665 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.493 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 3.7 mp -105.14 173.65 3.16 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.498 -0.752 . . . . 0.0 109.942 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 41.6 Cg_endo -67.83 -20.12 46.02 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.551 1.29 . . . . 0.0 110.274 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.4 p -83.28 -23.56 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 110.189 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -62.32 -28.34 69.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.225 -0.922 . . . . 0.0 110.266 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.403 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 4.4 mm? -58.32 -68.55 0.24 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.308 -0.87 . . . . 0.0 109.941 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -61.64 -43.54 98.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.871 . . . . 0.0 109.725 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -48.98 -31.99 8.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.513 -0.742 . . . . 0.0 109.51 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 115' ' ' GLN . 10.8 tt0 -66.97 -62.94 1.18 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.608 -0.683 . . . . 0.0 109.212 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER 172.46 113.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.541 -0.724 . . . . 0.0 110.221 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.43 -53.19 0.42 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.628 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.436 ' CD2' ' O ' ' A' ' 80' ' ' ALA . 1.2 m-70 -138.86 75.78 1.54 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.176 -1.19 . . . . 0.0 110.566 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -61.41 -22.78 65.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 0.0 109.979 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -72.87 -42.21 63.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.401 -0.812 . . . . 0.0 110.451 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 80' ' ' ALA . 0.6 OUTLIER -61.87 -30.75 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.917 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 125' ' ' HIS . . . -65.1 -52.61 54.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.421 -0.8 . . . . 0.0 109.644 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.4 mtm180 -45.81 -46.38 15.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.285 -0.884 . . . . 0.0 110.662 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -81.77 -56.74 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 111.057 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.475 ' HG ' ' N ' ' A' ' 125' ' ' HIS . 0.3 OUTLIER -59.51 -39.65 84.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.034 . . . . 0.0 111.158 -178.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.519 ' CD2' ' C ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -67.81 -39.76 83.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.747 -1.22 . . . . 0.0 109.461 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . 0.449 ' N ' ' CD2' ' A' ' 125' ' ' HIS . . . -54.23 -27.94 37.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.412 -0.805 . . . . 0.0 109.548 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -90.86 -16.8 27.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.595 -0.69 . . . . 0.0 110.411 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 124' ' ' LEU . 29.1 p -98.16 26.03 5.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.194 -0.941 . . . . 0.0 109.71 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.73 65.28 0.84 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.419 -1.047 . . . . 0.0 110.606 -179.886 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.672 -1.371 . . . . 12.42 109.672 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 83.9 p 44.45 72.79 1.1 Allowed Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.614 -0.933 . . . . 10.76 110.876 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.68 -17.5 42.64 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.995 1.524 . . . . 10.95 110.609 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' GLY . . . . . 0.868 ' O ' ' N ' ' A' ' 0' ' ' HIS . . . -96.41 -34.03 5.98 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.106 -1.198 . . . . 10.45 110.106 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 0' ' ' HIS . 11.1 tt 43.6 -51.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 121.947 -0.737 . . . . 12.1 112.384 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' HIS . . . . . 0.868 ' N ' ' O ' ' A' ' -2' ' ' GLY . 11.5 t-80 -68.87 -32.13 71.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.634 -1.291 . . . . 10.85 110.224 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.92 129.78 41.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.237 -0.914 . . . . 9.45 110.247 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.5 33.07 4.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 6.43 110.029 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.86 30.87 5.62 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.734 -1.346 . . . . 5.01 109.734 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.47 73.23 2.07 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.486 -1.446 . . . . 4.06 109.486 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.24 -58.75 0.75 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.369 -1.077 . . . . 4.5 110.5 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.14 27.59 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.233 -0.917 . . . . 3.03 110.613 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.64 -54.75 34.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.209 -0.932 . . . . 3.36 109.873 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.34 18.24 12.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 3.58 110.236 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.96 -37.35 92.08 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.385 -1.486 . . . . 2.79 109.385 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.93 -27.25 66.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.384 -1.068 . . . . 2.88 110.154 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.47 -47.08 14.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.45 -0.781 . . . . 2.34 110.0 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.8 p -62.17 -51.2 68.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.373 -0.83 . . . . 2.55 109.837 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.53 -34.01 72.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.377 -0.827 . . . . 2.01 109.791 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -73.07 -36.18 66.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.536 -0.728 . . . . 1.66 109.91 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 46' ' ' MET . . . -60.75 -27.07 67.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.421 -0.799 . . . . 2.08 110.066 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -93.52 -17.51 23.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.372 -0.83 . . . . 5.69 110.321 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.17 54.04 1.31 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.518 -1.433 . . . . 1.44 109.518 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -124.92 79.42 1.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -1.118 . . . . 3.26 110.521 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.669 ' CG2' ' HB3' ' A' ' 52' ' ' GLN . 84.5 t -61.71 -38.84 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.222 -0.924 . . . . 1.8 109.66 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.78 -44.57 90.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.348 -0.845 . . . . 2.51 110.346 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 m -64.35 -42.68 96.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.869 . . . . 2.25 109.974 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.66 -25.77 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.429 -0.794 . . . . 2.02 110.198 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.418 ' HG2' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -64.26 -51.31 64.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.317 -0.864 . . . . 2.38 110.464 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.82 -21.06 60.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.275 -0.89 . . . . 5.21 110.599 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.26 -63.61 1.08 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.202 -0.936 . . . . 3.0 110.551 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.413 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 10.2 mt -56.83 -46.37 81.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.289 -0.882 . . . . 3.45 110.646 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.36 -35.24 75.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.38 -0.825 . . . . 3.3 110.375 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.08 -65.8 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.362 -0.836 . . . . 2.66 110.134 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.99 57.33 0.07 OUTLIER Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.563 -1.415 . . . . 3.23 109.563 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.01 133.93 52.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -1.114 . . . . 2.91 110.168 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -69.57 127.65 92.58 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 3.66 109.996 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.86 -17.32 25.61 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.592 1.312 . . . . 2.35 110.547 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -107.93 29.03 7.64 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -0.906 . . . . 2.17 110.227 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.22 106.2 13.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.363 -0.836 . . . . 2.69 110.153 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 13.2 mt -65.3 164.92 12.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.384 -0.822 . . . . 3.46 110.386 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -107.69 -170.0 1.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 3.25 110.14 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -81.77 -18.58 43.66 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.397 -0.814 . . . . 4.9 110.341 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -91.46 18.46 7.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.311 -0.868 . . . . 3.9 110.43 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.07 37.4 45.62 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.836 -1.306 . . . . 2.3 109.836 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.05 162.94 17.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.37 -1.077 . . . . 3.25 110.325 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.601 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.2 mmp_? -77.08 170.76 14.77 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.503 -0.748 . . . . 2.55 109.516 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 41.1 Cg_endo -67.58 -13.1 37.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.478 1.252 . . . . 1.72 110.52 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.4 HG23 ' HE2' ' A' ' 46' ' ' MET . 74.2 mt -109.92 -17.86 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -0.918 . . . . 1.87 109.862 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.81 -4.97 49.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.218 -0.926 . . . . 2.69 110.282 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.2 p -120.36 -6.43 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.251 -0.906 . . . . 2.0 110.903 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -69.41 162.42 27.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.024 -1.047 . . . . 1.8 110.174 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -54.67 -19.62 6.53 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.344 -0.847 . . . . 2.26 110.865 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 60.96 19.68 10.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.29 -0.881 . . . . 1.43 110.156 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.418 ' HA2' ' CD2' ' A' ' 84' ' ' PHE . . . -124.81 24.39 6.07 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.369 -1.492 . . . . 1.25 109.369 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.9 t -154.59 106.84 2.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -1.083 . . . . 1.93 110.071 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -58.88 -25.68 63.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.419 -0.801 . . . . 1.66 110.348 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.669 ' HB3' ' CG2' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -58.08 -29.54 65.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.269 -0.895 . . . . 3.15 110.185 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.403 ' CG2' ' CG2' ' A' ' 19' ' ' VAL . 34.6 t -84.19 -47.93 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.396 -0.815 . . . . 1.81 110.504 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.15 83.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.31 -0.869 . . . . 1.64 110.661 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -74.93 -33.76 62.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 2.74 110.457 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.418 HD12 ' HG2' ' A' ' 23' ' ' ARG . 1.9 tt -57.22 -64.31 0.93 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.294 -0.879 . . . . 2.59 110.725 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.6 mt -61.41 -40.24 93.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.353 -0.842 . . . . 2.34 110.9 -179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.47 -57.46 12.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 2.73 110.745 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -53.49 -26.35 20.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.287 -0.883 . . . . 2.78 110.236 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.413 ' CE1' ' HB3' ' A' ' 26' ' ' LEU . 3.1 m170 -84.2 -73.9 0.4 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 2.98 110.054 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.16 50.11 0.05 OUTLIER Glycine 0 N--CA 1.483 1.831 0 N-CA-C 109.741 -1.343 . . . . 1.62 109.741 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.8 -162.11 0.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -1.109 . . . . 1.95 110.177 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.91 76.83 39.63 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 2.16 110.183 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.75 -24.44 8.69 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.775 1.408 . . . . 1.35 110.573 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -92.84 -50.01 5.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 3.1 110.4 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.07 120.85 6.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.244 -0.91 . . . . 1.88 110.449 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.36 -179.44 3.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.396 -0.815 . . . . 2.11 110.329 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -76.95 125.59 86.71 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 2.51 110.003 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.78 -13.0 24.41 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.495 1.26 . . . . 2.53 110.727 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.0 -30.86 44.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.958 . . . . 3.02 110.557 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.7 m -142.66 17.15 2.0 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 3.31 110.567 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.98 32.08 7.05 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.288 -0.883 . . . . 2.76 110.506 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.7 121.47 28.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.389 -0.819 . . . . 2.11 110.379 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.412 ' HB2' ' CG1' ' A' ' 100' ' ' VAL . 1.0 OUTLIER -93.1 172.65 5.78 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.775 . . . . 2.97 110.161 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.13 -9.38 24.4 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.719 1.379 . . . . 1.08 110.772 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.83 -23.94 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.178 -0.951 . . . . 1.2 110.141 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -72.03 -52.14 18.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.311 -0.868 . . . . 0.95 110.476 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -58.44 -47.48 83.83 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.282 -0.886 . . . . 1.76 110.418 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -60.62 -26.36 66.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -0.853 . . . . 1.0 110.211 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -87.7 -21.33 25.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.352 -0.843 . . . . 1.48 110.442 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 -72.6 -30.83 64.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.256 -0.903 . . . . 3.61 110.344 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.404 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 1.3 mm-40 -86.61 -36.11 19.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.872 . . . . 2.1 110.211 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.37 46.06 1.9 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.699 -1.361 . . . . 1.17 109.699 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.418 ' CD2' ' HA2' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -115.13 103.15 10.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.366 -1.079 . . . . 2.48 109.923 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.3 mt -75.24 -22.62 57.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.847 . . . . 2.56 110.368 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.97 -43.31 95.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 1.68 110.114 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 63.7 m -73.24 -39.55 65.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.326 -0.859 . . . . 1.38 109.889 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.47 -46.51 76.83 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.393 -0.817 . . . . 1.75 109.952 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.18 -41.15 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.402 -0.811 . . . . 1.84 109.539 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.2 t -57.2 -47.9 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.596 -0.69 . . . . 1.67 110.276 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.11 -52.5 65.3 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.39 -0.819 . . . . 1.49 110.303 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -60.01 -27.2 66.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.514 -0.741 . . . . 1.94 110.323 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -67.8 -69.03 0.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 3.72 110.265 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.65 -28.19 45.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 1.91 110.669 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.17 87.86 1.21 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.564 -1.415 . . . . 1.92 109.564 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.33 134.43 37.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -1.118 . . . . 1.55 110.313 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -71.43 143.05 50.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.802 . . . . 4.14 110.103 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 mp -123.37 -2.78 8.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 2.1 110.823 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -93.69 69.97 4.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.122 -0.986 . . . . 2.12 110.151 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.412 ' CG1' ' HB2' ' A' ' 74' ' ' ARG . 12.2 p -135.27 151.23 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.433 -0.792 . . . . 1.79 110.156 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.401 ' O ' ' N ' ' A' ' 103' ' ' ALA . 12.3 m -116.22 159.17 22.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.243 -0.911 . . . . 2.38 109.404 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -68.55 74.54 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 2.65 109.755 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.43 ' HB3' ' CE3' ' A' ' 104' ' ' TRP . . . 61.16 -79.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.635 -0.666 . . . . 2.58 110.047 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.448 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.2 p90 -128.41 37.96 4.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 4.46 109.859 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -120.49 -141.25 6.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.99 -1.244 . . . . 2.7 109.99 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -101.74 -164.95 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.4 -1.059 . . . . 5.24 110.48 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -96.18 174.27 3.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.725 . . . . 2.54 110.035 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.8 Cg_endo -68.16 -22.39 40.85 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.697 1.367 . . . . 1.02 110.254 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.73 -27.31 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 1.77 110.042 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -80.26 -38.93 29.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.836 . . . . 2.42 110.095 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.48 -26.83 65.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.399 -0.813 . . . . 2.48 109.918 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -78.04 -54.26 6.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.51 -0.744 . . . . 1.82 109.971 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -53.09 -25.79 14.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.395 -0.816 . . . . 3.39 110.573 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -79.05 -54.98 5.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 3.16 110.235 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.38 -67.33 0.43 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.399 -0.813 . . . . 4.58 110.052 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 157.6 47.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.595 -1.402 . . . . 2.69 109.595 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' HIS . . . . . 0.404 ' CE1' ' O ' ' A' ' 82' ' ' GLU . 70.1 m-70 -122.23 64.63 0.93 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.361 -1.082 . . . . 2.8 109.999 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -35.43 67.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.283 -0.886 . . . . 5.16 110.158 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -61.9 -48.5 80.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.379 -0.825 . . . . 2.51 110.218 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.62 -25.38 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.397 -0.815 . . . . 1.97 110.347 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.0 -45.41 67.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.395 -0.816 . . . . 2.14 110.119 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.5 mtp85 -59.56 -53.54 56.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.357 -0.839 . . . . 4.59 110.126 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -60.52 -35.91 77.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.343 -0.848 . . . . 2.42 110.058 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 34.3 mt -72.6 -41.06 66.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.453 -0.78 . . . . 1.9 110.172 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -59.73 -22.53 62.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.401 -0.812 . . . . 4.51 110.327 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -86.47 -30.86 21.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.878 . . . . 2.64 110.308 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -96.84 -21.04 17.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.278 -0.888 . . . . 1.93 110.633 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 26.4 p -104.36 -15.87 15.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 2.39 110.458 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.42 -73.9 0.41 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.807 -1.317 . . . . 3.14 109.807 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 O-C-N 121.463 -1.022 . . . . 5.89 110.057 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 1.11 ' O ' HD11 ' A' ' 25' ' ' LEU . 6.4 p-10 . . . . . 0 C--O 1.211 -0.925 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 9' ' ' GLY . . . -115.47 5.45 14.49 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.239 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.846 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -41.22 -33.58 0.81 Allowed Glycine 0 N--CA 1.499 2.844 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.985 HD22 HD21 ' A' ' 57' ' ' LEU . 4.2 pp -53.66 -29.1 36.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.755 -0.85 . . . . 0.0 109.803 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.755 ' N ' HD12 ' A' ' 10' ' ' LEU . . . -88.06 -60.23 2.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.366 -0.834 . . . . 0.0 109.995 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.1 p -53.46 -47.67 69.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.444 -0.785 . . . . 0.0 110.525 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' A' ' 18' ' ' GLN . . . -67.73 -38.69 83.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 109.778 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -56.54 -52.88 63.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.413 -0.805 . . . . 0.0 109.706 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' A' ' 47' ' ' MET . . . -53.46 -30.4 40.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.891 . . . . 0.0 109.078 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -90.51 8.88 31.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.64 -0.662 . . . . 0.0 110.084 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.0 58.64 7.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.816 ' O ' HG23 ' A' ' 22' ' ' VAL . 27.0 mt-30 -131.92 81.07 1.95 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -1.133 . . . . 0.0 111.008 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.942 HG21 ' HB3' ' A' ' 52' ' ' GLN . 61.1 t -68.67 -29.39 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.065 -1.022 . . . . 0.0 109.217 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -61.8 -42.97 99.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.312 -0.868 . . . . 0.0 109.423 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.516 ' HB ' ' CB ' ' A' ' 13' ' ' ALA . 1.8 m -69.08 -41.25 77.76 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.933 HG12 HD13 ' A' ' 56' ' ' LEU . 21.6 t -61.61 -34.32 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.416 ' HA ' HD11 ' A' ' 56' ' ' LEU . 1.6 mmt180 -70.24 -33.73 71.99 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.41 -53.42 8.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.67 -0.643 . . . . 0.0 111.092 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.11 HD11 ' O ' ' A' ' 7' ' ' ASP . 2.9 tm? -55.91 -25.36 42.64 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.008 -1.058 . . . . 0.0 109.145 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -95.34 -68.82 0.78 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.053 -1.03 . . . . 0.0 111.713 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -50.54 -17.9 0.58 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.29 -0.881 . . . . 0.0 111.535 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.4 2.98 10.0 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.983 -1.073 . . . . 0.0 110.951 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.35 72.93 1.26 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.758 ' HB1' ' HB2' ' A' ' 7' ' ' ASP . . . -132.69 -166.49 1.75 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.412 -1.051 . . . . 0.0 111.42 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.13 140.76 21.55 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.675 -0.64 . . . . 0.0 109.609 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.43 5.36 3.75 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.48 1.253 . . . . 0.0 111.277 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -134.18 42.62 2.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.859 -1.15 . . . . 0.0 111.254 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.723 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . . . -69.36 79.3 0.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.96 -1.087 . . . . 0.0 109.186 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mt -49.5 158.58 0.41 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.532 -0.73 . . . . 0.0 111.397 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -121.26 159.14 26.59 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -22.79 13.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.153 -0.967 . . . . 0.0 110.566 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -77.3 -9.78 59.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 110.356 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.72 28.79 31.49 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 44' ' ' GLN . 13.4 mtm180 -101.77 37.96 1.72 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -1.079 . . . . 0.0 110.084 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.89 177.27 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.312 -0.867 . . . . 0.0 110.674 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -81.53 -24.78 4.12 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.608 1.32 . . . . 0.0 110.816 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.0 mt -102.39 -40.9 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.158 -0.963 . . . . 0.0 110.884 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.43 ' CB ' ' O ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -52.19 -20.68 2.74 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.029 -1.045 . . . . 0.0 110.777 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 45' ' ' VAL . 11.1 p -113.92 44.5 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.932 . . . . 0.0 110.85 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.613 ' CE ' HG21 ' A' ' 87' ' ' THR . 16.6 ptt? -111.8 26.58 10.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.032 -1.042 . . . . 0.0 110.163 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 3.5 tmm? 67.86 -2.39 1.43 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.583 -0.698 . . . . 0.0 111.086 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.608 ' O ' ' HZ ' ' A' ' 84' ' ' PHE . 14.3 mmt 42.35 31.23 0.25 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.211 -0.931 . . . . 0.0 110.988 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -125.01 -3.36 7.55 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.7 p -133.35 99.69 4.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.993 -1.298 . . . . 0.0 110.695 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.0 67.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.302 -0.874 . . . . 0.0 109.824 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.942 ' HB3' HG21 ' A' ' 19' ' ' VAL . 8.3 tp60 -52.01 -27.78 14.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.428 -0.795 . . . . 0.0 110.043 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.826 ' CG2' HG22 ' A' ' 19' ' ' VAL . 19.3 t -87.68 -36.46 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.828 . . . . 0.0 109.489 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.564 ' HB2' ' HE1' ' A' ' 46' ' ' MET . . . -60.8 -40.16 91.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.428 -0.795 . . . . 0.0 110.424 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' O ' HD23 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -76.17 -39.95 53.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.0 110.614 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.933 HD13 HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -49.43 -64.59 0.76 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.335 -0.853 . . . . 0.0 111.54 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.985 HD21 HD22 ' A' ' 10' ' ' LEU . 3.2 mt -67.25 -38.12 84.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.106 -0.996 . . . . 0.0 111.152 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.937 HD22 ' CG1' ' A' ' 90' ' ' VAL . 1.1 tp -52.79 -66.74 0.33 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.019 -1.051 . . . . 0.0 110.532 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 55' ' ' GLU . 4.0 pp -52.23 -27.57 15.3 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.283 -0.886 . . . . 0.0 110.004 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.474 ' N ' HD12 ' A' ' 59' ' ' LEU . 3.3 m80 -77.24 -68.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.368 -0.833 . . . . 0.0 110.073 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.25 38.34 0.03 OUTLIER Glycine 0 N--CA 1.484 1.842 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.861 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -60.16 -166.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.204 -1.174 . . . . 0.0 110.422 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -121.74 75.26 36.34 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 110.057 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.478 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . 48.5 Cg_endo -77.89 -21.35 11.07 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.831 1.437 . . . . 0.0 110.54 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -95.53 -47.69 6.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 110.457 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.58 172.96 0.44 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.276 -0.89 . . . . 0.0 110.22 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.448 ' HB2' ' NE ' ' A' ' 74' ' ' ARG . . . -169.27 -176.67 2.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.492 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.41 123.21 86.87 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.425 -0.797 . . . . 0.0 109.95 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.31 -13.98 20.61 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.681 1.358 . . . . 0.0 110.97 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.49 -20.95 56.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.197 -0.939 . . . . 0.0 110.85 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.762 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -155.03 27.15 0.42 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.082 -1.011 . . . . 0.0 110.877 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.647 ' HB2' ' H ' ' A' ' 103' ' ' ALA . 86.1 mt 43.14 45.11 4.62 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.277 -0.89 . . . . 0.0 111.417 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.42 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -93.39 103.48 15.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.223 -0.923 . . . . 0.0 110.56 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.798 ' HB2' HG11 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.54 179.38 1.89 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.849 . . . . 0.0 110.106 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD2' ' CG ' ' A' ' 74' ' ' ARG . 48.8 Cg_endo -78.68 -18.29 12.01 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.544 1.286 . . . . 0.0 110.603 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.516 HG11 HD23 ' A' ' 98' ' ' LEU . 75.8 t -67.94 -36.31 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 110.107 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.406 ' CG ' ' OD1' ' A' ' 102' ' ' ASP . 69.8 m-70 -68.4 -39.62 81.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.29 -0.881 . . . . 0.0 110.4 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' A' ' 81' ' ' ARG . 0.7 OUTLIER -57.67 -55.41 35.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.352 -0.843 . . . . 0.0 110.062 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -62.91 -18.47 63.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.082 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.743 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -82.27 -44.15 16.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.389 -0.819 . . . . 0.0 110.571 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -64.59 -20.57 66.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.186 -0.946 . . . . 0.0 110.126 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' N ' ' HG3' ' A' ' 81' ' ' ARG . 2.2 mm-40 -97.02 -48.04 5.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.017 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.49 14.43 10.57 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.608 ' HZ ' ' O ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -78.66 80.05 5.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.124 -1.221 . . . . 0.0 109.804 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -60.07 -23.66 63.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.448 -0.783 . . . . 0.0 110.431 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -61.54 -52.54 64.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.221 -0.924 . . . . 0.0 110.088 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.613 HG21 ' CE ' ' A' ' 46' ' ' MET . 37.6 m -58.59 -34.97 71.68 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.257 -0.902 . . . . 0.0 109.933 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.809 HD11 HD11 ' A' ' 120' ' ' ILE . 1.5 mp -57.4 -46.82 83.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 71.4 t -57.35 -46.94 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.451 -0.781 . . . . 0.0 109.288 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.937 ' CG1' HD22 ' A' ' 58' ' ' LEU . 49.4 t -50.77 -55.4 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.526 -0.734 . . . . 0.0 110.358 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.581 ' C ' ' HB2' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -50.62 -63.11 1.23 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.233 -0.917 . . . . 0.0 110.161 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -61.28 -21.72 64.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 0.0 110.133 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 48.4 ttt180 -77.91 -8.94 58.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.304 -0.873 . . . . 0.0 110.378 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.778 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -135.2 33.93 3.07 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.291 -0.881 . . . . 0.0 110.43 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.51 90.49 0.08 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.581 ' HB2' ' C ' ' A' ' 91' ' ' LEU . . . -120.75 154.98 34.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -1.065 . . . . 0.0 110.316 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.56 75.15 7.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 110.209 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.516 HD23 HG11 ' A' ' 76' ' ' VAL . 3.7 mt -83.81 68.63 10.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -170.06 44.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.393 -0.817 . . . . 0.0 109.725 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.798 HG11 ' HB2' ' A' ' 74' ' ' ARG . 7.8 p -124.5 171.21 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.442 ' N ' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -121.81 136.71 54.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 109.281 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.589 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -69.37 73.91 0.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.845 . . . . 0.0 109.361 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.762 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 66.83 -69.07 0.13 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.344 0.592 . . . . 0.0 109.774 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.421 ' N ' ' O ' ' A' ' 102' ' ' ASP . 1.8 m-90 -140.88 35.5 1.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.482 -0.761 . . . . 0.0 109.379 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 107' ' ' LEU . . . -107.38 24.54 24.11 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.388 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.572 ' C ' HD12 ' A' ' 107' ' ' LEU . 21.8 mtm180 59.52 -73.16 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.408 -1.054 . . . . 0.0 110.78 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -155.84 167.99 13.15 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 110.022 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.44 ' HB2' HG12 ' A' ' 76' ' ' VAL . 46.3 Cg_endo -70.82 -31.49 15.72 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.648 1.341 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 121' ' ' ALA . 10.8 p -63.64 -38.99 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.885 . . . . 0.0 110.042 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 109' ' ' VAL . 75.6 m-20 -66.09 -50.76 62.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.357 -0.839 . . . . 0.0 110.065 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.54 -29.12 58.36 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.376 -0.828 . . . . 0.0 110.288 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.426 ' HB1' HG23 ' A' ' 120' ' ' ILE . . . -67.71 -75.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.421 -0.799 . . . . 0.0 110.216 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 109' ' ' VAL . 4.5 pt-20 -52.73 -27.2 16.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.284 -0.885 . . . . 0.0 110.779 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -58.71 -50.48 73.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.321 -0.862 . . . . 0.0 110.685 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -78.02 -76.65 0.18 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.347 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -167.72 34.81 0.21 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -122.77 79.37 1.63 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.333 -1.098 . . . . 0.0 109.925 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.9 mtp85 -81.22 -40.05 24.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.61 -43.44 80.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.315 -0.865 . . . . 0.0 110.273 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.809 HD11 HD11 ' A' ' 88' ' ' LEU . 17.0 tt -76.64 -38.42 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.982 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 109' ' ' VAL . . . -58.64 -44.78 90.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.559 -0.713 . . . . 0.0 110.006 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -61.99 -45.2 94.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.352 -0.842 . . . . 0.0 110.012 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -64.53 -37.12 86.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.956 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.684 ' O ' HG22 ' A' ' 128' ' ' THR . 12.1 mt -61.34 -58.94 6.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.858 . . . . 0.0 110.196 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.619 ' ND1' HG21 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -53.22 -24.27 10.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.347 -0.846 . . . . 0.0 110.489 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.2 -11.18 44.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.476 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.73 12.08 6.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.967 . . . . 0.0 110.681 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 124' ' ' LEU . 11.9 t . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.143 -0.973 . . . . 0.0 110.324 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.684 ' OD2' ' HB1' ' A' ' 34' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 121.153 0.501 . . . . 0.0 110.894 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -124.59 -21.88 4.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.925 -1.11 . . . . 0.0 110.603 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.92 -29.21 50.54 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.835 HD11 HD12 ' A' ' 26' ' ' LEU . 63.1 tp -56.78 -53.72 54.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.367 -1.078 . . . . 0.0 110.545 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.497 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -65.69 -52.19 53.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.338 -0.851 . . . . 0.0 110.47 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 p -59.15 -46.67 87.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.351 -0.843 . . . . 0.0 110.452 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -59.69 -36.65 76.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 109.926 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.432 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -73.92 -31.71 63.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.903 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.562 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -72.72 -28.69 62.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.392 -0.817 . . . . 0.0 110.017 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -90.44 11.16 22.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.35 -0.844 . . . . 0.0 110.323 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.11 58.5 13.27 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.669 ' O ' HG23 ' A' ' 22' ' ' VAL . 88.0 mm-40 -126.66 81.88 2.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 110.379 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.673 HG22 HG23 ' A' ' 53' ' ' VAL . 53.8 t -60.43 -50.65 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.142 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -51.66 -51.66 54.05 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.283 -0.885 . . . . 0.0 110.55 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.0 m -61.82 -42.7 99.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.244 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.936 HG12 HD23 ' A' ' 56' ' ' LEU . 97.7 t -67.6 -38.22 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.355 -0.841 . . . . 0.0 110.207 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.509 ' HA ' HD22 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -69.65 -31.23 69.19 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.309 -0.869 . . . . 0.0 110.217 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 18.5 tm0? -80.48 -51.13 9.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 110.695 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.932 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -60.35 -60.92 3.05 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.254 -0.903 . . . . 0.0 110.483 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.865 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 1.2 tt -53.28 -43.68 67.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.215 -0.928 . . . . 0.0 110.588 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -78.1 1.51 20.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.533 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -105.84 -29.33 10.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 110.3 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.75 -26.87 0.1 Allowed Glycine 0 N--CA 1.484 1.858 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.456 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.932 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -48.56 135.25 14.68 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.199 -1.177 . . . . 0.0 110.9 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 30.7 t70 -87.96 141.43 31.44 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 46.1 Cg_endo -73.72 -28.35 11.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.663 1.349 . . . . 0.0 110.544 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -92.48 18.83 7.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 110.433 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.684 ' HB1' ' OD2' ' A' ' 7' ' ' ASP . . . -83.33 142.41 31.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -0.922 . . . . 0.0 110.205 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 35' ' ' LEU . 14.8 mt -99.47 153.84 18.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.364 -0.835 . . . . 0.0 110.196 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -102.08 30.9 4.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.331 -0.855 . . . . 0.0 110.206 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 54.77 24.67 5.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.363 -0.835 . . . . 0.0 110.496 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.09 2.7 9.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.315 -0.866 . . . . 0.0 110.587 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 54.04 27.31 37.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.445 ' O ' ' CB ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -120.17 18.1 12.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.334 -1.098 . . . . 0.0 110.38 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.49 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 21.1 mmt-85 53.73 175.63 0.03 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.168 -0.958 . . . . 0.0 110.314 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.585 ' HG2' ' HB1' ' A' ' 62' ' ' ALA . 51.3 Cg_endo -85.17 -0.05 8.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.54 1.284 . . . . 0.0 111.154 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.605 HD13 HD22 ' A' ' 57' ' ' LEU . 50.7 mm -114.29 -41.39 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.987 -1.071 . . . . 0.0 110.628 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.445 ' CB ' ' O ' ' A' ' 40' ' ' ARG . 2.9 tt0 -57.58 -41.49 81.24 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.157 -0.965 . . . . 0.0 109.927 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 15' ' ' ALA . 11.5 p -75.74 -11.86 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 0.0 110.288 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.52 ' HE1' HG21 ' A' ' 87' ' ' THR . 2.3 ttm -51.34 150.07 3.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.337 -0.852 . . . . 0.0 110.431 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.405 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 5.0 tmm? -62.42 -15.76 51.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 110.265 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.44 26.27 8.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.216 -0.927 . . . . 0.0 110.192 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.14 19.37 5.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.487 ' N ' ' CZ ' ' A' ' 84' ' ' PHE . 19.8 t -157.84 101.83 1.81 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -1.024 . . . . 0.0 110.243 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.447 ' HB2' ' CG ' ' A' ' 86' ' ' ASP . . . -57.82 -26.93 62.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.634 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 1.1 mp0 -54.82 -34.06 62.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.399 -0.813 . . . . 0.0 110.556 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.673 HG23 HG22 ' A' ' 19' ' ' VAL . 89.1 t -76.26 -62.76 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -0.865 . . . . 0.0 110.322 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.867 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -47.71 -27.6 2.05 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.393 -0.817 . . . . 0.0 110.894 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.541 ' HA ' HG11 ' A' ' 90' ' ' VAL . 18.0 tt0 -70.9 -56.05 7.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.406 -0.809 . . . . 0.0 110.452 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.936 HD23 HG12 ' A' ' 22' ' ' VAL . 15.4 tp -52.36 -56.28 15.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.331 -0.856 . . . . 0.0 110.681 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.605 HD22 HD13 ' A' ' 43' ' ' ILE . 3.2 mp -52.13 -53.92 36.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.326 -0.859 . . . . 0.0 110.731 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.639 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -61.64 -28.19 69.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.31 -0.869 . . . . 0.0 110.375 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.0 tp -69.83 -38.18 76.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 110.222 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -83.97 -20.35 33.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.398 -0.814 . . . . 0.0 110.297 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.54 53.54 0.72 Allowed Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.585 ' HB1' ' HG2' ' A' ' 42' ' ' PRO . . . -65.09 -147.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.269 -1.136 . . . . 0.0 109.803 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -125.81 70.69 66.61 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.09 -1.006 . . . . 0.0 110.365 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . 50.8 Cg_endo -82.36 -28.36 1.9 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.799 1.421 . . . . 0.0 110.042 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 74' ' ' ARG . 2.6 m120 -79.65 -34.98 39.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.41 -0.806 . . . . 0.0 110.255 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 129.49 41.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 110.298 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.588 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -118.06 162.69 17.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -0.862 . . . . 0.0 110.24 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 2.8 t0 -69.34 124.21 89.98 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.0 109.903 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.89 -23.41 16.4 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.592 1.311 . . . . 0.0 110.556 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.35 -33.21 75.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 0.0 110.512 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.788 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -146.63 24.7 1.22 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.26 49.87 9.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.373 -0.829 . . . . 0.0 110.863 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.7 HG23 ' OD1' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -99.48 131.8 45.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 0.0 110.36 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.89 ' CG ' HG11 ' A' ' 100' ' ' VAL . 9.8 mtp180 -101.54 165.89 13.25 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.479 -0.763 . . . . 0.0 110.166 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 43.1 Cg_endo -69.11 -11.7 32.33 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.66 1.347 . . . . 0.0 110.803 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.4 t -67.09 -28.29 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.903 . . . . 0.0 109.948 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.589 ' CE1' ' HD3' ' A' ' 108' ' ' PRO . 62.8 m-70 -67.75 -53.23 28.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 110.252 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.511 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 4.3 m-20 -51.84 -57.09 10.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.53 -0.731 . . . . 0.0 110.858 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.39 -16.05 59.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.314 -0.866 . . . . 0.0 110.693 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.53 -37.08 13.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.162 -0.961 . . . . 0.0 110.53 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 78' ' ' ASP . 14.9 ptt180 -70.76 -18.67 62.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.327 -0.858 . . . . 0.0 110.826 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.95 11.17 38.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.707 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.454 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 56.89 42.15 92.1 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.487 ' CZ ' ' N ' ' A' ' 50' ' ' SER . 0.7 OUTLIER -110.81 98.39 7.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.485 -1.009 . . . . 0.0 110.147 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' A' ' 119' ' ' ASP . 0.6 OUTLIER -84.15 -34.05 24.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 0.0 110.35 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 87' ' ' THR . 14.5 p30 -51.07 -44.43 61.16 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.244 -0.91 . . . . 0.0 110.599 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.867 HG23 ' CB ' ' A' ' 54' ' ' ALA . 45.1 m -76.21 -31.77 58.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 109.456 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.558 HD22 HG13 ' A' ' 120' ' ' ILE . 8.2 tp -60.48 -37.59 81.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.466 -0.771 . . . . 0.0 109.429 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.3 t -68.22 -44.04 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.507 -0.746 . . . . 0.0 109.325 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.574 HG12 HD13 ' A' ' 58' ' ' LEU . 66.9 t -56.77 -41.64 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.46 -0.775 . . . . 0.0 110.172 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.452 ' HA ' HD21 ' A' ' 58' ' ' LEU . 2.5 mt -60.03 -52.03 67.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.438 -0.789 . . . . 0.0 109.984 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -72.09 -29.4 64.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 0.0 109.762 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -68.01 -57.76 5.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.439 -0.788 . . . . 0.0 109.89 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.639 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . . . -70.49 -61.85 1.61 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.412 -0.805 . . . . 0.0 110.365 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 170.86 105.92 0.19 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.407 ' HB3' ' C ' ' A' ' 91' ' ' LEU . . . -168.04 133.42 1.86 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.275 -1.132 . . . . 0.0 110.245 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 100' ' ' VAL . 3.7 ttp180 -65.75 163.43 16.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 0.0 110.263 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.412 HD23 ' HB3' ' A' ' 127' ' ' ALA . 1.1 tp -148.4 48.59 1.03 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.452 -0.78 . . . . 0.0 109.931 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.843 ' HA ' HG23 ' A' ' 128' ' ' THR . 48.2 t0 -159.31 50.13 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.391 -0.818 . . . . 0.0 110.054 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.89 HG11 ' CG ' ' A' ' 74' ' ' ARG . 13.2 p -122.7 168.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.512 -0.742 . . . . 0.0 110.178 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.605 ' SG ' HD11 ' A' ' 107' ' ' LEU . 0.4 OUTLIER -132.87 166.85 21.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 109.256 179.388 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.7 ' OD1' HG23 ' A' ' 73' ' ' THR . 4.9 t0 -70.22 71.94 0.44 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.889 . . . . 0.0 109.824 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.788 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 60.84 -79.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.642 -0.661 . . . . 0.0 110.051 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.443 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.3 p90 -133.64 26.81 4.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 109.478 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.65 -139.38 7.81 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.636 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -168.95 2.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.532 -0.981 . . . . 0.0 111.046 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.605 HD11 ' SG ' ' A' ' 101' ' ' CYS . 0.3 OUTLIER -119.17 176.41 1.73 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.653 -0.655 . . . . 0.0 109.864 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.589 ' HD3' ' CE1' ' A' ' 77' ' ' HIS . 46.0 Cg_endo -71.29 -27.31 19.76 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.542 1.285 . . . . 0.0 110.263 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.604 ' HA ' HD13 ' A' ' 124' ' ' LEU . 12.5 p -78.05 -37.81 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 110.337 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 109' ' ' VAL . 74.5 m-20 -66.45 -42.58 87.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -0.831 . . . . 0.0 110.237 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 111' ' ' LEU . 1.6 tt -59.76 -36.15 76.06 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.332 -0.855 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.702 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -61.32 -59.9 4.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.381 -0.825 . . . . 0.0 110.028 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -52.29 -27.18 14.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.465 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.13 -42.96 96.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.352 -0.843 . . . . 0.0 110.175 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.98 -32.4 34.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.867 . . . . 0.0 110.262 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.22 29.16 2.01 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.532 ' CB ' HG22 ' A' ' 120' ' ' ILE . 18.5 m-70 -90.85 72.62 6.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -1.091 . . . . 0.0 109.984 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -58.75 -28.25 65.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.387 -0.82 . . . . 0.0 110.386 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.421 ' HB2' HD12 ' A' ' 85' ' ' LEU . 12.4 p-10 -74.88 -41.01 60.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.311 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.702 ' CG2' ' HB1' ' A' ' 112' ' ' ALA . 1.9 tt -79.18 -34.02 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.962 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.0 -29.06 69.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.84 . . . . 0.0 109.842 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 126' ' ' ALA . 1.1 ttt180 -73.26 -53.08 11.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -62.07 -30.13 70.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 110.106 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.604 HD13 ' HA ' ' A' ' 109' ' ' VAL . 36.4 mt -71.15 -71.65 0.25 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.442 -0.786 . . . . 0.0 110.556 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -53.1 -28.49 25.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.268 -0.895 . . . . 0.0 110.235 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 122' ' ' ARG . . . -63.92 -36.15 83.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.293 -0.879 . . . . 0.0 109.68 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.412 ' HB3' HD23 ' A' ' 98' ' ' LEU . . . -120.24 23.81 10.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 110.084 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.843 HG23 ' HA ' ' A' ' 99' ' ' ASP . 89.4 m . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 110.327 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.9 t0 . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 121.028 0.442 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.28 29.1 0.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 110.386 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.2 -34.24 53.08 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.863 HD13 ' CD2' ' A' ' 57' ' ' LEU . 4.0 pp -53.47 -28.39 30.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.623 -0.928 . . . . 0.0 110.049 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.776 ' N ' HD12 ' A' ' 10' ' ' LEU . . . -81.45 -43.81 18.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.445 -0.784 . . . . 0.0 110.209 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.1 p -59.11 -57.73 11.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.332 -0.855 . . . . 0.0 109.899 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.5 -34.78 69.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.3 -0.875 . . . . 0.0 109.787 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.778 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -64.05 -41.69 97.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.557 -0.714 . . . . 0.0 109.742 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -58.92 -30.65 67.99 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.347 -0.845 . . . . 0.0 110.063 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -84.82 5.51 28.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.382 -0.824 . . . . 0.0 110.536 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.29 42.4 83.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.51 ' O ' HG23 ' A' ' 22' ' ' VAL . 77.2 mt-30 -112.39 74.85 0.88 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.469 -1.019 . . . . 0.0 110.432 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.71 HG21 ' CB ' ' A' ' 52' ' ' GLN . 42.4 t -57.7 -38.41 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.286 -0.884 . . . . 0.0 109.568 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -57.52 -49.08 77.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.811 . . . . 0.0 110.193 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 m -67.18 -39.26 86.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.383 -0.823 . . . . 0.0 110.004 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.913 HG12 HD13 ' A' ' 56' ' ' LEU . 58.2 t -69.83 -29.85 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.434 -0.791 . . . . 0.0 109.757 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.7 ' HA ' HD11 ' A' ' 56' ' ' LEU . 6.0 mmt180 -68.38 -32.67 72.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.479 -0.763 . . . . 0.0 110.145 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 79.0 mt-30 -79.31 -52.73 7.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 0.0 110.579 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.611 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -52.0 -54.6 27.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.283 -0.886 . . . . 0.0 110.599 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.689 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -55.43 -61.63 2.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.232 -0.918 . . . . 0.0 110.432 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.22 -23.9 64.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -72.56 -61.79 1.68 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.238 -0.913 . . . . 0.0 110.297 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 176.48 50.03 0.06 OUTLIER Glycine 0 N--CA 1.48 1.632 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . . . -101.58 135.38 43.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.287 -1.125 . . . . 0.0 110.241 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 3.0 t70 -65.0 140.03 97.98 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.801 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.17 -3.35 13.78 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.665 1.35 . . . . 0.0 111.049 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -130.84 17.39 5.17 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.008 -1.058 . . . . 0.0 111.108 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -65.32 93.46 0.14 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.06 -1.025 . . . . 0.0 109.6 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mt -51.9 172.36 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.322 -0.861 . . . . 0.0 110.867 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -103.02 -163.0 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.471 -0.768 . . . . 0.0 110.075 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -96.07 -20.48 18.63 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 110.418 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.72 33.3 1.67 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 109.781 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.41 26.01 21.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG3' ' CB ' ' A' ' 44' ' ' GLN . 2.1 tpp85 -102.56 163.02 12.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.437 -1.037 . . . . 0.0 110.194 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.477 ' CB ' ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -81.0 179.4 1.93 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.442 -0.786 . . . . 0.0 110.042 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.5 ' HB2' HD22 ' A' ' 57' ' ' LEU . 42.4 Cg_endo -69.87 -25.63 27.87 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.593 1.312 . . . . 0.0 110.933 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.482 ' O ' ' CG ' ' A' ' 46' ' ' MET . 10.6 mt -102.34 -34.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.148 -0.97 . . . . 0.0 109.847 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.499 ' HA ' ' HE1' ' A' ' 48' ' ' MET . 56.8 mt-30 -54.74 -17.72 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 110.783 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 45' ' ' VAL . 11.7 p -115.27 26.37 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.095 -1.003 . . . . 0.0 110.575 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.63 ' CE ' HG21 ' A' ' 87' ' ' THR . 0.4 OUTLIER -95.73 32.07 1.92 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.187 -0.945 . . . . 0.0 110.2 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.416 ' CB ' ' O ' ' A' ' 46' ' ' MET . 3.4 tmm? 68.41 -7.4 0.69 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.469 -0.769 . . . . 0.0 111.102 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.499 ' HE1' ' HA ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER 46.9 27.28 0.69 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.003 -1.06 . . . . 0.0 110.716 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.46 ' HA2' ' CD2' ' A' ' 84' ' ' PHE . . . -130.67 13.45 5.6 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 p -143.78 90.34 2.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -1.145 . . . . 0.0 110.257 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.46 -26.31 12.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.918 . . . . 0.0 110.19 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.71 ' CB ' HG21 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -55.13 -34.24 63.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.397 -0.815 . . . . 0.0 110.247 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.778 HG11 ' HB1' ' A' ' 14' ' ' ALA . 26.8 t -83.41 -33.06 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.466 -0.771 . . . . 0.0 110.465 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.649 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -63.08 -52.34 63.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.194 -0.941 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.63 ' O ' HD23 ' A' ' 59' ' ' LEU . 12.3 pt-20 -66.55 -34.03 77.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.429 -0.794 . . . . 0.0 110.564 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.913 HD13 HG12 ' A' ' 22' ' ' VAL . 1.6 tt -53.3 -63.58 1.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.288 -0.883 . . . . 0.0 110.736 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.863 ' CD2' HD13 ' A' ' 10' ' ' LEU . 1.8 mt -70.4 -33.76 71.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.373 -0.83 . . . . 0.0 110.654 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.013 HD21 ' HB2' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -58.14 -61.51 2.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.921 . . . . 0.0 110.409 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 55' ' ' GLU . 3.1 pp -60.06 -25.1 65.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 110.448 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.669 ' CD2' HD12 ' A' ' 26' ' ' LEU . 3.4 m80 -78.61 -63.55 1.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.848 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.85 38.16 0.04 OUTLIER Glycine 0 N--CA 1.484 1.844 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -71.02 -175.67 1.2 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.053 -1.263 . . . . 0.0 110.242 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -119.12 76.8 15.93 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.492 -0.755 . . . . 0.0 110.002 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.641 ' HB2' ' HB2' ' A' ' 96' ' ' ALA . 47.5 Cg_endo -76.56 -5.72 16.34 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.86 1.453 . . . . 0.0 110.632 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.93 -51.95 2.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.316 -0.865 . . . . 0.0 110.049 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.24 134.73 39.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.366 -0.834 . . . . 0.0 110.445 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.883 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -119.51 -174.79 2.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.358 -0.839 . . . . 0.0 110.394 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 16.7 t0 -86.59 127.52 60.26 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.719 . . . . 0.0 109.994 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.31 -29.49 11.3 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.518 1.273 . . . . 0.0 110.57 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.62 80.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 0.0 110.411 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.811 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -143.76 38.88 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.255 -0.903 . . . . 0.0 110.557 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.535 ' C ' ' O ' ' A' ' 71' ' ' THR . 1.6 mt 25.45 61.83 0.06 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.765 -0.584 . . . . 0.0 111.561 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -113.08 119.81 39.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.9 . . . . 0.0 110.468 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.883 ' HG2' ' HB2' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -93.39 173.33 4.94 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.479 -0.763 . . . . 0.0 110.345 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.463 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 45.1 Cg_endo -71.87 -22.26 23.65 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.835 1.439 . . . . 0.0 110.33 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 52.0 t -59.45 -39.0 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.322 -0.861 . . . . 0.0 109.981 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.524 ' CE1' ' HD3' ' A' ' 108' ' ' PRO . 71.9 m-70 -64.1 -45.19 89.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 110.09 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.451 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -52.82 -65.7 0.51 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.447 -0.783 . . . . 0.0 110.429 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.68 -26.77 24.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.33 -0.856 . . . . 0.0 110.132 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.66 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -78.28 -43.05 29.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 0.0 109.754 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -61.32 -21.75 64.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 110.223 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.41 -32.47 12.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 0.0 109.735 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.82 24.9 24.18 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.46 ' CD2' ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -88.95 93.81 9.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -1.161 . . . . 0.0 109.993 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.463 HD21 ' O ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -61.97 -34.71 76.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.526 -0.733 . . . . 0.0 110.798 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.491 ' O ' HG23 ' A' ' 90' ' ' VAL . 39.5 t0 -58.67 -35.65 72.91 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.247 -0.908 . . . . 0.0 110.97 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.649 HG23 ' CB ' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -75.15 -41.03 59.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.007 -1.058 . . . . 0.0 110.228 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.96 HD22 HG13 ' A' ' 120' ' ' ILE . 2.4 tp -55.3 -40.79 71.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.349 -0.845 . . . . 0.0 109.873 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.39 -45.72 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 109.373 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.723 HG12 HD13 ' A' ' 58' ' ' LEU . 88.1 t -53.72 -45.86 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.551 -0.718 . . . . 0.0 110.227 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 6.2 mp -64.78 -20.93 66.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.399 -0.813 . . . . 0.0 110.676 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -78.13 -62.78 1.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.196 -0.94 . . . . 0.0 110.715 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.704 HH21 HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -54.1 -33.06 56.73 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.469 -0.769 . . . . 0.0 110.553 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.013 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -68.69 -34.89 76.44 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.284 -0.885 . . . . 0.0 110.216 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 111.15 45.79 0.85 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 64' ' ' PRO . . . -97.9 138.62 34.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.403 -1.057 . . . . 0.0 110.321 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -73.0 151.84 41.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.405 -0.81 . . . . 0.0 110.225 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.81 HD23 HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -127.35 -8.15 5.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.395 -0.816 . . . . 0.0 110.843 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -92.73 39.94 1.04 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.207 -0.933 . . . . 0.0 110.807 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.774 HG21 ' HG3' ' A' ' 74' ' ' ARG . 14.6 p -100.65 148.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -0.889 . . . . 0.0 110.039 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m -99.17 154.2 18.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.293 -0.879 . . . . 0.0 110.231 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 27.1 p-10 -81.86 57.01 3.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.811 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 64.95 -67.9 0.11 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.598 -0.688 . . . . 0.0 110.586 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.44 ' N ' ' O ' ' A' ' 102' ' ' ASP . 1.7 m95 -59.37 -61.14 2.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 167.01 -28.89 0.18 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -56.5 124.05 16.88 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.252 -1.146 . . . . 0.0 110.43 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 82.3 mt -80.06 167.02 36.6 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.38 -0.825 . . . . 0.0 110.081 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.524 ' HD3' ' CE1' ' A' ' 77' ' ' HIS . 42.9 Cg_endo -69.65 -23.36 31.36 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.642 1.338 . . . . 0.0 110.378 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.732 ' HA ' HD13 ' A' ' 124' ' ' LEU . 14.4 p -75.41 -35.67 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.794 . . . . 0.0 109.956 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.43 ' N ' HG13 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -67.15 -42.1 84.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.492 -0.755 . . . . 0.0 109.705 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.06 -30.32 70.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.44 -0.788 . . . . 0.0 109.944 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.585 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -65.33 -73.38 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.503 -0.748 . . . . 0.0 109.954 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.449 ' N ' ' HB2' ' A' ' 121' ' ' ALA . 1.3 pt-20 -53.37 -22.19 7.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.775 . . . . 0.0 110.949 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.49 -71.22 0.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 0.0 110.642 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -59.69 -94.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.284 -0.885 . . . . 0.0 110.711 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.45 30.63 0.95 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -110.56 79.11 1.17 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.375 -1.074 . . . . 0.0 109.7 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -79.31 -42.25 26.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.88 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.463 ' O ' HD21 ' A' ' 85' ' ' LEU . 20.7 p-10 -59.37 -37.35 77.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.442 -0.786 . . . . 0.0 110.049 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.96 HG13 HD22 ' A' ' 88' ' ' LEU . 3.1 tt -80.48 -31.32 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 109.755 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.449 ' HB2' ' N ' ' A' ' 113' ' ' GLU . . . -63.78 -54.17 39.33 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.922 0.868 . . . . 0.0 109.815 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.647 ' HA ' ' CD2' ' A' ' 125' ' ' HIS . 8.3 ttt-85 -59.11 -52.96 63.48 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.866 -0.521 . . . . 0.0 110.347 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.751 ' HD2' HD23 ' A' ' 88' ' ' LEU . 78.9 t80 -61.07 -26.67 67.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.089 -1.007 . . . . 0.0 110.363 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.841 ' O ' HG22 ' A' ' 128' ' ' THR . 4.1 mt -66.63 -60.07 3.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.667 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.647 ' CD2' ' HA ' ' A' ' 122' ' ' ARG . 3.2 p80 -54.95 -24.68 25.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.13 -24.89 51.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 110.633 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -107.65 -23.96 11.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.297 -0.877 . . . . 0.0 110.995 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.841 HG22 ' O ' ' A' ' 124' ' ' LEU . 10.0 t . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.144 -0.973 . . . . 0.0 110.959 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 56.2 m-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.207 0.527 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' ASP . . . 58.35 19.59 6.51 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.398 -0.814 . . . . 0.0 110.508 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.97 -17.45 79.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.728 HD11 HD13 ' A' ' 26' ' ' LEU . 60.4 mt -78.9 -44.24 23.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.355 -1.085 . . . . 0.0 109.819 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -62.31 -44.86 95.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.496 -0.752 . . . . 0.0 110.065 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 p -57.12 -55.51 33.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 109.94 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.96 72.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.898 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -65.18 -49.92 67.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.824 . . . . 0.0 110.141 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.772 ' HB2' ' O ' ' A' ' 45' ' ' VAL . . . -63.91 -23.97 67.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.353 -0.842 . . . . 0.0 110.147 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -91.52 3.48 54.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 0.0 110.636 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.61 45.97 72.6 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -110.96 66.12 0.62 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -1.084 . . . . 0.0 110.231 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.833 HG22 HG23 ' A' ' 53' ' ' VAL . 19.1 t -52.31 -34.63 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.324 -0.86 . . . . 0.0 110.113 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -65.55 -54.64 25.19 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.405 -0.809 . . . . 0.0 110.937 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.6 m -57.3 -34.94 69.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.235 -0.915 . . . . 0.0 110.941 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.668 HG12 HD13 ' A' ' 56' ' ' LEU . 58.9 t -73.59 -26.71 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.261 -0.9 . . . . 0.0 110.417 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.734 ' HA ' HD11 ' A' ' 56' ' ' LEU . 18.9 mmt180 -68.59 -45.75 71.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.202 -0.936 . . . . 0.0 110.476 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 11.8 tm0? -73.81 -58.44 3.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.452 -0.78 . . . . 0.0 111.28 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.905 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -55.25 -53.49 55.41 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.252 -0.905 . . . . 0.0 111.328 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.861 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -52.61 -61.29 2.38 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.134 -0.979 . . . . 0.0 111.147 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -65.49 -13.07 58.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -0.977 . . . . 0.0 110.688 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -83.28 -26.71 30.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -0.989 . . . . 0.0 110.743 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.07 -7.64 0.39 Allowed Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.326 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.905 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -50.95 142.46 11.84 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.842 -1.387 . . . . 0.0 110.77 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.647 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 27.0 t70 -72.83 125.33 91.21 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 110.21 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.65 -21.05 22.43 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.573 1.302 . . . . 0.0 110.765 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.37 26.31 10.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.262 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.647 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -73.37 135.16 44.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.313 -0.867 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.0 mt -84.22 170.13 14.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.833 . . . . 0.0 110.149 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.682 ' ND2' HG21 ' A' ' 45' ' ' VAL . 15.0 t30 -106.94 -168.47 1.41 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.417 -0.802 . . . . 0.0 110.167 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -77.92 -23.44 48.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.389 -0.819 . . . . 0.0 110.27 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -96.28 25.38 4.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.315 -0.865 . . . . 0.0 110.095 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.54 32.09 37.98 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.05 -156.57 0.55 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.446 -1.032 . . . . 0.0 110.283 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.617 ' O ' HG12 ' A' ' 45' ' ' VAL . 28.0 mmt-85 -110.49 170.29 5.46 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 0.0 109.598 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HB2' HD22 ' A' ' 57' ' ' LEU . 41.0 Cg_endo -68.01 -21.67 42.87 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.484 1.254 . . . . 0.0 110.334 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.564 ' O ' ' HG2' ' A' ' 46' ' ' MET . 73.4 mt -107.67 -44.1 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.272 -0.892 . . . . 0.0 109.703 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.58 -22.54 3.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.155 -0.966 . . . . 0.0 110.501 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.772 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 7.1 p -105.29 25.73 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 110.798 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.906 ' HE2' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -95.83 165.63 12.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -0.999 . . . . 0.0 109.891 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.411 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 9.5 tmm? -61.06 -13.17 15.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.275 -0.891 . . . . 0.0 110.677 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 23.0 mmt 55.3 23.23 5.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.256 -0.902 . . . . 0.0 110.327 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.37 -19.71 5.74 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.416 ' HB3' ' CG2' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -118.15 105.77 12.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -1.156 . . . . 0.0 110.341 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' ' 86' ' ' ASP . . . -59.36 -22.42 61.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.872 . . . . 0.0 110.598 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.796 ' HB2' ' CG2' ' A' ' 19' ' ' VAL . 3.4 mm-40 -61.46 -18.16 57.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.833 HG23 HG22 ' A' ' 19' ' ' VAL . 88.4 t -86.26 -41.7 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.714 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.906 ' HB2' ' HE2' ' A' ' 46' ' ' MET . . . -72.45 -25.31 61.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.502 -0.749 . . . . 0.0 110.166 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HA ' HG11 ' A' ' 90' ' ' VAL . 7.7 tm-20 -79.03 -43.94 23.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.375 -0.828 . . . . 0.0 110.346 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.734 HD11 ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -59.06 -63.06 1.44 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.372 -0.83 . . . . 0.0 110.481 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.801 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 4.0 mt -52.52 -48.76 65.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.445 -0.784 . . . . 0.0 110.679 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -58.11 -38.65 76.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.35 -0.844 . . . . 0.0 110.213 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.85 -33.69 76.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -0.834 . . . . 0.0 110.188 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.461 ' CE1' ' HG ' ' A' ' 26' ' ' LEU . 12.5 m170 -84.69 -63.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.013 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.26 54.38 0.03 OUTLIER Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -69.76 -158.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -1.115 . . . . 0.0 110.112 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -126.71 71.87 74.01 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.368 -0.833 . . . . 0.0 109.988 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . 49.6 Cg_endo -79.43 -21.36 8.93 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.809 1.426 . . . . 0.0 110.59 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -89.33 -52.55 4.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.857 . . . . 0.0 110.31 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 166.42 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.34 -0.85 . . . . 0.0 110.481 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.54 -167.75 2.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 0.0 110.198 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 70' ' ' ALA . 7.4 t70 -86.77 127.23 60.89 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.094 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.76 -25.28 14.76 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.573 1.302 . . . . 0.0 110.378 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . . . -63.66 -51.43 65.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.372 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.806 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -124.78 26.63 7.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 110.463 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 44.17 37.73 2.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.334 -0.854 . . . . 0.0 110.959 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.5 125.67 42.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.298 -0.876 . . . . 0.0 110.559 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.594 ' HD2' ' HB ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -94.4 -175.99 0.52 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 110.144 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 47.7 Cg_endo -75.81 -35.45 2.59 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.386 1.203 . . . . 0.0 111.622 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.628 ' CG1' HD23 ' A' ' 98' ' ' LEU . 93.5 t -52.92 -31.61 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.049 -1.032 . . . . 0.0 110.301 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CE1' ' HB3' ' A' ' 108' ' ' PRO . 14.8 m80 -62.29 -44.34 96.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 109.969 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.68 -49.23 66.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.386 -0.821 . . . . 0.0 110.082 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.639 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -53.89 -28.44 36.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.862 . . . . 0.0 110.109 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.01 -30.31 22.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.384 -0.823 . . . . 0.0 109.805 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.413 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 2.5 mmt85 -61.0 -24.62 66.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.462 -0.774 . . . . 0.0 110.235 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -100.58 -27.27 13.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 110.416 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.73 35.35 6.88 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.65 ' HD1' ' HB2' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -98.68 94.64 6.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.446 -1.032 . . . . 0.0 110.251 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.885 HD22 HD12 ' A' ' 120' ' ' ILE . 3.5 mm? -64.75 -25.67 68.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.356 -0.84 . . . . 0.0 110.524 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.669 ' O ' HG23 ' A' ' 90' ' ' VAL . 2.9 m-20 -61.66 -56.36 20.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.192 -0.942 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.527 HG23 ' CB ' ' A' ' 54' ' ' ALA . 23.1 m -57.6 -42.77 83.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.241 -0.912 . . . . 0.0 109.991 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.99 HD13 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -57.68 -44.42 85.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.772 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 85' ' ' LEU . 86.9 t -63.84 -42.51 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 0.0 109.003 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 86' ' ' ASP . 93.4 t -57.21 -46.18 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.647 -0.658 . . . . 0.0 109.981 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.672 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 5.6 mp -61.8 -47.04 86.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.418 -0.801 . . . . 0.0 109.929 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -66.34 -26.25 67.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 110.165 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -68.38 -30.67 69.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 110.267 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB3' HD11 ' A' ' 58' ' ' LEU . . . -114.47 41.84 2.23 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.361 -0.837 . . . . 0.0 110.406 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.33 109.97 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . -149.01 105.46 3.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -1.085 . . . . 0.0 110.722 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.509 ' O ' ' NE ' ' A' ' 74' ' ' ARG . 0.3 OUTLIER -58.91 107.28 0.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.395 -0.816 . . . . 0.0 109.133 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 128' ' ' THR . 1.1 mt -104.14 23.62 12.73 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.166 -0.959 . . . . 0.0 110.347 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.422 ' HA ' HG23 ' A' ' 128' ' ' THR . 18.8 t0 -126.95 17.64 7.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.852 . . . . 0.0 110.499 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 74' ' ' ARG . 3.4 p -67.98 162.0 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 109.81 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.7 m -100.64 137.17 39.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 104' ' ' TRP . 13.0 t70 -73.71 60.69 0.71 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 110.294 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 58.17 -79.6 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.591 -0.693 . . . . 0.0 110.655 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.471 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.9 OUTLIER -53.76 -42.92 68.73 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.269 -0.894 . . . . 0.0 110.115 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 146.25 -18.94 1.72 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.28 123.98 15.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.209 -1.171 . . . . 0.0 110.518 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.451 ' O ' HD12 ' A' ' 111' ' ' LEU . 22.1 mt -79.85 168.32 27.03 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.809 . . . . 0.0 109.891 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.0 Cg_endo -69.13 -25.51 31.45 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.684 1.36 . . . . 0.0 110.39 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.433 ' HA ' HD13 ' A' ' 124' ' ' LEU . 10.8 p -82.09 -23.13 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.0 110.14 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -67.07 -43.29 82.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.381 -0.824 . . . . 0.0 110.202 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 107' ' ' LEU . 0.5 OUTLIER -59.08 -31.66 69.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -0.829 . . . . 0.0 110.151 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HB1' HG22 ' A' ' 120' ' ' ILE . . . -64.86 -65.26 0.7 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.415 -0.803 . . . . 0.0 110.109 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -51.94 -26.31 10.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.457 -0.777 . . . . 0.0 110.567 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -43.35 16.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.342 -0.848 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -77.21 -77.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.27 -0.894 . . . . 0.0 110.181 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 165.12 43.83 0.02 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.413 ' CE1' ' O ' ' A' ' 81' ' ' ARG . 24.1 m80 -117.5 60.14 0.77 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.331 -1.099 . . . . 0.0 109.782 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -50.41 -29.64 10.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.32 -0.863 . . . . 0.0 110.568 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -69.99 -39.13 76.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.99 HD11 HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -75.41 -35.08 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.264 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.73 -29.27 70.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 110.026 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -73.74 -55.19 6.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.326 -0.859 . . . . 0.0 110.044 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -36.38 83.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.317 -0.865 . . . . 0.0 110.09 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.615 HD12 HG23 ' A' ' 120' ' ' ILE . 16.8 mt -59.03 -62.44 1.88 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.376 -0.828 . . . . 0.0 110.283 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -51.01 -26.27 5.87 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.339 -0.851 . . . . 0.0 110.315 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.17 -38.51 51.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 110.136 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -112.67 29.1 8.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.87 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 98' ' ' LEU . 95.7 m . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 109.876 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.427 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 121.227 0.537 . . . . 0.0 110.955 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -138.88 -48.64 0.5 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -0.959 . . . . 0.0 109.958 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.63 -22.02 58.78 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 1.036 HD12 HG13 ' A' ' 22' ' ' VAL . 27.3 tp -67.27 -49.62 63.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -1.023 . . . . 0.0 110.314 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.8 -49.55 24.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 110.62 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.8 p -58.15 -49.18 77.91 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.298 -0.876 . . . . 0.0 110.623 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -60.46 -38.41 84.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.204 -0.935 . . . . 0.0 110.184 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.479 ' HA ' HG11 ' A' ' 53' ' ' VAL . . . -62.96 -29.94 71.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.35 -0.844 . . . . 0.0 110.033 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.742 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -83.35 -33.45 25.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.336 -0.853 . . . . 0.0 110.047 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -75.91 -24.9 55.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.168 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.98 45.12 1.8 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.472 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -119.86 96.84 5.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -1.069 . . . . 0.0 110.001 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.743 ' CG2' ' HB2' ' A' ' 52' ' ' GLN . 38.4 t -76.76 -39.32 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.473 -0.767 . . . . 0.0 110.163 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.78 -46.0 90.56 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.276 -0.89 . . . . 0.0 110.757 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.2 m -64.6 -42.28 95.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.344 -0.847 . . . . 0.0 110.577 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 1.036 HG13 HD12 ' A' ' 10' ' ' LEU . 65.1 t -70.28 -45.24 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.284 -0.885 . . . . 0.0 110.501 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.593 ' CA ' HD21 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -59.29 -39.89 84.42 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.722 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.521 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -72.76 -44.2 61.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.365 -0.834 . . . . 0.0 110.783 -179.479 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.964 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.6 OUTLIER -63.62 -48.03 78.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.236 -0.915 . . . . 0.0 110.689 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.565 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 3.1 mt -54.11 -63.99 0.97 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.283 -0.886 . . . . 0.0 110.602 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -16.22 40.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 0.0 110.305 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -84.2 -37.91 21.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.873 . . . . 0.0 110.543 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.71 -23.63 0.09 OUTLIER Glycine 0 N--CA 1.484 1.843 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.745 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.964 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -48.05 124.82 8.12 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.092 -1.24 . . . . 0.0 110.997 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.37 126.92 70.51 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 109.955 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.53 -9.72 20.13 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.606 1.319 . . . . 0.0 110.864 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.12 29.55 7.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.118 -0.989 . . . . 0.0 110.257 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.17 103.48 9.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 0.0 110.26 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 35' ' ' LEU . 2.4 pp -84.53 145.65 27.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.478 ' O ' HD12 ' A' ' 35' ' ' LEU . 29.3 m120 -104.42 -154.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.424 -0.797 . . . . 0.0 109.814 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 38' ' ' PHE . 2.0 ptp180 -57.95 -171.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 110.252 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER 66.66 1.94 2.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.438 -0.789 . . . . 0.0 111.268 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 45.85 31.98 4.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.77 -168.54 1.54 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -1.15 . . . . 0.0 110.662 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.716 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -118.27 177.67 1.24 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 0.0 109.391 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.716 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 43.4 Cg_endo -70.53 -19.29 32.62 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.383 1.202 . . . . 0.0 110.847 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 46' ' ' MET . 53.5 mt -115.01 -34.83 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.134 -0.979 . . . . 0.0 110.001 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 41' ' ' ARG . 17.8 tt0 -53.43 -29.11 33.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.066 -1.021 . . . . 0.0 110.144 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 15' ' ' ALA . 11.8 p -92.85 -2.76 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.407 -0.808 . . . . 0.0 110.339 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.841 ' HE1' ' HB2' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -56.05 154.54 7.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.398 -0.814 . . . . 0.0 110.345 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -70.97 -6.9 42.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 110.149 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.633 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 23.4 mmt 53.59 25.25 4.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.9 . . . . 0.0 110.411 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -118.03 -11.7 8.16 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 m -129.51 113.45 14.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -1.163 . . . . 0.0 110.296 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -64.53 -13.9 54.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.429 -0.794 . . . . 0.0 110.598 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.743 ' HB2' ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -73.08 -22.93 60.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.216 -0.928 . . . . 0.0 109.821 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.549 ' CG2' HG22 ' A' ' 19' ' ' VAL . 22.0 t -84.2 -36.84 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.149 -0.969 . . . . 0.0 110.188 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.841 ' HB2' ' HE1' ' A' ' 46' ' ' MET . . . -70.35 -57.14 5.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.421 -0.799 . . . . 0.0 110.299 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -59.32 -45.82 90.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.439 -0.788 . . . . 0.0 110.474 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.593 HD21 ' CA ' ' A' ' 23' ' ' ARG . 52.1 tp -52.63 -52.63 54.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.371 -0.83 . . . . 0.0 110.666 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.811 HD21 HD11 ' A' ' 10' ' ' LEU . 7.6 mt -69.89 -30.39 67.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.262 -0.899 . . . . 0.0 110.854 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.506 HD22 ' CB ' ' A' ' 94' ' ' ALA . 1.1 tt -75.72 -55.23 5.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.178 -0.951 . . . . 0.0 110.944 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.548 HD12 ' C ' ' A' ' 59' ' ' LEU . 3.1 pp -54.07 -28.5 39.3 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.136 -0.978 . . . . 0.0 110.07 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.53 ' CD2' HD22 ' A' ' 26' ' ' LEU . 6.9 m80 -75.61 -56.87 4.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.359 -0.838 . . . . 0.0 109.821 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.49 44.61 0.02 OUTLIER Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 57' ' ' LEU . . . -76.27 -169.55 1.21 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.335 -1.097 . . . . 0.0 110.62 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -115.38 80.83 7.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.77 -27.0 9.19 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.854 1.45 . . . . 0.0 110.325 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -93.08 -41.44 9.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 110.081 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 151.37 7.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.273 -0.892 . . . . 0.0 110.277 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.512 ' HB2' ' NE ' ' A' ' 74' ' ' ARG . . . -143.87 -172.72 3.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.416 -0.802 . . . . 0.0 110.565 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.495 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 15.5 t0 -89.69 125.07 62.34 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.33 -21.55 19.8 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.484 1.255 . . . . 0.0 110.62 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.24 -20.89 65.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 110.678 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.726 HG23 ' OG1' ' A' ' 73' ' ' THR . 5.3 t -158.42 22.03 0.23 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.027 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.4 mt 44.05 65.29 1.06 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.306 -0.871 . . . . 0.0 110.403 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.726 ' OG1' HG23 ' A' ' 71' ' ' THR . 0.1 OUTLIER -119.21 103.23 9.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.092 -1.005 . . . . 0.0 111.156 -178.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.907 ' HB2' HG11 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -75.29 169.65 19.4 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.728 . . . . 0.0 109.197 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.497 ' HD2' ' CG ' ' A' ' 74' ' ' ARG . 46.7 Cg_endo -74.49 -4.34 15.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.458 1.241 . . . . 0.0 110.904 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.684 HG13 HD23 ' A' ' 98' ' ' LEU . 62.6 t -71.84 -35.39 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.211 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -62.16 -43.17 99.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 110.331 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.633 ' HB2' ' HE3' ' A' ' 48' ' ' MET . 50.5 m-20 -56.33 -57.98 9.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.477 -0.764 . . . . 0.0 110.438 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.87 -28.25 65.95 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.284 -0.885 . . . . 0.0 109.876 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.52 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -79.94 -27.9 39.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 110.032 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -71.9 -23.42 61.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.826 . . . . 0.0 110.367 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -97.08 -44.52 6.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.368 -0.832 . . . . 0.0 110.227 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.85 29.62 3.03 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.458 ' CZ ' ' CA ' ' A' ' 84' ' ' PHE . 4.3 t80 -93.61 91.8 7.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.43 -1.041 . . . . 0.0 110.224 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' A' ' 123' ' ' TYR . 1.5 mt -62.22 -27.85 69.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.333 -0.855 . . . . 0.0 109.863 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.726 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.3 t0 -59.07 -54.44 47.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.397 -0.815 . . . . 0.0 110.348 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.473 HG23 ' HB1' ' A' ' 54' ' ' ALA . 29.9 m -61.46 -35.19 76.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.326 -0.859 . . . . 0.0 109.962 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.811 HD22 HG13 ' A' ' 120' ' ' ILE . 5.7 tp -59.53 -51.97 67.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.212 -0.93 . . . . 0.0 109.776 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.78 -45.01 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 109.269 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 86' ' ' ASP . 96.4 t -50.48 -46.47 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.614 -0.679 . . . . 0.0 110.452 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.498 ' HA ' HD11 ' A' ' 58' ' ' LEU . 1.3 mp -65.01 -57.35 8.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 110.088 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -63.68 -17.43 62.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 110.36 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -87.78 -13.88 41.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 0.0 110.615 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.506 ' CB ' HD22 ' A' ' 58' ' ' LEU . . . -133.46 49.57 2.28 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.186 -0.946 . . . . 0.0 110.512 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.64 108.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -168.63 104.98 0.43 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -1.101 . . . . 0.0 110.248 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -68.04 108.7 3.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.418 -0.802 . . . . 0.0 110.071 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.795 HD13 ' HB1' ' A' ' 127' ' ' ALA . 1.4 mp -93.18 -21.58 19.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.313 -0.867 . . . . 0.0 110.449 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.663 ' HA ' HG23 ' A' ' 128' ' ' THR . 6.1 p-10 -70.4 72.71 0.49 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.907 HG11 ' HB2' ' A' ' 74' ' ' ARG . 7.5 p -143.37 161.18 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -0.86 . . . . 0.0 110.341 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.423 ' N ' HG22 ' A' ' 100' ' ' VAL . 13.3 p -128.6 147.33 50.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.51 -0.744 . . . . 0.0 109.422 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 104' ' ' TRP . 5.1 p-10 -69.86 65.3 0.23 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.254 -0.904 . . . . 0.0 110.607 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.714 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 56.66 -81.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.688 -0.632 . . . . 0.0 111.097 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.467 ' N ' ' O ' ' A' ' 102' ' ' ASP . 8.2 m-90 -91.52 43.98 1.16 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.265 -0.897 . . . . 0.0 110.359 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.54 -162.62 10.15 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.506 ' O ' ' CD1' ' A' ' 107' ' ' LEU . 10.5 mtm180 -120.79 -51.45 2.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.395 -1.062 . . . . 0.0 110.259 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.817 ' HG ' ' HD2' ' A' ' 108' ' ' PRO . 2.0 tp -174.13 162.72 2.91 Favored Pre-proline 0 N--CA 1.497 1.884 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.817 ' HD2' ' HG ' ' A' ' 107' ' ' LEU . 42.8 Cg_endo -70.39 -31.54 17.53 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.026 1.014 . . . . 0.0 110.24 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.624 HG12 ' HB3' ' A' ' 107' ' ' LEU . 7.4 p -62.05 -21.03 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 109.648 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -77.56 -45.29 25.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.383 -0.823 . . . . 0.0 109.621 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.59 -26.85 62.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.743 ' HB1' ' O ' ' A' ' 117' ' ' HIS . . . -78.0 -50.13 12.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.507 -0.746 . . . . 0.0 109.962 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -52.77 -23.28 6.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.478 -0.763 . . . . 0.0 110.898 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -94.63 -54.12 3.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.262 -0.899 . . . . 0.0 110.667 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -59.73 -95.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.254 -0.904 . . . . 0.0 110.435 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -170.29 31.79 0.15 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.743 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 9.0 m-70 -117.03 79.47 1.34 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -1.035 . . . . 0.0 109.536 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 30.0 mmt85 -81.32 -40.54 23.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.386 -0.821 . . . . 0.0 110.167 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.4 -54.45 43.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.307 -0.871 . . . . 0.0 109.702 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.811 HG13 HD22 ' A' ' 88' ' ' LEU . 10.0 tt -60.13 -34.75 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.468 -0.77 . . . . 0.0 109.359 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 118' ' ' ARG . . . -61.7 -39.42 91.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.658 -0.651 . . . . 0.0 109.799 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -56.17 -53.21 59.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.392 -0.817 . . . . 0.0 109.571 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.679 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -58.71 -45.19 90.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.357 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.752 ' HG ' HD21 ' A' ' 88' ' ' LEU . 78.3 mt -55.9 -48.53 75.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.435 -0.79 . . . . 0.0 109.928 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -53.5 -27.33 24.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.295 -0.878 . . . . 0.0 110.191 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.19 -38.69 15.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.316 -0.865 . . . . 0.0 110.467 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.795 ' HB1' HD13 ' A' ' 98' ' ' LEU . . . -98.02 10.62 39.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.304 -0.872 . . . . 0.0 110.783 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.784 HG22 HD21 ' A' ' 107' ' ' LEU . 7.4 m . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 110.365 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 121.086 0.47 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.8 -22.07 1.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 110.835 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -53.91 -32.58 48.9 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.959 HD13 HD11 ' A' ' 57' ' ' LEU . 3.8 pp -61.23 -27.69 68.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.444 -1.033 . . . . 0.0 110.09 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.456 ' N ' HD12 ' A' ' 10' ' ' LEU . . . -83.4 -50.7 8.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.412 -0.805 . . . . 0.0 110.257 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.2 p -63.18 -50.17 71.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.421 -0.8 . . . . 0.0 110.08 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -58.5 -40.8 83.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.342 -0.849 . . . . 0.0 109.769 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -61.01 -38.93 87.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.038 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 45' ' ' VAL . . . -60.73 -32.6 71.87 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.309 -0.869 . . . . 0.0 110.168 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.87 15.43 11.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.394 -0.816 . . . . 0.0 110.543 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.47 52.97 49.3 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -119.67 72.26 0.91 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -1.102 . . . . 0.0 110.536 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.909 HG21 ' HB3' ' A' ' 52' ' ' GLN . 58.0 t -56.96 -35.69 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.048 -1.032 . . . . 0.0 109.496 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -59.62 -54.95 40.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.557 -0.715 . . . . 0.0 109.988 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 84.0 m -56.92 -38.3 72.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.438 -0.789 . . . . 0.0 110.129 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.534 HG12 HD12 ' A' ' 26' ' ' LEU . 57.7 t -79.76 -22.05 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 110.475 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.54 ' HA ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -62.65 -45.87 90.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.163 -0.961 . . . . 0.0 110.422 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 24.7 tt0 -76.41 -51.22 12.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.46 -0.775 . . . . 0.0 111.408 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 25' ' ' LEU . 4.0 mt -51.2 -62.06 1.85 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.989 . . . . 0.0 111.227 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.665 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 2.0 mt -53.56 -46.82 70.38 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.15 -0.969 . . . . 0.0 111.365 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.66 9.34 7.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.06 -1.025 . . . . 0.0 110.962 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -114.47 -31.33 6.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.68 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.35 -27.81 0.08 OUTLIER Glycine 0 N--CA 1.484 1.849 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.598 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.808 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -48.22 128.65 14.5 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.136 -1.214 . . . . 0.0 110.758 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.793 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -74.22 145.36 82.97 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.397 -0.814 . . . . 0.0 110.301 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . 0.415 ' HB3' ' HB3' ' A' ' 60' ' ' HIS . 48.9 Cg_endo -76.98 -25.97 8.34 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.753 1.396 . . . . 0.0 110.784 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -114.44 32.38 5.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.324 -0.86 . . . . 0.0 110.403 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.793 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -89.8 96.87 10.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.354 -0.841 . . . . 0.0 110.281 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.94 HD13 ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -71.62 157.69 37.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.32 -0.862 . . . . 0.0 110.083 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.838 ' N ' HD22 ' A' ' 35' ' ' LEU . 47.7 p30 -112.9 173.83 6.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.121 -0.987 . . . . 0.0 110.97 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -49.73 -26.9 4.2 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.368 -0.832 . . . . 0.0 110.608 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -11.93 60.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.28 -0.887 . . . . 0.0 109.887 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.658 ' HA2' HD23 ' A' ' 35' ' ' LEU . . . 52.21 25.61 18.86 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.41 ' HG2' ' HB3' ' A' ' 44' ' ' GLN . 17.8 ttt180 -93.99 1.2 56.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -1.014 . . . . 0.0 110.227 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 55.89 171.45 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.25 -0.906 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.634 ' HB2' HD12 ' A' ' 57' ' ' LEU . 45.7 Cg_endo -72.65 169.44 21.89 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.534 1.281 . . . . 0.0 110.724 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.583 ' HA ' ' HG2' ' A' ' 46' ' ' MET . 30.7 mt 62.95 -60.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.821 -0.549 . . . . 0.0 111.017 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -43.12 -29.2 0.35 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.879 -1.138 . . . . 0.0 110.793 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 45' ' ' VAL . 11.0 p -113.79 35.55 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 0.0 109.942 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.828 ' CE ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -110.46 171.86 7.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.256 -0.903 . . . . 0.0 110.267 -179.805 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 8.5 ttp -73.45 98.91 2.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.319 -0.863 . . . . 0.0 108.685 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.488 ' O ' ' CD2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -61.73 -6.16 2.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 111.138 -179.162 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.5 20.78 32.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.618 ' N ' ' HD2' ' A' ' 84' ' ' PHE . 27.9 t -154.06 109.05 3.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -1.129 . . . . 0.0 110.227 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.676 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . . . -66.25 -29.54 69.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.404 -0.81 . . . . 0.0 110.033 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.909 ' HB3' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -51.35 -32.88 27.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.543 -0.723 . . . . 0.0 110.297 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.495 HG11 ' HB2' ' A' ' 46' ' ' MET . 41.2 t -75.17 -47.94 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.359 -0.838 . . . . 0.0 110.053 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.849 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -70.56 -23.44 62.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.399 -0.813 . . . . 0.0 110.158 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.522 ' HA ' HG11 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -66.71 -53.1 37.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.361 -0.837 . . . . 0.0 110.689 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.54 HD11 ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -61.58 -57.11 13.37 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.909 . . . . 0.0 110.647 -179.526 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.959 HD11 HD13 ' A' ' 10' ' ' LEU . 2.8 mm? -47.36 -50.37 22.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 110.97 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.033 HD23 HG12 ' A' ' 90' ' ' VAL . 60.5 tp -70.68 -24.7 62.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.406 -0.809 . . . . 0.0 110.544 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.1 tp -67.67 -41.28 83.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 109.982 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.518 ' ND1' HD22 ' A' ' 26' ' ' LEU . 12.0 m170 -78.91 -30.89 45.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.348 -0.845 . . . . 0.0 109.864 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.42 54.89 0.07 OUTLIER Glycine 0 N--CA 1.482 1.758 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.484 ' HB2' ' C ' ' A' ' 57' ' ' LEU . . . -69.83 -168.3 0.19 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.273 -1.133 . . . . 0.0 110.051 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -117.21 78.52 10.36 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.853 . . . . 0.0 110.007 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.78 -27.47 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.719 1.378 . . . . 0.0 110.417 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -87.55 -59.27 2.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.433 -0.792 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.1 168.59 0.13 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.308 -0.87 . . . . 0.0 110.444 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 74' ' ' ARG . . . -167.93 -158.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.875 . . . . 0.0 110.734 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -79.7 123.85 83.81 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.499 -0.75 . . . . 0.0 110.292 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.39 -24.11 14.54 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.549 1.289 . . . . 0.0 110.401 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.39 -46.24 86.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -0.892 . . . . 0.0 110.424 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.783 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 41.9 p -146.65 68.69 1.17 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 110.355 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.604 ' C ' ' O ' ' A' ' 71' ' ' THR . 13.9 mt 5.41 86.75 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.933 -0.479 . . . . 0.0 112.175 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.05 83.57 2.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 110.363 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.756 ' HD3' HG21 ' A' ' 100' ' ' VAL . 5.2 mpt_? -61.51 161.31 20.11 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.481 -0.762 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.36 -18.74 29.68 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.855 1.45 . . . . 0.0 110.422 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.88 -32.13 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.35 -0.844 . . . . 0.0 109.997 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.498 ' HE1' HG13 ' A' ' 100' ' ' VAL . 64.0 m80 -64.63 -41.72 95.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 110.34 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -70.31 -48.44 56.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.355 -0.841 . . . . 0.0 110.416 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.36 -29.18 14.58 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.293 -0.879 . . . . 0.0 110.448 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.899 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -96.55 -27.92 14.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.4 -0.812 . . . . 0.0 109.796 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -53.47 -28.43 30.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.402 -0.811 . . . . 0.0 109.765 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -99.5 -28.44 13.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.814 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.69 44.92 2.03 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.618 ' HD2' ' N ' ' A' ' 50' ' ' SER . 12.7 t80 -108.0 96.43 6.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.368 -1.078 . . . . 0.0 110.046 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.765 ' CD2' HD13 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -72.25 -24.29 61.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.516 -0.74 . . . . 0.0 110.663 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.676 ' HB2' ' HB2' ' A' ' 51' ' ' ALA . 63.9 m-20 -59.67 -54.35 47.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.407 -0.808 . . . . 0.0 110.499 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.849 HG23 ' CB ' ' A' ' 54' ' ' ALA . 90.9 m -61.2 -36.75 80.72 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.094 -1.004 . . . . 0.0 110.157 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -57.54 -48.79 78.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.318 -0.864 . . . . 0.0 110.252 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 85' ' ' LEU . 96.0 t -59.66 -50.95 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 109.914 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 1.033 HG12 HD23 ' A' ' 58' ' ' LEU . 85.1 t -54.27 -45.57 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.838 . . . . 0.0 110.221 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.547 HD13 HG22 ' A' ' 87' ' ' THR . 0.4 OUTLIER -57.23 -56.06 26.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.39 -0.819 . . . . 0.0 110.35 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -64.32 -23.32 67.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.446 -0.784 . . . . 0.0 110.657 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -78.77 -33.75 46.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.202 -0.936 . . . . 0.0 110.575 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.987 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -98.12 39.69 1.22 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.322 -0.862 . . . . 0.0 111.012 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.55 108.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.412 ' O ' HD11 ' A' ' 98' ' ' LEU . . . -168.31 132.45 1.62 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.532 -0.981 . . . . 0.0 110.05 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.55 140.01 42.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.242 -0.911 . . . . 0.0 110.071 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.808 ' O ' HG22 ' A' ' 128' ' ' THR . 2.4 mp -128.31 19.49 6.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.315 -0.866 . . . . 0.0 110.48 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.437 ' HB3' ' HA ' ' A' ' 128' ' ' THR . 4.3 p30 -123.29 55.87 1.2 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.151 -0.968 . . . . 0.0 110.421 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.756 HG21 ' HD3' ' A' ' 74' ' ' ARG . 12.6 p -112.76 164.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.383 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.43 ' N ' HG22 ' A' ' 100' ' ' VAL . 98.8 m -106.47 150.88 25.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.474 -0.767 . . . . 0.0 109.802 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.562 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 22.6 t70 -78.89 58.87 2.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.324 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.783 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 64.69 -71.97 0.07 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.519 -0.738 . . . . 0.0 110.719 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.431 ' N ' ' O ' ' A' ' 102' ' ' ASP . 2.1 m95 -65.49 -56.09 14.28 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.413 -0.804 . . . . 0.0 110.443 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.578 ' O ' HD12 ' A' ' 107' ' ' LEU . . . 168.63 -28.15 0.14 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.01 105.79 0.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.237 -1.155 . . . . 0.0 110.423 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -73.62 170.64 13.4 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.277 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.3 -43.19 0.74 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.738 1.388 . . . . 0.0 110.425 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.487 HG23 ' HA ' ' A' ' 121' ' ' ALA . 9.9 p -58.97 -36.02 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.35 -0.844 . . . . 0.0 110.115 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.442 ' N ' HG13 ' A' ' 109' ' ' VAL . 2.5 m-20 -66.06 -45.8 80.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.441 -0.787 . . . . 0.0 110.187 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 111' ' ' LEU . 4.0 tt -60.84 -27.74 68.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.222 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.3 -63.98 0.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 0.0 110.137 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -53.99 -23.63 13.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.92 -40.66 78.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.676 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.426 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 0.9 OUTLIER -91.29 5.32 49.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.228 -0.92 . . . . 0.0 110.77 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.63 37.06 8.92 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.465 ' HB3' ' CG1' ' A' ' 120' ' ' ILE . 23.9 m-70 -113.09 55.34 0.7 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -1.102 . . . . 0.0 109.791 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.96 -30.5 24.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.435 -0.791 . . . . 0.0 109.988 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -62.39 -40.62 97.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.735 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.899 HG21 ' CB ' ' A' ' 80' ' ' ALA . 4.1 mm -75.87 -36.28 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.509 -0.744 . . . . 0.0 109.601 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.487 ' HA ' HG23 ' A' ' 109' ' ' VAL . . . -64.33 -59.11 4.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 111.178 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 123' ' ' TYR . 14.2 ptm180 -53.99 -41.27 67.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.007 -1.058 . . . . 0.0 110.133 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.408 ' N ' ' HG3' ' A' ' 122' ' ' ARG . 11.7 t80 -68.86 -42.48 76.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.227 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.722 ' O ' HG23 ' A' ' 128' ' ' THR . 21.2 mt -66.24 -47.56 73.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.475 -0.766 . . . . 0.0 109.741 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -50.24 -32.11 15.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.411 -0.806 . . . . 0.0 110.333 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.49 -27.0 46.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.737 . . . . 0.0 110.293 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.497 ' HB1' HD13 ' A' ' 98' ' ' LEU . . . -102.73 -11.45 18.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.342 -0.849 . . . . 0.0 110.85 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 98' ' ' LEU . 73.2 p . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 110.48 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 68.3 m-20 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.135 0.493 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.45 -19.53 62.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.761 . . . . 0.0 110.048 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.34 -25.95 55.57 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.828 HD11 ' HB1' ' A' ' 30' ' ' ALA . 80.7 mt -64.15 -37.41 87.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.404 -1.057 . . . . 0.0 110.178 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.28 -49.03 14.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.286 -0.884 . . . . 0.0 110.107 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.9 p -56.39 -54.93 39.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.419 -0.801 . . . . 0.0 110.267 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.55 74.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.0 110.071 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.511 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -73.7 -43.75 58.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 110.134 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 45' ' ' VAL . . . -61.44 -28.53 69.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.386 -0.821 . . . . 0.0 110.189 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -72.84 -27.77 62.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.409 -0.807 . . . . 0.0 110.159 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.34 28.04 4.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -106.65 143.0 35.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.379 -1.071 . . . . 0.0 110.483 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.747 HG11 ' HB3' ' A' ' 52' ' ' GLN . 95.0 t -109.53 -54.42 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.442 -0.787 . . . . 0.0 109.9 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -54.9 -32.54 61.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.51 -0.744 . . . . 0.0 110.418 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 m -62.07 -60.89 2.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 110.292 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.443 HG13 ' CD2' ' A' ' 10' ' ' LEU . 58.3 t -61.49 -27.51 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.27 -0.894 . . . . 0.0 110.146 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HD2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.1 -43.44 82.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 110.161 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.31 -38.47 91.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.587 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.17 -44.68 68.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.0 110.619 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.499 HD22 ' CG ' ' A' ' 60' ' ' HIS . 14.2 mt -65.88 -57.0 8.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.311 -0.868 . . . . 0.0 110.481 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.84 -25.29 18.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.233 -0.917 . . . . 0.0 110.097 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.55 -67.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 110.046 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.88 47.21 0.06 OUTLIER Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.828 ' HB1' HD11 ' A' ' 10' ' ' LEU . . . -85.93 169.79 12.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -1.143 . . . . 0.0 110.175 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.782 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 7.3 t70 -89.85 125.37 61.09 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.95 -17.46 25.18 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.603 1.318 . . . . 0.0 110.649 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.32 39.86 3.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 110.062 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.782 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -71.91 109.79 5.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.403 -0.81 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 36' ' ' ASN . 1.9 tm? -72.83 99.26 2.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.309 -0.87 . . . . 0.0 109.744 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.553 ' O ' HD13 ' A' ' 35' ' ' LEU . 33.9 m120 -54.82 -179.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.468 -0.77 . . . . 0.0 110.439 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -93.94 22.7 5.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.894 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 64.8 m-85 -111.8 21.57 15.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.202 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.74 26.9 26.47 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -131.2 -168.71 2.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.381 -1.07 . . . . 0.0 110.393 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.67 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.2 mmt180 -104.16 176.19 1.88 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.47 -0.769 . . . . 0.0 109.421 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 42.9 Cg_endo -69.76 -19.49 36.08 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.273 1.144 . . . . 0.0 110.648 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.463 ' O ' ' HG2' ' A' ' 46' ' ' MET . 44.7 mt -104.17 -27.94 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 109.775 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.32 -19.68 56.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.094 -1.004 . . . . 0.0 109.875 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.638 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 14.4 p -126.75 35.7 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.232 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.487 ' CE ' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -96.16 31.59 2.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.259 -0.9 . . . . 0.0 110.298 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.473 ' CB ' ' O ' ' A' ' 46' ' ' MET . 4.8 tmm? 72.15 -18.08 0.34 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.557 -0.714 . . . . 0.0 111.208 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.44 ' CE ' ' HB3' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 50.43 26.2 2.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.019 -1.05 . . . . 0.0 110.679 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -125.32 28.88 4.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.11 100.87 0.75 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.318 -1.107 . . . . 0.0 110.312 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.436 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -59.52 -26.96 65.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.301 -0.874 . . . . 0.0 110.063 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.747 ' HB3' HG11 ' A' ' 19' ' ' VAL . 3.5 mm100 -55.04 -29.39 57.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.488 -0.757 . . . . 0.0 110.591 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.564 HG23 HG22 ' A' ' 19' ' ' VAL . 55.2 t -88.24 -33.16 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 109.932 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.8 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -64.77 -39.72 94.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.323 -0.86 . . . . 0.0 110.115 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -80.08 -38.68 31.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.341 -0.849 . . . . 0.0 110.559 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.645 HD22 ' HD2' ' A' ' 23' ' ' ARG . 37.5 tp -53.98 -58.04 8.76 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.295 -0.878 . . . . 0.0 110.32 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 8.2 mt -67.15 -28.04 67.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.958 . . . . 0.0 110.21 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.958 HD22 HG13 ' A' ' 90' ' ' VAL . 1.3 tp -66.92 -64.96 0.74 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.332 -0.855 . . . . 0.0 110.637 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.533 HD11 ' ND1' ' A' ' 60' ' ' HIS . 3.9 pp -49.91 -27.78 5.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.266 -0.896 . . . . 0.0 110.315 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.533 ' ND1' HD11 ' A' ' 59' ' ' LEU . 4.3 m80 -77.22 -62.81 1.53 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -0.855 . . . . 0.0 109.788 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 165.56 41.71 0.02 OUTLIER Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -61.17 -170.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.312 -1.111 . . . . 0.0 110.329 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -125.28 73.73 67.3 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.461 -0.774 . . . . 0.0 110.282 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.848 1.446 . . . . 0.0 110.601 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.423 ' HA ' ' NH1' ' A' ' 74' ' ' ARG . 39.3 m-80 -89.93 -50.01 6.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.931 . . . . 0.0 110.725 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.21 172.24 0.22 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.173 -0.954 . . . . 0.0 110.459 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.716 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -156.76 -178.14 7.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.483 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.43 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 4.4 t0 -89.59 116.67 66.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 110.036 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.89 -17.18 32.63 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.61 1.321 . . . . 0.0 110.363 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.26 -24.12 63.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 110.686 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.737 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 2.1 m -150.73 21.48 0.8 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.25 -0.906 . . . . 0.0 110.599 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 103' ' ' ALA . 17.9 mt 49.23 27.64 1.92 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.176 -0.952 . . . . 0.0 110.385 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -84.79 121.9 28.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.422 -0.799 . . . . 0.0 110.722 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.76 ' CG ' HG11 ' A' ' 100' ' ' VAL . 2.2 mtt180 -94.79 173.59 4.35 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 110.003 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 42.1 Cg_endo -68.39 -17.55 44.13 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.654 1.344 . . . . 0.0 110.23 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.1 t -69.96 -32.33 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.363 -0.836 . . . . 0.0 109.605 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.423 ' CG ' ' HB3' ' A' ' 108' ' ' PRO . 72.7 m-70 -67.97 -43.73 78.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.477 -0.764 . . . . 0.0 110.082 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.44 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 0.6 OUTLIER -59.73 -60.63 3.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 0.0 109.648 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.84 -24.34 8.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.478 -0.764 . . . . 0.0 109.624 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.419 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -83.56 -30.11 27.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.523 -0.736 . . . . 0.0 109.613 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -57.35 -35.59 70.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.416 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 8.6 mp0 -98.01 -15.65 19.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.494 -0.754 . . . . 0.0 110.291 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.444 ' HA3' ' CG ' ' A' ' 117' ' ' HIS . . . 76.71 49.33 7.99 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.14 88.42 3.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.378 -1.072 . . . . 0.0 110.037 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.412 HD21 ' CB ' ' A' ' 123' ' ' TYR . 6.2 mt -60.09 -31.65 70.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.398 -0.814 . . . . 0.0 110.47 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 21.2 t0 -56.88 -48.17 78.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.8 HG23 ' HB1' ' A' ' 54' ' ' ALA . 97.7 m -68.64 -32.87 73.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 109.814 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mp -57.8 -44.06 86.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.343 -0.848 . . . . 0.0 109.821 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 34.1 t -60.89 -54.29 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.448 -0.783 . . . . 0.0 109.439 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.958 HG13 HD22 ' A' ' 58' ' ' LEU . 96.9 t -44.8 -45.91 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.714 -0.616 . . . . 0.0 110.807 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -54.07 24.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 110.512 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -64.59 -46.83 81.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.331 -0.855 . . . . 0.0 110.996 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -69.19 -10.05 55.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.178 -0.951 . . . . 0.0 110.922 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.943 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -120.02 26.71 9.11 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.156 -0.965 . . . . 0.0 110.447 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.77 107.18 0.25 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -170.54 114.99 0.47 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.328 -1.101 . . . . 0.0 110.143 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 74' ' ' ARG . 6.4 ttt85 -69.78 132.89 46.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -0.828 . . . . 0.0 110.082 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.4 mp -119.8 26.83 9.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.418 -0.801 . . . . 0.0 110.191 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -115.54 53.03 0.85 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 110.287 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.76 HG11 ' CG ' ' A' ' 74' ' ' ARG . 14.4 p -123.06 153.75 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 110.103 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 78.2 m -109.48 147.47 32.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 0.0 109.924 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 6.6 p-10 -70.75 67.25 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 0.0 110.325 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.791 ' HB1' ' CZ3' ' A' ' 104' ' ' TRP . . . 57.48 111.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.424 -0.797 . . . . 0.0 110.481 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.791 ' CZ3' ' HB1' ' A' ' 103' ' ' ALA . 38.4 p90 35.64 34.96 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.76 -0.588 . . . . 0.0 111.432 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -122.84 -126.9 3.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.38 179.01 6.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -1.09 . . . . 0.0 110.269 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.544 ' HB2' HG12 ' A' ' 109' ' ' VAL . 96.9 mt -62.85 166.72 7.14 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.477 -0.764 . . . . 0.0 110.013 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.7 Cg_endo -69.94 -16.91 36.99 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.67 1.353 . . . . 0.0 110.536 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.544 HG12 ' HB2' ' A' ' 107' ' ' LEU . 11.6 p -61.64 -35.21 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.218 -0.926 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.428 ' N ' HG13 ' A' ' 109' ' ' VAL . 6.1 m-20 -69.3 -41.74 76.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 110.153 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.01 -31.15 66.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.753 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -68.92 -67.72 0.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.843 . . . . 0.0 110.225 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -25.72 20.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.85 -27.12 60.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.358 -0.839 . . . . 0.0 110.53 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -95.29 -16.02 22.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.667 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 125.28 -13.99 7.4 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.47 ' HB3' ' CG2' ' A' ' 120' ' ' ILE . 24.0 m-70 -75.87 96.87 3.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -1.196 . . . . 0.0 109.594 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' A' ' 119' ' ' ASP . 2.7 ptm180 -91.38 -41.82 10.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.923 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 118' ' ' ARG . 74.4 m-20 -63.29 -38.85 92.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -0.919 . . . . 0.0 109.634 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.753 ' CG2' ' HB1' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -65.63 -37.24 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.567 -0.708 . . . . 0.0 109.92 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.435 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -60.66 -37.0 80.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.453 -0.779 . . . . 0.0 109.9 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -51.15 70.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.408 -0.807 . . . . 0.0 109.759 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.412 ' CB ' HD21 ' A' ' 85' ' ' LEU . 30.9 t80 -60.28 -28.24 67.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.39 -0.819 . . . . 0.0 110.066 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.9 mt -85.59 -38.1 18.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 110.266 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.45 ' CG ' HG21 ' A' ' 109' ' ' VAL . 18.7 m-70 -54.62 -29.3 51.6 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.215 -0.928 . . . . 0.0 110.355 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.86 -20.63 16.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 110.312 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -92.68 -26.85 17.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 0.0 110.582 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.2 p . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.319 -0.863 . . . . 0.0 110.378 -179.837 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.319 0.581 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.46 -21.7 61.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.399 -0.813 . . . . 0.0 110.321 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.422 ' HA2' ' CG2' ' A' ' 12' ' ' THR . . . -57.65 -25.21 55.19 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.703 HD13 ' HG ' ' A' ' 26' ' ' LEU . 13.5 tp -75.92 -38.52 57.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -1.071 . . . . 0.0 110.506 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.17 -38.09 22.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.091 -1.005 . . . . 0.0 111.041 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.511 HG23 ' N ' ' A' ' 13' ' ' ALA . 15.2 t -61.81 -41.11 97.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.144 -0.972 . . . . 0.0 110.487 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.515 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -68.15 -50.56 53.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.175 -0.953 . . . . 0.0 109.534 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 46' ' ' MET . . . -52.57 -45.88 66.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.91 . . . . 0.0 110.563 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.589 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -71.4 -18.02 62.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.422 -0.799 . . . . 0.0 110.648 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -97.15 26.03 5.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 0.0 110.587 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 56.93 37.85 81.2 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.625 ' HB3' ' OG1' ' A' ' 21' ' ' THR . 62.6 mm-40 -112.96 93.87 4.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.42 -1.047 . . . . 0.0 110.271 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.682 HG21 ' HB2' ' A' ' 52' ' ' GLN . 11.3 t -82.78 -59.31 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.215 -0.928 . . . . 0.0 110.47 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -50.23 -48.99 54.28 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.625 ' OG1' ' HB3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -53.88 -34.57 59.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.518 -0.739 . . . . 0.0 110.362 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.872 HG12 HD13 ' A' ' 56' ' ' LEU . 95.3 t -81.12 -30.15 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.779 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.751 ' HA ' HD11 ' A' ' 56' ' ' LEU . 4.5 mmm180 -58.9 -37.56 76.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.296 -0.877 . . . . 0.0 110.108 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 4.2 tt0 -79.28 -51.42 9.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 110.42 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.73 -53.93 45.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 0.0 110.672 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.999 HD13 HD22 ' A' ' 56' ' ' LEU . 8.5 mt -56.56 -59.88 4.35 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.247 -0.908 . . . . 0.0 110.404 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.67 -24.15 65.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.369 -0.832 . . . . 0.0 110.266 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -74.43 -64.93 0.92 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.35 48.69 0.07 OUTLIER Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.637 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . . . -88.4 172.24 9.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -1.088 . . . . 0.0 110.22 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 6.5 t0 -110.82 102.75 53.25 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 0.0 110.239 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.3 -15.08 31.55 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.655 1.345 . . . . 0.0 110.64 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -109.31 26.83 10.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.909 . . . . 0.0 110.163 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -95.63 102.62 14.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.365 -0.835 . . . . 0.0 110.405 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 35' ' ' LEU . 25.7 mt -65.82 123.08 18.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.355 -0.841 . . . . 0.0 110.076 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -62.48 175.64 0.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.395 -0.815 . . . . 0.0 109.886 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -6.12 45.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.305 -0.872 . . . . 0.0 110.459 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -93.3 17.59 10.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.173 -0.955 . . . . 0.0 110.084 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.98 24.0 18.27 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -110.15 155.85 21.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.387 -1.066 . . . . 0.0 109.836 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.565 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.9 mmp_? -73.61 168.86 21.65 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.387 -0.821 . . . . 0.0 109.524 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 41.0 Cg_endo -68.03 -14.98 42.48 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.454 1.239 . . . . 0.0 110.173 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.54 ' HA ' ' HG2' ' A' ' 46' ' ' MET . 58.0 mt -107.95 -17.94 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.85 . . . . 0.0 109.87 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -69.12 -20.93 64.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 110.15 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.589 HG22 ' HB2' ' A' ' 15' ' ' ALA . 8.9 p -109.59 -17.0 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.355 -0.841 . . . . 0.0 110.399 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.54 ' HG2' ' HA ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -55.92 164.49 1.17 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.195 -0.941 . . . . 0.0 110.31 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -63.14 89.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.171 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.424 ' HG3' ' HA ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -49.82 -19.93 0.76 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.47 -0.768 . . . . 0.0 111.28 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . -86.66 20.44 23.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.416 ' O ' HG23 ' A' ' 53' ' ' VAL . 21.2 t -140.67 118.62 11.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.007 -1.29 . . . . 0.0 110.375 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -74.76 -26.25 59.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.924 . . . . 0.0 109.647 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.682 ' HB2' HG21 ' A' ' 19' ' ' VAL . 30.1 mt-30 -53.44 -27.35 24.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.525 -0.735 . . . . 0.0 110.644 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.834 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -90.05 -48.3 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 110.186 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.653 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -55.05 -35.11 64.14 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.297 -0.877 . . . . 0.0 110.368 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.407 ' HA ' HG11 ' A' ' 90' ' ' VAL . 7.3 tp10 -78.03 -48.24 16.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.361 -0.837 . . . . 0.0 110.635 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.999 HD22 HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -52.83 -65.54 0.54 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.201 -0.937 . . . . 0.0 110.761 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.834 HD12 ' O ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -50.95 -47.01 61.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.458 -0.776 . . . . 0.0 110.823 -179.535 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -55.3 -43.5 74.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.3 tp -60.4 -25.61 66.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.673 ' CG ' HD22 ' A' ' 26' ' ' LEU . 29.3 m-70 -95.98 24.68 5.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.201 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.55 54.41 37.94 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.28 -146.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -1.083 . . . . 0.0 109.464 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.63 70.7 77.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.004 -1.06 . . . . 0.0 110.048 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.502 ' HB2' ' HB2' ' A' ' 96' ' ' ALA . 48.8 Cg_endo -81.57 -24.1 4.51 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.806 1.424 . . . . 0.0 110.134 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -95.75 -29.13 14.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 110.358 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.489 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -64.39 139.58 58.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 110.375 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -128.51 175.12 8.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.335 -0.853 . . . . 0.0 110.5 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.515 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 8.6 t70 -76.95 137.18 65.92 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.753 . . . . 0.0 109.84 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.06 -28.35 3.92 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.519 1.273 . . . . 0.0 111.106 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.49 -22.69 58.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.133 -0.979 . . . . 0.0 110.686 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.754 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 3.5 m -144.25 19.57 1.74 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 111.13 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.422 ' HB2' ' CA ' ' A' ' 103' ' ' ALA . 4.9 mt 40.25 36.68 0.35 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.313 -0.867 . . . . 0.0 110.861 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -87.3 126.16 34.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.405 -0.809 . . . . 0.0 110.851 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.709 ' CG ' HG11 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -92.62 173.25 5.23 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.557 -0.714 . . . . 0.0 110.178 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.09 -18.72 16.25 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.663 1.349 . . . . 0.0 110.348 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.89 -32.79 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.33 -0.856 . . . . 0.0 109.939 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.633 ' HE1' HG13 ' A' ' 100' ' ' VAL . 68.8 m80 -60.92 -46.15 91.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.04 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.403 ' CB ' ' CE ' ' A' ' 48' ' ' MET . 1.2 m-20 -60.21 -57.1 14.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.3 -0.875 . . . . 0.0 110.037 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.621 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -51.64 -30.53 21.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.357 -0.84 . . . . 0.0 109.818 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.16 -23.55 30.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.562 -0.711 . . . . 0.0 109.749 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.448 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -60.38 -35.58 76.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.457 -0.777 . . . . 0.0 110.122 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -94.76 -19.5 20.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.34 -0.85 . . . . 0.0 110.463 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.23 30.63 13.55 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.574 ' CA ' ' HZ ' ' A' ' 84' ' ' PHE . 18.0 t80 -97.65 92.01 5.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -1.004 . . . . 0.0 110.092 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 89' ' ' VAL . 2.7 mt -65.63 -22.45 66.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.273 -0.892 . . . . 0.0 110.349 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 90' ' ' VAL . 6.5 m-20 -57.47 -41.14 80.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.397 -0.814 . . . . 0.0 110.392 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.653 HG23 ' CB ' ' A' ' 54' ' ' ALA . 74.8 m -72.86 -36.38 67.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.349 -0.844 . . . . 0.0 109.96 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.726 ' CD1' HD11 ' A' ' 120' ' ' ILE . 5.4 mp -62.52 -42.26 99.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 109.769 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 85' ' ' LEU . 67.6 t -61.31 -44.59 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.448 -0.783 . . . . 0.0 109.332 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 86' ' ' ASP . 65.1 t -55.49 -44.29 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.444 -0.785 . . . . 0.0 109.857 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 87' ' ' THR . 5.5 mp -62.52 -45.95 90.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.428 -0.795 . . . . 0.0 109.744 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -70.97 -15.91 62.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.0 110.254 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -74.61 -71.64 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.349 -0.844 . . . . 0.0 110.136 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -60.78 -78.47 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.331 -0.855 . . . . 0.0 110.286 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.06 107.61 0.26 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 64' ' ' PRO . . . -160.68 119.36 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -1.046 . . . . 0.0 109.834 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -60.43 126.59 28.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.263 -0.898 . . . . 0.0 110.379 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.768 ' O ' HG22 ' A' ' 128' ' ' THR . 0.3 OUTLIER -111.51 64.64 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 110.283 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -171.29 61.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -0.859 . . . . 0.0 110.053 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.709 HG11 ' CG ' ' A' ' 74' ' ' ARG . 7.3 p -131.86 173.13 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 110.065 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.483 ' N ' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -135.1 160.87 36.98 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 104' ' ' TRP . 29.5 m-20 -68.76 71.91 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.709 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.754 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 56.49 -80.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.64 -0.663 . . . . 0.0 110.113 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.503 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -126.78 32.69 5.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -115.46 -142.15 7.59 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.388 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HB3' ' CB ' ' A' ' 110' ' ' ASP . 5.4 mtt85 -98.06 159.13 15.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -1.024 . . . . 0.0 110.787 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -78.99 175.64 4.53 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.604 -0.685 . . . . 0.0 109.618 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 40.8 Cg_endo -66.12 -16.87 53.7 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.385 1.203 . . . . 0.0 110.174 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.521 HG21 ' CG ' ' A' ' 125' ' ' HIS . 9.7 p -91.69 -34.9 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.873 . . . . 0.0 109.796 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.418 ' N ' HG13 ' A' ' 109' ' ' VAL . 10.0 m-20 -66.91 -41.65 86.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -0.8 . . . . 0.0 109.954 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 111' ' ' LEU . 5.8 tt -57.04 -31.02 64.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.419 -0.801 . . . . 0.0 109.951 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.729 ' HB1' ' HB2' ' A' ' 117' ' ' HIS . . . -83.85 -36.85 23.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.532 -0.73 . . . . 0.0 109.979 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -54.99 -26.21 35.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 0.0 110.644 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -91.88 -47.28 7.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.377 -0.827 . . . . 0.0 110.72 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.432 ' HG2' ' CE1' ' A' ' 117' ' ' HIS . 52.6 tp60 -66.4 -100.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.913 . . . . 0.0 110.547 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.12 24.7 0.2 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.523 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.729 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 1.6 m170 -100.51 86.2 3.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.0 -1.294 . . . . 0.0 109.386 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 122' ' ' ARG . 2.6 mpt_? -80.72 -57.93 3.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.415 -0.803 . . . . 0.0 110.71 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -45.76 -46.84 15.42 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.627 -0.671 . . . . 0.0 110.894 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.726 HD11 ' CD1' ' A' ' 88' ' ' LEU . 2.7 tt -65.41 -37.44 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 0.0 109.644 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -61.82 -39.7 92.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 110.0 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 11.5 mmt180 -63.8 -41.37 97.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -74.34 -30.64 62.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.548 -0.72 . . . . 0.0 109.587 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.504 HD23 HD21 ' A' ' 98' ' ' LEU . 20.4 mt -72.89 -59.55 2.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.522 -0.737 . . . . 0.0 109.972 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.521 ' CG ' HG21 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -56.06 -28.57 58.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.38 -0.825 . . . . 0.0 110.096 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.82 -33.77 71.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.429 -0.794 . . . . 0.0 110.243 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.462 ' HB3' ' CD2' ' A' ' 98' ' ' LEU . . . -99.81 -22.41 15.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.398 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 98' ' ' LEU . 64.2 p . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 0.0 110.354 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.236 0.541 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.601 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -148.51 50.74 1.0 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.08 -27.76 46.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.993 HD13 HD21 ' A' ' 57' ' ' LEU . 3.9 pp -57.96 -33.6 69.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.503 -0.998 . . . . 0.0 109.866 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.722 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -76.49 -39.28 53.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.381 -0.824 . . . . 0.0 109.733 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.7 m -62.36 -54.46 40.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.406 -0.809 . . . . 0.0 109.785 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 16' ' ' ARG . . . -64.13 -32.33 73.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 0.0 109.783 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.654 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -67.19 -32.68 73.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.206 -0.934 . . . . 0.0 109.494 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' CA ' ' HA ' ' A' ' 46' ' ' MET . . . -70.87 -27.02 63.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 110.02 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 19.2 ptt180 -100.17 20.25 14.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.33 -0.856 . . . . 0.0 110.411 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.414 ' HA3' ' CE ' ' A' ' 47' ' ' MET . . . 62.5 83.0 0.07 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.74 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.6 mm100 -151.74 71.25 0.97 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 110.174 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.822 HG22 HG23 ' A' ' 53' ' ' VAL . 24.8 t -57.0 -43.01 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.236 -0.915 . . . . 0.0 109.889 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -56.89 -52.61 64.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.343 -0.848 . . . . 0.0 110.541 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.427 ' OG1' ' NE2' ' A' ' 18' ' ' GLN . 0.3 OUTLIER -64.26 -41.44 96.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.359 -0.838 . . . . 0.0 110.249 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.818 HG12 HD23 ' A' ' 56' ' ' LEU . 62.1 t -63.24 -38.28 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.45 -0.781 . . . . 0.0 110.024 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.781 ' HD2' HD13 ' A' ' 56' ' ' LEU . 6.8 mmm-85 -69.5 -24.56 63.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 110.148 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 89.8 mm-40 -79.31 -53.6 6.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.836 . . . . 0.0 110.464 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.937 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -59.58 -44.07 93.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.347 -0.846 . . . . 0.0 110.484 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.432 HD11 ' CG ' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -57.24 -53.33 59.35 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.18 -0.95 . . . . 0.0 110.245 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -75.35 -5.56 45.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.427 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -84.1 -39.05 19.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.139 -0.975 . . . . 0.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.98 -20.19 0.14 Allowed Glycine 0 N--CA 1.484 1.881 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.642 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.937 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -47.46 136.27 10.01 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.151 -1.205 . . . . 0.0 111.009 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.92 ' OD2' ' HB2' ' A' ' 34' ' ' ALA . 10.4 p-10 -78.19 150.59 77.61 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 110.203 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.73 4.45 6.91 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.852 1.448 . . . . 0.0 111.051 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -136.35 43.25 2.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.036 -1.04 . . . . 0.0 110.917 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.92 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . . . -109.72 104.69 13.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 35' ' ' LEU . 3.7 pp -73.61 138.76 45.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.201 -0.937 . . . . 0.0 110.253 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.601 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 15.6 p-10 -107.7 82.72 1.69 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.471 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 52.02 -171.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.313 -0.867 . . . . 0.0 110.862 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 39' ' ' GLY . 80.2 m-85 55.56 13.28 0.94 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.571 -0.705 . . . . 0.0 110.924 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' PHE . . . 38.54 35.31 0.31 Allowed Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -107.11 -164.68 1.0 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -1.041 . . . . 0.0 110.478 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.672 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.8 mmp_? -116.71 176.64 1.47 Allowed Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.672 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 43.1 Cg_endo -72.07 -19.78 26.02 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.31 1.163 . . . . 0.0 110.2 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.455 ' O ' ' HG2' ' A' ' 46' ' ' MET . 25.4 mt -104.27 -27.44 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -74.47 -4.26 35.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.536 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.722 HG11 ' HB1' ' A' ' 11' ' ' ALA . 12.4 p -115.03 -17.95 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.084 -1.01 . . . . 0.0 110.748 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -64.34 164.82 10.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.966 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' MET . . . . . 0.414 ' CE ' ' HA3' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -55.67 -16.92 4.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.375 -0.828 . . . . 0.0 110.545 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.566 ' HE3' ' CB ' ' A' ' 78' ' ' ASP . 45.3 tpp 58.93 24.66 12.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.294 -0.878 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.23 20.54 5.59 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 m -149.13 96.26 2.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 110.04 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.419 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -52.49 -26.76 13.86 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.274 -0.891 . . . . 0.0 110.296 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.641 ' HB2' HG21 ' A' ' 19' ' ' VAL . 6.0 mt-30 -53.28 -34.8 58.76 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.822 HG23 HG22 ' A' ' 19' ' ' VAL . 60.3 t -84.13 -38.47 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 110.223 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.877 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -68.18 -33.18 73.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.415 -0.803 . . . . 0.0 110.553 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.402 ' O ' HD23 ' A' ' 59' ' ' LEU . 8.5 tt0 -76.6 -39.98 50.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.966 . . . . 0.0 110.659 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.818 HD23 HG12 ' A' ' 22' ' ' VAL . 46.5 tp -56.2 -63.03 1.32 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.284 -0.885 . . . . 0.0 110.732 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.993 HD21 HD13 ' A' ' 10' ' ' LEU . 5.1 mt -59.78 -30.31 68.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.254 -0.904 . . . . 0.0 110.84 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.948 HD22 HG13 ' A' ' 90' ' ' VAL . 2.7 tp -60.13 -67.51 0.38 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.13 -0.981 . . . . 0.0 110.99 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.434 HD11 ' CE1' ' A' ' 60' ' ' HIS . 2.2 pp -51.85 -25.28 7.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.247 -0.908 . . . . 0.0 110.7 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.434 ' CE1' HD11 ' A' ' 59' ' ' LEU . 12.7 m80 -80.88 -67.3 0.79 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.179 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.52 40.9 0.04 OUTLIER Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' A' ' 57' ' ' LEU . . . -61.67 -164.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.314 -1.109 . . . . 0.0 110.13 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.59 74.43 74.63 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.959 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.89 -32.61 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.901 1.474 . . . . 0.0 110.158 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -95.6 -30.18 13.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.388 -0.82 . . . . 0.0 110.012 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 171.08 2.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.438 -0.789 . . . . 0.0 110.139 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.809 ' HB1' ' O ' ' A' ' 73' ' ' THR . . . -169.46 -179.51 3.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.421 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 72' ' ' LEU . 21.8 t0 -78.69 131.44 67.71 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.396 -0.815 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.67 -23.16 11.39 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.544 1.286 . . . . 0.0 110.398 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.83 -29.41 62.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 0.0 110.59 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.827 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 7.8 m -138.92 17.32 2.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.907 . . . . 0.0 110.665 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER 42.38 29.47 0.15 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.317 -0.864 . . . . 0.0 110.794 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.809 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -72.31 134.84 45.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 110.556 -179.38 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.682 ' HG3' HG11 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -107.72 165.17 13.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 110.324 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.37 -24.68 22.5 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.698 1.367 . . . . 0.0 110.322 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 108' ' ' PRO . 58.9 t -58.7 -29.14 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.353 -0.842 . . . . 0.0 110.007 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.443 ' CE1' ' N ' ' A' ' 108' ' ' PRO . 29.7 m-70 -68.65 -34.33 75.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.344 -0.848 . . . . 0.0 110.126 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.566 ' CB ' ' HE3' ' A' ' 48' ' ' MET . 43.4 m-20 -77.82 -56.5 4.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.409 -0.807 . . . . 0.0 110.239 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.566 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -52.65 -26.6 14.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.093 -1.004 . . . . 0.0 109.888 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.436 ' O ' ' CD2' ' A' ' 117' ' ' HIS . . . -85.3 -21.31 29.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.435 -0.791 . . . . 0.0 109.566 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.67 ' CD ' HD12 ' A' ' 111' ' ' LEU . 10.3 tpt180 -76.44 -17.25 59.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.429 -0.794 . . . . 0.0 110.341 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.406 ' HG3' ' HB3' ' A' ' 48' ' ' MET . 30.6 mm-40 -100.84 -34.54 9.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.18 -0.95 . . . . 0.0 110.323 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.9 34.18 4.42 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.2 105.61 15.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -1.091 . . . . 0.0 110.123 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.681 HD22 HD12 ' A' ' 120' ' ' ILE . 2.8 mm? -77.6 -21.98 51.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.466 -0.772 . . . . 0.0 110.256 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.692 ' O ' HG23 ' A' ' 90' ' ' VAL . 46.6 t0 -68.0 -48.71 64.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.361 -0.837 . . . . 0.0 110.565 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.877 HG23 ' CB ' ' A' ' 54' ' ' ALA . 97.8 m -65.3 -33.98 77.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.14 -0.975 . . . . 0.0 110.071 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.799 HD13 HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -61.87 -48.53 80.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.226 -0.921 . . . . 0.0 109.857 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 85' ' ' LEU . 67.6 t -60.06 -40.7 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 109.527 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.948 HG13 HD22 ' A' ' 58' ' ' LEU . 91.3 t -53.82 -53.79 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.446 -0.784 . . . . 0.0 110.234 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mp -52.74 -52.01 58.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.387 -0.821 . . . . 0.0 110.581 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -60.99 -24.69 66.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.254 -0.904 . . . . 0.0 110.177 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.42 -22.88 60.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.407 -0.808 . . . . 0.0 110.338 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.752 ' HB3' HD11 ' A' ' 58' ' ' LEU . . . -121.46 35.05 4.99 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.278 -0.889 . . . . 0.0 110.616 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.59 114.05 0.14 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.417 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -155.6 131.56 9.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -1.099 . . . . 0.0 110.034 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 141.47 38.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 109.951 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.754 ' O ' HG22 ' A' ' 128' ' ' THR . 0.5 OUTLIER -133.59 11.09 4.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -0.816 . . . . 0.0 110.307 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -110.73 22.92 14.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 110.019 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.682 HG11 ' HG3' ' A' ' 74' ' ' ARG . 9.5 p -91.56 144.93 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.451 -0.78 . . . . 0.0 109.932 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.542 ' SG ' HD11 ' A' ' 107' ' ' LEU . 53.4 m -115.17 41.96 2.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 110.383 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.671 ' OD1' HG23 ' A' ' 73' ' ' THR . 32.0 t0 52.64 69.47 0.68 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.351 -0.843 . . . . 0.0 110.36 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.827 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 62.89 -77.93 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.519 -0.738 . . . . 0.0 110.254 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -155.5 45.92 0.48 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.356 -0.84 . . . . 0.0 109.801 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -129.42 -118.09 2.03 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -95.83 -178.36 4.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -1.102 . . . . 0.0 110.665 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.542 HD11 ' SG ' ' A' ' 101' ' ' CYS . 3.7 mp -105.14 173.65 3.16 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.498 -0.752 . . . . 0.0 109.942 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 41.6 Cg_endo -67.83 -20.12 46.02 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.551 1.29 . . . . 0.0 110.274 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.741 ' HB ' HD11 ' A' ' 124' ' ' LEU . 14.4 p -83.28 -23.56 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 110.189 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -62.32 -28.34 69.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.225 -0.922 . . . . 0.0 110.266 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.67 HD12 ' CD ' ' A' ' 81' ' ' ARG . 4.4 mm? -58.32 -68.55 0.24 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.308 -0.87 . . . . 0.0 109.941 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.801 ' HB1' ' O ' ' A' ' 117' ' ' HIS . . . -61.64 -43.54 98.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.871 . . . . 0.0 109.725 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.543 ' HG3' HG22 ' A' ' 109' ' ' VAL . 8.8 mm-40 -48.98 -31.99 8.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.513 -0.742 . . . . 0.0 109.51 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 115' ' ' GLN . 10.8 tt0 -66.97 -62.94 1.18 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.608 -0.683 . . . . 0.0 109.212 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER 172.46 113.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.541 -0.724 . . . . 0.0 110.221 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.43 -53.19 0.42 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.628 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.801 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 1.2 m-70 -138.86 75.78 1.54 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.176 -1.19 . . . . 0.0 110.566 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -61.41 -22.78 65.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 0.0 109.979 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.42 ' OD2' HD23 ' A' ' 85' ' ' LEU . 12.5 p-10 -72.87 -42.21 63.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.401 -0.812 . . . . 0.0 110.451 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.799 HD11 HD13 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -61.87 -30.75 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.917 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 125' ' ' HIS . . . -65.1 -52.61 54.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.421 -0.8 . . . . 0.0 109.644 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.43 ' HA ' ' CE1' ' A' ' 125' ' ' HIS . 5.4 mtm180 -45.81 -46.38 15.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.285 -0.884 . . . . 0.0 110.662 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -81.77 -56.74 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 111.057 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.839 ' O ' HG23 ' A' ' 128' ' ' THR . 0.3 OUTLIER -59.51 -39.65 84.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.034 . . . . 0.0 111.158 -178.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.519 ' CD2' ' C ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -67.81 -39.76 83.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.747 -1.22 . . . . 0.0 109.461 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ALA . . . . . 0.449 ' N ' ' CD2' ' A' ' 125' ' ' HIS . . . -54.23 -27.94 37.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.412 -0.805 . . . . 0.0 109.548 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.723 ' CB ' HD22 ' A' ' 98' ' ' LEU . . . -90.86 -16.8 27.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.595 -0.69 . . . . 0.0 110.411 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 124' ' ' LEU . 29.1 p . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.194 -0.941 . . . . 0.0 109.71 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.236 0.541 . . . . 3.31 109.873 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.589 ' HB1' ' OD1' ' A' ' 36' ' ' ASN . . . -95.34 18.24 12.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 3.29 110.236 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.96 -37.35 92.08 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.385 -1.486 . . . . 2.63 109.385 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.8 HD13 ' CD2' ' A' ' 57' ' ' LEU . 4.0 pp -59.93 -27.25 66.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.384 -1.068 . . . . 2.24 110.154 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -80.47 -47.08 14.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.45 -0.781 . . . . 1.89 110.0 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.8 p -62.17 -51.2 68.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.373 -0.83 . . . . 2.15 109.837 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.53 -34.01 72.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.377 -0.827 . . . . 1.65 109.791 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.61 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -73.07 -36.18 66.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.536 -0.728 . . . . 1.38 109.91 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 46' ' ' MET . . . -60.75 -27.07 67.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.421 -0.799 . . . . 1.41 110.066 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -93.52 -17.51 23.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.372 -0.83 . . . . 4.94 110.321 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.17 54.04 1.31 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.518 -1.433 . . . . 1.44 109.518 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -124.92 79.42 1.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -1.118 . . . . 2.77 110.521 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.829 HG21 ' HB3' ' A' ' 52' ' ' GLN . 84.5 t -61.71 -38.84 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.222 -0.924 . . . . 1.58 109.66 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.78 -44.57 90.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.348 -0.845 . . . . 2.28 110.346 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 m -64.35 -42.68 96.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.869 . . . . 1.8 109.974 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.607 HG12 HD13 ' A' ' 56' ' ' LEU . 61.0 t -74.66 -25.77 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.429 -0.794 . . . . 1.6 110.198 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.569 ' HA ' HD11 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -64.26 -51.31 64.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.317 -0.864 . . . . 1.96 110.464 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.82 -21.06 60.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.275 -0.89 . . . . 4.45 110.599 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.469 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -71.26 -63.61 1.08 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.202 -0.936 . . . . 2.55 110.551 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.81 HD11 HD23 ' A' ' 57' ' ' LEU . 10.2 mt -56.83 -46.37 81.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.289 -0.882 . . . . 2.71 110.646 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.36 -35.24 75.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.38 -0.825 . . . . 3.3 110.375 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.08 -65.8 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.362 -0.836 . . . . 2.66 110.134 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.99 57.33 0.07 OUTLIER Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.563 -1.415 . . . . 2.97 109.563 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.717 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . . . -109.01 133.93 52.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -1.114 . . . . 2.78 110.168 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 1.2 t0 -69.57 127.65 92.58 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 3.66 109.996 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.86 -17.32 25.61 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.592 1.312 . . . . 2.22 110.547 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -107.93 29.03 7.64 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -0.906 . . . . 2.17 110.227 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -81.22 106.2 13.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.363 -0.836 . . . . 2.32 110.153 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 35' ' ' LEU . 13.2 mt -65.3 164.92 12.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.384 -0.822 . . . . 2.98 110.386 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' OD1' ' HB1' ' A' ' 8' ' ' ALA . 1.3 m120 -107.69 -170.0 1.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 3.25 110.14 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -81.77 -18.58 43.66 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.397 -0.814 . . . . 4.62 110.341 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -91.46 18.46 7.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.311 -0.868 . . . . 3.21 110.43 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.07 37.4 45.62 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.836 -1.306 . . . . 2.18 109.836 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.05 162.94 17.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.37 -1.077 . . . . 2.77 110.325 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.616 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.2 mmp_? -77.08 170.76 14.77 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.503 -0.748 . . . . 2.2 109.516 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 41.1 Cg_endo -67.58 -13.1 37.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.478 1.252 . . . . 1.57 110.52 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.454 HG23 ' HE1' ' A' ' 46' ' ' MET . 74.2 mt -109.92 -17.86 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -0.918 . . . . 1.31 109.862 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.81 -4.97 49.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.218 -0.926 . . . . 2.02 110.282 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.545 HG11 ' HB1' ' A' ' 11' ' ' ALA . 14.2 p -120.36 -6.43 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.251 -0.906 . . . . 1.59 110.903 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.572 ' HE1' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -69.41 162.42 27.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.024 -1.047 . . . . 1.8 110.174 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -54.67 -19.62 6.53 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.344 -0.847 . . . . 1.63 110.865 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.497 ' HE2' ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER 60.96 19.68 10.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.29 -0.881 . . . . 1.36 110.156 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.418 ' HA2' ' CD2' ' A' ' 84' ' ' PHE . . . -124.81 24.39 6.07 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.369 -1.492 . . . . 1.25 109.369 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.9 t -154.59 106.84 2.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -1.083 . . . . 1.72 110.071 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -58.88 -25.68 63.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.419 -0.801 . . . . 1.05 110.348 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.829 ' HB3' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -58.08 -29.54 65.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.269 -0.895 . . . . 2.53 110.185 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.683 ' CG2' HG22 ' A' ' 19' ' ' VAL . 34.6 t -84.19 -47.93 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.396 -0.815 . . . . 1.2 110.504 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.754 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -62.1 -37.15 83.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.31 -0.869 . . . . 1.0 110.661 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.417 ' HA ' HG11 ' A' ' 90' ' ' VAL . 16.4 tt0 -74.93 -33.76 62.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 2.74 110.457 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.804 HD22 HD12 ' A' ' 26' ' ' LEU . 1.9 tt -57.22 -64.31 0.93 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.294 -0.879 . . . . 2.1 110.725 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.81 HD23 HD11 ' A' ' 26' ' ' LEU . 6.6 mt -61.41 -40.24 93.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.353 -0.842 . . . . 1.9 110.9 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.745 HD13 HG12 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -58.47 -57.46 12.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 2.12 110.745 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -53.49 -26.35 20.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.287 -0.883 . . . . 2.08 110.236 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.428 ' CE1' ' HB3' ' A' ' 26' ' ' LEU . 3.1 m170 -84.2 -73.9 0.4 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 2.46 110.054 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.16 50.11 0.05 OUTLIER Glycine 0 N--CA 1.483 1.831 0 N-CA-C 109.741 -1.343 . . . . 1.57 109.741 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -70.8 -162.11 0.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -1.109 . . . . 1.54 110.177 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.408 ' CB ' ' HD3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -121.91 76.83 39.63 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 2.16 110.183 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 96' ' ' ALA . 48.7 Cg_endo -77.75 -24.44 8.69 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.775 1.408 . . . . 1.29 110.573 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -92.84 -50.01 5.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 2.56 110.4 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.07 120.85 6.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.244 -0.91 . . . . 1.86 110.449 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.789 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -109.36 -179.44 3.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.396 -0.815 . . . . 1.98 110.329 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -76.95 125.59 86.71 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 2.51 110.003 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.78 -13.0 24.41 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.495 1.26 . . . . 2.48 110.727 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.0 -30.86 44.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.958 . . . . 2.68 110.557 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.62 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 1.7 m -142.66 17.15 2.0 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 2.71 110.567 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.98 32.08 7.05 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.288 -0.883 . . . . 2.34 110.506 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.42 HG23 ' OD1' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -85.7 121.47 28.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.389 -0.819 . . . . 1.77 110.379 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.802 ' HB2' HG11 ' A' ' 100' ' ' VAL . 1.0 OUTLIER -93.1 172.65 5.78 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.775 . . . . 2.6 110.161 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.45 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 45.1 Cg_endo -72.13 -9.38 24.4 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.719 1.379 . . . . 0.94 110.772 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.83 -23.94 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.178 -0.951 . . . . 0.6 110.141 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -72.03 -52.14 18.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.311 -0.868 . . . . 0.87 110.476 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -58.44 -47.48 83.83 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.282 -0.886 . . . . 1.76 110.418 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.497 ' N ' ' HE2' ' A' ' 48' ' ' MET . . . -60.62 -26.36 66.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -0.853 . . . . 0.73 110.211 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -87.7 -21.33 25.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.352 -0.843 . . . . 1.05 110.442 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 -72.6 -30.83 64.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.256 -0.903 . . . . 3.11 110.344 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.404 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 1.3 mm-40 -86.61 -36.11 19.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.872 . . . . 2.1 110.211 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.37 46.06 1.9 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.699 -1.361 . . . . 1.06 109.699 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.418 ' CD2' ' HA2' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -115.13 103.15 10.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.366 -1.079 . . . . 1.69 109.923 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 119' ' ' ASP . 2.3 mt -75.24 -22.62 57.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.847 . . . . 1.92 110.368 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -59.97 -43.31 95.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 1.68 110.114 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.754 HG23 ' HB1' ' A' ' 54' ' ' ALA . 63.7 m -73.24 -39.55 65.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.326 -0.859 . . . . 0.85 109.889 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.775 HD13 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -55.47 -46.51 76.83 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.393 -0.817 . . . . 1.21 109.952 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 85' ' ' LEU . 87.7 t -63.18 -41.15 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.402 -0.811 . . . . 1.41 109.539 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 86' ' ' ASP . 90.2 t -57.2 -47.9 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.596 -0.69 . . . . 1.1 110.276 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.11 -52.5 65.3 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.39 -0.819 . . . . 1.01 110.303 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -60.01 -27.2 66.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.514 -0.741 . . . . 1.66 110.323 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -67.8 -69.03 0.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 3.26 110.265 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.731 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -54.65 -28.19 45.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 1.58 110.669 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.17 87.86 1.21 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.564 -1.415 . . . . 1.55 109.564 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -136.33 134.43 37.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -1.118 . . . . 1.25 110.313 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -71.43 143.05 50.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.802 . . . . 3.46 110.103 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 96' ' ' ALA . 2.1 mp -123.37 -2.78 8.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 1.72 110.823 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -93.69 69.97 4.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.122 -0.986 . . . . 2.12 110.151 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 74' ' ' ARG . 12.2 p -135.27 151.23 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.433 -0.792 . . . . 1.3 110.156 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' CYS . . . . . 0.401 ' O ' ' N ' ' A' ' 103' ' ' ALA . 12.3 m -116.22 159.17 22.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.243 -0.911 . . . . 2.07 109.404 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -68.55 74.54 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 2.65 109.755 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 61.16 -79.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.635 -0.666 . . . . 2.58 110.047 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.448 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.2 p90 -128.41 37.96 4.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 3.81 109.859 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -120.49 -141.25 6.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.99 -1.244 . . . . 2.11 109.99 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -101.74 -164.95 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.4 -1.059 . . . . 4.59 110.48 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -96.18 174.27 3.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.725 . . . . 1.94 110.035 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.8 Cg_endo -68.16 -22.39 40.85 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.697 1.367 . . . . 1.02 110.254 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 107' ' ' LEU . 11.1 p -73.73 -27.31 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 1.34 110.042 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -80.26 -38.93 29.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.836 . . . . 2.42 110.095 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.48 -26.83 65.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.399 -0.813 . . . . 1.99 109.918 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' A' ' 117' ' ' HIS . . . -78.04 -54.26 6.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.51 -0.744 . . . . 1.78 109.971 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -53.09 -25.79 14.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.395 -0.816 . . . . 3.39 110.573 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -79.05 -54.98 5.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 3.16 110.235 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.38 -67.33 0.43 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.399 -0.813 . . . . 4.06 110.052 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 157.6 47.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.595 -1.402 . . . . 2.4 109.595 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' HIS . . . . . 0.565 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 70.1 m-70 -122.23 64.63 0.93 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.361 -1.082 . . . . 2.12 109.999 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -35.43 67.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.283 -0.886 . . . . 4.53 110.158 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.503 ' HB3' HD12 ' A' ' 85' ' ' LEU . 31.4 m-20 -61.9 -48.5 80.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.379 -0.825 . . . . 2.51 110.218 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.775 HD11 HD13 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -71.62 -25.38 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.397 -0.815 . . . . 1.52 110.347 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.0 -45.41 67.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.395 -0.816 . . . . 1.71 110.119 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.5 mtp85 -59.56 -53.54 56.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.357 -0.839 . . . . 3.93 110.126 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.49 ' CB ' HD21 ' A' ' 85' ' ' LEU . 37.7 t80 -60.52 -35.91 77.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.343 -0.848 . . . . 1.96 110.058 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.466 ' CG ' HD21 ' A' ' 88' ' ' LEU . 34.3 mt -72.6 -41.06 66.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.453 -0.78 . . . . 1.42 110.172 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -59.73 -22.53 62.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.401 -0.812 . . . . 3.72 110.327 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -86.47 -30.86 21.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.878 . . . . 2.04 110.308 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -96.84 -21.04 17.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.278 -0.888 . . . . 1.64 110.633 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 98' ' ' LEU . 26.4 p . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 1.96 110.458 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 46.4 t -71.27 146.19 91.82 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.341 -1.094 . . . . 0.0 109.805 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.96 144.49 30.46 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.614 1.323 . . . . 0.0 110.652 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -176.79 174.09 46.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' ILE . . . . . 0.925 HG23 ' CD2' ' A' ' 0' ' ' HIS . 5.5 tp -173.42 153.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.118 -1.225 . . . . 0.0 111.175 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.925 ' CD2' HG23 ' A' ' -1' ' ' ILE . 26.2 p80 40.52 108.21 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 122.099 0.952 . . . . 0.0 113.207 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.4 mmt 55.21 -163.19 0.14 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.489 -0.757 . . . . 0.0 111.673 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.5 tp -159.16 -55.23 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.698 -0.626 . . . . 0.0 110.309 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 152.27 167.0 14.72 Favored Glycine 0 N--CA 1.498 2.824 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.25 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.64 139.94 2.76 Favored Glycine 0 N--CA 1.498 2.798 0 O-C-N 121.291 -1.123 . . . . 0.0 110.434 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -120.69 -167.1 1.42 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.444 -1.033 . . . . 0.0 109.69 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.273 58.9 m -169.18 178.63 4.3 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 123.881 1.8 . . . . 0.0 114.733 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 1.11 ' O ' HD11 ' A' ' 25' ' ' LEU . 6.4 p-10 -115.09 49.23 1.07 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 171.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 9' ' ' GLY . . . -115.47 5.45 14.49 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.239 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.846 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -41.22 -33.58 0.81 Allowed Glycine 0 N--CA 1.499 2.844 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.985 HD22 HD21 ' A' ' 57' ' ' LEU . 4.2 pp -53.66 -29.1 36.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.755 -0.85 . . . . 0.0 109.803 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.755 ' N ' HD12 ' A' ' 10' ' ' LEU . . . -88.06 -60.23 2.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.366 -0.834 . . . . 0.0 109.995 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.1 p -53.46 -47.67 69.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.444 -0.785 . . . . 0.0 110.525 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' A' ' 18' ' ' GLN . . . -67.73 -38.69 83.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 109.778 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -56.54 -52.88 63.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.413 -0.805 . . . . 0.0 109.706 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' A' ' 47' ' ' MET . . . -53.46 -30.4 40.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.891 . . . . 0.0 109.078 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -90.51 8.88 31.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.64 -0.662 . . . . 0.0 110.084 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.0 58.64 7.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.816 ' O ' HG23 ' A' ' 22' ' ' VAL . 27.0 mt-30 -131.92 81.07 1.95 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -1.133 . . . . 0.0 111.008 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.942 HG21 ' HB3' ' A' ' 52' ' ' GLN . 61.1 t -68.67 -29.39 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.065 -1.022 . . . . 0.0 109.217 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -61.8 -42.97 99.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.312 -0.868 . . . . 0.0 109.423 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.516 ' HB ' ' CB ' ' A' ' 13' ' ' ALA . 1.8 m -69.08 -41.25 77.76 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.933 HG12 HD13 ' A' ' 56' ' ' LEU . 21.6 t -61.61 -34.32 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.416 ' HA ' HD11 ' A' ' 56' ' ' LEU . 1.6 mmt180 -70.24 -33.73 71.99 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.41 -53.42 8.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.67 -0.643 . . . . 0.0 111.092 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.11 HD11 ' O ' ' A' ' 7' ' ' ASP . 2.9 tm? -55.91 -25.36 42.64 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.008 -1.058 . . . . 0.0 109.145 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -95.34 -68.82 0.78 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.053 -1.03 . . . . 0.0 111.713 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -50.54 -17.9 0.58 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.29 -0.881 . . . . 0.0 111.535 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.4 2.98 10.0 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.983 -1.073 . . . . 0.0 110.951 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.35 72.93 1.26 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.758 ' HB1' ' HB2' ' A' ' 7' ' ' ASP . . . -132.69 -166.49 1.75 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.412 -1.051 . . . . 0.0 111.42 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.13 140.76 21.55 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.675 -0.64 . . . . 0.0 109.609 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.43 5.36 3.75 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.48 1.253 . . . . 0.0 111.277 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -134.18 42.62 2.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.859 -1.15 . . . . 0.0 111.254 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.723 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . . . -69.36 79.3 0.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.96 -1.087 . . . . 0.0 109.186 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mt -49.5 158.58 0.41 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.532 -0.73 . . . . 0.0 111.397 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -121.26 159.14 26.59 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -22.79 13.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.153 -0.967 . . . . 0.0 110.566 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -77.3 -9.78 59.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 110.356 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.72 28.79 31.49 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 44' ' ' GLN . 13.4 mtm180 -101.77 37.96 1.72 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -1.079 . . . . 0.0 110.084 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.89 177.27 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.312 -0.867 . . . . 0.0 110.674 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -81.53 -24.78 4.12 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.608 1.32 . . . . 0.0 110.816 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.0 mt -102.39 -40.9 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.158 -0.963 . . . . 0.0 110.884 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.43 ' CB ' ' O ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -52.19 -20.68 2.74 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.029 -1.045 . . . . 0.0 110.777 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 45' ' ' VAL . 11.1 p -113.92 44.5 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.932 . . . . 0.0 110.85 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.613 ' CE ' HG21 ' A' ' 87' ' ' THR . 16.6 ptt? -111.8 26.58 10.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.032 -1.042 . . . . 0.0 110.163 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 3.5 tmm? 67.86 -2.39 1.43 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.583 -0.698 . . . . 0.0 111.086 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.608 ' O ' ' HZ ' ' A' ' 84' ' ' PHE . 14.3 mmt 42.35 31.23 0.25 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.211 -0.931 . . . . 0.0 110.988 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -125.01 -3.36 7.55 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.7 p -133.35 99.69 4.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.993 -1.298 . . . . 0.0 110.695 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.0 67.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.302 -0.874 . . . . 0.0 109.824 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.942 ' HB3' HG21 ' A' ' 19' ' ' VAL . 8.3 tp60 -52.01 -27.78 14.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.428 -0.795 . . . . 0.0 110.043 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.826 ' CG2' HG22 ' A' ' 19' ' ' VAL . 19.3 t -87.68 -36.46 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.828 . . . . 0.0 109.489 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.564 ' HB2' ' HE1' ' A' ' 46' ' ' MET . . . -60.8 -40.16 91.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.428 -0.795 . . . . 0.0 110.424 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' O ' HD23 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -76.17 -39.95 53.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.0 110.614 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.933 HD13 HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -49.43 -64.59 0.76 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.335 -0.853 . . . . 0.0 111.54 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.985 HD21 HD22 ' A' ' 10' ' ' LEU . 3.2 mt -67.25 -38.12 84.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.106 -0.996 . . . . 0.0 111.152 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.937 HD22 ' CG1' ' A' ' 90' ' ' VAL . 1.1 tp -52.79 -66.74 0.33 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.019 -1.051 . . . . 0.0 110.532 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 55' ' ' GLU . 4.0 pp -52.23 -27.57 15.3 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.283 -0.886 . . . . 0.0 110.004 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.474 ' N ' HD12 ' A' ' 59' ' ' LEU . 3.3 m80 -77.24 -68.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.368 -0.833 . . . . 0.0 110.073 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.25 38.34 0.03 OUTLIER Glycine 0 N--CA 1.484 1.842 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.861 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -60.16 -166.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.204 -1.174 . . . . 0.0 110.422 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -121.74 75.26 36.34 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 110.057 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.478 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . 48.5 Cg_endo -77.89 -21.35 11.07 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.831 1.437 . . . . 0.0 110.54 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -95.53 -47.69 6.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 110.457 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.58 172.96 0.44 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.276 -0.89 . . . . 0.0 110.22 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.448 ' HB2' ' NE ' ' A' ' 74' ' ' ARG . . . -169.27 -176.67 2.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.492 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.41 123.21 86.87 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.425 -0.797 . . . . 0.0 109.95 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.31 -13.98 20.61 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.681 1.358 . . . . 0.0 110.97 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.49 -20.95 56.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.197 -0.939 . . . . 0.0 110.85 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.762 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -155.03 27.15 0.42 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.082 -1.011 . . . . 0.0 110.877 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.647 ' HB2' ' H ' ' A' ' 103' ' ' ALA . 86.1 mt 43.14 45.11 4.62 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.277 -0.89 . . . . 0.0 111.417 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.42 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -93.39 103.48 15.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.223 -0.923 . . . . 0.0 110.56 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.798 ' HB2' HG11 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.54 179.38 1.89 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.849 . . . . 0.0 110.106 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD2' ' CG ' ' A' ' 74' ' ' ARG . 48.8 Cg_endo -78.68 -18.29 12.01 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.544 1.286 . . . . 0.0 110.603 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG11 HD23 ' A' ' 98' ' ' LEU . 75.8 t -67.94 -36.31 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 110.107 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.406 ' CG ' ' OD1' ' A' ' 102' ' ' ASP . 69.8 m-70 -68.4 -39.62 81.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.29 -0.881 . . . . 0.0 110.4 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' A' ' 81' ' ' ARG . 0.7 OUTLIER -57.67 -55.41 35.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.352 -0.843 . . . . 0.0 110.062 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -62.91 -18.47 63.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.082 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.743 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -82.27 -44.15 16.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.389 -0.819 . . . . 0.0 110.571 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -64.59 -20.57 66.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.186 -0.946 . . . . 0.0 110.126 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' N ' ' HG3' ' A' ' 81' ' ' ARG . 2.2 mm-40 -97.02 -48.04 5.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.017 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.49 14.43 10.57 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.608 ' HZ ' ' O ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -78.66 80.05 5.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.124 -1.221 . . . . 0.0 109.804 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -60.07 -23.66 63.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.448 -0.783 . . . . 0.0 110.431 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -61.54 -52.54 64.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.221 -0.924 . . . . 0.0 110.088 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.613 HG21 ' CE ' ' A' ' 46' ' ' MET . 37.6 m -58.59 -34.97 71.68 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.257 -0.902 . . . . 0.0 109.933 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.809 HD11 HD11 ' A' ' 120' ' ' ILE . 1.5 mp -57.4 -46.82 83.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 71.4 t -57.35 -46.94 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.451 -0.781 . . . . 0.0 109.288 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.937 ' CG1' HD22 ' A' ' 58' ' ' LEU . 49.4 t -50.77 -55.4 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.526 -0.734 . . . . 0.0 110.358 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.581 ' C ' ' HB2' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -50.62 -63.11 1.23 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.233 -0.917 . . . . 0.0 110.161 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -61.28 -21.72 64.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 0.0 110.133 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 48.4 ttt180 -77.91 -8.94 58.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.304 -0.873 . . . . 0.0 110.378 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.778 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -135.2 33.93 3.07 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.291 -0.881 . . . . 0.0 110.43 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.51 90.49 0.08 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.581 ' HB2' ' C ' ' A' ' 91' ' ' LEU . . . -120.75 154.98 34.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -1.065 . . . . 0.0 110.316 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.56 75.15 7.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 110.209 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.516 HD23 HG11 ' A' ' 76' ' ' VAL . 3.7 mt -83.81 68.63 10.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -170.06 44.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.393 -0.817 . . . . 0.0 109.725 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.798 HG11 ' HB2' ' A' ' 74' ' ' ARG . 7.8 p -124.5 171.21 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.442 ' N ' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -121.81 136.71 54.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 109.281 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.589 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -69.37 73.91 0.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.845 . . . . 0.0 109.361 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.762 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 66.83 -69.07 0.13 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.344 0.592 . . . . 0.0 109.774 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.421 ' N ' ' O ' ' A' ' 102' ' ' ASP . 1.8 m-90 -140.88 35.5 1.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.482 -0.761 . . . . 0.0 109.379 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 107' ' ' LEU . . . -107.38 24.54 24.11 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.388 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.572 ' C ' HD12 ' A' ' 107' ' ' LEU . 21.8 mtm180 59.52 -73.16 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.408 -1.054 . . . . 0.0 110.78 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -155.84 167.99 13.15 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 110.022 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.44 ' HB2' HG12 ' A' ' 76' ' ' VAL . 46.3 Cg_endo -70.82 -31.49 15.72 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.648 1.341 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 121' ' ' ALA . 10.8 p -63.64 -38.99 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.885 . . . . 0.0 110.042 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 109' ' ' VAL . 75.6 m-20 -66.09 -50.76 62.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.357 -0.839 . . . . 0.0 110.065 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.54 -29.12 58.36 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.376 -0.828 . . . . 0.0 110.288 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.426 ' HB1' HG23 ' A' ' 120' ' ' ILE . . . -67.71 -75.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.421 -0.799 . . . . 0.0 110.216 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 109' ' ' VAL . 4.5 pt-20 -52.73 -27.2 16.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.284 -0.885 . . . . 0.0 110.779 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -58.71 -50.48 73.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.321 -0.862 . . . . 0.0 110.685 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -78.02 -76.65 0.18 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.347 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -167.72 34.81 0.21 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -122.77 79.37 1.63 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.333 -1.098 . . . . 0.0 109.925 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.9 mtp85 -81.22 -40.05 24.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.61 -43.44 80.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.315 -0.865 . . . . 0.0 110.273 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.809 HD11 HD11 ' A' ' 88' ' ' LEU . 17.0 tt -76.64 -38.42 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.982 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 109' ' ' VAL . . . -58.64 -44.78 90.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.559 -0.713 . . . . 0.0 110.006 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -61.99 -45.2 94.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.352 -0.842 . . . . 0.0 110.012 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -64.53 -37.12 86.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.956 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.684 ' O ' HG22 ' A' ' 128' ' ' THR . 12.1 mt -61.34 -58.94 6.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.858 . . . . 0.0 110.196 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.619 ' ND1' HG21 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -53.22 -24.27 10.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.347 -0.846 . . . . 0.0 110.489 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.2 -11.18 44.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.476 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.73 12.08 6.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.967 . . . . 0.0 110.681 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 124' ' ' LEU . 11.9 t -118.61 -23.64 7.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.143 -0.973 . . . . 0.0 110.324 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.19 114.87 0.29 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.9 t0 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.363 -1.08 . . . . 0.0 110.508 -179.826 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 1.1 t 62.24 152.49 0.11 Allowed Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.368 -1.077 . . . . 0.0 110.218 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.98 160.21 46.33 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.675 1.355 . . . . 0.0 110.54 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -78.19 102.33 1.81 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' ILE . . . . . 0.7 HD13 ' O ' ' A' ' -1' ' ' ILE . 0.3 OUTLIER -80.59 -19.36 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -1.104 . . . . 0.0 110.359 -179.594 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.411 ' O ' ' O ' ' A' ' 1' ' ' MET . 79.5 t60 54.91 97.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.182 -0.949 . . . . 0.0 110.593 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' O ' ' A' ' 0' ' ' HIS . 10.5 tmm? 58.25 119.3 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.539 -0.725 . . . . 0.0 110.937 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp -75.71 164.83 25.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.922 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.44 -26.84 64.87 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 122.1 -143.13 15.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.8 p -105.81 41.3 1.41 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.376 -1.073 . . . . 0.0 110.307 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.8 m -62.41 -84.52 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 109.941 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.684 ' OD2' ' HB1' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 54.89 14.69 0.95 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.172 -0.955 . . . . 0.0 110.894 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -124.59 -21.88 4.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.925 -1.11 . . . . 0.0 110.603 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.92 -29.21 50.54 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.835 HD11 HD12 ' A' ' 26' ' ' LEU . 63.1 tp -56.78 -53.72 54.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.367 -1.078 . . . . 0.0 110.545 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.497 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -65.69 -52.19 53.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.338 -0.851 . . . . 0.0 110.47 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 p -59.15 -46.67 87.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.351 -0.843 . . . . 0.0 110.452 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -59.69 -36.65 76.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 109.926 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.432 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -73.92 -31.71 63.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.903 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.562 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -72.72 -28.69 62.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.392 -0.817 . . . . 0.0 110.017 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -90.44 11.16 22.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.35 -0.844 . . . . 0.0 110.323 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.11 58.5 13.27 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.669 ' O ' HG23 ' A' ' 22' ' ' VAL . 88.0 mm-40 -126.66 81.88 2.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 110.379 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.673 HG22 HG23 ' A' ' 53' ' ' VAL . 53.8 t -60.43 -50.65 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.142 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -51.66 -51.66 54.05 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.283 -0.885 . . . . 0.0 110.55 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.0 m -61.82 -42.7 99.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.244 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.936 HG12 HD23 ' A' ' 56' ' ' LEU . 97.7 t -67.6 -38.22 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.355 -0.841 . . . . 0.0 110.207 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.509 ' HA ' HD22 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -69.65 -31.23 69.19 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.309 -0.869 . . . . 0.0 110.217 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 18.5 tm0? -80.48 -51.13 9.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 110.695 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.932 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -60.35 -60.92 3.05 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.254 -0.903 . . . . 0.0 110.483 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.865 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 1.2 tt -53.28 -43.68 67.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.215 -0.928 . . . . 0.0 110.588 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -78.1 1.51 20.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.533 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -105.84 -29.33 10.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 110.3 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.75 -26.87 0.1 Allowed Glycine 0 N--CA 1.484 1.858 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.456 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.932 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -48.56 135.25 14.68 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.199 -1.177 . . . . 0.0 110.9 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 30.7 t70 -87.96 141.43 31.44 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 46.1 Cg_endo -73.72 -28.35 11.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.663 1.349 . . . . 0.0 110.544 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 -92.48 18.83 7.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 110.433 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.684 ' HB1' ' OD2' ' A' ' 7' ' ' ASP . . . -83.33 142.41 31.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -0.922 . . . . 0.0 110.205 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 35' ' ' LEU . 14.8 mt -99.47 153.84 18.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.364 -0.835 . . . . 0.0 110.196 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -102.08 30.9 4.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.331 -0.855 . . . . 0.0 110.206 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 54.77 24.67 5.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.363 -0.835 . . . . 0.0 110.496 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.09 2.7 9.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.315 -0.866 . . . . 0.0 110.587 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 54.04 27.31 37.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.445 ' O ' ' CB ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -120.17 18.1 12.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.334 -1.098 . . . . 0.0 110.38 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.49 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 21.1 mmt-85 53.73 175.63 0.03 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.168 -0.958 . . . . 0.0 110.314 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.585 ' HG2' ' HB1' ' A' ' 62' ' ' ALA . 51.3 Cg_endo -85.17 -0.05 8.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.54 1.284 . . . . 0.0 111.154 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.605 HD13 HD22 ' A' ' 57' ' ' LEU . 50.7 mm -114.29 -41.39 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.987 -1.071 . . . . 0.0 110.628 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.445 ' CB ' ' O ' ' A' ' 40' ' ' ARG . 2.9 tt0 -57.58 -41.49 81.24 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.157 -0.965 . . . . 0.0 109.927 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 15' ' ' ALA . 11.5 p -75.74 -11.86 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 0.0 110.288 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.52 ' HE1' HG21 ' A' ' 87' ' ' THR . 2.3 ttm -51.34 150.07 3.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.337 -0.852 . . . . 0.0 110.431 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.405 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 5.0 tmm? -62.42 -15.76 51.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 110.265 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.44 26.27 8.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.216 -0.927 . . . . 0.0 110.192 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.14 19.37 5.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.487 ' N ' ' CZ ' ' A' ' 84' ' ' PHE . 19.8 t -157.84 101.83 1.81 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -1.024 . . . . 0.0 110.243 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.447 ' HB2' ' CG ' ' A' ' 86' ' ' ASP . . . -57.82 -26.93 62.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.634 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 1.1 mp0 -54.82 -34.06 62.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.399 -0.813 . . . . 0.0 110.556 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.673 HG23 HG22 ' A' ' 19' ' ' VAL . 89.1 t -76.26 -62.76 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -0.865 . . . . 0.0 110.322 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.867 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -47.71 -27.6 2.05 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.393 -0.817 . . . . 0.0 110.894 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.541 ' HA ' HG11 ' A' ' 90' ' ' VAL . 18.0 tt0 -70.9 -56.05 7.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.406 -0.809 . . . . 0.0 110.452 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.936 HD23 HG12 ' A' ' 22' ' ' VAL . 15.4 tp -52.36 -56.28 15.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.331 -0.856 . . . . 0.0 110.681 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.605 HD22 HD13 ' A' ' 43' ' ' ILE . 3.2 mp -52.13 -53.92 36.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.326 -0.859 . . . . 0.0 110.731 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.639 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -61.64 -28.19 69.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.31 -0.869 . . . . 0.0 110.375 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.0 tp -69.83 -38.18 76.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 110.222 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -83.97 -20.35 33.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.398 -0.814 . . . . 0.0 110.297 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.54 53.54 0.72 Allowed Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.585 ' HB1' ' HG2' ' A' ' 42' ' ' PRO . . . -65.09 -147.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.269 -1.136 . . . . 0.0 109.803 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -125.81 70.69 66.61 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.09 -1.006 . . . . 0.0 110.365 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . 50.8 Cg_endo -82.36 -28.36 1.9 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.799 1.421 . . . . 0.0 110.042 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 74' ' ' ARG . 2.6 m120 -79.65 -34.98 39.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.41 -0.806 . . . . 0.0 110.255 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 129.49 41.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 110.298 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.588 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -118.06 162.69 17.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -0.862 . . . . 0.0 110.24 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 2.8 t0 -69.34 124.21 89.98 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.0 109.903 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.89 -23.41 16.4 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.592 1.311 . . . . 0.0 110.556 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.35 -33.21 75.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 0.0 110.512 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.788 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -146.63 24.7 1.22 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.26 49.87 9.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.373 -0.829 . . . . 0.0 110.863 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.7 HG23 ' OD1' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -99.48 131.8 45.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 0.0 110.36 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.89 ' CG ' HG11 ' A' ' 100' ' ' VAL . 9.8 mtp180 -101.54 165.89 13.25 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.479 -0.763 . . . . 0.0 110.166 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 43.1 Cg_endo -69.11 -11.7 32.33 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.66 1.347 . . . . 0.0 110.803 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.4 t -67.09 -28.29 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.903 . . . . 0.0 109.948 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.589 ' CE1' ' HD3' ' A' ' 108' ' ' PRO . 62.8 m-70 -67.75 -53.23 28.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 110.252 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.511 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 4.3 m-20 -51.84 -57.09 10.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.53 -0.731 . . . . 0.0 110.858 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.39 -16.05 59.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.314 -0.866 . . . . 0.0 110.693 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.53 -37.08 13.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.162 -0.961 . . . . 0.0 110.53 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 78' ' ' ASP . 14.9 ptt180 -70.76 -18.67 62.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.327 -0.858 . . . . 0.0 110.826 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.95 11.17 38.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.707 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.454 ' HA3' ' CE1' ' A' ' 117' ' ' HIS . . . 56.89 42.15 92.1 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.487 ' CZ ' ' N ' ' A' ' 50' ' ' SER . 0.7 OUTLIER -110.81 98.39 7.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.485 -1.009 . . . . 0.0 110.147 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' A' ' 119' ' ' ASP . 0.6 OUTLIER -84.15 -34.05 24.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 0.0 110.35 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 87' ' ' THR . 14.5 p30 -51.07 -44.43 61.16 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.244 -0.91 . . . . 0.0 110.599 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.867 HG23 ' CB ' ' A' ' 54' ' ' ALA . 45.1 m -76.21 -31.77 58.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 109.456 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.558 HD22 HG13 ' A' ' 120' ' ' ILE . 8.2 tp -60.48 -37.59 81.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.466 -0.771 . . . . 0.0 109.429 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.3 t -68.22 -44.04 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.507 -0.746 . . . . 0.0 109.325 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.574 HG12 HD13 ' A' ' 58' ' ' LEU . 66.9 t -56.77 -41.64 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.46 -0.775 . . . . 0.0 110.172 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.452 ' HA ' HD21 ' A' ' 58' ' ' LEU . 2.5 mt -60.03 -52.03 67.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.438 -0.789 . . . . 0.0 109.984 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -72.09 -29.4 64.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 0.0 109.762 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -68.01 -57.76 5.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.439 -0.788 . . . . 0.0 109.89 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.639 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . . . -70.49 -61.85 1.61 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.412 -0.805 . . . . 0.0 110.365 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 170.86 105.92 0.19 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.407 ' HB3' ' C ' ' A' ' 91' ' ' LEU . . . -168.04 133.42 1.86 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.275 -1.132 . . . . 0.0 110.245 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 100' ' ' VAL . 3.7 ttp180 -65.75 163.43 16.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 0.0 110.263 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.412 HD23 ' HB3' ' A' ' 127' ' ' ALA . 1.1 tp -148.4 48.59 1.03 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.452 -0.78 . . . . 0.0 109.931 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.843 ' HA ' HG23 ' A' ' 128' ' ' THR . 48.2 t0 -159.31 50.13 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.391 -0.818 . . . . 0.0 110.054 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.89 HG11 ' CG ' ' A' ' 74' ' ' ARG . 13.2 p -122.7 168.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.512 -0.742 . . . . 0.0 110.178 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.605 ' SG ' HD11 ' A' ' 107' ' ' LEU . 0.4 OUTLIER -132.87 166.85 21.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 109.256 179.388 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.7 ' OD1' HG23 ' A' ' 73' ' ' THR . 4.9 t0 -70.22 71.94 0.44 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.889 . . . . 0.0 109.824 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.788 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 60.84 -79.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.642 -0.661 . . . . 0.0 110.051 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.443 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.3 p90 -133.64 26.81 4.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 109.478 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.65 -139.38 7.81 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.636 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -168.95 2.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.532 -0.981 . . . . 0.0 111.046 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.605 HD11 ' SG ' ' A' ' 101' ' ' CYS . 0.3 OUTLIER -119.17 176.41 1.73 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.653 -0.655 . . . . 0.0 109.864 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.589 ' HD3' ' CE1' ' A' ' 77' ' ' HIS . 46.0 Cg_endo -71.29 -27.31 19.76 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.542 1.285 . . . . 0.0 110.263 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.604 ' HA ' HD13 ' A' ' 124' ' ' LEU . 12.5 p -78.05 -37.81 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 110.337 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 109' ' ' VAL . 74.5 m-20 -66.45 -42.58 87.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -0.831 . . . . 0.0 110.237 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 111' ' ' LEU . 1.6 tt -59.76 -36.15 76.06 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.332 -0.855 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.702 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -61.32 -59.9 4.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.381 -0.825 . . . . 0.0 110.028 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -52.29 -27.18 14.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.465 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.13 -42.96 96.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.352 -0.843 . . . . 0.0 110.175 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.98 -32.4 34.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.867 . . . . 0.0 110.262 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.22 29.16 2.01 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.532 ' CB ' HG22 ' A' ' 120' ' ' ILE . 18.5 m-70 -90.85 72.62 6.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -1.091 . . . . 0.0 109.984 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -58.75 -28.25 65.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.387 -0.82 . . . . 0.0 110.386 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.421 ' HB2' HD12 ' A' ' 85' ' ' LEU . 12.4 p-10 -74.88 -41.01 60.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.311 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.702 ' CG2' ' HB1' ' A' ' 112' ' ' ALA . 1.9 tt -79.18 -34.02 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.962 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.0 -29.06 69.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.84 . . . . 0.0 109.842 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 126' ' ' ALA . 1.1 ttt180 -73.26 -53.08 11.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -62.07 -30.13 70.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 110.106 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.604 HD13 ' HA ' ' A' ' 109' ' ' VAL . 36.4 mt -71.15 -71.65 0.25 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.442 -0.786 . . . . 0.0 110.556 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -53.1 -28.49 25.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.268 -0.895 . . . . 0.0 110.235 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 122' ' ' ARG . . . -63.92 -36.15 83.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.293 -0.879 . . . . 0.0 109.68 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.412 ' HB3' HD23 ' A' ' 98' ' ' LEU . . . -120.24 23.81 10.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 110.084 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.843 HG23 ' HA ' ' A' ' 99' ' ' ASP . 89.4 m -131.64 -43.68 1.0 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 110.327 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -108.57 6.31 33.53 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.1 -1.235 . . . . 0.0 110.596 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 47.5 t 51.93 71.52 1.46 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.375 -1.074 . . . . 0.0 110.428 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.94 172.04 15.42 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.744 1.392 . . . . 0.0 110.447 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . 84.24 -0.19 89.4 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' ILE . . . . . 0.434 ' HA ' HD12 ' A' ' -1' ' ' ILE . 10.7 tp -66.84 160.64 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.138 -1.213 . . . . 0.0 110.215 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -103.65 -19.8 14.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.325 -0.859 . . . . 0.0 110.909 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -149.82 0.27 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.825 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.2 mt -78.08 -155.9 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.227 -0.92 . . . . 0.0 110.426 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.63 -100.05 0.56 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.66 162.19 1.66 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.7 p -166.61 -68.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.082 -1.246 . . . . 0.0 111.255 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -61.57 -80.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.425 -0.797 . . . . 0.0 111.183 -178.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.9 t0 54.38 -81.28 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.202 -0.936 . . . . 0.0 109.999 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 6' ' ' SER . . . -87.28 29.1 0.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 110.386 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.2 -34.24 53.08 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.863 HD13 ' CD2' ' A' ' 57' ' ' LEU . 4.0 pp -53.47 -28.39 30.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.623 -0.928 . . . . 0.0 110.049 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.776 ' N ' HD12 ' A' ' 10' ' ' LEU . . . -81.45 -43.81 18.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.445 -0.784 . . . . 0.0 110.209 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.1 p -59.11 -57.73 11.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.332 -0.855 . . . . 0.0 109.899 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.5 -34.78 69.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.3 -0.875 . . . . 0.0 109.787 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.778 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -64.05 -41.69 97.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.557 -0.714 . . . . 0.0 109.742 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -58.92 -30.65 67.99 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.347 -0.845 . . . . 0.0 110.063 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -84.82 5.51 28.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.382 -0.824 . . . . 0.0 110.536 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.29 42.4 83.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.51 ' O ' HG23 ' A' ' 22' ' ' VAL . 77.2 mt-30 -112.39 74.85 0.88 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.469 -1.019 . . . . 0.0 110.432 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.71 HG21 ' CB ' ' A' ' 52' ' ' GLN . 42.4 t -57.7 -38.41 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.286 -0.884 . . . . 0.0 109.568 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -57.52 -49.08 77.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.811 . . . . 0.0 110.193 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 m -67.18 -39.26 86.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.383 -0.823 . . . . 0.0 110.004 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.913 HG12 HD13 ' A' ' 56' ' ' LEU . 58.2 t -69.83 -29.85 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.434 -0.791 . . . . 0.0 109.757 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.7 ' HA ' HD11 ' A' ' 56' ' ' LEU . 6.0 mmt180 -68.38 -32.67 72.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.479 -0.763 . . . . 0.0 110.145 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 79.0 mt-30 -79.31 -52.73 7.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 0.0 110.579 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.611 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -52.0 -54.6 27.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.283 -0.886 . . . . 0.0 110.599 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.689 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -55.43 -61.63 2.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.232 -0.918 . . . . 0.0 110.432 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.22 -23.9 64.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -72.56 -61.79 1.68 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.238 -0.913 . . . . 0.0 110.297 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 176.48 50.03 0.06 OUTLIER Glycine 0 N--CA 1.48 1.632 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . . . -101.58 135.38 43.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.287 -1.125 . . . . 0.0 110.241 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 3.0 t70 -65.0 140.03 97.98 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.801 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.17 -3.35 13.78 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.665 1.35 . . . . 0.0 111.049 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -130.84 17.39 5.17 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.008 -1.058 . . . . 0.0 111.108 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -65.32 93.46 0.14 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.06 -1.025 . . . . 0.0 109.6 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mt -51.9 172.36 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.322 -0.861 . . . . 0.0 110.867 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -103.02 -163.0 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.471 -0.768 . . . . 0.0 110.075 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -96.07 -20.48 18.63 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 110.418 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.72 33.3 1.67 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 109.781 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.41 26.01 21.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG3' ' CB ' ' A' ' 44' ' ' GLN . 2.1 tpp85 -102.56 163.02 12.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.437 -1.037 . . . . 0.0 110.194 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.477 ' CB ' ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -81.0 179.4 1.93 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.442 -0.786 . . . . 0.0 110.042 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.5 ' HB2' HD22 ' A' ' 57' ' ' LEU . 42.4 Cg_endo -69.87 -25.63 27.87 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.593 1.312 . . . . 0.0 110.933 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.482 ' O ' ' CG ' ' A' ' 46' ' ' MET . 10.6 mt -102.34 -34.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.148 -0.97 . . . . 0.0 109.847 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.423 ' CB ' ' HG3' ' A' ' 40' ' ' ARG . 56.8 mt-30 -54.74 -17.72 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 110.783 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 45' ' ' VAL . 11.7 p -115.27 26.37 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.095 -1.003 . . . . 0.0 110.575 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.686 ' HE1' HG21 ' A' ' 87' ' ' THR . 0.4 OUTLIER -95.73 32.07 1.92 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.187 -0.945 . . . . 0.0 110.2 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.416 ' CB ' ' O ' ' A' ' 46' ' ' MET . 3.4 tmm? 68.41 -7.4 0.69 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.469 -0.769 . . . . 0.0 111.102 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.451 ' CE ' ' HB3' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 46.9 27.28 0.69 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.003 -1.06 . . . . 0.0 110.716 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.46 ' HA2' ' CD2' ' A' ' 84' ' ' PHE . . . -130.67 13.45 5.6 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 p -143.78 90.34 2.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -1.145 . . . . 0.0 110.257 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.46 -26.31 12.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.918 . . . . 0.0 110.19 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.71 ' CB ' HG21 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -55.13 -34.24 63.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.397 -0.815 . . . . 0.0 110.247 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.778 HG11 ' HB1' ' A' ' 14' ' ' ALA . 26.8 t -83.41 -33.06 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.466 -0.771 . . . . 0.0 110.465 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.649 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -63.08 -52.34 63.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.194 -0.941 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.63 ' O ' HD23 ' A' ' 59' ' ' LEU . 12.3 pt-20 -66.55 -34.03 77.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.429 -0.794 . . . . 0.0 110.564 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.913 HD13 HG12 ' A' ' 22' ' ' VAL . 1.6 tt -53.3 -63.58 1.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.288 -0.883 . . . . 0.0 110.736 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.863 ' CD2' HD13 ' A' ' 10' ' ' LEU . 1.8 mt -70.4 -33.76 71.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.373 -0.83 . . . . 0.0 110.654 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.013 HD21 ' HB2' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -58.14 -61.51 2.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.921 . . . . 0.0 110.409 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 55' ' ' GLU . 3.1 pp -60.06 -25.1 65.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 110.448 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.669 ' CD2' HD12 ' A' ' 26' ' ' LEU . 3.4 m80 -78.61 -63.55 1.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.848 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.85 38.16 0.04 OUTLIER Glycine 0 N--CA 1.484 1.844 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -71.02 -175.67 1.2 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.053 -1.263 . . . . 0.0 110.242 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -119.12 76.8 15.93 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.492 -0.755 . . . . 0.0 110.002 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.641 ' HB2' ' HB2' ' A' ' 96' ' ' ALA . 47.5 Cg_endo -76.56 -5.72 16.34 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.86 1.453 . . . . 0.0 110.632 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.93 -51.95 2.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.316 -0.865 . . . . 0.0 110.049 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.24 134.73 39.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.366 -0.834 . . . . 0.0 110.445 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.883 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -119.51 -174.79 2.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.358 -0.839 . . . . 0.0 110.394 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 16.7 t0 -86.59 127.52 60.26 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.719 . . . . 0.0 109.994 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.31 -29.49 11.3 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.518 1.273 . . . . 0.0 110.57 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.62 80.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 0.0 110.411 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.811 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -143.76 38.88 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.255 -0.903 . . . . 0.0 110.557 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.535 ' C ' ' O ' ' A' ' 71' ' ' THR . 1.6 mt 25.45 61.83 0.06 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.765 -0.584 . . . . 0.0 111.561 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -113.08 119.81 39.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.9 . . . . 0.0 110.468 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.883 ' HG2' ' HB2' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -93.39 173.33 4.94 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.479 -0.763 . . . . 0.0 110.345 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.463 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 45.1 Cg_endo -71.87 -22.26 23.65 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.835 1.439 . . . . 0.0 110.33 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 52.0 t -59.45 -39.0 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.322 -0.861 . . . . 0.0 109.981 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.524 ' CE1' ' HD3' ' A' ' 108' ' ' PRO . 71.9 m-70 -64.1 -45.19 89.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 110.09 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.451 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -52.82 -65.7 0.51 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.447 -0.783 . . . . 0.0 110.429 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.68 -26.77 24.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.33 -0.856 . . . . 0.0 110.132 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.66 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -78.28 -43.05 29.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 0.0 109.754 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -61.32 -21.75 64.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 110.223 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.41 -32.47 12.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 0.0 109.735 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.82 24.9 24.18 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.46 ' CD2' ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -88.95 93.81 9.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -1.161 . . . . 0.0 109.993 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.463 HD21 ' O ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -61.97 -34.71 76.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.526 -0.733 . . . . 0.0 110.798 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.491 ' O ' HG23 ' A' ' 90' ' ' VAL . 39.5 t0 -58.67 -35.65 72.91 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.247 -0.908 . . . . 0.0 110.97 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.686 HG21 ' HE1' ' A' ' 46' ' ' MET . 0.2 OUTLIER -75.15 -41.03 59.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.007 -1.058 . . . . 0.0 110.228 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.96 HD22 HG13 ' A' ' 120' ' ' ILE . 2.4 tp -55.3 -40.79 71.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.349 -0.845 . . . . 0.0 109.873 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.39 -45.72 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 109.373 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.723 HG12 HD13 ' A' ' 58' ' ' LEU . 88.1 t -53.72 -45.86 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.551 -0.718 . . . . 0.0 110.227 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 6.2 mp -64.78 -20.93 66.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.399 -0.813 . . . . 0.0 110.676 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -78.13 -62.78 1.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.196 -0.94 . . . . 0.0 110.715 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.704 HH21 HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -54.1 -33.06 56.73 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.469 -0.769 . . . . 0.0 110.553 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.013 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -68.69 -34.89 76.44 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.284 -0.885 . . . . 0.0 110.216 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 111.15 45.79 0.85 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 64' ' ' PRO . . . -97.9 138.62 34.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.403 -1.057 . . . . 0.0 110.321 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -73.0 151.84 41.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.405 -0.81 . . . . 0.0 110.225 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.81 HD23 HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -127.35 -8.15 5.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.395 -0.816 . . . . 0.0 110.843 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -92.73 39.94 1.04 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.207 -0.933 . . . . 0.0 110.807 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.774 HG21 ' HG3' ' A' ' 74' ' ' ARG . 14.6 p -100.65 148.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -0.889 . . . . 0.0 110.039 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m -99.17 154.2 18.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.293 -0.879 . . . . 0.0 110.231 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 27.1 p-10 -81.86 57.01 3.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.811 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 64.95 -67.9 0.11 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.598 -0.688 . . . . 0.0 110.586 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.44 ' N ' ' O ' ' A' ' 102' ' ' ASP . 1.7 m95 -59.37 -61.14 2.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 167.01 -28.89 0.18 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -56.5 124.05 16.88 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.252 -1.146 . . . . 0.0 110.43 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 82.3 mt -80.06 167.02 36.6 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.38 -0.825 . . . . 0.0 110.081 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.524 ' HD3' ' CE1' ' A' ' 77' ' ' HIS . 42.9 Cg_endo -69.65 -23.36 31.36 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.642 1.338 . . . . 0.0 110.378 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.732 ' HA ' HD13 ' A' ' 124' ' ' LEU . 14.4 p -75.41 -35.67 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.794 . . . . 0.0 109.956 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.43 ' N ' HG13 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -67.15 -42.1 84.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.492 -0.755 . . . . 0.0 109.705 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.06 -30.32 70.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.44 -0.788 . . . . 0.0 109.944 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.585 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -65.33 -73.38 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.503 -0.748 . . . . 0.0 109.954 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.449 ' N ' ' HB2' ' A' ' 121' ' ' ALA . 1.3 pt-20 -53.37 -22.19 7.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.775 . . . . 0.0 110.949 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.49 -71.22 0.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 0.0 110.642 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -59.69 -94.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.284 -0.885 . . . . 0.0 110.711 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.45 30.63 0.95 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -110.56 79.11 1.17 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.375 -1.074 . . . . 0.0 109.7 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -79.31 -42.25 26.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.88 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.463 ' O ' HD21 ' A' ' 85' ' ' LEU . 20.7 p-10 -59.37 -37.35 77.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.442 -0.786 . . . . 0.0 110.049 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.96 HG13 HD22 ' A' ' 88' ' ' LEU . 3.1 tt -80.48 -31.32 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 109.755 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.449 ' HB2' ' N ' ' A' ' 113' ' ' GLU . . . -63.78 -54.17 39.33 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.922 0.868 . . . . 0.0 109.815 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.647 ' HA ' ' CD2' ' A' ' 125' ' ' HIS . 8.3 ttt-85 -59.11 -52.96 63.48 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.866 -0.521 . . . . 0.0 110.347 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.751 ' HD2' HD23 ' A' ' 88' ' ' LEU . 78.9 t80 -61.07 -26.67 67.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.089 -1.007 . . . . 0.0 110.363 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.841 ' O ' HG22 ' A' ' 128' ' ' THR . 4.1 mt -66.63 -60.07 3.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.667 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.647 ' CD2' ' HA ' ' A' ' 122' ' ' ARG . 3.2 p80 -54.95 -24.68 25.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 130' ' ' ASP . . . -77.13 -24.89 51.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 110.633 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -107.65 -23.96 11.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.297 -0.877 . . . . 0.0 110.995 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.841 HG22 ' O ' ' A' ' 124' ' ' LEU . 10.0 t -92.12 15.64 13.04 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.144 -0.973 . . . . 0.0 110.959 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.1 -67.36 0.03 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.444 ' HB2' ' HA ' ' A' ' 126' ' ' ALA . 1.8 m-20 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.41 -1.053 . . . . 0.0 110.489 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 26.3 t -91.35 150.84 42.08 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.313 -1.11 . . . . 0.0 110.121 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.02 -37.51 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.786 1.414 . . . . 0.0 110.381 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . 90.94 63.55 1.2 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' ILE . . . . . 0.432 HG23 ' H ' ' A' ' 0' ' ' HIS . 2.3 tp -159.77 -47.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -1.13 . . . . 0.0 110.158 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.432 ' H ' HG23 ' A' ' -1' ' ' ILE . 64.4 t-80 -177.2 137.09 0.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.208 -0.932 . . . . 0.0 110.337 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -170.52 149.1 3.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.286 -0.884 . . . . 0.0 110.213 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 2' ' ' LEU . 6.4 mp -75.67 158.18 32.69 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.267 -0.896 . . . . 0.0 110.157 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.24 113.31 3.81 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.71 69.22 0.41 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 p -61.86 -168.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.36 -1.082 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.5 m -94.74 123.89 38.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.409 -0.807 . . . . 0.0 110.225 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 56.2 m-20 -120.73 174.89 6.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 0.0 110.172 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' ASP . . . 58.35 19.59 6.51 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.398 -0.814 . . . . 0.0 110.508 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.97 -17.45 79.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.728 HD11 HD13 ' A' ' 26' ' ' LEU . 60.4 mt -78.9 -44.24 23.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.355 -1.085 . . . . 0.0 109.819 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -62.31 -44.86 95.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.496 -0.752 . . . . 0.0 110.065 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 p -57.12 -55.51 33.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 109.94 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.96 72.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.898 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -65.18 -49.92 67.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.824 . . . . 0.0 110.141 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.772 ' HB2' ' O ' ' A' ' 45' ' ' VAL . . . -63.91 -23.97 67.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.353 -0.842 . . . . 0.0 110.147 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -91.52 3.48 54.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 0.0 110.636 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.61 45.97 72.6 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -110.96 66.12 0.62 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -1.084 . . . . 0.0 110.231 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.833 HG22 HG23 ' A' ' 53' ' ' VAL . 19.1 t -52.31 -34.63 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.324 -0.86 . . . . 0.0 110.113 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -65.55 -54.64 25.19 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.405 -0.809 . . . . 0.0 110.937 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.6 m -57.3 -34.94 69.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.235 -0.915 . . . . 0.0 110.941 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.668 HG12 HD13 ' A' ' 56' ' ' LEU . 58.9 t -73.59 -26.71 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.261 -0.9 . . . . 0.0 110.417 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.734 ' HA ' HD11 ' A' ' 56' ' ' LEU . 18.9 mmt180 -68.59 -45.75 71.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.202 -0.936 . . . . 0.0 110.476 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 11.8 tm0? -73.81 -58.44 3.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.452 -0.78 . . . . 0.0 111.28 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.905 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -55.25 -53.49 55.41 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.252 -0.905 . . . . 0.0 111.328 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.861 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -52.61 -61.29 2.38 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.134 -0.979 . . . . 0.0 111.147 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -65.49 -13.07 58.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -0.977 . . . . 0.0 110.688 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -83.28 -26.71 30.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -0.989 . . . . 0.0 110.743 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.07 -7.64 0.39 Allowed Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.326 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.905 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -50.95 142.46 11.84 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.842 -1.387 . . . . 0.0 110.77 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.647 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 27.0 t70 -72.83 125.33 91.21 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 110.21 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.65 -21.05 22.43 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.573 1.302 . . . . 0.0 110.765 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.37 26.31 10.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.262 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.647 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -73.37 135.16 44.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.313 -0.867 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.0 mt -84.22 170.13 14.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.833 . . . . 0.0 110.149 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.682 ' ND2' HG21 ' A' ' 45' ' ' VAL . 15.0 t30 -106.94 -168.47 1.41 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.417 -0.802 . . . . 0.0 110.167 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -77.92 -23.44 48.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.389 -0.819 . . . . 0.0 110.27 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -96.28 25.38 4.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.315 -0.865 . . . . 0.0 110.095 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.54 32.09 37.98 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.05 -156.57 0.55 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.446 -1.032 . . . . 0.0 110.283 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.617 ' O ' HG12 ' A' ' 45' ' ' VAL . 28.0 mmt-85 -110.49 170.29 5.46 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 0.0 109.598 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HB2' HD22 ' A' ' 57' ' ' LEU . 41.0 Cg_endo -68.01 -21.67 42.87 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.484 1.254 . . . . 0.0 110.334 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.564 ' O ' ' HG2' ' A' ' 46' ' ' MET . 73.4 mt -107.67 -44.1 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.272 -0.892 . . . . 0.0 109.703 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.58 -22.54 3.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.155 -0.966 . . . . 0.0 110.501 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.772 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 7.1 p -105.29 25.73 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 110.798 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.906 ' HE2' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -95.83 165.63 12.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -0.999 . . . . 0.0 109.891 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.411 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 9.5 tmm? -61.06 -13.17 15.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.275 -0.891 . . . . 0.0 110.677 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 23.0 mmt 55.3 23.23 5.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.256 -0.902 . . . . 0.0 110.327 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.37 -19.71 5.74 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.416 ' HB3' ' CG2' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -118.15 105.77 12.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -1.156 . . . . 0.0 110.341 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' ' 86' ' ' ASP . . . -59.36 -22.42 61.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.872 . . . . 0.0 110.598 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.796 ' HB2' ' CG2' ' A' ' 19' ' ' VAL . 3.4 mm-40 -61.46 -18.16 57.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.833 HG23 HG22 ' A' ' 19' ' ' VAL . 88.4 t -86.26 -41.7 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.714 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.906 ' HB2' ' HE2' ' A' ' 46' ' ' MET . . . -72.45 -25.31 61.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.502 -0.749 . . . . 0.0 110.166 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HA ' HG11 ' A' ' 90' ' ' VAL . 7.7 tm-20 -79.03 -43.94 23.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.375 -0.828 . . . . 0.0 110.346 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.734 HD11 ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -59.06 -63.06 1.44 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.372 -0.83 . . . . 0.0 110.481 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.801 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 4.0 mt -52.52 -48.76 65.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.445 -0.784 . . . . 0.0 110.679 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -58.11 -38.65 76.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.35 -0.844 . . . . 0.0 110.213 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.85 -33.69 76.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -0.834 . . . . 0.0 110.188 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.461 ' CE1' ' HG ' ' A' ' 26' ' ' LEU . 12.5 m170 -84.69 -63.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.013 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.26 54.38 0.03 OUTLIER Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -69.76 -158.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -1.115 . . . . 0.0 110.112 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -126.71 71.87 74.01 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.368 -0.833 . . . . 0.0 109.988 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . 49.6 Cg_endo -79.43 -21.36 8.93 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.809 1.426 . . . . 0.0 110.59 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -89.33 -52.55 4.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.857 . . . . 0.0 110.31 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 166.42 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.34 -0.85 . . . . 0.0 110.481 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.54 -167.75 2.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 0.0 110.198 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 70' ' ' ALA . 7.4 t70 -86.77 127.23 60.89 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.094 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.76 -25.28 14.76 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.573 1.302 . . . . 0.0 110.378 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . . . -63.66 -51.43 65.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.372 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.806 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -124.78 26.63 7.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 110.463 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 44.17 37.73 2.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.334 -0.854 . . . . 0.0 110.959 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.5 125.67 42.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.298 -0.876 . . . . 0.0 110.559 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.594 ' HD2' ' HB ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -94.4 -175.99 0.52 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 110.144 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 47.7 Cg_endo -75.81 -35.45 2.59 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.386 1.203 . . . . 0.0 111.622 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.628 ' CG1' HD23 ' A' ' 98' ' ' LEU . 93.5 t -52.92 -31.61 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.049 -1.032 . . . . 0.0 110.301 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CE1' ' HB3' ' A' ' 108' ' ' PRO . 14.8 m80 -62.29 -44.34 96.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 109.969 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.68 -49.23 66.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.386 -0.821 . . . . 0.0 110.082 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.639 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -53.89 -28.44 36.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.862 . . . . 0.0 110.109 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.01 -30.31 22.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.384 -0.823 . . . . 0.0 109.805 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.413 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 2.5 mmt85 -61.0 -24.62 66.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.462 -0.774 . . . . 0.0 110.235 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -100.58 -27.27 13.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 110.416 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.73 35.35 6.88 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.65 ' HD1' ' HB2' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -98.68 94.64 6.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.446 -1.032 . . . . 0.0 110.251 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.885 HD22 HD12 ' A' ' 120' ' ' ILE . 3.5 mm? -64.75 -25.67 68.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.356 -0.84 . . . . 0.0 110.524 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.669 ' O ' HG23 ' A' ' 90' ' ' VAL . 2.9 m-20 -61.66 -56.36 20.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.192 -0.942 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.527 HG23 ' CB ' ' A' ' 54' ' ' ALA . 23.1 m -57.6 -42.77 83.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.241 -0.912 . . . . 0.0 109.991 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.99 HD13 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -57.68 -44.42 85.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.772 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 85' ' ' LEU . 86.9 t -63.84 -42.51 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 0.0 109.003 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 86' ' ' ASP . 93.4 t -57.21 -46.18 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.647 -0.658 . . . . 0.0 109.981 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.672 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 5.6 mp -61.8 -47.04 86.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.418 -0.801 . . . . 0.0 109.929 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -66.34 -26.25 67.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 110.165 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -68.38 -30.67 69.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 110.267 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB3' HD11 ' A' ' 58' ' ' LEU . . . -114.47 41.84 2.23 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.361 -0.837 . . . . 0.0 110.406 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.33 109.97 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . -149.01 105.46 3.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -1.085 . . . . 0.0 110.722 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.509 ' O ' ' NE ' ' A' ' 74' ' ' ARG . 0.3 OUTLIER -58.91 107.28 0.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.395 -0.816 . . . . 0.0 109.133 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 128' ' ' THR . 1.1 mt -104.14 23.62 12.73 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.166 -0.959 . . . . 0.0 110.347 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.422 ' HA ' HG23 ' A' ' 128' ' ' THR . 18.8 t0 -126.95 17.64 7.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.852 . . . . 0.0 110.499 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 74' ' ' ARG . 3.4 p -67.98 162.0 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 109.81 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.7 m -100.64 137.17 39.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 104' ' ' TRP . 13.0 t70 -73.71 60.69 0.71 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 110.294 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 58.17 -79.6 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.591 -0.693 . . . . 0.0 110.655 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.471 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.9 OUTLIER -53.76 -42.92 68.73 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.269 -0.894 . . . . 0.0 110.115 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 146.25 -18.94 1.72 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.28 123.98 15.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.209 -1.171 . . . . 0.0 110.518 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.451 ' O ' HD12 ' A' ' 111' ' ' LEU . 22.1 mt -79.85 168.32 27.03 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.809 . . . . 0.0 109.891 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.0 Cg_endo -69.13 -25.51 31.45 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.684 1.36 . . . . 0.0 110.39 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.433 ' HA ' HD13 ' A' ' 124' ' ' LEU . 10.8 p -82.09 -23.13 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.0 110.14 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -67.07 -43.29 82.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.381 -0.824 . . . . 0.0 110.202 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 107' ' ' LEU . 0.5 OUTLIER -59.08 -31.66 69.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -0.829 . . . . 0.0 110.151 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HB1' HG22 ' A' ' 120' ' ' ILE . . . -64.86 -65.26 0.7 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.415 -0.803 . . . . 0.0 110.109 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -51.94 -26.31 10.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.457 -0.777 . . . . 0.0 110.567 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -43.35 16.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.342 -0.848 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -77.21 -77.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.27 -0.894 . . . . 0.0 110.181 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 165.12 43.83 0.02 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.413 ' CE1' ' O ' ' A' ' 81' ' ' ARG . 24.1 m80 -117.5 60.14 0.77 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.331 -1.099 . . . . 0.0 109.782 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -50.41 -29.64 10.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.32 -0.863 . . . . 0.0 110.568 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -69.99 -39.13 76.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.99 HD11 HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -75.41 -35.08 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.264 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.73 -29.27 70.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 110.026 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -73.74 -55.19 6.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.326 -0.859 . . . . 0.0 110.044 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -36.38 83.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.317 -0.865 . . . . 0.0 110.09 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.615 HD12 HG23 ' A' ' 120' ' ' ILE . 16.8 mt -59.03 -62.44 1.88 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.376 -0.828 . . . . 0.0 110.283 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -51.01 -26.27 5.87 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.339 -0.851 . . . . 0.0 110.315 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.17 -38.51 51.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 110.136 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -112.67 29.1 8.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.87 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 98' ' ' LEU . 95.7 m -134.35 44.68 2.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 109.876 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.32 30.53 10.74 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.9 t0 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.351 -1.088 . . . . 0.0 110.571 -179.883 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -4' ' ' SER . . . . . 0.46 ' N ' ' HD2' ' A' ' -3' ' ' PRO . 0.5 OUTLIER -70.41 -56.39 6.69 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.325 -1.103 . . . . 0.0 110.349 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' -3' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' -4' ' ' SER . 47.2 Cg_endo -72.77 90.45 0.83 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.456 1.24 . . . . 0.0 110.4 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . 168.11 171.24 33.81 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' ILE . . . . . 0.409 HG13 ' N ' ' A' ' 0' ' ' HIS . 4.2 pt -113.1 -20.6 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.269 -1.136 . . . . 0.0 110.434 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.409 ' N ' HG13 ' A' ' -1' ' ' ILE . 6.8 t60 -65.15 121.91 15.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.2 -0.938 . . . . 0.0 110.166 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ptp -102.12 -22.92 14.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.385 -0.822 . . . . 0.0 110.33 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.406 ' O ' ' CD2' ' A' ' 0' ' ' HIS . 0.9 OUTLIER -100.28 142.95 31.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.329 -0.857 . . . . 0.0 110.261 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.12 167.82 14.71 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.33 -12.33 8.24 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 6' ' ' SER . 16.4 m -101.92 154.76 18.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.21 -1.17 . . . . 0.0 110.291 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 5' ' ' SER . 82.1 p 45.17 -168.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.764 -0.585 . . . . 0.0 110.947 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.427 ' O ' ' ND2' ' A' ' 36' ' ' ASN . 0.0 OUTLIER 47.38 22.07 0.25 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.474 -0.767 . . . . 0.0 110.955 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -138.88 -48.64 0.5 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -0.959 . . . . 0.0 109.958 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.63 -22.02 58.78 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 1.036 HD12 HG13 ' A' ' 22' ' ' VAL . 27.3 tp -67.27 -49.62 63.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -1.023 . . . . 0.0 110.314 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.8 -49.55 24.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 110.62 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.8 p -58.15 -49.18 77.91 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.298 -0.876 . . . . 0.0 110.623 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -60.46 -38.41 84.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.204 -0.935 . . . . 0.0 110.184 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.479 ' HA ' HG11 ' A' ' 53' ' ' VAL . . . -62.96 -29.94 71.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.35 -0.844 . . . . 0.0 110.033 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.742 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -83.35 -33.45 25.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.336 -0.853 . . . . 0.0 110.047 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -75.91 -24.9 55.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.168 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.98 45.12 1.8 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.472 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -119.86 96.84 5.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -1.069 . . . . 0.0 110.001 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.743 ' CG2' ' HB2' ' A' ' 52' ' ' GLN . 38.4 t -76.76 -39.32 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.473 -0.767 . . . . 0.0 110.163 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.78 -46.0 90.56 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.276 -0.89 . . . . 0.0 110.757 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.2 m -64.6 -42.28 95.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.344 -0.847 . . . . 0.0 110.577 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.036 HG13 HD12 ' A' ' 10' ' ' LEU . 65.1 t -70.28 -45.24 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.284 -0.885 . . . . 0.0 110.501 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.593 ' CA ' HD21 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -59.29 -39.89 84.42 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.722 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.521 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -72.76 -44.2 61.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.365 -0.834 . . . . 0.0 110.783 -179.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.964 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.6 OUTLIER -63.62 -48.03 78.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.236 -0.915 . . . . 0.0 110.689 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.565 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 3.1 mt -54.11 -63.99 0.97 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.283 -0.886 . . . . 0.0 110.602 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -16.22 40.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 0.0 110.305 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -84.2 -37.91 21.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.873 . . . . 0.0 110.543 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.71 -23.63 0.09 OUTLIER Glycine 0 N--CA 1.484 1.843 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.745 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.964 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -48.05 124.82 8.12 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.092 -1.24 . . . . 0.0 110.997 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.37 126.92 70.51 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 109.955 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.53 -9.72 20.13 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.606 1.319 . . . . 0.0 110.864 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.12 29.55 7.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.118 -0.989 . . . . 0.0 110.257 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.17 103.48 9.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 0.0 110.26 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 35' ' ' LEU . 2.4 pp -84.53 145.65 27.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.478 ' O ' HD12 ' A' ' 35' ' ' LEU . 29.3 m120 -104.42 -154.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.424 -0.797 . . . . 0.0 109.814 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 38' ' ' PHE . 2.0 ptp180 -57.95 -171.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 110.252 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER 66.66 1.94 2.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.438 -0.789 . . . . 0.0 111.268 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 45.85 31.98 4.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.77 -168.54 1.54 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -1.15 . . . . 0.0 110.662 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.716 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -118.27 177.67 1.24 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 0.0 109.391 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.716 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 43.4 Cg_endo -70.53 -19.29 32.62 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.383 1.202 . . . . 0.0 110.847 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 46' ' ' MET . 53.5 mt -115.01 -34.83 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.134 -0.979 . . . . 0.0 110.001 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 41' ' ' ARG . 17.8 tt0 -53.43 -29.11 33.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.066 -1.021 . . . . 0.0 110.144 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 15' ' ' ALA . 11.8 p -92.85 -2.76 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.407 -0.808 . . . . 0.0 110.339 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.841 ' HE1' ' HB2' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -56.05 154.54 7.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.398 -0.814 . . . . 0.0 110.345 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -70.97 -6.9 42.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 110.149 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.633 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 23.4 mmt 53.59 25.25 4.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.9 . . . . 0.0 110.411 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -118.03 -11.7 8.16 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 m -129.51 113.45 14.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -1.163 . . . . 0.0 110.296 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -64.53 -13.9 54.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.429 -0.794 . . . . 0.0 110.598 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.743 ' HB2' ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -73.08 -22.93 60.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.216 -0.928 . . . . 0.0 109.821 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.549 ' CG2' HG22 ' A' ' 19' ' ' VAL . 22.0 t -84.2 -36.84 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.149 -0.969 . . . . 0.0 110.188 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.841 ' HB2' ' HE1' ' A' ' 46' ' ' MET . . . -70.35 -57.14 5.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.421 -0.799 . . . . 0.0 110.299 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -59.32 -45.82 90.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.439 -0.788 . . . . 0.0 110.474 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.593 HD21 ' CA ' ' A' ' 23' ' ' ARG . 52.1 tp -52.63 -52.63 54.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.371 -0.83 . . . . 0.0 110.666 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.811 HD21 HD11 ' A' ' 10' ' ' LEU . 7.6 mt -69.89 -30.39 67.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.262 -0.899 . . . . 0.0 110.854 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.506 HD22 ' CB ' ' A' ' 94' ' ' ALA . 1.1 tt -75.72 -55.23 5.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.178 -0.951 . . . . 0.0 110.944 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.548 HD12 ' C ' ' A' ' 59' ' ' LEU . 3.1 pp -54.07 -28.5 39.3 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.136 -0.978 . . . . 0.0 110.07 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.53 ' CD2' HD22 ' A' ' 26' ' ' LEU . 6.9 m80 -75.61 -56.87 4.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.359 -0.838 . . . . 0.0 109.821 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.49 44.61 0.02 OUTLIER Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 57' ' ' LEU . . . -76.27 -169.55 1.21 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.335 -1.097 . . . . 0.0 110.62 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -115.38 80.83 7.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.77 -27.0 9.19 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.854 1.45 . . . . 0.0 110.325 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.0 t30 -93.08 -41.44 9.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 110.081 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 151.37 7.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.273 -0.892 . . . . 0.0 110.277 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.512 ' HB2' ' NE ' ' A' ' 74' ' ' ARG . . . -143.87 -172.72 3.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.416 -0.802 . . . . 0.0 110.565 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.495 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 15.5 t0 -89.69 125.07 62.34 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.33 -21.55 19.8 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.484 1.255 . . . . 0.0 110.62 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.24 -20.89 65.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 110.678 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.726 HG23 ' OG1' ' A' ' 73' ' ' THR . 5.3 t -158.42 22.03 0.23 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.027 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.4 mt 44.05 65.29 1.06 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.306 -0.871 . . . . 0.0 110.403 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.726 ' OG1' HG23 ' A' ' 71' ' ' THR . 0.1 OUTLIER -119.21 103.23 9.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.092 -1.005 . . . . 0.0 111.156 -178.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.907 ' HB2' HG11 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -75.29 169.65 19.4 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.728 . . . . 0.0 109.197 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.497 ' HD2' ' CG ' ' A' ' 74' ' ' ARG . 46.7 Cg_endo -74.49 -4.34 15.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.458 1.241 . . . . 0.0 110.904 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.684 HG13 HD23 ' A' ' 98' ' ' LEU . 62.6 t -71.84 -35.39 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.211 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -62.16 -43.17 99.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 110.331 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.633 ' HB2' ' HE3' ' A' ' 48' ' ' MET . 50.5 m-20 -56.33 -57.98 9.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.477 -0.764 . . . . 0.0 110.438 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.87 -28.25 65.95 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.284 -0.885 . . . . 0.0 109.876 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.52 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -79.94 -27.9 39.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 110.032 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -71.9 -23.42 61.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.826 . . . . 0.0 110.367 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -97.08 -44.52 6.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.368 -0.832 . . . . 0.0 110.227 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.85 29.62 3.03 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.458 ' CZ ' ' CA ' ' A' ' 84' ' ' PHE . 4.3 t80 -93.61 91.8 7.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.43 -1.041 . . . . 0.0 110.224 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' A' ' 123' ' ' TYR . 1.5 mt -62.22 -27.85 69.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.333 -0.855 . . . . 0.0 109.863 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.726 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.3 t0 -59.07 -54.44 47.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.397 -0.815 . . . . 0.0 110.348 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.473 HG23 ' HB1' ' A' ' 54' ' ' ALA . 29.9 m -61.46 -35.19 76.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.326 -0.859 . . . . 0.0 109.962 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.811 HD22 HG13 ' A' ' 120' ' ' ILE . 5.7 tp -59.53 -51.97 67.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.212 -0.93 . . . . 0.0 109.776 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.78 -45.01 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 109.269 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 86' ' ' ASP . 96.4 t -50.48 -46.47 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.614 -0.679 . . . . 0.0 110.452 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.498 ' HA ' HD11 ' A' ' 58' ' ' LEU . 1.3 mp -65.01 -57.35 8.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 110.088 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -63.68 -17.43 62.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 110.36 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -87.78 -13.88 41.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 0.0 110.615 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.506 ' CB ' HD22 ' A' ' 58' ' ' LEU . . . -133.46 49.57 2.28 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.186 -0.946 . . . . 0.0 110.512 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.64 108.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -168.63 104.98 0.43 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -1.101 . . . . 0.0 110.248 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -68.04 108.7 3.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.418 -0.802 . . . . 0.0 110.071 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.795 HD13 ' HB1' ' A' ' 127' ' ' ALA . 1.4 mp -93.18 -21.58 19.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.313 -0.867 . . . . 0.0 110.449 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.663 ' HA ' HG23 ' A' ' 128' ' ' THR . 6.1 p-10 -70.4 72.71 0.49 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.907 HG11 ' HB2' ' A' ' 74' ' ' ARG . 7.5 p -143.37 161.18 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -0.86 . . . . 0.0 110.341 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.423 ' N ' HG22 ' A' ' 100' ' ' VAL . 13.3 p -128.6 147.33 50.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.51 -0.744 . . . . 0.0 109.422 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 104' ' ' TRP . 5.1 p-10 -69.86 65.3 0.23 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.254 -0.904 . . . . 0.0 110.607 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.714 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 56.66 -81.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.688 -0.632 . . . . 0.0 111.097 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.467 ' N ' ' O ' ' A' ' 102' ' ' ASP . 8.2 m-90 -91.52 43.98 1.16 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.265 -0.897 . . . . 0.0 110.359 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.54 -162.62 10.15 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.506 ' O ' ' CD1' ' A' ' 107' ' ' LEU . 10.5 mtm180 -120.79 -51.45 2.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.395 -1.062 . . . . 0.0 110.259 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.817 ' HG ' ' HD2' ' A' ' 108' ' ' PRO . 2.0 tp -174.13 162.72 2.91 Favored Pre-proline 0 N--CA 1.497 1.884 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.817 ' HD2' ' HG ' ' A' ' 107' ' ' LEU . 42.8 Cg_endo -70.39 -31.54 17.53 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.026 1.014 . . . . 0.0 110.24 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.624 HG12 ' HB3' ' A' ' 107' ' ' LEU . 7.4 p -62.05 -21.03 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 109.648 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -77.56 -45.29 25.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.383 -0.823 . . . . 0.0 109.621 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.59 -26.85 62.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.743 ' HB1' ' O ' ' A' ' 117' ' ' HIS . . . -78.0 -50.13 12.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.507 -0.746 . . . . 0.0 109.962 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -52.77 -23.28 6.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.478 -0.763 . . . . 0.0 110.898 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -94.63 -54.12 3.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.262 -0.899 . . . . 0.0 110.667 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -59.73 -95.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.254 -0.904 . . . . 0.0 110.435 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -170.29 31.79 0.15 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.743 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 9.0 m-70 -117.03 79.47 1.34 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -1.035 . . . . 0.0 109.536 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 30.0 mmt85 -81.32 -40.54 23.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.386 -0.821 . . . . 0.0 110.167 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.4 -54.45 43.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.307 -0.871 . . . . 0.0 109.702 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.811 HG13 HD22 ' A' ' 88' ' ' LEU . 10.0 tt -60.13 -34.75 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.468 -0.77 . . . . 0.0 109.359 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 118' ' ' ARG . . . -61.7 -39.42 91.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.658 -0.651 . . . . 0.0 109.799 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -56.17 -53.21 59.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.392 -0.817 . . . . 0.0 109.571 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.679 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -58.71 -45.19 90.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.357 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.752 ' HG ' HD21 ' A' ' 88' ' ' LEU . 78.3 mt -55.9 -48.53 75.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.435 -0.79 . . . . 0.0 109.928 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -53.5 -27.33 24.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.295 -0.878 . . . . 0.0 110.191 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.19 -38.69 15.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.316 -0.865 . . . . 0.0 110.467 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.795 ' HB1' HD13 ' A' ' 98' ' ' LEU . . . -98.02 10.62 39.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.304 -0.872 . . . . 0.0 110.783 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.784 HG22 HD21 ' A' ' 107' ' ' LEU . 7.4 m -133.39 -52.02 0.88 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 110.365 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.95 101.37 1.23 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.294 -1.121 . . . . 0.0 110.673 -179.837 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 11.5 t 52.17 92.29 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.284 -1.127 . . . . 0.0 110.617 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.43 -24.41 19.26 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.685 1.36 . . . . 0.0 110.29 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . 77.19 76.97 0.83 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 0' ' ' HIS . 4.3 tp -153.05 -42.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -1.102 . . . . 0.0 110.372 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.468 ' N ' HG23 ' A' ' -1' ' ' ILE . 6.8 t60 -110.25 163.69 13.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.178 -0.951 . . . . 0.0 110.344 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 tpt -107.32 120.84 43.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.81 . . . . 0.0 110.331 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp -109.57 26.47 10.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.516 -0.74 . . . . 0.0 109.921 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.23 -28.73 21.9 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.6 91.73 0.1 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.9 m -78.51 84.0 4.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.318 -1.107 . . . . 0.0 110.073 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.3 m -68.39 -83.58 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.269 -0.895 . . . . 0.0 110.348 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 49.77 23.96 1.14 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.055 -1.028 . . . . 0.0 110.638 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.8 -22.07 1.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 110.835 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -53.91 -32.58 48.9 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.959 HD13 HD11 ' A' ' 57' ' ' LEU . 3.8 pp -61.23 -27.69 68.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.444 -1.033 . . . . 0.0 110.09 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.456 ' N ' HD12 ' A' ' 10' ' ' LEU . . . -83.4 -50.7 8.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.412 -0.805 . . . . 0.0 110.257 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.2 p -63.18 -50.17 71.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.421 -0.8 . . . . 0.0 110.08 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -58.5 -40.8 83.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.342 -0.849 . . . . 0.0 109.769 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -61.01 -38.93 87.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.038 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 45' ' ' VAL . . . -60.73 -32.6 71.87 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.309 -0.869 . . . . 0.0 110.168 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.87 15.43 11.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.394 -0.816 . . . . 0.0 110.543 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.47 52.97 49.3 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -119.67 72.26 0.91 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -1.102 . . . . 0.0 110.536 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.909 HG21 ' HB3' ' A' ' 52' ' ' GLN . 58.0 t -56.96 -35.69 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.048 -1.032 . . . . 0.0 109.496 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -59.62 -54.95 40.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.557 -0.715 . . . . 0.0 109.988 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 84.0 m -56.92 -38.3 72.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.438 -0.789 . . . . 0.0 110.129 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.534 HG12 HD12 ' A' ' 26' ' ' LEU . 57.7 t -79.76 -22.05 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 110.475 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.54 ' HA ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -62.65 -45.87 90.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.163 -0.961 . . . . 0.0 110.422 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 24.7 tt0 -76.41 -51.22 12.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.46 -0.775 . . . . 0.0 111.408 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 25' ' ' LEU . 4.0 mt -51.2 -62.06 1.85 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.989 . . . . 0.0 111.227 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.665 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 2.0 mt -53.56 -46.82 70.38 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.15 -0.969 . . . . 0.0 111.365 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.66 9.34 7.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.06 -1.025 . . . . 0.0 110.962 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -114.47 -31.33 6.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.68 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.35 -27.81 0.08 OUTLIER Glycine 0 N--CA 1.484 1.849 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.598 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.808 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -48.22 128.65 14.5 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.136 -1.214 . . . . 0.0 110.758 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.793 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -74.22 145.36 82.97 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.397 -0.814 . . . . 0.0 110.301 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . 0.415 ' HB3' ' HB3' ' A' ' 60' ' ' HIS . 48.9 Cg_endo -76.98 -25.97 8.34 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.753 1.396 . . . . 0.0 110.784 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -114.44 32.38 5.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.324 -0.86 . . . . 0.0 110.403 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.793 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -89.8 96.87 10.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.354 -0.841 . . . . 0.0 110.281 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.94 HD13 ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -71.62 157.69 37.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.32 -0.862 . . . . 0.0 110.083 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.838 ' N ' HD22 ' A' ' 35' ' ' LEU . 47.7 p30 -112.9 173.83 6.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.121 -0.987 . . . . 0.0 110.97 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -49.73 -26.9 4.2 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.368 -0.832 . . . . 0.0 110.608 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -11.93 60.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.28 -0.887 . . . . 0.0 109.887 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.658 ' HA2' HD23 ' A' ' 35' ' ' LEU . . . 52.21 25.61 18.86 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.41 ' HG2' ' HB3' ' A' ' 44' ' ' GLN . 17.8 ttt180 -93.99 1.2 56.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -1.014 . . . . 0.0 110.227 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 55.89 171.45 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.25 -0.906 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.634 ' HB2' HD12 ' A' ' 57' ' ' LEU . 45.7 Cg_endo -72.65 169.44 21.89 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.534 1.281 . . . . 0.0 110.724 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.583 ' HA ' ' HG2' ' A' ' 46' ' ' MET . 30.7 mt 62.95 -60.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.821 -0.549 . . . . 0.0 111.017 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -43.12 -29.2 0.35 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.879 -1.138 . . . . 0.0 110.793 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 45' ' ' VAL . 11.0 p -113.79 35.55 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 0.0 109.942 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.828 ' CE ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -110.46 171.86 7.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.256 -0.903 . . . . 0.0 110.267 -179.805 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 8.5 ttp -73.45 98.91 2.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.319 -0.863 . . . . 0.0 108.685 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.488 ' O ' ' CD2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -61.73 -6.16 2.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 111.138 -179.162 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.5 20.78 32.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.618 ' N ' ' HD2' ' A' ' 84' ' ' PHE . 27.9 t -154.06 109.05 3.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -1.129 . . . . 0.0 110.227 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.676 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . . . -66.25 -29.54 69.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.404 -0.81 . . . . 0.0 110.033 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.909 ' HB3' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -51.35 -32.88 27.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.543 -0.723 . . . . 0.0 110.297 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.495 HG11 ' HB2' ' A' ' 46' ' ' MET . 41.2 t -75.17 -47.94 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.359 -0.838 . . . . 0.0 110.053 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.849 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -70.56 -23.44 62.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.399 -0.813 . . . . 0.0 110.158 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.522 ' HA ' HG11 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -66.71 -53.1 37.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.361 -0.837 . . . . 0.0 110.689 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.54 HD11 ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -61.58 -57.11 13.37 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.909 . . . . 0.0 110.647 -179.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.959 HD11 HD13 ' A' ' 10' ' ' LEU . 2.8 mm? -47.36 -50.37 22.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 110.97 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.033 HD23 HG12 ' A' ' 90' ' ' VAL . 60.5 tp -70.68 -24.7 62.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.406 -0.809 . . . . 0.0 110.544 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.1 tp -67.67 -41.28 83.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 109.982 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.518 ' ND1' HD22 ' A' ' 26' ' ' LEU . 12.0 m170 -78.91 -30.89 45.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.348 -0.845 . . . . 0.0 109.864 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.42 54.89 0.07 OUTLIER Glycine 0 N--CA 1.482 1.758 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.484 ' HB2' ' C ' ' A' ' 57' ' ' LEU . . . -69.83 -168.3 0.19 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.273 -1.133 . . . . 0.0 110.051 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -117.21 78.52 10.36 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.853 . . . . 0.0 110.007 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.78 -27.47 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.719 1.378 . . . . 0.0 110.417 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -87.55 -59.27 2.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.433 -0.792 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.1 168.59 0.13 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.308 -0.87 . . . . 0.0 110.444 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 74' ' ' ARG . . . -167.93 -158.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.875 . . . . 0.0 110.734 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -79.7 123.85 83.81 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.499 -0.75 . . . . 0.0 110.292 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.39 -24.11 14.54 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.549 1.289 . . . . 0.0 110.401 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.39 -46.24 86.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -0.892 . . . . 0.0 110.424 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.783 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 41.9 p -146.65 68.69 1.17 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 110.355 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.604 ' C ' ' O ' ' A' ' 71' ' ' THR . 13.9 mt 5.41 86.75 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.933 -0.479 . . . . 0.0 112.175 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.05 83.57 2.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 110.363 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.756 ' HD3' HG21 ' A' ' 100' ' ' VAL . 5.2 mpt_? -61.51 161.31 20.11 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.481 -0.762 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.36 -18.74 29.68 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.855 1.45 . . . . 0.0 110.422 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.88 -32.13 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.35 -0.844 . . . . 0.0 109.997 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.498 ' HE1' HG13 ' A' ' 100' ' ' VAL . 64.0 m80 -64.63 -41.72 95.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 110.34 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -70.31 -48.44 56.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.355 -0.841 . . . . 0.0 110.416 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.36 -29.18 14.58 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.293 -0.879 . . . . 0.0 110.448 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.899 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -96.55 -27.92 14.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.4 -0.812 . . . . 0.0 109.796 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -53.47 -28.43 30.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.402 -0.811 . . . . 0.0 109.765 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -99.5 -28.44 13.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.814 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.69 44.92 2.03 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.618 ' HD2' ' N ' ' A' ' 50' ' ' SER . 12.7 t80 -108.0 96.43 6.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.368 -1.078 . . . . 0.0 110.046 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.765 ' CD2' HD13 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -72.25 -24.29 61.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.516 -0.74 . . . . 0.0 110.663 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.676 ' HB2' ' HB2' ' A' ' 51' ' ' ALA . 63.9 m-20 -59.67 -54.35 47.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.407 -0.808 . . . . 0.0 110.499 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.849 HG23 ' CB ' ' A' ' 54' ' ' ALA . 90.9 m -61.2 -36.75 80.72 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.094 -1.004 . . . . 0.0 110.157 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -57.54 -48.79 78.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.318 -0.864 . . . . 0.0 110.252 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 85' ' ' LEU . 96.0 t -59.66 -50.95 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 109.914 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 1.033 HG12 HD23 ' A' ' 58' ' ' LEU . 85.1 t -54.27 -45.57 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.838 . . . . 0.0 110.221 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.547 HD13 HG22 ' A' ' 87' ' ' THR . 0.4 OUTLIER -57.23 -56.06 26.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.39 -0.819 . . . . 0.0 110.35 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -64.32 -23.32 67.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.446 -0.784 . . . . 0.0 110.657 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -78.77 -33.75 46.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.202 -0.936 . . . . 0.0 110.575 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.987 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -98.12 39.69 1.22 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.322 -0.862 . . . . 0.0 111.012 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.55 108.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.412 ' O ' HD11 ' A' ' 98' ' ' LEU . . . -168.31 132.45 1.62 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.532 -0.981 . . . . 0.0 110.05 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.55 140.01 42.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.242 -0.911 . . . . 0.0 110.071 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.808 ' O ' HG22 ' A' ' 128' ' ' THR . 2.4 mp -128.31 19.49 6.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.315 -0.866 . . . . 0.0 110.48 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.437 ' HB3' ' HA ' ' A' ' 128' ' ' THR . 4.3 p30 -123.29 55.87 1.2 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.151 -0.968 . . . . 0.0 110.421 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.756 HG21 ' HD3' ' A' ' 74' ' ' ARG . 12.6 p -112.76 164.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.383 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.43 ' N ' HG22 ' A' ' 100' ' ' VAL . 98.8 m -106.47 150.88 25.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.474 -0.767 . . . . 0.0 109.802 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.562 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 22.6 t70 -78.89 58.87 2.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.324 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.783 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 64.69 -71.97 0.07 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.519 -0.738 . . . . 0.0 110.719 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.431 ' N ' ' O ' ' A' ' 102' ' ' ASP . 2.1 m95 -65.49 -56.09 14.28 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.413 -0.804 . . . . 0.0 110.443 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.578 ' O ' HD12 ' A' ' 107' ' ' LEU . . . 168.63 -28.15 0.14 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.01 105.79 0.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.237 -1.155 . . . . 0.0 110.423 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -73.62 170.64 13.4 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.277 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.3 -43.19 0.74 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.738 1.388 . . . . 0.0 110.425 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.487 HG23 ' HA ' ' A' ' 121' ' ' ALA . 9.9 p -58.97 -36.02 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.35 -0.844 . . . . 0.0 110.115 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.442 ' N ' HG13 ' A' ' 109' ' ' VAL . 2.5 m-20 -66.06 -45.8 80.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.441 -0.787 . . . . 0.0 110.187 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 111' ' ' LEU . 4.0 tt -60.84 -27.74 68.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.222 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.3 -63.98 0.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 0.0 110.137 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -53.99 -23.63 13.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.92 -40.66 78.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.676 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.426 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 0.9 OUTLIER -91.29 5.32 49.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.228 -0.92 . . . . 0.0 110.77 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.63 37.06 8.92 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.465 ' HB3' ' CG1' ' A' ' 120' ' ' ILE . 23.9 m-70 -113.09 55.34 0.7 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -1.102 . . . . 0.0 109.791 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.96 -30.5 24.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.435 -0.791 . . . . 0.0 109.988 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -62.39 -40.62 97.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.735 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.899 HG21 ' CB ' ' A' ' 80' ' ' ALA . 4.1 mm -75.87 -36.28 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.509 -0.744 . . . . 0.0 109.601 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.487 ' HA ' HG23 ' A' ' 109' ' ' VAL . . . -64.33 -59.11 4.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 111.178 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 123' ' ' TYR . 14.2 ptm180 -53.99 -41.27 67.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.007 -1.058 . . . . 0.0 110.133 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.408 ' N ' ' HG3' ' A' ' 122' ' ' ARG . 11.7 t80 -68.86 -42.48 76.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.227 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.722 ' O ' HG23 ' A' ' 128' ' ' THR . 21.2 mt -66.24 -47.56 73.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.475 -0.766 . . . . 0.0 109.741 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -50.24 -32.11 15.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.411 -0.806 . . . . 0.0 110.333 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.49 -27.0 46.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.737 . . . . 0.0 110.293 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.497 ' HB1' HD13 ' A' ' 98' ' ' LEU . . . -102.73 -11.45 18.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.342 -0.849 . . . . 0.0 110.85 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 98' ' ' LEU . 73.2 p -90.16 -29.79 18.04 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 110.48 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.88 -98.57 0.01 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 . . . . . 0 C--N 1.307 -1.249 0 O-C-N 121.41 -1.053 . . . . 0.0 110.254 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 7.5 t -78.73 138.51 58.11 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.345 -1.091 . . . . 0.0 110.192 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -72.94 -35.29 5.6 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.683 1.359 . . . . 0.0 110.427 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . 123.36 118.27 2.41 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' ILE . . . . . 0.491 HD12 ' N ' ' A' ' 0' ' ' HIS . 1.3 pp -64.47 -153.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.339 -1.095 . . . . 0.0 110.078 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.491 ' N ' HD12 ' A' ' -1' ' ' ILE . 57.7 m80 -52.14 -75.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.171 -0.956 . . . . 0.0 110.731 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.463 ' C ' ' O ' ' A' ' 0' ' ' HIS . 9.8 ptp 32.07 87.95 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.422 0.63 . . . . 0.0 111.64 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 2' ' ' LEU . 4.4 mm? -63.44 100.09 0.24 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 0.0 110.241 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.8 147.86 17.98 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.58 159.94 0.18 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.4 p -168.83 108.13 0.47 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -1.141 . . . . 0.0 110.506 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.68 -27.64 40.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.492 -0.755 . . . . 0.0 109.896 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 68.3 m-20 -59.35 -36.92 76.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.322 -0.861 . . . . 0.0 110.019 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.45 -19.53 62.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.761 . . . . 0.0 110.048 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.34 -25.95 55.57 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.828 HD11 ' HB1' ' A' ' 30' ' ' ALA . 80.7 mt -64.15 -37.41 87.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.404 -1.057 . . . . 0.0 110.178 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.28 -49.03 14.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.286 -0.884 . . . . 0.0 110.107 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.9 p -56.39 -54.93 39.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.419 -0.801 . . . . 0.0 110.267 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.55 74.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.0 110.071 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.511 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -73.7 -43.75 58.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 110.134 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 45' ' ' VAL . . . -61.44 -28.53 69.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.386 -0.821 . . . . 0.0 110.189 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -72.84 -27.77 62.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.409 -0.807 . . . . 0.0 110.159 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.34 28.04 4.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -106.65 143.0 35.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.379 -1.071 . . . . 0.0 110.483 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.747 HG11 ' HB3' ' A' ' 52' ' ' GLN . 95.0 t -109.53 -54.42 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.442 -0.787 . . . . 0.0 109.9 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -54.9 -32.54 61.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.51 -0.744 . . . . 0.0 110.418 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 m -62.07 -60.89 2.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 110.292 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.443 HG13 ' CD2' ' A' ' 10' ' ' LEU . 58.3 t -61.49 -27.51 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.27 -0.894 . . . . 0.0 110.146 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HD2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.1 -43.44 82.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 110.161 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -63.31 -38.47 91.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.587 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.17 -44.68 68.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.0 110.619 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.499 HD22 ' CG ' ' A' ' 60' ' ' HIS . 14.2 mt -65.88 -57.0 8.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.311 -0.868 . . . . 0.0 110.481 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.84 -25.29 18.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.233 -0.917 . . . . 0.0 110.097 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.55 -67.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 110.046 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.88 47.21 0.06 OUTLIER Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.828 ' HB1' HD11 ' A' ' 10' ' ' LEU . . . -85.93 169.79 12.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -1.143 . . . . 0.0 110.175 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.782 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 7.3 t70 -89.85 125.37 61.09 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.95 -17.46 25.18 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.603 1.318 . . . . 0.0 110.649 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.32 39.86 3.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 110.062 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.782 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -71.91 109.79 5.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.403 -0.81 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 36' ' ' ASN . 1.9 tm? -72.83 99.26 2.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.309 -0.87 . . . . 0.0 109.744 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.553 ' O ' HD13 ' A' ' 35' ' ' LEU . 33.9 m120 -54.82 -179.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.468 -0.77 . . . . 0.0 110.439 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -93.94 22.7 5.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.894 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 64.8 m-85 -111.8 21.57 15.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.202 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.74 26.9 26.47 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -131.2 -168.71 2.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.381 -1.07 . . . . 0.0 110.393 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.67 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.2 mmt180 -104.16 176.19 1.88 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.47 -0.769 . . . . 0.0 109.421 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 42.9 Cg_endo -69.76 -19.49 36.08 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.273 1.144 . . . . 0.0 110.648 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.463 ' O ' ' HG2' ' A' ' 46' ' ' MET . 44.7 mt -104.17 -27.94 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 109.775 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.32 -19.68 56.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.094 -1.004 . . . . 0.0 109.875 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.638 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 14.4 p -126.75 35.7 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.232 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.487 ' CE ' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -96.16 31.59 2.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.259 -0.9 . . . . 0.0 110.298 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.473 ' CB ' ' O ' ' A' ' 46' ' ' MET . 4.8 tmm? 72.15 -18.08 0.34 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.557 -0.714 . . . . 0.0 111.208 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.44 ' CE ' ' HB3' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 50.43 26.2 2.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.019 -1.05 . . . . 0.0 110.679 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -125.32 28.88 4.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.11 100.87 0.75 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.318 -1.107 . . . . 0.0 110.312 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.436 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -59.52 -26.96 65.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.301 -0.874 . . . . 0.0 110.063 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.747 ' HB3' HG11 ' A' ' 19' ' ' VAL . 3.5 mm100 -55.04 -29.39 57.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.488 -0.757 . . . . 0.0 110.591 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.564 HG23 HG22 ' A' ' 19' ' ' VAL . 55.2 t -88.24 -33.16 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 109.932 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.8 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -64.77 -39.72 94.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.323 -0.86 . . . . 0.0 110.115 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -80.08 -38.68 31.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.341 -0.849 . . . . 0.0 110.559 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.645 HD22 ' HD2' ' A' ' 23' ' ' ARG . 37.5 tp -53.98 -58.04 8.76 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.295 -0.878 . . . . 0.0 110.32 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 8.2 mt -67.15 -28.04 67.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.958 . . . . 0.0 110.21 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.958 HD22 HG13 ' A' ' 90' ' ' VAL . 1.3 tp -66.92 -64.96 0.74 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.332 -0.855 . . . . 0.0 110.637 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.533 HD11 ' ND1' ' A' ' 60' ' ' HIS . 3.9 pp -49.91 -27.78 5.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.266 -0.896 . . . . 0.0 110.315 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.533 ' ND1' HD11 ' A' ' 59' ' ' LEU . 4.3 m80 -77.22 -62.81 1.53 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -0.855 . . . . 0.0 109.788 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 165.56 41.71 0.02 OUTLIER Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -61.17 -170.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.312 -1.111 . . . . 0.0 110.329 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -125.28 73.73 67.3 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.461 -0.774 . . . . 0.0 110.282 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.848 1.446 . . . . 0.0 110.601 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.423 ' HA ' ' NH1' ' A' ' 74' ' ' ARG . 39.3 m-80 -89.93 -50.01 6.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.931 . . . . 0.0 110.725 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.21 172.24 0.22 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.173 -0.954 . . . . 0.0 110.459 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.716 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -156.76 -178.14 7.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.483 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.43 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 4.4 t0 -89.59 116.67 66.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 110.036 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.89 -17.18 32.63 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.61 1.321 . . . . 0.0 110.363 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.26 -24.12 63.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 110.686 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.737 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 2.1 m -150.73 21.48 0.8 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.25 -0.906 . . . . 0.0 110.599 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 103' ' ' ALA . 17.9 mt 49.23 27.64 1.92 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.176 -0.952 . . . . 0.0 110.385 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -84.79 121.9 28.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.422 -0.799 . . . . 0.0 110.722 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.76 ' CG ' HG11 ' A' ' 100' ' ' VAL . 2.2 mtt180 -94.79 173.59 4.35 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 110.003 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 42.1 Cg_endo -68.39 -17.55 44.13 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.654 1.344 . . . . 0.0 110.23 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.1 t -69.96 -32.33 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.363 -0.836 . . . . 0.0 109.605 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.423 ' CG ' ' HB3' ' A' ' 108' ' ' PRO . 72.7 m-70 -67.97 -43.73 78.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.477 -0.764 . . . . 0.0 110.082 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.44 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 0.6 OUTLIER -59.73 -60.63 3.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 0.0 109.648 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.84 -24.34 8.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.478 -0.764 . . . . 0.0 109.624 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.419 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -83.56 -30.11 27.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.523 -0.736 . . . . 0.0 109.613 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -57.35 -35.59 70.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 8.6 mp0 -98.01 -15.65 19.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.494 -0.754 . . . . 0.0 110.291 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.444 ' HA3' ' CG ' ' A' ' 117' ' ' HIS . . . 76.71 49.33 7.99 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.14 88.42 3.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.378 -1.072 . . . . 0.0 110.037 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.412 HD21 ' CB ' ' A' ' 123' ' ' TYR . 6.2 mt -60.09 -31.65 70.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.398 -0.814 . . . . 0.0 110.47 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 21.2 t0 -56.88 -48.17 78.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.8 HG23 ' HB1' ' A' ' 54' ' ' ALA . 97.7 m -68.64 -32.87 73.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 109.814 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mp -57.8 -44.06 86.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.343 -0.848 . . . . 0.0 109.821 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 34.1 t -60.89 -54.29 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.448 -0.783 . . . . 0.0 109.439 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.958 HG13 HD22 ' A' ' 58' ' ' LEU . 96.9 t -44.8 -45.91 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.714 -0.616 . . . . 0.0 110.807 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -54.07 24.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 110.512 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -64.59 -46.83 81.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.331 -0.855 . . . . 0.0 110.996 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -69.19 -10.05 55.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.178 -0.951 . . . . 0.0 110.922 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.943 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -120.02 26.71 9.11 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.156 -0.965 . . . . 0.0 110.447 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.77 107.18 0.25 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -170.54 114.99 0.47 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.328 -1.101 . . . . 0.0 110.143 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 74' ' ' ARG . 6.4 ttt85 -69.78 132.89 46.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -0.828 . . . . 0.0 110.082 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.4 mp -119.8 26.83 9.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.418 -0.801 . . . . 0.0 110.191 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -115.54 53.03 0.85 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 110.287 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.76 HG11 ' CG ' ' A' ' 74' ' ' ARG . 14.4 p -123.06 153.75 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 110.103 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 78.2 m -109.48 147.47 32.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 0.0 109.924 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 6.6 p-10 -70.75 67.25 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 0.0 110.325 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.791 ' HB1' ' CZ3' ' A' ' 104' ' ' TRP . . . 57.48 111.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.424 -0.797 . . . . 0.0 110.481 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.791 ' CZ3' ' HB1' ' A' ' 103' ' ' ALA . 38.4 p90 35.64 34.96 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.76 -0.588 . . . . 0.0 111.432 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -122.84 -126.9 3.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.38 179.01 6.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -1.09 . . . . 0.0 110.269 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.544 ' HB2' HG12 ' A' ' 109' ' ' VAL . 96.9 mt -62.85 166.72 7.14 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.477 -0.764 . . . . 0.0 110.013 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.7 Cg_endo -69.94 -16.91 36.99 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.67 1.353 . . . . 0.0 110.536 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.544 HG12 ' HB2' ' A' ' 107' ' ' LEU . 11.6 p -61.64 -35.21 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.218 -0.926 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.428 ' N ' HG13 ' A' ' 109' ' ' VAL . 6.1 m-20 -69.3 -41.74 76.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 110.153 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.01 -31.15 66.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.753 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -68.92 -67.72 0.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.843 . . . . 0.0 110.225 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -25.72 20.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.85 -27.12 60.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.358 -0.839 . . . . 0.0 110.53 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -95.29 -16.02 22.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.667 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 125.28 -13.99 7.4 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.47 ' HB3' ' CG2' ' A' ' 120' ' ' ILE . 24.0 m-70 -75.87 96.87 3.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -1.196 . . . . 0.0 109.594 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' A' ' 119' ' ' ASP . 2.7 ptm180 -91.38 -41.82 10.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.923 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 118' ' ' ARG . 74.4 m-20 -63.29 -38.85 92.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -0.919 . . . . 0.0 109.634 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.753 ' CG2' ' HB1' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -65.63 -37.24 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.567 -0.708 . . . . 0.0 109.92 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.435 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -60.66 -37.0 80.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.453 -0.779 . . . . 0.0 109.9 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -51.15 70.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.408 -0.807 . . . . 0.0 109.759 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.412 ' CB ' HD21 ' A' ' 85' ' ' LEU . 30.9 t80 -60.28 -28.24 67.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.39 -0.819 . . . . 0.0 110.066 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.9 mt -85.59 -38.1 18.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 110.266 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.45 ' CG ' HG21 ' A' ' 109' ' ' VAL . 18.7 m-70 -54.62 -29.3 51.6 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.215 -0.928 . . . . 0.0 110.355 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.86 -20.63 16.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 110.312 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -92.68 -26.85 17.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 0.0 110.582 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.2 p -98.51 15.71 24.09 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.319 -0.863 . . . . 0.0 110.378 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -107.73 -111.98 3.58 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 130' ' ' ASP . 21.2 p-10 . . . . . 0 N--CA 1.486 1.361 0 O-C-N 121.363 -1.081 . . . . 0.0 110.403 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 44.6 m -74.07 160.45 81.65 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.33 -1.1 . . . . 0.0 110.206 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.91 134.79 22.24 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.882 1.464 . . . . 0.0 110.456 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -141.13 53.43 0.66 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' ILE . . . . . . . . . . . . . 29.2 pt -110.95 34.01 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -1.116 . . . . 0.0 110.258 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -95.35 14.35 22.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.436 -0.79 . . . . 0.0 110.439 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttm 58.33 163.8 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.246 -0.909 . . . . 0.0 110.393 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.409 HD12 ' OG ' ' A' ' 5' ' ' SER . 13.9 tp -154.66 96.52 1.89 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.22 -0.925 . . . . 0.0 110.153 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.67 -56.62 0.05 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.91 -26.72 74.01 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.409 ' OG ' HD12 ' A' ' 2' ' ' LEU . 8.6 p -88.7 -179.18 5.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -1.115 . . . . 0.0 110.179 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 55.71 22.9 5.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.379 -0.826 . . . . 0.0 110.439 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.62 -36.96 73.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.959 . . . . 0.0 109.967 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.46 -21.7 61.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.399 -0.813 . . . . 0.0 110.321 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.422 ' HA2' ' CG2' ' A' ' 12' ' ' THR . . . -57.65 -25.21 55.19 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.703 HD13 ' HG ' ' A' ' 26' ' ' LEU . 13.5 tp -75.92 -38.52 57.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -1.071 . . . . 0.0 110.506 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.17 -38.09 22.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.091 -1.005 . . . . 0.0 111.041 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.511 HG23 ' N ' ' A' ' 13' ' ' ALA . 15.2 t -61.81 -41.11 97.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.144 -0.972 . . . . 0.0 110.487 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.515 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -68.15 -50.56 53.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.175 -0.953 . . . . 0.0 109.534 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 46' ' ' MET . . . -52.57 -45.88 66.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.91 . . . . 0.0 110.563 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.589 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -71.4 -18.02 62.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.422 -0.799 . . . . 0.0 110.648 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -97.15 26.03 5.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 0.0 110.587 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 56.93 37.85 81.2 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.625 ' HB3' ' OG1' ' A' ' 21' ' ' THR . 62.6 mm-40 -112.96 93.87 4.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.42 -1.047 . . . . 0.0 110.271 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.682 HG21 ' HB2' ' A' ' 52' ' ' GLN . 11.3 t -82.78 -59.31 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.215 -0.928 . . . . 0.0 110.47 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -50.23 -48.99 54.28 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.625 ' OG1' ' HB3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -53.88 -34.57 59.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.518 -0.739 . . . . 0.0 110.362 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.872 HG12 HD13 ' A' ' 56' ' ' LEU . 95.3 t -81.12 -30.15 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.779 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.751 ' HA ' HD11 ' A' ' 56' ' ' LEU . 4.5 mmm180 -58.9 -37.56 76.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.296 -0.877 . . . . 0.0 110.108 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 4.2 tt0 -79.28 -51.42 9.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 110.42 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.73 -53.93 45.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 0.0 110.672 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.999 HD13 HD22 ' A' ' 56' ' ' LEU . 8.5 mt -56.56 -59.88 4.35 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.247 -0.908 . . . . 0.0 110.404 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.67 -24.15 65.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.369 -0.832 . . . . 0.0 110.266 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -74.43 -64.93 0.92 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.35 48.69 0.07 OUTLIER Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.637 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . . . -88.4 172.24 9.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -1.088 . . . . 0.0 110.22 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 6.5 t0 -110.82 102.75 53.25 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 0.0 110.239 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.3 -15.08 31.55 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.655 1.345 . . . . 0.0 110.64 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -109.31 26.83 10.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.909 . . . . 0.0 110.163 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -95.63 102.62 14.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.365 -0.835 . . . . 0.0 110.405 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 35' ' ' LEU . 25.7 mt -65.82 123.08 18.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.355 -0.841 . . . . 0.0 110.076 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -62.48 175.64 0.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.395 -0.815 . . . . 0.0 109.886 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -6.12 45.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.305 -0.872 . . . . 0.0 110.459 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -93.3 17.59 10.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.173 -0.955 . . . . 0.0 110.084 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.98 24.0 18.27 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -110.15 155.85 21.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.387 -1.066 . . . . 0.0 109.836 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.565 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.9 mmp_? -73.61 168.86 21.65 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.387 -0.821 . . . . 0.0 109.524 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 41.0 Cg_endo -68.03 -14.98 42.48 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.454 1.239 . . . . 0.0 110.173 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.54 ' HA ' ' HG2' ' A' ' 46' ' ' MET . 58.0 mt -107.95 -17.94 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.85 . . . . 0.0 109.87 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -69.12 -20.93 64.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 110.15 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.589 HG22 ' HB2' ' A' ' 15' ' ' ALA . 8.9 p -109.59 -17.0 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.355 -0.841 . . . . 0.0 110.399 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.54 ' HG2' ' HA ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -55.92 164.49 1.17 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.195 -0.941 . . . . 0.0 110.31 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -63.14 89.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.171 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.424 ' HG3' ' HA ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -49.82 -19.93 0.76 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.47 -0.768 . . . . 0.0 111.28 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . -86.66 20.44 23.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.416 ' O ' HG23 ' A' ' 53' ' ' VAL . 21.2 t -140.67 118.62 11.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.007 -1.29 . . . . 0.0 110.375 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -74.76 -26.25 59.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.924 . . . . 0.0 109.647 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.682 ' HB2' HG21 ' A' ' 19' ' ' VAL . 30.1 mt-30 -53.44 -27.35 24.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.525 -0.735 . . . . 0.0 110.644 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.834 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -90.05 -48.3 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 110.186 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.653 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -55.05 -35.11 64.14 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.297 -0.877 . . . . 0.0 110.368 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.407 ' HA ' HG11 ' A' ' 90' ' ' VAL . 7.3 tp10 -78.03 -48.24 16.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.361 -0.837 . . . . 0.0 110.635 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.999 HD22 HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -52.83 -65.54 0.54 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.201 -0.937 . . . . 0.0 110.761 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.834 HD12 ' O ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -50.95 -47.01 61.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.458 -0.776 . . . . 0.0 110.823 -179.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -55.3 -43.5 74.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.3 tp -60.4 -25.61 66.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.673 ' CG ' HD22 ' A' ' 26' ' ' LEU . 29.3 m-70 -95.98 24.68 5.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.201 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.55 54.41 37.94 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.28 -146.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -1.083 . . . . 0.0 109.464 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.63 70.7 77.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.004 -1.06 . . . . 0.0 110.048 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.502 ' HB2' ' HB2' ' A' ' 96' ' ' ALA . 48.8 Cg_endo -81.57 -24.1 4.51 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.806 1.424 . . . . 0.0 110.134 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -95.75 -29.13 14.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 110.358 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.489 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -64.39 139.58 58.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 110.375 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -128.51 175.12 8.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.335 -0.853 . . . . 0.0 110.5 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.515 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 8.6 t70 -76.95 137.18 65.92 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.753 . . . . 0.0 109.84 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.06 -28.35 3.92 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.519 1.273 . . . . 0.0 111.106 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.49 -22.69 58.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.133 -0.979 . . . . 0.0 110.686 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.754 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 3.5 m -144.25 19.57 1.74 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 111.13 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.422 ' HB2' ' CA ' ' A' ' 103' ' ' ALA . 4.9 mt 40.25 36.68 0.35 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.313 -0.867 . . . . 0.0 110.861 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -87.3 126.16 34.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.405 -0.809 . . . . 0.0 110.851 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.709 ' CG ' HG11 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -92.62 173.25 5.23 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.557 -0.714 . . . . 0.0 110.178 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.09 -18.72 16.25 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.663 1.349 . . . . 0.0 110.348 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.89 -32.79 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.33 -0.856 . . . . 0.0 109.939 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.633 ' HE1' HG13 ' A' ' 100' ' ' VAL . 68.8 m80 -60.92 -46.15 91.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.04 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.403 ' CB ' ' CE ' ' A' ' 48' ' ' MET . 1.2 m-20 -60.21 -57.1 14.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.3 -0.875 . . . . 0.0 110.037 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.621 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -51.64 -30.53 21.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.357 -0.84 . . . . 0.0 109.818 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.16 -23.55 30.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.562 -0.711 . . . . 0.0 109.749 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.448 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -60.38 -35.58 76.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.457 -0.777 . . . . 0.0 110.122 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -94.76 -19.5 20.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.34 -0.85 . . . . 0.0 110.463 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.23 30.63 13.55 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.574 ' CA ' ' HZ ' ' A' ' 84' ' ' PHE . 18.0 t80 -97.65 92.01 5.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -1.004 . . . . 0.0 110.092 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 89' ' ' VAL . 2.7 mt -65.63 -22.45 66.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.273 -0.892 . . . . 0.0 110.349 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 90' ' ' VAL . 6.5 m-20 -57.47 -41.14 80.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.397 -0.814 . . . . 0.0 110.392 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.653 HG23 ' CB ' ' A' ' 54' ' ' ALA . 74.8 m -72.86 -36.38 67.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.349 -0.844 . . . . 0.0 109.96 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.726 ' CD1' HD11 ' A' ' 120' ' ' ILE . 5.4 mp -62.52 -42.26 99.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 109.769 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 85' ' ' LEU . 67.6 t -61.31 -44.59 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.448 -0.783 . . . . 0.0 109.332 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 86' ' ' ASP . 65.1 t -55.49 -44.29 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.444 -0.785 . . . . 0.0 109.857 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 87' ' ' THR . 5.5 mp -62.52 -45.95 90.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.428 -0.795 . . . . 0.0 109.744 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -70.97 -15.91 62.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.0 110.254 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -74.61 -71.64 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.349 -0.844 . . . . 0.0 110.136 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -60.78 -78.47 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.331 -0.855 . . . . 0.0 110.286 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.06 107.61 0.26 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 64' ' ' PRO . . . -160.68 119.36 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -1.046 . . . . 0.0 109.834 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -60.43 126.59 28.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.263 -0.898 . . . . 0.0 110.379 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.768 ' O ' HG22 ' A' ' 128' ' ' THR . 0.3 OUTLIER -111.51 64.64 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 110.283 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -171.29 61.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -0.859 . . . . 0.0 110.053 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.709 HG11 ' CG ' ' A' ' 74' ' ' ARG . 7.3 p -131.86 173.13 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 110.065 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.483 ' N ' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -135.1 160.87 36.98 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 104' ' ' TRP . 29.5 m-20 -68.76 71.91 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.709 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.754 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 56.49 -80.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.64 -0.663 . . . . 0.0 110.113 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.503 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -126.78 32.69 5.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -115.46 -142.15 7.59 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.388 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HB3' ' CB ' ' A' ' 110' ' ' ASP . 5.4 mtt85 -98.06 159.13 15.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -1.024 . . . . 0.0 110.787 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -78.99 175.64 4.53 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.604 -0.685 . . . . 0.0 109.618 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 40.8 Cg_endo -66.12 -16.87 53.7 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.385 1.203 . . . . 0.0 110.174 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.521 HG21 ' CG ' ' A' ' 125' ' ' HIS . 9.7 p -91.69 -34.9 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.873 . . . . 0.0 109.796 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.418 ' N ' HG13 ' A' ' 109' ' ' VAL . 10.0 m-20 -66.91 -41.65 86.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -0.8 . . . . 0.0 109.954 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 111' ' ' LEU . 5.8 tt -57.04 -31.02 64.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.419 -0.801 . . . . 0.0 109.951 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.729 ' HB1' ' HB2' ' A' ' 117' ' ' HIS . . . -83.85 -36.85 23.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.532 -0.73 . . . . 0.0 109.979 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -54.99 -26.21 35.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 0.0 110.644 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -91.88 -47.28 7.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.377 -0.827 . . . . 0.0 110.72 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.432 ' HG2' ' CE1' ' A' ' 117' ' ' HIS . 52.6 tp60 -66.4 -100.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.913 . . . . 0.0 110.547 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.12 24.7 0.2 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.523 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.729 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 1.6 m170 -100.51 86.2 3.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.0 -1.294 . . . . 0.0 109.386 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 122' ' ' ARG . 2.6 mpt_? -80.72 -57.93 3.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.415 -0.803 . . . . 0.0 110.71 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -45.76 -46.84 15.42 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.627 -0.671 . . . . 0.0 110.894 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.726 HD11 ' CD1' ' A' ' 88' ' ' LEU . 2.7 tt -65.41 -37.44 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 0.0 109.644 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -61.82 -39.7 92.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 110.0 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 11.5 mmt180 -63.8 -41.37 97.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -74.34 -30.64 62.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.548 -0.72 . . . . 0.0 109.587 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.504 HD23 HD21 ' A' ' 98' ' ' LEU . 20.4 mt -72.89 -59.55 2.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.522 -0.737 . . . . 0.0 109.972 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.521 ' CG ' HG21 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -56.06 -28.57 58.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.38 -0.825 . . . . 0.0 110.096 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.82 -33.77 71.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.429 -0.794 . . . . 0.0 110.243 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.462 ' HB3' ' CD2' ' A' ' 98' ' ' LEU . . . -99.81 -22.41 15.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.398 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 98' ' ' LEU . 64.2 p -93.99 16.1 15.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 0.0 110.354 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -83.15 67.34 3.76 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.629 -179.71 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -4' ' ' SER . . . . . 0.463 ' N ' ' HD2' ' A' ' -3' ' ' PRO . 1.2 t -64.89 -56.8 18.78 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.363 -1.081 . . . . 0.0 110.404 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' -3' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' -4' ' ' SER . 47.2 Cg_endo -72.34 -32.27 10.49 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.472 1.249 . . . . 0.0 110.64 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -66.29 127.19 29.25 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' ILE . . . . . . . . . . . . . 13.4 pt -144.72 23.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.369 -1.077 . . . . 0.0 110.564 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -170.17 -141.62 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.923 . . . . 0.0 110.438 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.92 175.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.236 -0.915 . . . . 0.0 111.17 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 2' ' ' LEU . 2.0 tt -154.16 87.42 1.19 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.508 -0.745 . . . . 0.0 109.991 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.45 -160.37 36.29 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.82 -101.84 2.48 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.6 p -135.22 -78.14 0.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -1.127 . . . . 0.0 110.626 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.8 m -125.57 95.49 4.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.201 -0.937 . . . . 0.0 110.695 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.88 -17.93 51.95 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.358 -0.839 . . . . 0.0 110.01 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.601 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -148.51 50.74 1.0 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.08 -27.76 46.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.993 HD13 HD21 ' A' ' 57' ' ' LEU . 3.9 pp -57.96 -33.6 69.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.503 -0.998 . . . . 0.0 109.866 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.722 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -76.49 -39.28 53.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.381 -0.824 . . . . 0.0 109.733 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.7 m -62.36 -54.46 40.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.406 -0.809 . . . . 0.0 109.785 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 16' ' ' ARG . . . -64.13 -32.33 73.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 0.0 109.783 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.654 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -67.19 -32.68 73.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.206 -0.934 . . . . 0.0 109.494 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' CA ' ' HA ' ' A' ' 46' ' ' MET . . . -70.87 -27.02 63.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 110.02 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 19.2 ptt180 -100.17 20.25 14.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.33 -0.856 . . . . 0.0 110.411 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.414 ' HA3' ' CE ' ' A' ' 47' ' ' MET . . . 62.5 83.0 0.07 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.74 ' O ' HG23 ' A' ' 22' ' ' VAL . 6.6 mm100 -151.74 71.25 0.97 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 110.174 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.822 HG22 HG23 ' A' ' 53' ' ' VAL . 24.8 t -57.0 -43.01 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.236 -0.915 . . . . 0.0 109.889 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -56.89 -52.61 64.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.343 -0.848 . . . . 0.0 110.541 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.427 ' OG1' ' NE2' ' A' ' 18' ' ' GLN . 0.3 OUTLIER -64.26 -41.44 96.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.359 -0.838 . . . . 0.0 110.249 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.818 HG12 HD23 ' A' ' 56' ' ' LEU . 62.1 t -63.24 -38.28 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.45 -0.781 . . . . 0.0 110.024 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.781 ' HD2' HD13 ' A' ' 56' ' ' LEU . 6.8 mmm-85 -69.5 -24.56 63.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 110.148 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 89.8 mm-40 -79.31 -53.6 6.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.836 . . . . 0.0 110.464 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.937 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -59.58 -44.07 93.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.347 -0.846 . . . . 0.0 110.484 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.432 HD11 ' CG ' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -57.24 -53.33 59.35 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.18 -0.95 . . . . 0.0 110.245 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -75.35 -5.56 45.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.427 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -84.1 -39.05 19.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.139 -0.975 . . . . 0.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.98 -20.19 0.14 Allowed Glycine 0 N--CA 1.484 1.881 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.642 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.937 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -47.46 136.27 10.01 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.151 -1.205 . . . . 0.0 111.009 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.92 ' OD2' ' HB2' ' A' ' 34' ' ' ALA . 10.4 p-10 -78.19 150.59 77.61 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 110.203 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.73 4.45 6.91 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.852 1.448 . . . . 0.0 111.051 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -136.35 43.25 2.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.036 -1.04 . . . . 0.0 110.917 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.92 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . . . -109.72 104.69 13.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 35' ' ' LEU . 3.7 pp -73.61 138.76 45.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.201 -0.937 . . . . 0.0 110.253 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.601 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 15.6 p-10 -107.7 82.72 1.69 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.471 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 52.02 -171.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.313 -0.867 . . . . 0.0 110.862 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 39' ' ' GLY . 80.2 m-85 55.56 13.28 0.94 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.571 -0.705 . . . . 0.0 110.924 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' PHE . . . 38.54 35.31 0.31 Allowed Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -107.11 -164.68 1.0 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -1.041 . . . . 0.0 110.478 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.672 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.8 mmp_? -116.71 176.64 1.47 Allowed Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.672 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 43.1 Cg_endo -72.07 -19.78 26.02 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.31 1.163 . . . . 0.0 110.2 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.455 ' O ' ' HG2' ' A' ' 46' ' ' MET . 25.4 mt -104.27 -27.44 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -74.47 -4.26 35.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.536 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.722 HG11 ' HB1' ' A' ' 11' ' ' ALA . 12.4 p -115.03 -17.95 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.084 -1.01 . . . . 0.0 110.748 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -64.34 164.82 10.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.966 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' MET . . . . . 0.414 ' CE ' ' HA3' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -55.67 -16.92 4.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.375 -0.828 . . . . 0.0 110.545 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.566 ' HE3' ' CB ' ' A' ' 78' ' ' ASP . 45.3 tpp 58.93 24.66 12.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.294 -0.878 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.23 20.54 5.59 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 m -149.13 96.26 2.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 110.04 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.419 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -52.49 -26.76 13.86 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.274 -0.891 . . . . 0.0 110.296 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.641 ' HB2' HG21 ' A' ' 19' ' ' VAL . 6.0 mt-30 -53.28 -34.8 58.76 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.822 HG23 HG22 ' A' ' 19' ' ' VAL . 60.3 t -84.13 -38.47 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 110.223 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.877 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -68.18 -33.18 73.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.415 -0.803 . . . . 0.0 110.553 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.402 ' O ' HD23 ' A' ' 59' ' ' LEU . 8.5 tt0 -76.6 -39.98 50.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.966 . . . . 0.0 110.659 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.818 HD23 HG12 ' A' ' 22' ' ' VAL . 46.5 tp -56.2 -63.03 1.32 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.284 -0.885 . . . . 0.0 110.732 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.993 HD21 HD13 ' A' ' 10' ' ' LEU . 5.1 mt -59.78 -30.31 68.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.254 -0.904 . . . . 0.0 110.84 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.948 HD22 HG13 ' A' ' 90' ' ' VAL . 2.7 tp -60.13 -67.51 0.38 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.13 -0.981 . . . . 0.0 110.99 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.434 HD11 ' CE1' ' A' ' 60' ' ' HIS . 2.2 pp -51.85 -25.28 7.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.247 -0.908 . . . . 0.0 110.7 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.434 ' CE1' HD11 ' A' ' 59' ' ' LEU . 12.7 m80 -80.88 -67.3 0.79 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.179 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.52 40.9 0.04 OUTLIER Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' A' ' 57' ' ' LEU . . . -61.67 -164.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.314 -1.109 . . . . 0.0 110.13 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.59 74.43 74.63 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.959 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.89 -32.61 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.901 1.474 . . . . 0.0 110.158 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 43.5 t30 -95.6 -30.18 13.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.388 -0.82 . . . . 0.0 110.012 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 171.08 2.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.438 -0.789 . . . . 0.0 110.139 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.809 ' HB1' ' O ' ' A' ' 73' ' ' THR . . . -169.46 -179.51 3.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.421 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 72' ' ' LEU . 21.8 t0 -78.69 131.44 67.71 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.396 -0.815 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.67 -23.16 11.39 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.544 1.286 . . . . 0.0 110.398 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.83 -29.41 62.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 0.0 110.59 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.827 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 7.8 m -138.92 17.32 2.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.907 . . . . 0.0 110.665 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER 42.38 29.47 0.15 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.317 -0.864 . . . . 0.0 110.794 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.809 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -72.31 134.84 45.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 110.556 -179.38 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.682 ' HG3' HG11 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -107.72 165.17 13.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 110.324 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.37 -24.68 22.5 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.698 1.367 . . . . 0.0 110.322 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 108' ' ' PRO . 58.9 t -58.7 -29.14 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.353 -0.842 . . . . 0.0 110.007 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.443 ' CE1' ' N ' ' A' ' 108' ' ' PRO . 29.7 m-70 -68.65 -34.33 75.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.344 -0.848 . . . . 0.0 110.126 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.566 ' CB ' ' HE3' ' A' ' 48' ' ' MET . 43.4 m-20 -77.82 -56.5 4.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.409 -0.807 . . . . 0.0 110.239 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.566 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -52.65 -26.6 14.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.093 -1.004 . . . . 0.0 109.888 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.436 ' O ' ' CD2' ' A' ' 117' ' ' HIS . . . -85.3 -21.31 29.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.435 -0.791 . . . . 0.0 109.566 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.67 ' CD ' HD12 ' A' ' 111' ' ' LEU . 10.3 tpt180 -76.44 -17.25 59.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.429 -0.794 . . . . 0.0 110.341 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' HG3' ' HB3' ' A' ' 48' ' ' MET . 30.6 mm-40 -100.84 -34.54 9.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.18 -0.95 . . . . 0.0 110.323 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.9 34.18 4.42 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.2 105.61 15.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -1.091 . . . . 0.0 110.123 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.681 HD22 HD12 ' A' ' 120' ' ' ILE . 2.8 mm? -77.6 -21.98 51.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.466 -0.772 . . . . 0.0 110.256 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.692 ' O ' HG23 ' A' ' 90' ' ' VAL . 46.6 t0 -68.0 -48.71 64.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.361 -0.837 . . . . 0.0 110.565 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.877 HG23 ' CB ' ' A' ' 54' ' ' ALA . 97.8 m -65.3 -33.98 77.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.14 -0.975 . . . . 0.0 110.071 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.799 HD13 HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -61.87 -48.53 80.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.226 -0.921 . . . . 0.0 109.857 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 85' ' ' LEU . 67.6 t -60.06 -40.7 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 109.527 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.948 HG13 HD22 ' A' ' 58' ' ' LEU . 91.3 t -53.82 -53.79 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.446 -0.784 . . . . 0.0 110.234 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mp -52.74 -52.01 58.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.387 -0.821 . . . . 0.0 110.581 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -60.99 -24.69 66.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.254 -0.904 . . . . 0.0 110.177 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.42 -22.88 60.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.407 -0.808 . . . . 0.0 110.338 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.752 ' HB3' HD11 ' A' ' 58' ' ' LEU . . . -121.46 35.05 4.99 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.278 -0.889 . . . . 0.0 110.616 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.59 114.05 0.14 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.417 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -155.6 131.56 9.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -1.099 . . . . 0.0 110.034 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 141.47 38.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 109.951 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.754 ' O ' HG22 ' A' ' 128' ' ' THR . 0.5 OUTLIER -133.59 11.09 4.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -0.816 . . . . 0.0 110.307 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -110.73 22.92 14.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 110.019 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.682 HG11 ' HG3' ' A' ' 74' ' ' ARG . 9.5 p -91.56 144.93 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.451 -0.78 . . . . 0.0 109.932 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.542 ' SG ' HD11 ' A' ' 107' ' ' LEU . 53.4 m -115.17 41.96 2.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 110.383 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.671 ' OD1' HG23 ' A' ' 73' ' ' THR . 32.0 t0 52.64 69.47 0.68 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.351 -0.843 . . . . 0.0 110.36 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.827 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 62.89 -77.93 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.519 -0.738 . . . . 0.0 110.254 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -155.5 45.92 0.48 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.356 -0.84 . . . . 0.0 109.801 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -129.42 -118.09 2.03 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -95.83 -178.36 4.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -1.102 . . . . 0.0 110.665 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.542 HD11 ' SG ' ' A' ' 101' ' ' CYS . 3.7 mp -105.14 173.65 3.16 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.498 -0.752 . . . . 0.0 109.942 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 41.6 Cg_endo -67.83 -20.12 46.02 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.551 1.29 . . . . 0.0 110.274 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.741 ' HB ' HD11 ' A' ' 124' ' ' LEU . 14.4 p -83.28 -23.56 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 110.189 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -62.32 -28.34 69.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.225 -0.922 . . . . 0.0 110.266 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.67 HD12 ' CD ' ' A' ' 81' ' ' ARG . 4.4 mm? -58.32 -68.55 0.24 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.308 -0.87 . . . . 0.0 109.941 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.801 ' HB1' ' O ' ' A' ' 117' ' ' HIS . . . -61.64 -43.54 98.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.871 . . . . 0.0 109.725 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.543 ' HG3' HG22 ' A' ' 109' ' ' VAL . 8.8 mm-40 -48.98 -31.99 8.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.513 -0.742 . . . . 0.0 109.51 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 115' ' ' GLN . 10.8 tt0 -66.97 -62.94 1.18 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.608 -0.683 . . . . 0.0 109.212 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER 172.46 113.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.541 -0.724 . . . . 0.0 110.221 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.43 -53.19 0.42 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.628 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.801 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 1.2 m-70 -138.86 75.78 1.54 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.176 -1.19 . . . . 0.0 110.566 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -61.41 -22.78 65.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 0.0 109.979 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.42 ' OD2' HD23 ' A' ' 85' ' ' LEU . 12.5 p-10 -72.87 -42.21 63.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.401 -0.812 . . . . 0.0 110.451 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.799 HD11 HD13 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -61.87 -30.75 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.917 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 125' ' ' HIS . . . -65.1 -52.61 54.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.421 -0.8 . . . . 0.0 109.644 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.43 ' HA ' ' CE1' ' A' ' 125' ' ' HIS . 5.4 mtm180 -45.81 -46.38 15.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.285 -0.884 . . . . 0.0 110.662 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -81.77 -56.74 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 111.057 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.839 ' O ' HG23 ' A' ' 128' ' ' THR . 0.3 OUTLIER -59.51 -39.65 84.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.034 . . . . 0.0 111.158 -178.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.519 ' CD2' ' C ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -67.81 -39.76 83.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.747 -1.22 . . . . 0.0 109.461 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . 0.449 ' N ' ' CD2' ' A' ' 125' ' ' HIS . . . -54.23 -27.94 37.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.412 -0.805 . . . . 0.0 109.548 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.723 ' CB ' HD22 ' A' ' 98' ' ' LEU . . . -90.86 -16.8 27.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.595 -0.69 . . . . 0.0 110.411 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 124' ' ' LEU . 29.1 p -98.16 26.03 5.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.194 -0.941 . . . . 0.0 109.71 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.73 65.28 0.84 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.419 -1.047 . . . . 0.0 110.606 -179.886 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.672 -1.371 . . . . 11.96 109.672 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 83.9 p 44.45 72.79 1.1 Allowed Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.614 -0.933 . . . . 10.58 110.876 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.68 -17.5 42.64 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.995 1.524 . . . . 10.23 110.609 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' GLY . . . . . 0.868 ' O ' ' N ' ' A' ' 0' ' ' HIS . . . -96.41 -34.03 5.98 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.106 -1.198 . . . . 10.45 110.106 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' -1' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' -2' ' ' GLY . 11.1 tt 43.6 -51.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 121.947 -0.737 . . . . 11.59 112.384 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 0' ' ' HIS . . . . . 0.868 ' N ' ' O ' ' A' ' -2' ' ' GLY . 11.5 t-80 -68.87 -32.13 71.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.634 -1.291 . . . . 10.43 110.224 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.92 129.78 41.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.237 -0.914 . . . . 9.03 110.247 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.5 33.07 4.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 6.09 110.029 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.86 30.87 5.62 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.734 -1.346 . . . . 4.57 109.734 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.47 73.23 2.07 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.486 -1.446 . . . . 3.6 109.486 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.24 -58.75 0.75 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.369 -1.077 . . . . 3.98 110.5 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.904 ' HB3' HD21 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -154.14 27.59 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.233 -0.917 . . . . 2.96 110.613 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.64 -54.75 34.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.209 -0.932 . . . . 3.31 109.873 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.589 ' HB1' ' OD1' ' A' ' 36' ' ' ASN . . . -95.34 18.24 12.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 3.29 110.236 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.96 -37.35 92.08 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.385 -1.486 . . . . 2.63 109.385 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.8 HD13 ' CD2' ' A' ' 57' ' ' LEU . 4.0 pp -59.93 -27.25 66.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.384 -1.068 . . . . 2.24 110.154 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -80.47 -47.08 14.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.45 -0.781 . . . . 1.89 110.0 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.8 p -62.17 -51.2 68.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.373 -0.83 . . . . 2.15 109.837 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.53 -34.01 72.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.377 -0.827 . . . . 1.65 109.791 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.61 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -73.07 -36.18 66.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.536 -0.728 . . . . 1.38 109.91 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 46' ' ' MET . . . -60.75 -27.07 67.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.421 -0.799 . . . . 1.41 110.066 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -93.52 -17.51 23.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.372 -0.83 . . . . 4.94 110.321 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.17 54.04 1.31 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.518 -1.433 . . . . 1.44 109.518 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -124.92 79.42 1.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -1.118 . . . . 2.77 110.521 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.829 HG21 ' HB3' ' A' ' 52' ' ' GLN . 84.5 t -61.71 -38.84 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.222 -0.924 . . . . 1.58 109.66 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.78 -44.57 90.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.348 -0.845 . . . . 2.28 110.346 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 m -64.35 -42.68 96.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.869 . . . . 1.8 109.974 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.607 HG12 HD13 ' A' ' 56' ' ' LEU . 61.0 t -74.66 -25.77 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.429 -0.794 . . . . 1.6 110.198 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.569 ' HA ' HD11 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -64.26 -51.31 64.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.317 -0.864 . . . . 1.96 110.464 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.82 -21.06 60.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.275 -0.89 . . . . 4.45 110.599 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.904 HD21 ' HB3' ' A' ' 6' ' ' SER . 0.5 OUTLIER -71.26 -63.61 1.08 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.202 -0.936 . . . . 2.55 110.551 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.81 HD11 HD23 ' A' ' 57' ' ' LEU . 10.2 mt -56.83 -46.37 81.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.289 -0.882 . . . . 2.71 110.646 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.36 -35.24 75.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.38 -0.825 . . . . 3.3 110.375 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.08 -65.8 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.362 -0.836 . . . . 2.66 110.134 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.99 57.33 0.07 OUTLIER Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.563 -1.415 . . . . 2.97 109.563 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.717 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . . . -109.01 133.93 52.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -1.114 . . . . 2.78 110.168 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 1.2 t0 -69.57 127.65 92.58 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 3.66 109.996 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.86 -17.32 25.61 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.592 1.312 . . . . 2.22 110.547 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -107.93 29.03 7.64 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -0.906 . . . . 2.17 110.227 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -81.22 106.2 13.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.363 -0.836 . . . . 2.32 110.153 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 35' ' ' LEU . 13.2 mt -65.3 164.92 12.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.384 -0.822 . . . . 2.98 110.386 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' OD1' ' HB1' ' A' ' 8' ' ' ALA . 1.3 m120 -107.69 -170.0 1.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 3.25 110.14 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -81.77 -18.58 43.66 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.397 -0.814 . . . . 4.62 110.341 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -91.46 18.46 7.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.311 -0.868 . . . . 3.21 110.43 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.07 37.4 45.62 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.836 -1.306 . . . . 2.18 109.836 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.05 162.94 17.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.37 -1.077 . . . . 2.77 110.325 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.616 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.2 mmp_? -77.08 170.76 14.77 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.503 -0.748 . . . . 2.2 109.516 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 41.1 Cg_endo -67.58 -13.1 37.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.478 1.252 . . . . 1.57 110.52 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.454 HG23 ' HE1' ' A' ' 46' ' ' MET . 74.2 mt -109.92 -17.86 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -0.918 . . . . 1.31 109.862 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.81 -4.97 49.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.218 -0.926 . . . . 2.02 110.282 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.545 HG11 ' HB1' ' A' ' 11' ' ' ALA . 14.2 p -120.36 -6.43 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.251 -0.906 . . . . 1.59 110.903 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.572 ' HE1' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -69.41 162.42 27.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.024 -1.047 . . . . 1.8 110.174 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -54.67 -19.62 6.53 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.344 -0.847 . . . . 1.63 110.865 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.497 ' HE2' ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER 60.96 19.68 10.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.29 -0.881 . . . . 1.36 110.156 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.418 ' HA2' ' CD2' ' A' ' 84' ' ' PHE . . . -124.81 24.39 6.07 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.369 -1.492 . . . . 1.25 109.369 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.9 t -154.59 106.84 2.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -1.083 . . . . 1.72 110.071 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -58.88 -25.68 63.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.419 -0.801 . . . . 1.05 110.348 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.829 ' HB3' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -58.08 -29.54 65.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.269 -0.895 . . . . 2.53 110.185 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.683 ' CG2' HG22 ' A' ' 19' ' ' VAL . 34.6 t -84.19 -47.93 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.396 -0.815 . . . . 1.2 110.504 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.754 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -62.1 -37.15 83.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.31 -0.869 . . . . 1.0 110.661 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.417 ' HA ' HG11 ' A' ' 90' ' ' VAL . 16.4 tt0 -74.93 -33.76 62.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 2.74 110.457 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.804 HD22 HD12 ' A' ' 26' ' ' LEU . 1.9 tt -57.22 -64.31 0.93 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.294 -0.879 . . . . 2.1 110.725 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.81 HD23 HD11 ' A' ' 26' ' ' LEU . 6.6 mt -61.41 -40.24 93.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.353 -0.842 . . . . 1.9 110.9 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.745 HD13 HG12 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -58.47 -57.46 12.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 2.12 110.745 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -53.49 -26.35 20.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.287 -0.883 . . . . 2.08 110.236 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.428 ' CE1' ' HB3' ' A' ' 26' ' ' LEU . 3.1 m170 -84.2 -73.9 0.4 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 2.46 110.054 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.16 50.11 0.05 OUTLIER Glycine 0 N--CA 1.483 1.831 0 N-CA-C 109.741 -1.343 . . . . 1.57 109.741 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -70.8 -162.11 0.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -1.109 . . . . 1.54 110.177 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.408 ' CB ' ' HD3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -121.91 76.83 39.63 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 2.16 110.183 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 96' ' ' ALA . 48.7 Cg_endo -77.75 -24.44 8.69 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.775 1.408 . . . . 1.29 110.573 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -92.84 -50.01 5.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 2.56 110.4 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.07 120.85 6.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.244 -0.91 . . . . 1.86 110.449 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.789 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -109.36 -179.44 3.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.396 -0.815 . . . . 1.98 110.329 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -76.95 125.59 86.71 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 2.51 110.003 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.78 -13.0 24.41 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.495 1.26 . . . . 2.48 110.727 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.0 -30.86 44.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.958 . . . . 2.68 110.557 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.62 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 1.7 m -142.66 17.15 2.0 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 2.71 110.567 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.98 32.08 7.05 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.288 -0.883 . . . . 2.34 110.506 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.42 HG23 ' OD1' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -85.7 121.47 28.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.389 -0.819 . . . . 1.77 110.379 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.802 ' HB2' HG11 ' A' ' 100' ' ' VAL . 1.0 OUTLIER -93.1 172.65 5.78 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.775 . . . . 2.6 110.161 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.45 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 45.1 Cg_endo -72.13 -9.38 24.4 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.719 1.379 . . . . 0.94 110.772 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.83 -23.94 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.178 -0.951 . . . . 0.6 110.141 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -72.03 -52.14 18.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.311 -0.868 . . . . 0.87 110.476 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -58.44 -47.48 83.83 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.282 -0.886 . . . . 1.76 110.418 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.497 ' N ' ' HE2' ' A' ' 48' ' ' MET . . . -60.62 -26.36 66.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -0.853 . . . . 0.73 110.211 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -87.7 -21.33 25.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.352 -0.843 . . . . 1.05 110.442 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 -72.6 -30.83 64.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.256 -0.903 . . . . 3.11 110.344 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.404 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 1.3 mm-40 -86.61 -36.11 19.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.872 . . . . 2.1 110.211 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.37 46.06 1.9 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.699 -1.361 . . . . 1.06 109.699 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.418 ' CD2' ' HA2' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -115.13 103.15 10.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.366 -1.079 . . . . 1.69 109.923 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 119' ' ' ASP . 2.3 mt -75.24 -22.62 57.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.847 . . . . 1.92 110.368 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -59.97 -43.31 95.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 1.68 110.114 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.754 HG23 ' HB1' ' A' ' 54' ' ' ALA . 63.7 m -73.24 -39.55 65.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.326 -0.859 . . . . 0.85 109.889 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.775 HD13 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -55.47 -46.51 76.83 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.393 -0.817 . . . . 1.21 109.952 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 85' ' ' LEU . 87.7 t -63.18 -41.15 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.402 -0.811 . . . . 1.41 109.539 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 86' ' ' ASP . 90.2 t -57.2 -47.9 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.596 -0.69 . . . . 1.1 110.276 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.11 -52.5 65.3 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.39 -0.819 . . . . 1.01 110.303 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -60.01 -27.2 66.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.514 -0.741 . . . . 1.66 110.323 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -67.8 -69.03 0.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 3.26 110.265 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.731 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -54.65 -28.19 45.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 1.58 110.669 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.17 87.86 1.21 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.564 -1.415 . . . . 1.55 109.564 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -136.33 134.43 37.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -1.118 . . . . 1.25 110.313 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -71.43 143.05 50.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.802 . . . . 3.46 110.103 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 96' ' ' ALA . 2.1 mp -123.37 -2.78 8.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 1.72 110.823 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -93.69 69.97 4.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.122 -0.986 . . . . 2.12 110.151 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 74' ' ' ARG . 12.2 p -135.27 151.23 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.433 -0.792 . . . . 1.3 110.156 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.401 ' O ' ' N ' ' A' ' 103' ' ' ALA . 12.3 m -116.22 159.17 22.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.243 -0.911 . . . . 2.07 109.404 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -68.55 74.54 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 2.65 109.755 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 61.16 -79.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.635 -0.666 . . . . 2.58 110.047 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.448 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.2 p90 -128.41 37.96 4.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 3.81 109.859 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -120.49 -141.25 6.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.99 -1.244 . . . . 2.11 109.99 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -101.74 -164.95 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.4 -1.059 . . . . 4.59 110.48 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -96.18 174.27 3.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.725 . . . . 1.94 110.035 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.8 Cg_endo -68.16 -22.39 40.85 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.697 1.367 . . . . 1.02 110.254 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 107' ' ' LEU . 11.1 p -73.73 -27.31 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 1.34 110.042 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -80.26 -38.93 29.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.836 . . . . 2.42 110.095 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.48 -26.83 65.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.399 -0.813 . . . . 1.99 109.918 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' A' ' 117' ' ' HIS . . . -78.04 -54.26 6.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.51 -0.744 . . . . 1.78 109.971 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -53.09 -25.79 14.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.395 -0.816 . . . . 3.39 110.573 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -79.05 -54.98 5.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 3.16 110.235 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.38 -67.33 0.43 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.399 -0.813 . . . . 4.06 110.052 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 157.6 47.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.595 -1.402 . . . . 2.4 109.595 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' HIS . . . . . 0.565 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 70.1 m-70 -122.23 64.63 0.93 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.361 -1.082 . . . . 2.12 109.999 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -35.43 67.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.283 -0.886 . . . . 4.53 110.158 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.503 ' HB3' HD12 ' A' ' 85' ' ' LEU . 31.4 m-20 -61.9 -48.5 80.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.379 -0.825 . . . . 2.51 110.218 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.775 HD11 HD13 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -71.62 -25.38 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.397 -0.815 . . . . 1.52 110.347 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.0 -45.41 67.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.395 -0.816 . . . . 1.71 110.119 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.5 mtp85 -59.56 -53.54 56.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.357 -0.839 . . . . 3.93 110.126 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.49 ' CB ' HD21 ' A' ' 85' ' ' LEU . 37.7 t80 -60.52 -35.91 77.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.343 -0.848 . . . . 1.96 110.058 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.466 ' CG ' HD21 ' A' ' 88' ' ' LEU . 34.3 mt -72.6 -41.06 66.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.453 -0.78 . . . . 1.42 110.172 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -59.73 -22.53 62.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.401 -0.812 . . . . 3.72 110.327 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -86.47 -30.86 21.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.878 . . . . 2.04 110.308 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -96.84 -21.04 17.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.278 -0.888 . . . . 1.64 110.633 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 98' ' ' LEU . 26.4 p -104.36 -15.87 15.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 1.96 110.458 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.42 -73.9 0.41 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.807 -1.317 . . . . 3.14 109.807 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 O-C-N 121.463 -1.022 . . . . 5.89 110.057 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 1.11 ' O ' HD11 ' A' ' 25' ' ' LEU . 6.4 p-10 . . . . . 0 C--O 1.211 -0.925 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 9' ' ' GLY . . . -115.47 5.45 14.49 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.239 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.846 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -41.22 -33.58 0.81 Allowed Glycine 0 N--CA 1.499 2.844 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.985 HD22 HD21 ' A' ' 57' ' ' LEU . 4.2 pp -53.66 -29.1 36.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.755 -0.85 . . . . 0.0 109.803 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.755 ' N ' HD12 ' A' ' 10' ' ' LEU . . . -88.06 -60.23 2.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.366 -0.834 . . . . 0.0 109.995 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.1 p -53.46 -47.67 69.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.444 -0.785 . . . . 0.0 110.525 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' A' ' 18' ' ' GLN . . . -67.73 -38.69 83.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 109.778 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -56.54 -52.88 63.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.413 -0.805 . . . . 0.0 109.706 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' A' ' 47' ' ' MET . . . -53.46 -30.4 40.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.891 . . . . 0.0 109.078 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -90.51 8.88 31.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.64 -0.662 . . . . 0.0 110.084 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.0 58.64 7.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.816 ' O ' HG23 ' A' ' 22' ' ' VAL . 27.0 mt-30 -131.92 81.07 1.95 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -1.133 . . . . 0.0 111.008 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.942 HG21 ' HB3' ' A' ' 52' ' ' GLN . 61.1 t -68.67 -29.39 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.065 -1.022 . . . . 0.0 109.217 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -61.8 -42.97 99.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.312 -0.868 . . . . 0.0 109.423 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.516 ' HB ' ' CB ' ' A' ' 13' ' ' ALA . 1.8 m -69.08 -41.25 77.76 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.933 HG12 HD13 ' A' ' 56' ' ' LEU . 21.6 t -61.61 -34.32 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.416 ' HA ' HD11 ' A' ' 56' ' ' LEU . 1.6 mmt180 -70.24 -33.73 71.99 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.41 -53.42 8.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.67 -0.643 . . . . 0.0 111.092 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.11 HD11 ' O ' ' A' ' 7' ' ' ASP . 2.9 tm? -55.91 -25.36 42.64 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.008 -1.058 . . . . 0.0 109.145 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -95.34 -68.82 0.78 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.053 -1.03 . . . . 0.0 111.713 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -50.54 -17.9 0.58 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.29 -0.881 . . . . 0.0 111.535 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.4 2.98 10.0 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.983 -1.073 . . . . 0.0 110.951 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.35 72.93 1.26 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.758 ' HB1' ' HB2' ' A' ' 7' ' ' ASP . . . -132.69 -166.49 1.75 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.412 -1.051 . . . . 0.0 111.42 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.13 140.76 21.55 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.675 -0.64 . . . . 0.0 109.609 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.43 5.36 3.75 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.48 1.253 . . . . 0.0 111.277 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -134.18 42.62 2.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.859 -1.15 . . . . 0.0 111.254 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.723 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . . . -69.36 79.3 0.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.96 -1.087 . . . . 0.0 109.186 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mt -49.5 158.58 0.41 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.532 -0.73 . . . . 0.0 111.397 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -121.26 159.14 26.59 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -22.79 13.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.153 -0.967 . . . . 0.0 110.566 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -77.3 -9.78 59.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 110.356 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.72 28.79 31.49 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 44' ' ' GLN . 13.4 mtm180 -101.77 37.96 1.72 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -1.079 . . . . 0.0 110.084 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.89 177.27 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.312 -0.867 . . . . 0.0 110.674 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -81.53 -24.78 4.12 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.608 1.32 . . . . 0.0 110.816 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.0 mt -102.39 -40.9 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.158 -0.963 . . . . 0.0 110.884 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.43 ' CB ' ' O ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -52.19 -20.68 2.74 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.029 -1.045 . . . . 0.0 110.777 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 45' ' ' VAL . 11.1 p -113.92 44.5 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.932 . . . . 0.0 110.85 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.613 ' CE ' HG21 ' A' ' 87' ' ' THR . 16.6 ptt? -111.8 26.58 10.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.032 -1.042 . . . . 0.0 110.163 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 3.5 tmm? 67.86 -2.39 1.43 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.583 -0.698 . . . . 0.0 111.086 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.608 ' O ' ' HZ ' ' A' ' 84' ' ' PHE . 14.3 mmt 42.35 31.23 0.25 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.211 -0.931 . . . . 0.0 110.988 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -125.01 -3.36 7.55 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.7 p -133.35 99.69 4.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.993 -1.298 . . . . 0.0 110.695 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.0 67.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.302 -0.874 . . . . 0.0 109.824 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.942 ' HB3' HG21 ' A' ' 19' ' ' VAL . 8.3 tp60 -52.01 -27.78 14.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.428 -0.795 . . . . 0.0 110.043 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.826 ' CG2' HG22 ' A' ' 19' ' ' VAL . 19.3 t -87.68 -36.46 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.828 . . . . 0.0 109.489 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.564 ' HB2' ' HE1' ' A' ' 46' ' ' MET . . . -60.8 -40.16 91.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.428 -0.795 . . . . 0.0 110.424 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.474 ' O ' HD23 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -76.17 -39.95 53.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.0 110.614 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.933 HD13 HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -49.43 -64.59 0.76 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.335 -0.853 . . . . 0.0 111.54 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.985 HD21 HD22 ' A' ' 10' ' ' LEU . 3.2 mt -67.25 -38.12 84.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.106 -0.996 . . . . 0.0 111.152 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.937 HD22 ' CG1' ' A' ' 90' ' ' VAL . 1.1 tp -52.79 -66.74 0.33 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.019 -1.051 . . . . 0.0 110.532 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 55' ' ' GLU . 4.0 pp -52.23 -27.57 15.3 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.283 -0.886 . . . . 0.0 110.004 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.474 ' N ' HD12 ' A' ' 59' ' ' LEU . 3.3 m80 -77.24 -68.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.368 -0.833 . . . . 0.0 110.073 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.25 38.34 0.03 OUTLIER Glycine 0 N--CA 1.484 1.842 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.861 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -60.16 -166.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.204 -1.174 . . . . 0.0 110.422 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -121.74 75.26 36.34 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 110.057 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.478 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . 48.5 Cg_endo -77.89 -21.35 11.07 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.831 1.437 . . . . 0.0 110.54 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -95.53 -47.69 6.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 110.457 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.58 172.96 0.44 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.276 -0.89 . . . . 0.0 110.22 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.448 ' HB2' ' NE ' ' A' ' 74' ' ' ARG . . . -169.27 -176.67 2.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.492 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.41 123.21 86.87 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.425 -0.797 . . . . 0.0 109.95 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.31 -13.98 20.61 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.681 1.358 . . . . 0.0 110.97 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.49 -20.95 56.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.197 -0.939 . . . . 0.0 110.85 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.762 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -155.03 27.15 0.42 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.082 -1.011 . . . . 0.0 110.877 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.647 ' HB2' ' H ' ' A' ' 103' ' ' ALA . 86.1 mt 43.14 45.11 4.62 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.277 -0.89 . . . . 0.0 111.417 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.42 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -93.39 103.48 15.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.223 -0.923 . . . . 0.0 110.56 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.798 ' HB2' HG11 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.54 179.38 1.89 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.849 . . . . 0.0 110.106 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD2' ' CG ' ' A' ' 74' ' ' ARG . 48.8 Cg_endo -78.68 -18.29 12.01 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.544 1.286 . . . . 0.0 110.603 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.516 HG11 HD23 ' A' ' 98' ' ' LEU . 75.8 t -67.94 -36.31 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 110.107 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.557 ' HE1' HG13 ' A' ' 100' ' ' VAL . 74.7 m80 -68.4 -39.62 81.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.29 -0.881 . . . . 0.0 110.4 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' A' ' 81' ' ' ARG . 0.7 OUTLIER -57.67 -55.41 35.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.352 -0.843 . . . . 0.0 110.062 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -62.91 -18.47 63.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.082 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.743 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -82.27 -44.15 16.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.389 -0.819 . . . . 0.0 110.571 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -64.59 -20.57 66.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.186 -0.946 . . . . 0.0 110.126 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' N ' ' HG3' ' A' ' 81' ' ' ARG . 2.2 mm-40 -97.02 -48.04 5.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.017 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.49 14.43 10.57 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.608 ' HZ ' ' O ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -78.66 80.05 5.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.124 -1.221 . . . . 0.0 109.804 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -60.07 -23.66 63.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.448 -0.783 . . . . 0.0 110.431 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -61.54 -52.54 64.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.221 -0.924 . . . . 0.0 110.088 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.613 HG21 ' CE ' ' A' ' 46' ' ' MET . 37.6 m -58.59 -34.97 71.68 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.257 -0.902 . . . . 0.0 109.933 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.809 HD11 HD11 ' A' ' 120' ' ' ILE . 1.5 mp -57.4 -46.82 83.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 71.4 t -57.35 -46.94 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.451 -0.781 . . . . 0.0 109.288 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.937 ' CG1' HD22 ' A' ' 58' ' ' LEU . 49.4 t -50.77 -55.4 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.526 -0.734 . . . . 0.0 110.358 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.581 ' C ' ' HB2' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -50.62 -63.11 1.23 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.233 -0.917 . . . . 0.0 110.161 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -61.28 -21.72 64.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 0.0 110.133 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 48.4 ttt180 -77.91 -8.94 58.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.304 -0.873 . . . . 0.0 110.378 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.778 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -135.2 33.93 3.07 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.291 -0.881 . . . . 0.0 110.43 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.51 90.49 0.08 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.581 ' HB2' ' C ' ' A' ' 91' ' ' LEU . . . -120.75 154.98 34.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -1.065 . . . . 0.0 110.316 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.56 75.15 7.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 110.209 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.516 HD23 HG11 ' A' ' 76' ' ' VAL . 3.7 mt -83.81 68.63 10.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -170.06 44.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.393 -0.817 . . . . 0.0 109.725 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.798 HG11 ' HB2' ' A' ' 74' ' ' ARG . 7.8 p -124.5 171.21 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.442 ' N ' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -121.81 136.71 54.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 109.281 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.589 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -69.37 73.91 0.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.845 . . . . 0.0 109.361 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.762 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 66.83 -69.07 0.13 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.344 0.592 . . . . 0.0 109.774 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.421 ' N ' ' O ' ' A' ' 102' ' ' ASP . 1.8 m-90 -140.88 35.5 1.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.482 -0.761 . . . . 0.0 109.379 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 107' ' ' LEU . . . -107.38 24.54 24.11 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.388 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.572 ' C ' HD12 ' A' ' 107' ' ' LEU . 21.8 mtm180 59.52 -73.16 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.408 -1.054 . . . . 0.0 110.78 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -155.84 167.99 13.15 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 110.022 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.44 ' HB2' HG12 ' A' ' 76' ' ' VAL . 46.3 Cg_endo -70.82 -31.49 15.72 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.648 1.341 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 121' ' ' ALA . 10.8 p -63.64 -38.99 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.885 . . . . 0.0 110.042 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 109' ' ' VAL . 75.6 m-20 -66.09 -50.76 62.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.357 -0.839 . . . . 0.0 110.065 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.54 -29.12 58.36 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.376 -0.828 . . . . 0.0 110.288 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.426 ' HB1' HG23 ' A' ' 120' ' ' ILE . . . -67.71 -75.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.421 -0.799 . . . . 0.0 110.216 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 109' ' ' VAL . 4.5 pt-20 -52.73 -27.2 16.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.284 -0.885 . . . . 0.0 110.779 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -58.71 -50.48 73.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.321 -0.862 . . . . 0.0 110.685 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -78.02 -76.65 0.18 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.347 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -167.72 34.81 0.21 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -122.77 79.37 1.63 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.333 -1.098 . . . . 0.0 109.925 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.9 mtp85 -81.22 -40.05 24.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.61 -43.44 80.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.315 -0.865 . . . . 0.0 110.273 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.809 HD11 HD11 ' A' ' 88' ' ' LEU . 17.0 tt -76.64 -38.42 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.982 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 109' ' ' VAL . . . -58.64 -44.78 90.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.559 -0.713 . . . . 0.0 110.006 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -61.99 -45.2 94.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.352 -0.842 . . . . 0.0 110.012 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -64.53 -37.12 86.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.956 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.684 ' O ' HG22 ' A' ' 128' ' ' THR . 12.1 mt -61.34 -58.94 6.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.858 . . . . 0.0 110.196 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.619 ' ND1' HG21 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -53.22 -24.27 10.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.347 -0.846 . . . . 0.0 110.489 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.2 -11.18 44.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.476 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.73 12.08 6.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.967 . . . . 0.0 110.681 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 124' ' ' LEU . 11.9 t . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.143 -0.973 . . . . 0.0 110.324 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.684 ' OD2' ' HB1' ' A' ' 34' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 121.153 0.501 . . . . 0.0 110.894 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -124.59 -21.88 4.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.925 -1.11 . . . . 0.0 110.603 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.92 -29.21 50.54 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.835 HD11 HD12 ' A' ' 26' ' ' LEU . 63.1 tp -56.78 -53.72 54.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.367 -1.078 . . . . 0.0 110.545 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.497 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -65.69 -52.19 53.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.338 -0.851 . . . . 0.0 110.47 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 p -59.15 -46.67 87.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.351 -0.843 . . . . 0.0 110.452 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -59.69 -36.65 76.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 109.926 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.432 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -73.92 -31.71 63.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.903 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.562 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -72.72 -28.69 62.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.392 -0.817 . . . . 0.0 110.017 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -90.44 11.16 22.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.35 -0.844 . . . . 0.0 110.323 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.11 58.5 13.27 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.669 ' O ' HG23 ' A' ' 22' ' ' VAL . 88.0 mm-40 -126.66 81.88 2.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 110.379 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.673 HG22 HG23 ' A' ' 53' ' ' VAL . 53.8 t -60.43 -50.65 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.142 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -51.66 -51.66 54.05 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.283 -0.885 . . . . 0.0 110.55 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.0 m -61.82 -42.7 99.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.244 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.936 HG12 HD23 ' A' ' 56' ' ' LEU . 97.7 t -67.6 -38.22 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.355 -0.841 . . . . 0.0 110.207 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.509 ' HA ' HD22 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -69.65 -31.23 69.19 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.309 -0.869 . . . . 0.0 110.217 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 18.5 tm0? -80.48 -51.13 9.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 110.695 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.932 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -60.35 -60.92 3.05 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.254 -0.903 . . . . 0.0 110.483 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.865 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 1.2 tt -53.28 -43.68 67.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.215 -0.928 . . . . 0.0 110.588 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -78.1 1.51 20.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.533 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -105.84 -29.33 10.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 110.3 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.75 -26.87 0.1 Allowed Glycine 0 N--CA 1.484 1.858 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.456 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.932 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -48.56 135.25 14.68 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.199 -1.177 . . . . 0.0 110.9 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 30.7 t70 -87.96 141.43 31.44 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 46.1 Cg_endo -73.72 -28.35 11.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.663 1.349 . . . . 0.0 110.544 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -92.48 18.83 7.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 110.433 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.684 ' HB1' ' OD2' ' A' ' 7' ' ' ASP . . . -83.33 142.41 31.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -0.922 . . . . 0.0 110.205 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 35' ' ' LEU . 14.8 mt -99.47 153.84 18.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.364 -0.835 . . . . 0.0 110.196 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -102.08 30.9 4.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.331 -0.855 . . . . 0.0 110.206 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 54.77 24.67 5.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.363 -0.835 . . . . 0.0 110.496 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.09 2.7 9.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.315 -0.866 . . . . 0.0 110.587 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 54.04 27.31 37.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.445 ' O ' ' CB ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -120.17 18.1 12.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.334 -1.098 . . . . 0.0 110.38 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.49 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 21.1 mmt-85 53.73 175.63 0.03 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.168 -0.958 . . . . 0.0 110.314 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.585 ' HG2' ' HB1' ' A' ' 62' ' ' ALA . 51.3 Cg_endo -85.17 -0.05 8.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.54 1.284 . . . . 0.0 111.154 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.605 HD13 HD22 ' A' ' 57' ' ' LEU . 50.7 mm -114.29 -41.39 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.987 -1.071 . . . . 0.0 110.628 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.445 ' CB ' ' O ' ' A' ' 40' ' ' ARG . 2.9 tt0 -57.58 -41.49 81.24 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.157 -0.965 . . . . 0.0 109.927 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 15' ' ' ALA . 11.5 p -75.74 -11.86 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 0.0 110.288 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.52 ' HE1' HG21 ' A' ' 87' ' ' THR . 2.3 ttm -51.34 150.07 3.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.337 -0.852 . . . . 0.0 110.431 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.405 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 5.0 tmm? -62.42 -15.76 51.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 110.265 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.44 26.27 8.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.216 -0.927 . . . . 0.0 110.192 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.14 19.37 5.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.487 ' N ' ' CZ ' ' A' ' 84' ' ' PHE . 19.8 t -157.84 101.83 1.81 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -1.024 . . . . 0.0 110.243 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.447 ' HB2' ' CG ' ' A' ' 86' ' ' ASP . . . -57.82 -26.93 62.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.634 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 1.1 mp0 -54.82 -34.06 62.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.399 -0.813 . . . . 0.0 110.556 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.673 HG23 HG22 ' A' ' 19' ' ' VAL . 89.1 t -76.26 -62.76 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -0.865 . . . . 0.0 110.322 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.867 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -47.71 -27.6 2.05 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.393 -0.817 . . . . 0.0 110.894 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.541 ' HA ' HG11 ' A' ' 90' ' ' VAL . 18.0 tt0 -70.9 -56.05 7.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.406 -0.809 . . . . 0.0 110.452 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.936 HD23 HG12 ' A' ' 22' ' ' VAL . 15.4 tp -52.36 -56.28 15.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.331 -0.856 . . . . 0.0 110.681 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.605 HD22 HD13 ' A' ' 43' ' ' ILE . 3.2 mp -52.13 -53.92 36.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.326 -0.859 . . . . 0.0 110.731 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.639 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -61.64 -28.19 69.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.31 -0.869 . . . . 0.0 110.375 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.0 tp -69.83 -38.18 76.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 110.222 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -83.97 -20.35 33.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.398 -0.814 . . . . 0.0 110.297 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.54 53.54 0.72 Allowed Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.585 ' HB1' ' HG2' ' A' ' 42' ' ' PRO . . . -65.09 -147.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.269 -1.136 . . . . 0.0 109.803 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -125.81 70.69 66.61 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.09 -1.006 . . . . 0.0 110.365 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . 50.8 Cg_endo -82.36 -28.36 1.9 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.799 1.421 . . . . 0.0 110.042 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 74' ' ' ARG . 2.6 m120 -79.65 -34.98 39.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.41 -0.806 . . . . 0.0 110.255 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 129.49 41.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 110.298 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.588 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -118.06 162.69 17.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -0.862 . . . . 0.0 110.24 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 2.8 t0 -69.34 124.21 89.98 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.0 109.903 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.89 -23.41 16.4 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.592 1.311 . . . . 0.0 110.556 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.35 -33.21 75.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 0.0 110.512 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.788 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -146.63 24.7 1.22 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.26 49.87 9.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.373 -0.829 . . . . 0.0 110.863 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.7 HG23 ' OD1' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -99.48 131.8 45.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 0.0 110.36 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.89 ' CG ' HG11 ' A' ' 100' ' ' VAL . 9.8 mtp180 -101.54 165.89 13.25 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.479 -0.763 . . . . 0.0 110.166 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 43.1 Cg_endo -69.11 -11.7 32.33 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.66 1.347 . . . . 0.0 110.803 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.4 t -67.09 -28.29 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.903 . . . . 0.0 109.948 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.667 ' HE1' HG13 ' A' ' 100' ' ' VAL . 72.1 m80 -67.75 -53.23 28.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 110.252 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.511 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 4.3 m-20 -51.84 -57.09 10.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.53 -0.731 . . . . 0.0 110.858 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.39 -16.05 59.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.314 -0.866 . . . . 0.0 110.693 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.53 -37.08 13.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.162 -0.961 . . . . 0.0 110.53 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 78' ' ' ASP . 14.9 ptt180 -70.76 -18.67 62.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.327 -0.858 . . . . 0.0 110.826 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.95 11.17 38.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.707 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.472 ' HA3' ' CD2' ' A' ' 117' ' ' HIS . . . 56.89 42.15 92.1 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.487 ' CZ ' ' N ' ' A' ' 50' ' ' SER . 0.7 OUTLIER -110.81 98.39 7.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.485 -1.009 . . . . 0.0 110.147 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' A' ' 119' ' ' ASP . 0.6 OUTLIER -84.15 -34.05 24.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 0.0 110.35 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 87' ' ' THR . 14.5 p30 -51.07 -44.43 61.16 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.244 -0.91 . . . . 0.0 110.599 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.867 HG23 ' CB ' ' A' ' 54' ' ' ALA . 45.1 m -76.21 -31.77 58.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 109.456 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.558 HD22 HG13 ' A' ' 120' ' ' ILE . 8.2 tp -60.48 -37.59 81.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.466 -0.771 . . . . 0.0 109.429 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.3 t -68.22 -44.04 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.507 -0.746 . . . . 0.0 109.325 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.574 HG12 HD13 ' A' ' 58' ' ' LEU . 66.9 t -56.77 -41.64 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.46 -0.775 . . . . 0.0 110.172 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.452 ' HA ' HD21 ' A' ' 58' ' ' LEU . 2.5 mt -60.03 -52.03 67.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.438 -0.789 . . . . 0.0 109.984 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -72.09 -29.4 64.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 0.0 109.762 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -68.01 -57.76 5.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.439 -0.788 . . . . 0.0 109.89 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.639 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . . . -70.49 -61.85 1.61 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.412 -0.805 . . . . 0.0 110.365 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 170.86 105.92 0.19 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.407 ' HB3' ' C ' ' A' ' 91' ' ' LEU . . . -168.04 133.42 1.86 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.275 -1.132 . . . . 0.0 110.245 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 100' ' ' VAL . 3.7 ttp180 -65.75 163.43 16.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 0.0 110.263 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.412 HD23 ' HB3' ' A' ' 127' ' ' ALA . 1.1 tp -148.4 48.59 1.03 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.452 -0.78 . . . . 0.0 109.931 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.843 ' HA ' HG23 ' A' ' 128' ' ' THR . 48.2 t0 -159.31 50.13 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.391 -0.818 . . . . 0.0 110.054 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.89 HG11 ' CG ' ' A' ' 74' ' ' ARG . 13.2 p -122.7 168.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.512 -0.742 . . . . 0.0 110.178 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.605 ' SG ' HD11 ' A' ' 107' ' ' LEU . 0.4 OUTLIER -132.87 166.85 21.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 109.256 179.388 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.7 ' OD1' HG23 ' A' ' 73' ' ' THR . 4.9 t0 -70.22 71.94 0.44 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.889 . . . . 0.0 109.824 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.788 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 60.84 -79.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.642 -0.661 . . . . 0.0 110.051 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.443 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.3 p90 -133.64 26.81 4.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 109.478 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.65 -139.38 7.81 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.636 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -168.95 2.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.532 -0.981 . . . . 0.0 111.046 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.605 HD11 ' SG ' ' A' ' 101' ' ' CYS . 0.3 OUTLIER -119.17 176.41 1.73 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.653 -0.655 . . . . 0.0 109.864 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 46.0 Cg_endo -71.29 -27.31 19.76 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.542 1.285 . . . . 0.0 110.263 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.604 ' HA ' HD13 ' A' ' 124' ' ' LEU . 12.5 p -78.05 -37.81 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 110.337 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 109' ' ' VAL . 74.5 m-20 -66.45 -42.58 87.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -0.831 . . . . 0.0 110.237 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 111' ' ' LEU . 1.6 tt -59.76 -36.15 76.06 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.332 -0.855 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.702 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -61.32 -59.9 4.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.381 -0.825 . . . . 0.0 110.028 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -52.29 -27.18 14.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.465 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.13 -42.96 96.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.352 -0.843 . . . . 0.0 110.175 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.44 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -80.98 -32.4 34.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.867 . . . . 0.0 110.262 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.22 29.16 2.01 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.532 ' CB ' HG22 ' A' ' 120' ' ' ILE . 29.9 m170 -90.85 72.62 6.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -1.091 . . . . 0.0 109.984 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -58.75 -28.25 65.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.387 -0.82 . . . . 0.0 110.386 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.421 ' HB2' HD12 ' A' ' 85' ' ' LEU . 12.4 p-10 -74.88 -41.01 60.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.311 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.702 ' CG2' ' HB1' ' A' ' 112' ' ' ALA . 1.9 tt -79.18 -34.02 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.962 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.0 -29.06 69.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.84 . . . . 0.0 109.842 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 126' ' ' ALA . 1.1 ttt180 -73.26 -53.08 11.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -62.07 -30.13 70.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 110.106 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.604 HD13 ' HA ' ' A' ' 109' ' ' VAL . 36.4 mt -71.15 -71.65 0.25 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.442 -0.786 . . . . 0.0 110.556 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -53.1 -28.49 25.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.268 -0.895 . . . . 0.0 110.235 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 122' ' ' ARG . . . -63.92 -36.15 83.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.293 -0.879 . . . . 0.0 109.68 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.412 ' HB3' HD23 ' A' ' 98' ' ' LEU . . . -120.24 23.81 10.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 110.084 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.843 HG23 ' HA ' ' A' ' 99' ' ' ASP . 89.4 m . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 110.327 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.9 t0 . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 121.028 0.442 . . . . 0.0 109.999 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.28 29.1 0.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 110.386 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.2 -34.24 53.08 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.863 HD13 ' CD2' ' A' ' 57' ' ' LEU . 4.0 pp -53.47 -28.39 30.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.623 -0.928 . . . . 0.0 110.049 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.776 ' N ' HD12 ' A' ' 10' ' ' LEU . . . -81.45 -43.81 18.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.445 -0.784 . . . . 0.0 110.209 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.1 p -59.11 -57.73 11.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.332 -0.855 . . . . 0.0 109.899 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.5 -34.78 69.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.3 -0.875 . . . . 0.0 109.787 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.778 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -64.05 -41.69 97.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.557 -0.714 . . . . 0.0 109.742 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -58.92 -30.65 67.99 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.347 -0.845 . . . . 0.0 110.063 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -84.82 5.51 28.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.382 -0.824 . . . . 0.0 110.536 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.29 42.4 83.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.51 ' O ' HG23 ' A' ' 22' ' ' VAL . 77.2 mt-30 -112.39 74.85 0.88 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.469 -1.019 . . . . 0.0 110.432 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.71 HG21 ' CB ' ' A' ' 52' ' ' GLN . 42.4 t -57.7 -38.41 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.286 -0.884 . . . . 0.0 109.568 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -57.52 -49.08 77.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.811 . . . . 0.0 110.193 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 m -67.18 -39.26 86.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.383 -0.823 . . . . 0.0 110.004 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.913 HG12 HD13 ' A' ' 56' ' ' LEU . 58.2 t -69.83 -29.85 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.434 -0.791 . . . . 0.0 109.757 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.7 ' HA ' HD11 ' A' ' 56' ' ' LEU . 6.0 mmt180 -68.38 -32.67 72.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.479 -0.763 . . . . 0.0 110.145 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 79.0 mt-30 -79.31 -52.73 7.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 0.0 110.579 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.611 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -52.0 -54.6 27.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.283 -0.886 . . . . 0.0 110.599 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.689 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -55.43 -61.63 2.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.232 -0.918 . . . . 0.0 110.432 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.22 -23.9 64.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -72.56 -61.79 1.68 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.238 -0.913 . . . . 0.0 110.297 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 176.48 50.03 0.06 OUTLIER Glycine 0 N--CA 1.48 1.632 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . . . -101.58 135.38 43.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.287 -1.125 . . . . 0.0 110.241 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 3.0 t70 -65.0 140.03 97.98 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.801 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.17 -3.35 13.78 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.665 1.35 . . . . 0.0 111.049 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -130.84 17.39 5.17 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.008 -1.058 . . . . 0.0 111.108 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -65.32 93.46 0.14 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.06 -1.025 . . . . 0.0 109.6 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mt -51.9 172.36 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.322 -0.861 . . . . 0.0 110.867 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -103.02 -163.0 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.471 -0.768 . . . . 0.0 110.075 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -96.07 -20.48 18.63 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 110.418 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.72 33.3 1.67 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 109.781 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.41 26.01 21.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG3' ' CB ' ' A' ' 44' ' ' GLN . 2.1 tpp85 -102.56 163.02 12.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.437 -1.037 . . . . 0.0 110.194 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.477 ' CB ' ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -81.0 179.4 1.93 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.442 -0.786 . . . . 0.0 110.042 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.5 ' HB2' HD22 ' A' ' 57' ' ' LEU . 42.4 Cg_endo -69.87 -25.63 27.87 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.593 1.312 . . . . 0.0 110.933 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.482 ' O ' ' CG ' ' A' ' 46' ' ' MET . 10.6 mt -102.34 -34.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.148 -0.97 . . . . 0.0 109.847 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.499 ' HA ' ' HE1' ' A' ' 48' ' ' MET . 56.8 mt-30 -54.74 -17.72 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 110.783 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 45' ' ' VAL . 11.7 p -115.27 26.37 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.095 -1.003 . . . . 0.0 110.575 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.63 ' CE ' HG21 ' A' ' 87' ' ' THR . 0.4 OUTLIER -95.73 32.07 1.92 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.187 -0.945 . . . . 0.0 110.2 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.416 ' CB ' ' O ' ' A' ' 46' ' ' MET . 3.4 tmm? 68.41 -7.4 0.69 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.469 -0.769 . . . . 0.0 111.102 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.499 ' HE1' ' HA ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER 46.9 27.28 0.69 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.003 -1.06 . . . . 0.0 110.716 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.46 ' HA2' ' CD2' ' A' ' 84' ' ' PHE . . . -130.67 13.45 5.6 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 p -143.78 90.34 2.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -1.145 . . . . 0.0 110.257 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.46 -26.31 12.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.918 . . . . 0.0 110.19 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.71 ' CB ' HG21 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -55.13 -34.24 63.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.397 -0.815 . . . . 0.0 110.247 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.778 HG11 ' HB1' ' A' ' 14' ' ' ALA . 26.8 t -83.41 -33.06 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.466 -0.771 . . . . 0.0 110.465 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.649 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -63.08 -52.34 63.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.194 -0.941 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.63 ' O ' HD23 ' A' ' 59' ' ' LEU . 12.3 pt-20 -66.55 -34.03 77.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.429 -0.794 . . . . 0.0 110.564 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.913 HD13 HG12 ' A' ' 22' ' ' VAL . 1.6 tt -53.3 -63.58 1.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.288 -0.883 . . . . 0.0 110.736 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.863 ' CD2' HD13 ' A' ' 10' ' ' LEU . 1.8 mt -70.4 -33.76 71.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.373 -0.83 . . . . 0.0 110.654 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.013 HD21 ' HB2' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -58.14 -61.51 2.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.921 . . . . 0.0 110.409 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 55' ' ' GLU . 3.1 pp -60.06 -25.1 65.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 110.448 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.627 ' CE1' HD12 ' A' ' 26' ' ' LEU . 2.9 m-70 -78.61 -63.55 1.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.848 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.85 38.16 0.04 OUTLIER Glycine 0 N--CA 1.484 1.844 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -71.02 -175.67 1.2 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.053 -1.263 . . . . 0.0 110.242 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -119.12 76.8 15.93 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.492 -0.755 . . . . 0.0 110.002 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.641 ' HB2' ' HB2' ' A' ' 96' ' ' ALA . 47.5 Cg_endo -76.56 -5.72 16.34 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.86 1.453 . . . . 0.0 110.632 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.93 -51.95 2.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.316 -0.865 . . . . 0.0 110.049 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.24 134.73 39.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.366 -0.834 . . . . 0.0 110.445 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.883 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -119.51 -174.79 2.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.358 -0.839 . . . . 0.0 110.394 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 16.7 t0 -86.59 127.52 60.26 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.719 . . . . 0.0 109.994 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.31 -29.49 11.3 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.518 1.273 . . . . 0.0 110.57 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.62 80.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 0.0 110.411 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.811 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -143.76 38.88 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.255 -0.903 . . . . 0.0 110.557 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.535 ' C ' ' O ' ' A' ' 71' ' ' THR . 1.6 mt 25.45 61.83 0.06 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.765 -0.584 . . . . 0.0 111.561 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -113.08 119.81 39.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.9 . . . . 0.0 110.468 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.883 ' HG2' ' HB2' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -93.39 173.33 4.94 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.479 -0.763 . . . . 0.0 110.345 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.463 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 45.1 Cg_endo -71.87 -22.26 23.65 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.835 1.439 . . . . 0.0 110.33 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 52.0 t -59.45 -39.0 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.322 -0.861 . . . . 0.0 109.981 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.538 ' HE1' HG13 ' A' ' 100' ' ' VAL . 73.5 m80 -64.1 -45.19 89.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 110.09 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.451 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -52.82 -65.7 0.51 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.447 -0.783 . . . . 0.0 110.429 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.68 -26.77 24.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.33 -0.856 . . . . 0.0 110.132 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.66 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -78.28 -43.05 29.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 0.0 109.754 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -61.32 -21.75 64.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 110.223 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.41 -32.47 12.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 0.0 109.735 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.82 24.9 24.18 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.46 ' CD2' ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -88.95 93.81 9.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -1.161 . . . . 0.0 109.993 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.463 HD21 ' O ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -61.97 -34.71 76.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.526 -0.733 . . . . 0.0 110.798 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.491 ' O ' HG23 ' A' ' 90' ' ' VAL . 39.5 t0 -58.67 -35.65 72.91 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.247 -0.908 . . . . 0.0 110.97 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.649 HG23 ' CB ' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -75.15 -41.03 59.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.007 -1.058 . . . . 0.0 110.228 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.96 HD22 HG13 ' A' ' 120' ' ' ILE . 2.4 tp -55.3 -40.79 71.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.349 -0.845 . . . . 0.0 109.873 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.39 -45.72 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 109.373 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.723 HG12 HD13 ' A' ' 58' ' ' LEU . 88.1 t -53.72 -45.86 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.551 -0.718 . . . . 0.0 110.227 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 6.2 mp -64.78 -20.93 66.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.399 -0.813 . . . . 0.0 110.676 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -78.13 -62.78 1.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.196 -0.94 . . . . 0.0 110.715 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.704 HH21 HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -54.1 -33.06 56.73 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.469 -0.769 . . . . 0.0 110.553 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.013 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -68.69 -34.89 76.44 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.284 -0.885 . . . . 0.0 110.216 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 111.15 45.79 0.85 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 64' ' ' PRO . . . -97.9 138.62 34.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.403 -1.057 . . . . 0.0 110.321 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -73.0 151.84 41.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.405 -0.81 . . . . 0.0 110.225 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.81 HD23 HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -127.35 -8.15 5.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.395 -0.816 . . . . 0.0 110.843 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -92.73 39.94 1.04 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.207 -0.933 . . . . 0.0 110.807 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.774 HG21 ' HG3' ' A' ' 74' ' ' ARG . 14.6 p -100.65 148.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -0.889 . . . . 0.0 110.039 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m -99.17 154.2 18.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.293 -0.879 . . . . 0.0 110.231 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 27.1 p-10 -81.86 57.01 3.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.811 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 64.95 -67.9 0.11 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.598 -0.688 . . . . 0.0 110.586 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.44 ' N ' ' O ' ' A' ' 102' ' ' ASP . 1.7 m95 -59.37 -61.14 2.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 167.01 -28.89 0.18 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -56.5 124.05 16.88 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.252 -1.146 . . . . 0.0 110.43 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 82.3 mt -80.06 167.02 36.6 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.38 -0.825 . . . . 0.0 110.081 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.9 Cg_endo -69.65 -23.36 31.36 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.642 1.338 . . . . 0.0 110.378 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.732 ' HA ' HD13 ' A' ' 124' ' ' LEU . 14.4 p -75.41 -35.67 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.794 . . . . 0.0 109.956 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.43 ' N ' HG13 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -67.15 -42.1 84.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.492 -0.755 . . . . 0.0 109.705 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.06 -30.32 70.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.44 -0.788 . . . . 0.0 109.944 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.585 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -65.33 -73.38 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.503 -0.748 . . . . 0.0 109.954 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.449 ' N ' ' HB2' ' A' ' 121' ' ' ALA . 1.3 pt-20 -53.37 -22.19 7.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.775 . . . . 0.0 110.949 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.49 -71.22 0.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 0.0 110.642 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -59.69 -94.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.284 -0.885 . . . . 0.0 110.711 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.45 30.63 0.95 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -110.56 79.11 1.17 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.375 -1.074 . . . . 0.0 109.7 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -79.31 -42.25 26.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.88 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.463 ' O ' HD21 ' A' ' 85' ' ' LEU . 20.7 p-10 -59.37 -37.35 77.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.442 -0.786 . . . . 0.0 110.049 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.96 HG13 HD22 ' A' ' 88' ' ' LEU . 3.1 tt -80.48 -31.32 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 109.755 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.449 ' HB2' ' N ' ' A' ' 113' ' ' GLU . . . -63.78 -54.17 39.33 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.922 0.868 . . . . 0.0 109.815 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.509 ' HA ' ' CE1' ' A' ' 125' ' ' HIS . 8.3 ttt-85 -59.11 -52.96 63.48 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.866 -0.521 . . . . 0.0 110.347 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.751 ' HD2' HD23 ' A' ' 88' ' ' LEU . 78.9 t80 -61.07 -26.67 67.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.089 -1.007 . . . . 0.0 110.363 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.841 ' O ' HG22 ' A' ' 128' ' ' THR . 4.1 mt -66.63 -60.07 3.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.667 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.509 ' CE1' ' HA ' ' A' ' 122' ' ' ARG . 2.6 p-80 -54.95 -24.68 25.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.457 ' N ' ' CD2' ' A' ' 125' ' ' HIS . . . -77.13 -24.89 51.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 110.633 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -107.65 -23.96 11.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.297 -0.877 . . . . 0.0 110.995 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.841 HG22 ' O ' ' A' ' 124' ' ' LEU . 10.0 t . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.144 -0.973 . . . . 0.0 110.959 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 56.2 m-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.207 0.527 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' ASP . . . 58.35 19.59 6.51 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.398 -0.814 . . . . 0.0 110.508 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.97 -17.45 79.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.728 HD11 HD13 ' A' ' 26' ' ' LEU . 60.4 mt -78.9 -44.24 23.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.355 -1.085 . . . . 0.0 109.819 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -62.31 -44.86 95.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.496 -0.752 . . . . 0.0 110.065 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 p -57.12 -55.51 33.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 109.94 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.96 72.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.898 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -65.18 -49.92 67.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.824 . . . . 0.0 110.141 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.772 ' HB2' ' O ' ' A' ' 45' ' ' VAL . . . -63.91 -23.97 67.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.353 -0.842 . . . . 0.0 110.147 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -91.52 3.48 54.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 0.0 110.636 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.61 45.97 72.6 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -110.96 66.12 0.62 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -1.084 . . . . 0.0 110.231 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.833 HG22 HG23 ' A' ' 53' ' ' VAL . 19.1 t -52.31 -34.63 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.324 -0.86 . . . . 0.0 110.113 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -65.55 -54.64 25.19 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.405 -0.809 . . . . 0.0 110.937 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.6 m -57.3 -34.94 69.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.235 -0.915 . . . . 0.0 110.941 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.668 HG12 HD13 ' A' ' 56' ' ' LEU . 58.9 t -73.59 -26.71 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.261 -0.9 . . . . 0.0 110.417 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.734 ' HA ' HD11 ' A' ' 56' ' ' LEU . 18.9 mmt180 -68.59 -45.75 71.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.202 -0.936 . . . . 0.0 110.476 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 11.8 tm0? -73.81 -58.44 3.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.452 -0.78 . . . . 0.0 111.28 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.905 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -55.25 -53.49 55.41 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.252 -0.905 . . . . 0.0 111.328 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.861 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -52.61 -61.29 2.38 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.134 -0.979 . . . . 0.0 111.147 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -65.49 -13.07 58.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -0.977 . . . . 0.0 110.688 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -83.28 -26.71 30.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -0.989 . . . . 0.0 110.743 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.07 -7.64 0.39 Allowed Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.326 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.905 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -50.95 142.46 11.84 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.842 -1.387 . . . . 0.0 110.77 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.647 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 27.0 t70 -72.83 125.33 91.21 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 110.21 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.65 -21.05 22.43 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.573 1.302 . . . . 0.0 110.765 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.37 26.31 10.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.262 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.647 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -73.37 135.16 44.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.313 -0.867 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.0 mt -84.22 170.13 14.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.833 . . . . 0.0 110.149 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.526 ' OD1' HG21 ' A' ' 45' ' ' VAL . 2.5 t-20 -106.94 -168.47 1.41 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.417 -0.802 . . . . 0.0 110.167 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -77.92 -23.44 48.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.389 -0.819 . . . . 0.0 110.27 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -96.28 25.38 4.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.315 -0.865 . . . . 0.0 110.095 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.54 32.09 37.98 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.05 -156.57 0.55 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.446 -1.032 . . . . 0.0 110.283 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.617 ' O ' HG12 ' A' ' 45' ' ' VAL . 28.0 mmt-85 -110.49 170.29 5.46 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 0.0 109.598 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HB2' HD22 ' A' ' 57' ' ' LEU . 41.0 Cg_endo -68.01 -21.67 42.87 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.484 1.254 . . . . 0.0 110.334 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.564 ' O ' ' HG2' ' A' ' 46' ' ' MET . 73.4 mt -107.67 -44.1 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.272 -0.892 . . . . 0.0 109.703 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.58 -22.54 3.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.155 -0.966 . . . . 0.0 110.501 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.772 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 7.1 p -105.29 25.73 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 110.798 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.906 ' HE2' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -95.83 165.63 12.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -0.999 . . . . 0.0 109.891 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.411 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 9.5 tmm? -61.06 -13.17 15.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.275 -0.891 . . . . 0.0 110.677 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 23.0 mmt 55.3 23.23 5.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.256 -0.902 . . . . 0.0 110.327 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.37 -19.71 5.74 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.416 ' HB3' ' CG2' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -118.15 105.77 12.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -1.156 . . . . 0.0 110.341 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' ' 86' ' ' ASP . . . -59.36 -22.42 61.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.872 . . . . 0.0 110.598 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.796 ' HB2' ' CG2' ' A' ' 19' ' ' VAL . 3.4 mm-40 -61.46 -18.16 57.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.833 HG23 HG22 ' A' ' 19' ' ' VAL . 88.4 t -86.26 -41.7 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.714 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.906 ' HB2' ' HE2' ' A' ' 46' ' ' MET . . . -72.45 -25.31 61.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.502 -0.749 . . . . 0.0 110.166 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HA ' HG11 ' A' ' 90' ' ' VAL . 7.7 tm-20 -79.03 -43.94 23.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.375 -0.828 . . . . 0.0 110.346 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.734 HD11 ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -59.06 -63.06 1.44 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.372 -0.83 . . . . 0.0 110.481 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.801 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 4.0 mt -52.52 -48.76 65.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.445 -0.784 . . . . 0.0 110.679 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -58.11 -38.65 76.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.35 -0.844 . . . . 0.0 110.213 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.85 -33.69 76.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -0.834 . . . . 0.0 110.188 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.461 ' CE1' ' HG ' ' A' ' 26' ' ' LEU . 12.5 m170 -84.69 -63.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.013 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.26 54.38 0.03 OUTLIER Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -69.76 -158.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -1.115 . . . . 0.0 110.112 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -126.71 71.87 74.01 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.368 -0.833 . . . . 0.0 109.988 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . 49.6 Cg_endo -79.43 -21.36 8.93 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.809 1.426 . . . . 0.0 110.59 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -89.33 -52.55 4.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.857 . . . . 0.0 110.31 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 166.42 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.34 -0.85 . . . . 0.0 110.481 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.54 -167.75 2.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 0.0 110.198 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 70' ' ' ALA . 7.4 t70 -86.77 127.23 60.89 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.094 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.76 -25.28 14.76 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.573 1.302 . . . . 0.0 110.378 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . . . -63.66 -51.43 65.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.372 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.806 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -124.78 26.63 7.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 110.463 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 44.17 37.73 2.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.334 -0.854 . . . . 0.0 110.959 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.5 125.67 42.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.298 -0.876 . . . . 0.0 110.559 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.594 ' HD2' ' HB ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -94.4 -175.99 0.52 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 110.144 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 47.7 Cg_endo -75.81 -35.45 2.59 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.386 1.203 . . . . 0.0 111.622 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.628 ' CG1' HD23 ' A' ' 98' ' ' LEU . 93.5 t -52.92 -31.61 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.049 -1.032 . . . . 0.0 110.301 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CE1' ' HB3' ' A' ' 108' ' ' PRO . 14.8 m80 -62.29 -44.34 96.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 109.969 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.68 -49.23 66.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.386 -0.821 . . . . 0.0 110.082 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.639 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -53.89 -28.44 36.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.862 . . . . 0.0 110.109 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.01 -30.31 22.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.384 -0.823 . . . . 0.0 109.805 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.413 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 2.5 mmt85 -61.0 -24.62 66.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.462 -0.774 . . . . 0.0 110.235 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -100.58 -27.27 13.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 110.416 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.73 35.35 6.88 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.65 ' HD1' ' HB2' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -98.68 94.64 6.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.446 -1.032 . . . . 0.0 110.251 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.885 HD22 HD12 ' A' ' 120' ' ' ILE . 3.5 mm? -64.75 -25.67 68.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.356 -0.84 . . . . 0.0 110.524 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.669 ' O ' HG23 ' A' ' 90' ' ' VAL . 2.9 m-20 -61.66 -56.36 20.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.192 -0.942 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.527 HG23 ' CB ' ' A' ' 54' ' ' ALA . 23.1 m -57.6 -42.77 83.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.241 -0.912 . . . . 0.0 109.991 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.99 HD13 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -57.68 -44.42 85.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.772 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 85' ' ' LEU . 86.9 t -63.84 -42.51 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 0.0 109.003 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 86' ' ' ASP . 93.4 t -57.21 -46.18 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.647 -0.658 . . . . 0.0 109.981 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.672 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 5.6 mp -61.8 -47.04 86.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.418 -0.801 . . . . 0.0 109.929 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.414 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 2.7 t-160 -66.34 -26.25 67.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 110.165 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -68.38 -30.67 69.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 110.267 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB3' HD11 ' A' ' 58' ' ' LEU . . . -114.47 41.84 2.23 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.361 -0.837 . . . . 0.0 110.406 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.33 109.97 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . -149.01 105.46 3.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -1.085 . . . . 0.0 110.722 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.509 ' O ' ' NE ' ' A' ' 74' ' ' ARG . 0.3 OUTLIER -58.91 107.28 0.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.395 -0.816 . . . . 0.0 109.133 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 128' ' ' THR . 1.1 mt -104.14 23.62 12.73 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.166 -0.959 . . . . 0.0 110.347 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.422 ' HA ' HG23 ' A' ' 128' ' ' THR . 18.8 t0 -126.95 17.64 7.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.852 . . . . 0.0 110.499 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 74' ' ' ARG . 3.4 p -67.98 162.0 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 109.81 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.7 m -100.64 137.17 39.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 104' ' ' TRP . 13.0 t70 -73.71 60.69 0.71 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 110.294 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 58.17 -79.6 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.591 -0.693 . . . . 0.0 110.655 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.471 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.9 OUTLIER -53.76 -42.92 68.73 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.269 -0.894 . . . . 0.0 110.115 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 146.25 -18.94 1.72 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.28 123.98 15.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.209 -1.171 . . . . 0.0 110.518 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.451 ' O ' HD12 ' A' ' 111' ' ' LEU . 22.1 mt -79.85 168.32 27.03 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.809 . . . . 0.0 109.891 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.0 Cg_endo -69.13 -25.51 31.45 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.684 1.36 . . . . 0.0 110.39 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.433 ' HA ' HD13 ' A' ' 124' ' ' LEU . 10.8 p -82.09 -23.13 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.0 110.14 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -67.07 -43.29 82.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.381 -0.824 . . . . 0.0 110.202 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 107' ' ' LEU . 0.5 OUTLIER -59.08 -31.66 69.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -0.829 . . . . 0.0 110.151 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HB1' HG22 ' A' ' 120' ' ' ILE . . . -64.86 -65.26 0.7 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.415 -0.803 . . . . 0.0 110.109 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -51.94 -26.31 10.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.457 -0.777 . . . . 0.0 110.567 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -43.35 16.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.342 -0.848 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -77.21 -77.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.27 -0.894 . . . . 0.0 110.181 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 165.12 43.83 0.02 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.413 ' CE1' ' O ' ' A' ' 81' ' ' ARG . 24.1 m80 -117.5 60.14 0.77 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.331 -1.099 . . . . 0.0 109.782 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -50.41 -29.64 10.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.32 -0.863 . . . . 0.0 110.568 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -69.99 -39.13 76.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.99 HD11 HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -75.41 -35.08 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.264 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.73 -29.27 70.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 110.026 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -73.74 -55.19 6.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.326 -0.859 . . . . 0.0 110.044 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -36.38 83.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.317 -0.865 . . . . 0.0 110.09 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.615 HD12 HG23 ' A' ' 120' ' ' ILE . 16.8 mt -59.03 -62.44 1.88 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.376 -0.828 . . . . 0.0 110.283 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -51.01 -26.27 5.87 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.339 -0.851 . . . . 0.0 110.315 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.17 -38.51 51.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 110.136 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -112.67 29.1 8.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.87 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 98' ' ' LEU . 95.7 m . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 109.876 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.89 0 CA-C-O 121.227 0.537 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -138.88 -48.64 0.5 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -0.959 . . . . 0.0 109.958 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.63 -22.02 58.78 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 1.036 HD12 HG13 ' A' ' 22' ' ' VAL . 27.3 tp -67.27 -49.62 63.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -1.023 . . . . 0.0 110.314 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.8 -49.55 24.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 110.62 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.8 p -58.15 -49.18 77.91 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.298 -0.876 . . . . 0.0 110.623 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -60.46 -38.41 84.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.204 -0.935 . . . . 0.0 110.184 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.479 ' HA ' HG11 ' A' ' 53' ' ' VAL . . . -62.96 -29.94 71.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.35 -0.844 . . . . 0.0 110.033 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.742 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -83.35 -33.45 25.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.336 -0.853 . . . . 0.0 110.047 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -75.91 -24.9 55.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.168 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.98 45.12 1.8 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.472 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -119.86 96.84 5.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -1.069 . . . . 0.0 110.001 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.743 ' CG2' ' HB2' ' A' ' 52' ' ' GLN . 38.4 t -76.76 -39.32 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.473 -0.767 . . . . 0.0 110.163 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.78 -46.0 90.56 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.276 -0.89 . . . . 0.0 110.757 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.2 m -64.6 -42.28 95.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.344 -0.847 . . . . 0.0 110.577 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 1.036 HG13 HD12 ' A' ' 10' ' ' LEU . 65.1 t -70.28 -45.24 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.284 -0.885 . . . . 0.0 110.501 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.593 ' CA ' HD21 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -59.29 -39.89 84.42 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.722 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.521 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -72.76 -44.2 61.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.365 -0.834 . . . . 0.0 110.783 -179.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.964 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.6 OUTLIER -63.62 -48.03 78.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.236 -0.915 . . . . 0.0 110.689 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.565 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 3.1 mt -54.11 -63.99 0.97 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.283 -0.886 . . . . 0.0 110.602 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -16.22 40.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 0.0 110.305 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -84.2 -37.91 21.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.873 . . . . 0.0 110.543 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.71 -23.63 0.09 OUTLIER Glycine 0 N--CA 1.484 1.843 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.745 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.964 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -48.05 124.82 8.12 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.092 -1.24 . . . . 0.0 110.997 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.37 126.92 70.51 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 109.955 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.53 -9.72 20.13 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.606 1.319 . . . . 0.0 110.864 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.12 29.55 7.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.118 -0.989 . . . . 0.0 110.257 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.17 103.48 9.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 0.0 110.26 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 35' ' ' LEU . 2.4 pp -84.53 145.65 27.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.478 ' O ' HD12 ' A' ' 35' ' ' LEU . 62.8 m-80 -104.42 -154.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.424 -0.797 . . . . 0.0 109.814 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 38' ' ' PHE . 2.0 ptp180 -57.95 -171.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 110.252 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER 66.66 1.94 2.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.438 -0.789 . . . . 0.0 111.268 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 45.85 31.98 4.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.77 -168.54 1.54 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -1.15 . . . . 0.0 110.662 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.716 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -118.27 177.67 1.24 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 0.0 109.391 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.716 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 43.4 Cg_endo -70.53 -19.29 32.62 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.383 1.202 . . . . 0.0 110.847 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 46' ' ' MET . 53.5 mt -115.01 -34.83 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.134 -0.979 . . . . 0.0 110.001 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 41' ' ' ARG . 17.8 tt0 -53.43 -29.11 33.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.066 -1.021 . . . . 0.0 110.144 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 15' ' ' ALA . 11.8 p -92.85 -2.76 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.407 -0.808 . . . . 0.0 110.339 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.841 ' HE1' ' HB2' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -56.05 154.54 7.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.398 -0.814 . . . . 0.0 110.345 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -70.97 -6.9 42.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 110.149 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.633 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 23.4 mmt 53.59 25.25 4.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.9 . . . . 0.0 110.411 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -118.03 -11.7 8.16 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 m -129.51 113.45 14.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -1.163 . . . . 0.0 110.296 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -64.53 -13.9 54.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.429 -0.794 . . . . 0.0 110.598 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.743 ' HB2' ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -73.08 -22.93 60.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.216 -0.928 . . . . 0.0 109.821 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.549 ' CG2' HG22 ' A' ' 19' ' ' VAL . 22.0 t -84.2 -36.84 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.149 -0.969 . . . . 0.0 110.188 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.841 ' HB2' ' HE1' ' A' ' 46' ' ' MET . . . -70.35 -57.14 5.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.421 -0.799 . . . . 0.0 110.299 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -59.32 -45.82 90.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.439 -0.788 . . . . 0.0 110.474 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.593 HD21 ' CA ' ' A' ' 23' ' ' ARG . 52.1 tp -52.63 -52.63 54.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.371 -0.83 . . . . 0.0 110.666 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.811 HD21 HD11 ' A' ' 10' ' ' LEU . 7.6 mt -69.89 -30.39 67.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.262 -0.899 . . . . 0.0 110.854 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.506 HD22 ' CB ' ' A' ' 94' ' ' ALA . 1.1 tt -75.72 -55.23 5.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.178 -0.951 . . . . 0.0 110.944 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.704 HD11 ' CD2' ' A' ' 60' ' ' HIS . 3.1 pp -54.07 -28.5 39.3 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.136 -0.978 . . . . 0.0 110.07 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.704 ' CD2' HD11 ' A' ' 59' ' ' LEU . 3.0 m-70 -75.61 -56.87 4.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.359 -0.838 . . . . 0.0 109.821 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.49 44.61 0.02 OUTLIER Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 57' ' ' LEU . . . -76.27 -169.55 1.21 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.335 -1.097 . . . . 0.0 110.62 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -115.38 80.83 7.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.77 -27.0 9.19 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.854 1.45 . . . . 0.0 110.325 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -93.08 -41.44 9.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 110.081 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 151.37 7.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.273 -0.892 . . . . 0.0 110.277 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.512 ' HB2' ' NE ' ' A' ' 74' ' ' ARG . . . -143.87 -172.72 3.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.416 -0.802 . . . . 0.0 110.565 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.495 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 15.5 t0 -89.69 125.07 62.34 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.33 -21.55 19.8 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.484 1.255 . . . . 0.0 110.62 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.24 -20.89 65.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 110.678 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.726 HG23 ' OG1' ' A' ' 73' ' ' THR . 5.3 t -158.42 22.03 0.23 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.027 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.4 mt 44.05 65.29 1.06 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.306 -0.871 . . . . 0.0 110.403 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.726 ' OG1' HG23 ' A' ' 71' ' ' THR . 0.1 OUTLIER -119.21 103.23 9.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.092 -1.005 . . . . 0.0 111.156 -178.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.907 ' HB2' HG11 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -75.29 169.65 19.4 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.728 . . . . 0.0 109.197 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.497 ' HD2' ' CG ' ' A' ' 74' ' ' ARG . 46.7 Cg_endo -74.49 -4.34 15.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.458 1.241 . . . . 0.0 110.904 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.684 HG13 HD23 ' A' ' 98' ' ' LEU . 62.6 t -71.84 -35.39 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.211 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.67 ' HE1' HG13 ' A' ' 100' ' ' VAL . 56.8 m80 -62.16 -43.17 99.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 110.331 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.633 ' HB2' ' HE3' ' A' ' 48' ' ' MET . 50.5 m-20 -56.33 -57.98 9.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.477 -0.764 . . . . 0.0 110.438 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.87 -28.25 65.95 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.284 -0.885 . . . . 0.0 109.876 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.52 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -79.94 -27.9 39.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 110.032 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -71.9 -23.42 61.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.826 . . . . 0.0 110.367 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -97.08 -44.52 6.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.368 -0.832 . . . . 0.0 110.227 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.85 29.62 3.03 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.458 ' CZ ' ' CA ' ' A' ' 84' ' ' PHE . 4.3 t80 -93.61 91.8 7.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.43 -1.041 . . . . 0.0 110.224 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' A' ' 123' ' ' TYR . 1.5 mt -62.22 -27.85 69.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.333 -0.855 . . . . 0.0 109.863 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.726 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.3 t0 -59.07 -54.44 47.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.397 -0.815 . . . . 0.0 110.348 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.473 HG23 ' HB1' ' A' ' 54' ' ' ALA . 29.9 m -61.46 -35.19 76.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.326 -0.859 . . . . 0.0 109.962 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.811 HD22 HG13 ' A' ' 120' ' ' ILE . 5.7 tp -59.53 -51.97 67.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.212 -0.93 . . . . 0.0 109.776 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.78 -45.01 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 109.269 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 86' ' ' ASP . 96.4 t -50.48 -46.47 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.614 -0.679 . . . . 0.0 110.452 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.498 ' HA ' HD11 ' A' ' 58' ' ' LEU . 1.3 mp -65.01 -57.35 8.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 110.088 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -63.68 -17.43 62.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 110.36 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -87.78 -13.88 41.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 0.0 110.615 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.506 ' CB ' HD22 ' A' ' 58' ' ' LEU . . . -133.46 49.57 2.28 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.186 -0.946 . . . . 0.0 110.512 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.64 108.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -168.63 104.98 0.43 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -1.101 . . . . 0.0 110.248 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -68.04 108.7 3.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.418 -0.802 . . . . 0.0 110.071 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.795 HD13 ' HB1' ' A' ' 127' ' ' ALA . 1.4 mp -93.18 -21.58 19.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.313 -0.867 . . . . 0.0 110.449 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.663 ' HA ' HG23 ' A' ' 128' ' ' THR . 6.1 p-10 -70.4 72.71 0.49 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.907 HG11 ' HB2' ' A' ' 74' ' ' ARG . 7.5 p -143.37 161.18 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -0.86 . . . . 0.0 110.341 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.423 ' N ' HG22 ' A' ' 100' ' ' VAL . 13.3 p -128.6 147.33 50.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.51 -0.744 . . . . 0.0 109.422 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 104' ' ' TRP . 5.1 p-10 -69.86 65.3 0.23 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.254 -0.904 . . . . 0.0 110.607 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.714 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 56.66 -81.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.688 -0.632 . . . . 0.0 111.097 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.467 ' N ' ' O ' ' A' ' 102' ' ' ASP . 8.2 m-90 -91.52 43.98 1.16 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.265 -0.897 . . . . 0.0 110.359 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.54 -162.62 10.15 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.506 ' O ' ' CD1' ' A' ' 107' ' ' LEU . 10.5 mtm180 -120.79 -51.45 2.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.395 -1.062 . . . . 0.0 110.259 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.817 ' HG ' ' HD2' ' A' ' 108' ' ' PRO . 2.0 tp -174.13 162.72 2.91 Favored Pre-proline 0 N--CA 1.497 1.884 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.817 ' HD2' ' HG ' ' A' ' 107' ' ' LEU . 42.8 Cg_endo -70.39 -31.54 17.53 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.026 1.014 . . . . 0.0 110.24 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.624 HG12 ' HB3' ' A' ' 107' ' ' LEU . 7.4 p -62.05 -21.03 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 109.648 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -77.56 -45.29 25.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.383 -0.823 . . . . 0.0 109.621 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.59 -26.85 62.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.743 ' HB1' ' O ' ' A' ' 117' ' ' HIS . . . -78.0 -50.13 12.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.507 -0.746 . . . . 0.0 109.962 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -52.77 -23.28 6.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.478 -0.763 . . . . 0.0 110.898 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -94.63 -54.12 3.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.262 -0.899 . . . . 0.0 110.667 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -59.73 -95.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.254 -0.904 . . . . 0.0 110.435 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -170.29 31.79 0.15 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.743 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 9.0 m-70 -117.03 79.47 1.34 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -1.035 . . . . 0.0 109.536 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 30.0 mmt85 -81.32 -40.54 23.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.386 -0.821 . . . . 0.0 110.167 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.4 -54.45 43.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.307 -0.871 . . . . 0.0 109.702 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.811 HG13 HD22 ' A' ' 88' ' ' LEU . 10.0 tt -60.13 -34.75 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.468 -0.77 . . . . 0.0 109.359 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 118' ' ' ARG . . . -61.7 -39.42 91.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.658 -0.651 . . . . 0.0 109.799 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -56.17 -53.21 59.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.392 -0.817 . . . . 0.0 109.571 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.679 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -58.71 -45.19 90.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.357 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.752 ' HG ' HD21 ' A' ' 88' ' ' LEU . 78.3 mt -55.9 -48.53 75.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.435 -0.79 . . . . 0.0 109.928 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -53.5 -27.33 24.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.295 -0.878 . . . . 0.0 110.191 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.19 -38.69 15.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.316 -0.865 . . . . 0.0 110.467 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.795 ' HB1' HD13 ' A' ' 98' ' ' LEU . . . -98.02 10.62 39.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.304 -0.872 . . . . 0.0 110.783 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.784 HG22 HD21 ' A' ' 107' ' ' LEU . 7.4 m . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 110.365 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 . . . . . 0 N--CA 1.498 1.961 0 CA-C-O 121.086 0.47 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.8 -22.07 1.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 110.835 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -53.91 -32.58 48.9 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.959 HD13 HD11 ' A' ' 57' ' ' LEU . 3.8 pp -61.23 -27.69 68.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.444 -1.033 . . . . 0.0 110.09 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.456 ' N ' HD12 ' A' ' 10' ' ' LEU . . . -83.4 -50.7 8.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.412 -0.805 . . . . 0.0 110.257 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.2 p -63.18 -50.17 71.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.421 -0.8 . . . . 0.0 110.08 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -58.5 -40.8 83.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.342 -0.849 . . . . 0.0 109.769 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -61.01 -38.93 87.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.038 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 45' ' ' VAL . . . -60.73 -32.6 71.87 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.309 -0.869 . . . . 0.0 110.168 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.87 15.43 11.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.394 -0.816 . . . . 0.0 110.543 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.47 52.97 49.3 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -119.67 72.26 0.91 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -1.102 . . . . 0.0 110.536 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.909 HG21 ' HB3' ' A' ' 52' ' ' GLN . 58.0 t -56.96 -35.69 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.048 -1.032 . . . . 0.0 109.496 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -59.62 -54.95 40.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.557 -0.715 . . . . 0.0 109.988 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 84.0 m -56.92 -38.3 72.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.438 -0.789 . . . . 0.0 110.129 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.534 HG12 HD12 ' A' ' 26' ' ' LEU . 57.7 t -79.76 -22.05 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 110.475 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.54 ' HA ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -62.65 -45.87 90.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.163 -0.961 . . . . 0.0 110.422 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 24.7 tt0 -76.41 -51.22 12.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.46 -0.775 . . . . 0.0 111.408 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 25' ' ' LEU . 4.0 mt -51.2 -62.06 1.85 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.989 . . . . 0.0 111.227 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.665 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 2.0 mt -53.56 -46.82 70.38 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.15 -0.969 . . . . 0.0 111.365 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.66 9.34 7.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.06 -1.025 . . . . 0.0 110.962 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -114.47 -31.33 6.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.68 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.35 -27.81 0.08 OUTLIER Glycine 0 N--CA 1.484 1.849 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.598 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.808 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -48.22 128.65 14.5 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.136 -1.214 . . . . 0.0 110.758 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.793 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -74.22 145.36 82.97 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.397 -0.814 . . . . 0.0 110.301 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . 0.415 ' HB3' ' HB3' ' A' ' 60' ' ' HIS . 48.9 Cg_endo -76.98 -25.97 8.34 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.753 1.396 . . . . 0.0 110.784 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -114.44 32.38 5.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.324 -0.86 . . . . 0.0 110.403 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.793 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -89.8 96.87 10.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.354 -0.841 . . . . 0.0 110.281 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.94 HD13 ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -71.62 157.69 37.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.32 -0.862 . . . . 0.0 110.083 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.838 ' N ' HD22 ' A' ' 35' ' ' LEU . 47.7 p30 -112.9 173.83 6.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.121 -0.987 . . . . 0.0 110.97 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -49.73 -26.9 4.2 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.368 -0.832 . . . . 0.0 110.608 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -11.93 60.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.28 -0.887 . . . . 0.0 109.887 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.658 ' HA2' HD23 ' A' ' 35' ' ' LEU . . . 52.21 25.61 18.86 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.41 ' HG2' ' HB3' ' A' ' 44' ' ' GLN . 17.8 ttt180 -93.99 1.2 56.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -1.014 . . . . 0.0 110.227 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 55.89 171.45 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.25 -0.906 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.634 ' HB2' HD12 ' A' ' 57' ' ' LEU . 45.7 Cg_endo -72.65 169.44 21.89 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.534 1.281 . . . . 0.0 110.724 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.583 ' HA ' ' HG2' ' A' ' 46' ' ' MET . 30.7 mt 62.95 -60.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.821 -0.549 . . . . 0.0 111.017 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -43.12 -29.2 0.35 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.879 -1.138 . . . . 0.0 110.793 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 45' ' ' VAL . 11.0 p -113.79 35.55 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 0.0 109.942 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.828 ' CE ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -110.46 171.86 7.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.256 -0.903 . . . . 0.0 110.267 -179.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 8.5 ttp -73.45 98.91 2.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.319 -0.863 . . . . 0.0 108.685 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.488 ' O ' ' CD2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -61.73 -6.16 2.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 111.138 -179.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.5 20.78 32.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.618 ' N ' ' HD2' ' A' ' 84' ' ' PHE . 27.9 t -154.06 109.05 3.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -1.129 . . . . 0.0 110.227 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.676 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . . . -66.25 -29.54 69.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.404 -0.81 . . . . 0.0 110.033 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.909 ' HB3' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -51.35 -32.88 27.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.543 -0.723 . . . . 0.0 110.297 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.495 HG11 ' HB2' ' A' ' 46' ' ' MET . 41.2 t -75.17 -47.94 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.359 -0.838 . . . . 0.0 110.053 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.849 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -70.56 -23.44 62.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.399 -0.813 . . . . 0.0 110.158 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.522 ' HA ' HG11 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -66.71 -53.1 37.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.361 -0.837 . . . . 0.0 110.689 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.54 HD11 ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -61.58 -57.11 13.37 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.909 . . . . 0.0 110.647 -179.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.959 HD11 HD13 ' A' ' 10' ' ' LEU . 2.8 mm? -47.36 -50.37 22.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 110.97 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.033 HD23 HG12 ' A' ' 90' ' ' VAL . 60.5 tp -70.68 -24.7 62.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.406 -0.809 . . . . 0.0 110.544 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.1 tp -67.67 -41.28 83.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 109.982 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.518 ' ND1' HD22 ' A' ' 26' ' ' LEU . 12.0 m170 -78.91 -30.89 45.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.348 -0.845 . . . . 0.0 109.864 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.42 54.89 0.07 OUTLIER Glycine 0 N--CA 1.482 1.758 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.484 ' HB2' ' C ' ' A' ' 57' ' ' LEU . . . -69.83 -168.3 0.19 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.273 -1.133 . . . . 0.0 110.051 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -117.21 78.52 10.36 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.853 . . . . 0.0 110.007 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.78 -27.47 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.719 1.378 . . . . 0.0 110.417 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -87.55 -59.27 2.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.433 -0.792 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.1 168.59 0.13 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.308 -0.87 . . . . 0.0 110.444 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 74' ' ' ARG . . . -167.93 -158.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.875 . . . . 0.0 110.734 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -79.7 123.85 83.81 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.499 -0.75 . . . . 0.0 110.292 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.39 -24.11 14.54 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.549 1.289 . . . . 0.0 110.401 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.39 -46.24 86.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -0.892 . . . . 0.0 110.424 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.783 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 41.9 p -146.65 68.69 1.17 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 110.355 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.604 ' C ' ' O ' ' A' ' 71' ' ' THR . 13.9 mt 5.41 86.75 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.933 -0.479 . . . . 0.0 112.175 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.05 83.57 2.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 110.363 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.756 ' HD3' HG21 ' A' ' 100' ' ' VAL . 5.2 mpt_? -61.51 161.31 20.11 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.481 -0.762 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.36 -18.74 29.68 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.855 1.45 . . . . 0.0 110.422 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.88 -32.13 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.35 -0.844 . . . . 0.0 109.997 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.498 ' HE1' HG13 ' A' ' 100' ' ' VAL . 64.0 m80 -64.63 -41.72 95.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 110.34 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -70.31 -48.44 56.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.355 -0.841 . . . . 0.0 110.416 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.36 -29.18 14.58 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.293 -0.879 . . . . 0.0 110.448 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.899 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -96.55 -27.92 14.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.4 -0.812 . . . . 0.0 109.796 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -53.47 -28.43 30.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.402 -0.811 . . . . 0.0 109.765 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -99.5 -28.44 13.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.814 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.69 44.92 2.03 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.618 ' HD2' ' N ' ' A' ' 50' ' ' SER . 12.7 t80 -108.0 96.43 6.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.368 -1.078 . . . . 0.0 110.046 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.765 ' CD2' HD13 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -72.25 -24.29 61.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.516 -0.74 . . . . 0.0 110.663 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.676 ' HB2' ' HB2' ' A' ' 51' ' ' ALA . 63.9 m-20 -59.67 -54.35 47.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.407 -0.808 . . . . 0.0 110.499 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.849 HG23 ' CB ' ' A' ' 54' ' ' ALA . 90.9 m -61.2 -36.75 80.72 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.094 -1.004 . . . . 0.0 110.157 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -57.54 -48.79 78.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.318 -0.864 . . . . 0.0 110.252 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 85' ' ' LEU . 96.0 t -59.66 -50.95 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 109.914 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 1.033 HG12 HD23 ' A' ' 58' ' ' LEU . 85.1 t -54.27 -45.57 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.838 . . . . 0.0 110.221 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.547 HD13 HG22 ' A' ' 87' ' ' THR . 0.4 OUTLIER -57.23 -56.06 26.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.39 -0.819 . . . . 0.0 110.35 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -64.32 -23.32 67.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.446 -0.784 . . . . 0.0 110.657 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -78.77 -33.75 46.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.202 -0.936 . . . . 0.0 110.575 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.987 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -98.12 39.69 1.22 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.322 -0.862 . . . . 0.0 111.012 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.55 108.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.412 ' O ' HD11 ' A' ' 98' ' ' LEU . . . -168.31 132.45 1.62 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.532 -0.981 . . . . 0.0 110.05 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.55 140.01 42.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.242 -0.911 . . . . 0.0 110.071 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.808 ' O ' HG22 ' A' ' 128' ' ' THR . 2.4 mp -128.31 19.49 6.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.315 -0.866 . . . . 0.0 110.48 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.437 ' HB3' ' HA ' ' A' ' 128' ' ' THR . 4.3 p30 -123.29 55.87 1.2 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.151 -0.968 . . . . 0.0 110.421 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.756 HG21 ' HD3' ' A' ' 74' ' ' ARG . 12.6 p -112.76 164.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.383 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.43 ' N ' HG22 ' A' ' 100' ' ' VAL . 98.8 m -106.47 150.88 25.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.474 -0.767 . . . . 0.0 109.802 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.562 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 22.6 t70 -78.89 58.87 2.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.324 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.783 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 64.69 -71.97 0.07 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.519 -0.738 . . . . 0.0 110.719 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.431 ' N ' ' O ' ' A' ' 102' ' ' ASP . 2.1 m95 -65.49 -56.09 14.28 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.413 -0.804 . . . . 0.0 110.443 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.578 ' O ' HD12 ' A' ' 107' ' ' LEU . . . 168.63 -28.15 0.14 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.01 105.79 0.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.237 -1.155 . . . . 0.0 110.423 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -73.62 170.64 13.4 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.277 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.3 -43.19 0.74 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.738 1.388 . . . . 0.0 110.425 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.487 HG23 ' HA ' ' A' ' 121' ' ' ALA . 9.9 p -58.97 -36.02 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.35 -0.844 . . . . 0.0 110.115 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.442 ' N ' HG13 ' A' ' 109' ' ' VAL . 2.5 m-20 -66.06 -45.8 80.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.441 -0.787 . . . . 0.0 110.187 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 111' ' ' LEU . 4.0 tt -60.84 -27.74 68.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.222 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.3 -63.98 0.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 0.0 110.137 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -53.99 -23.63 13.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.92 -40.66 78.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.676 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.426 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 0.9 OUTLIER -91.29 5.32 49.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.228 -0.92 . . . . 0.0 110.77 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.63 37.06 8.92 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.465 ' HB3' ' CG1' ' A' ' 120' ' ' ILE . 23.9 m-70 -113.09 55.34 0.7 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -1.102 . . . . 0.0 109.791 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.96 -30.5 24.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.435 -0.791 . . . . 0.0 109.988 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -62.39 -40.62 97.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.735 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.899 HG21 ' CB ' ' A' ' 80' ' ' ALA . 4.1 mm -75.87 -36.28 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.509 -0.744 . . . . 0.0 109.601 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.487 ' HA ' HG23 ' A' ' 109' ' ' VAL . . . -64.33 -59.11 4.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 111.178 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 123' ' ' TYR . 14.2 ptm180 -53.99 -41.27 67.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.007 -1.058 . . . . 0.0 110.133 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.408 ' N ' ' HG3' ' A' ' 122' ' ' ARG . 11.7 t80 -68.86 -42.48 76.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.227 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.722 ' O ' HG23 ' A' ' 128' ' ' THR . 21.2 mt -66.24 -47.56 73.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.475 -0.766 . . . . 0.0 109.741 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -50.24 -32.11 15.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.411 -0.806 . . . . 0.0 110.333 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.49 -27.0 46.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.737 . . . . 0.0 110.293 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.497 ' HB1' HD13 ' A' ' 98' ' ' LEU . . . -102.73 -11.45 18.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.342 -0.849 . . . . 0.0 110.85 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 98' ' ' LEU . 73.2 p . . . . . 0 N--CA 1.494 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 110.48 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 68.3 m-20 . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.135 0.493 . . . . 0.0 110.019 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.45 -19.53 62.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.761 . . . . 0.0 110.048 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.34 -25.95 55.57 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.828 HD11 ' HB1' ' A' ' 30' ' ' ALA . 80.7 mt -64.15 -37.41 87.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.404 -1.057 . . . . 0.0 110.178 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.28 -49.03 14.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.286 -0.884 . . . . 0.0 110.107 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.9 p -56.39 -54.93 39.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.419 -0.801 . . . . 0.0 110.267 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.55 74.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.0 110.071 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.511 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -73.7 -43.75 58.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 110.134 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 45' ' ' VAL . . . -61.44 -28.53 69.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.386 -0.821 . . . . 0.0 110.189 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -72.84 -27.77 62.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.409 -0.807 . . . . 0.0 110.159 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.34 28.04 4.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -106.65 143.0 35.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.379 -1.071 . . . . 0.0 110.483 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.747 HG11 ' HB3' ' A' ' 52' ' ' GLN . 95.0 t -109.53 -54.42 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.442 -0.787 . . . . 0.0 109.9 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -54.9 -32.54 61.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.51 -0.744 . . . . 0.0 110.418 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 m -62.07 -60.89 2.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 110.292 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.443 HG13 ' CD2' ' A' ' 10' ' ' LEU . 58.3 t -61.49 -27.51 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.27 -0.894 . . . . 0.0 110.146 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HD2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.1 -43.44 82.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 110.161 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -63.31 -38.47 91.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.587 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.17 -44.68 68.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.0 110.619 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.499 HD22 ' CG ' ' A' ' 60' ' ' HIS . 14.2 mt -65.88 -57.0 8.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.311 -0.868 . . . . 0.0 110.481 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.84 -25.29 18.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.233 -0.917 . . . . 0.0 110.097 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.55 -67.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 110.046 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.88 47.21 0.06 OUTLIER Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.828 ' HB1' HD11 ' A' ' 10' ' ' LEU . . . -85.93 169.79 12.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -1.143 . . . . 0.0 110.175 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.782 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 7.3 t70 -89.85 125.37 61.09 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.95 -17.46 25.18 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.603 1.318 . . . . 0.0 110.649 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.32 39.86 3.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 110.062 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.782 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -71.91 109.79 5.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.403 -0.81 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 36' ' ' ASN . 1.9 tm? -72.83 99.26 2.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.309 -0.87 . . . . 0.0 109.744 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.553 ' O ' HD13 ' A' ' 35' ' ' LEU . 33.9 m120 -54.82 -179.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.468 -0.77 . . . . 0.0 110.439 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -93.94 22.7 5.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.894 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 64.8 m-85 -111.8 21.57 15.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.202 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.74 26.9 26.47 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -131.2 -168.71 2.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.381 -1.07 . . . . 0.0 110.393 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.67 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.2 mmt180 -104.16 176.19 1.88 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.47 -0.769 . . . . 0.0 109.421 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 42.9 Cg_endo -69.76 -19.49 36.08 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.273 1.144 . . . . 0.0 110.648 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.463 ' O ' ' HG2' ' A' ' 46' ' ' MET . 44.7 mt -104.17 -27.94 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 109.775 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.32 -19.68 56.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.094 -1.004 . . . . 0.0 109.875 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.638 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 14.4 p -126.75 35.7 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.232 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.487 ' CE ' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -96.16 31.59 2.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.259 -0.9 . . . . 0.0 110.298 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.473 ' CB ' ' O ' ' A' ' 46' ' ' MET . 4.8 tmm? 72.15 -18.08 0.34 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.557 -0.714 . . . . 0.0 111.208 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.44 ' CE ' ' HB3' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 50.43 26.2 2.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.019 -1.05 . . . . 0.0 110.679 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -125.32 28.88 4.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.11 100.87 0.75 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.318 -1.107 . . . . 0.0 110.312 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.436 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -59.52 -26.96 65.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.301 -0.874 . . . . 0.0 110.063 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.747 ' HB3' HG11 ' A' ' 19' ' ' VAL . 5.7 mm-40 -55.04 -29.39 57.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.488 -0.757 . . . . 0.0 110.591 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.564 HG23 HG22 ' A' ' 19' ' ' VAL . 55.2 t -88.24 -33.16 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 109.932 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.8 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -64.77 -39.72 94.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.323 -0.86 . . . . 0.0 110.115 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -80.08 -38.68 31.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.341 -0.849 . . . . 0.0 110.559 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.645 HD22 ' HD2' ' A' ' 23' ' ' ARG . 37.5 tp -53.98 -58.04 8.76 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.295 -0.878 . . . . 0.0 110.32 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 8.2 mt -67.15 -28.04 67.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.958 . . . . 0.0 110.21 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.958 HD22 HG13 ' A' ' 90' ' ' VAL . 1.3 tp -66.92 -64.96 0.74 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.332 -0.855 . . . . 0.0 110.637 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.533 HD11 ' ND1' ' A' ' 60' ' ' HIS . 3.9 pp -49.91 -27.78 5.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.266 -0.896 . . . . 0.0 110.315 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.533 ' ND1' HD11 ' A' ' 59' ' ' LEU . 4.3 m80 -77.22 -62.81 1.53 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -0.855 . . . . 0.0 109.788 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 165.56 41.71 0.02 OUTLIER Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -61.17 -170.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.312 -1.111 . . . . 0.0 110.329 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -125.28 73.73 67.3 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.461 -0.774 . . . . 0.0 110.282 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.848 1.446 . . . . 0.0 110.601 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.423 ' HA ' ' NH1' ' A' ' 74' ' ' ARG . 39.3 m-80 -89.93 -50.01 6.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.931 . . . . 0.0 110.725 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.21 172.24 0.22 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.173 -0.954 . . . . 0.0 110.459 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.716 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -156.76 -178.14 7.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.483 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.43 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 4.4 t0 -89.59 116.67 66.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 110.036 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.89 -17.18 32.63 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.61 1.321 . . . . 0.0 110.363 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.26 -24.12 63.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 110.686 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.737 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 2.1 m -150.73 21.48 0.8 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.25 -0.906 . . . . 0.0 110.599 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 103' ' ' ALA . 17.9 mt 49.23 27.64 1.92 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.176 -0.952 . . . . 0.0 110.385 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -84.79 121.9 28.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.422 -0.799 . . . . 0.0 110.722 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.76 ' CG ' HG11 ' A' ' 100' ' ' VAL . 2.2 mtt180 -94.79 173.59 4.35 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 110.003 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 42.1 Cg_endo -68.39 -17.55 44.13 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.654 1.344 . . . . 0.0 110.23 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.1 t -69.96 -32.33 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.363 -0.836 . . . . 0.0 109.605 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.676 ' HE1' HG13 ' A' ' 100' ' ' VAL . 60.7 m80 -67.97 -43.73 78.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.477 -0.764 . . . . 0.0 110.082 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.44 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 0.6 OUTLIER -59.73 -60.63 3.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 0.0 109.648 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.84 -24.34 8.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.478 -0.764 . . . . 0.0 109.624 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.419 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -83.56 -30.11 27.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.523 -0.736 . . . . 0.0 109.613 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -57.35 -35.59 70.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.416 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 8.6 mp0 -98.01 -15.65 19.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.494 -0.754 . . . . 0.0 110.291 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.444 ' HA3' ' CG ' ' A' ' 117' ' ' HIS . . . 76.71 49.33 7.99 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.14 88.42 3.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.378 -1.072 . . . . 0.0 110.037 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.412 HD21 ' CB ' ' A' ' 123' ' ' TYR . 6.2 mt -60.09 -31.65 70.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.398 -0.814 . . . . 0.0 110.47 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 21.2 t0 -56.88 -48.17 78.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.8 HG23 ' HB1' ' A' ' 54' ' ' ALA . 97.7 m -68.64 -32.87 73.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 109.814 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mp -57.8 -44.06 86.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.343 -0.848 . . . . 0.0 109.821 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 34.1 t -60.89 -54.29 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.448 -0.783 . . . . 0.0 109.439 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.958 HG13 HD22 ' A' ' 58' ' ' LEU . 96.9 t -44.8 -45.91 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.714 -0.616 . . . . 0.0 110.807 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -54.07 24.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 110.512 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -64.59 -46.83 81.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.331 -0.855 . . . . 0.0 110.996 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -69.19 -10.05 55.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.178 -0.951 . . . . 0.0 110.922 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.943 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -120.02 26.71 9.11 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.156 -0.965 . . . . 0.0 110.447 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.77 107.18 0.25 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -170.54 114.99 0.47 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.328 -1.101 . . . . 0.0 110.143 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 74' ' ' ARG . 6.4 ttt85 -69.78 132.89 46.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -0.828 . . . . 0.0 110.082 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.4 mp -119.8 26.83 9.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.418 -0.801 . . . . 0.0 110.191 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -115.54 53.03 0.85 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 110.287 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.76 HG11 ' CG ' ' A' ' 74' ' ' ARG . 14.4 p -123.06 153.75 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 110.103 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 78.2 m -109.48 147.47 32.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 0.0 109.924 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 6.6 p-10 -70.75 67.25 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 0.0 110.325 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.791 ' HB1' ' CZ3' ' A' ' 104' ' ' TRP . . . 57.48 111.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.424 -0.797 . . . . 0.0 110.481 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.791 ' CZ3' ' HB1' ' A' ' 103' ' ' ALA . 38.4 p90 35.64 34.96 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.76 -0.588 . . . . 0.0 111.432 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -122.84 -126.9 3.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.38 179.01 6.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -1.09 . . . . 0.0 110.269 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.544 ' HB2' HG12 ' A' ' 109' ' ' VAL . 96.9 mt -62.85 166.72 7.14 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.477 -0.764 . . . . 0.0 110.013 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.7 Cg_endo -69.94 -16.91 36.99 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.67 1.353 . . . . 0.0 110.536 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.544 HG12 ' HB2' ' A' ' 107' ' ' LEU . 11.6 p -61.64 -35.21 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.218 -0.926 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.428 ' N ' HG13 ' A' ' 109' ' ' VAL . 6.1 m-20 -69.3 -41.74 76.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 110.153 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.01 -31.15 66.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.753 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -68.92 -67.72 0.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.843 . . . . 0.0 110.225 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -25.72 20.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.85 -27.12 60.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.358 -0.839 . . . . 0.0 110.53 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -95.29 -16.02 22.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.667 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 125.28 -13.99 7.4 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.47 ' HB3' ' CG2' ' A' ' 120' ' ' ILE . 24.0 m-70 -75.87 96.87 3.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -1.196 . . . . 0.0 109.594 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' A' ' 119' ' ' ASP . 2.7 ptm180 -91.38 -41.82 10.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.923 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 118' ' ' ARG . 74.4 m-20 -63.29 -38.85 92.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -0.919 . . . . 0.0 109.634 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.753 ' CG2' ' HB1' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -65.63 -37.24 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.567 -0.708 . . . . 0.0 109.92 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.435 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -60.66 -37.0 80.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.453 -0.779 . . . . 0.0 109.9 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -51.15 70.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.408 -0.807 . . . . 0.0 109.759 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.412 ' CB ' HD21 ' A' ' 85' ' ' LEU . 30.9 t80 -60.28 -28.24 67.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.39 -0.819 . . . . 0.0 110.066 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.9 mt -85.59 -38.1 18.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 110.266 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.45 ' CG ' HG21 ' A' ' 109' ' ' VAL . 18.7 m-70 -54.62 -29.3 51.6 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.215 -0.928 . . . . 0.0 110.355 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.86 -20.63 16.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 110.312 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -92.68 -26.85 17.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 0.0 110.582 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.2 p . . . . . 0 N--CA 1.495 1.776 0 O-C-N 121.319 -0.863 . . . . 0.0 110.378 -179.837 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.319 0.581 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.46 -21.7 61.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.399 -0.813 . . . . 0.0 110.321 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.422 ' HA2' ' CG2' ' A' ' 12' ' ' THR . . . -57.65 -25.21 55.19 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.703 HD13 ' HG ' ' A' ' 26' ' ' LEU . 13.5 tp -75.92 -38.52 57.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -1.071 . . . . 0.0 110.506 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.17 -38.09 22.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.091 -1.005 . . . . 0.0 111.041 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.511 HG23 ' N ' ' A' ' 13' ' ' ALA . 15.2 t -61.81 -41.11 97.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.144 -0.972 . . . . 0.0 110.487 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.515 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -68.15 -50.56 53.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.175 -0.953 . . . . 0.0 109.534 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 46' ' ' MET . . . -52.57 -45.88 66.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.91 . . . . 0.0 110.563 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.589 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -71.4 -18.02 62.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.422 -0.799 . . . . 0.0 110.648 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -97.15 26.03 5.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 0.0 110.587 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 56.93 37.85 81.2 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.625 ' HB3' ' OG1' ' A' ' 21' ' ' THR . 62.6 mm-40 -112.96 93.87 4.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.42 -1.047 . . . . 0.0 110.271 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.682 HG21 ' HB2' ' A' ' 52' ' ' GLN . 11.3 t -82.78 -59.31 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.215 -0.928 . . . . 0.0 110.47 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -50.23 -48.99 54.28 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.625 ' OG1' ' HB3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -53.88 -34.57 59.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.518 -0.739 . . . . 0.0 110.362 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.872 HG12 HD13 ' A' ' 56' ' ' LEU . 95.3 t -81.12 -30.15 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.779 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.751 ' HA ' HD11 ' A' ' 56' ' ' LEU . 4.5 mmm180 -58.9 -37.56 76.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.296 -0.877 . . . . 0.0 110.108 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 4.2 tt0 -79.28 -51.42 9.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 110.42 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.73 -53.93 45.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 0.0 110.672 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.999 HD13 HD22 ' A' ' 56' ' ' LEU . 8.5 mt -56.56 -59.88 4.35 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.247 -0.908 . . . . 0.0 110.404 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.67 -24.15 65.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.369 -0.832 . . . . 0.0 110.266 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -74.43 -64.93 0.92 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.35 48.69 0.07 OUTLIER Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.637 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . . . -88.4 172.24 9.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -1.088 . . . . 0.0 110.22 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 6.5 t0 -110.82 102.75 53.25 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 0.0 110.239 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.3 -15.08 31.55 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.655 1.345 . . . . 0.0 110.64 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -109.31 26.83 10.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.909 . . . . 0.0 110.163 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -95.63 102.62 14.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.365 -0.835 . . . . 0.0 110.405 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 35' ' ' LEU . 25.7 mt -65.82 123.08 18.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.355 -0.841 . . . . 0.0 110.076 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -62.48 175.64 0.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.395 -0.815 . . . . 0.0 109.886 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -6.12 45.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.305 -0.872 . . . . 0.0 110.459 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -93.3 17.59 10.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.173 -0.955 . . . . 0.0 110.084 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.98 24.0 18.27 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -110.15 155.85 21.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.387 -1.066 . . . . 0.0 109.836 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.565 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.9 mmp_? -73.61 168.86 21.65 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.387 -0.821 . . . . 0.0 109.524 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 41.0 Cg_endo -68.03 -14.98 42.48 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.454 1.239 . . . . 0.0 110.173 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.54 ' HA ' ' HG2' ' A' ' 46' ' ' MET . 58.0 mt -107.95 -17.94 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.85 . . . . 0.0 109.87 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -69.12 -20.93 64.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 110.15 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.589 HG22 ' HB2' ' A' ' 15' ' ' ALA . 8.9 p -109.59 -17.0 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.355 -0.841 . . . . 0.0 110.399 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.54 ' HG2' ' HA ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -55.92 164.49 1.17 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.195 -0.941 . . . . 0.0 110.31 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -63.14 89.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.171 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.424 ' HG3' ' HA ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -49.82 -19.93 0.76 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.47 -0.768 . . . . 0.0 111.28 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . -86.66 20.44 23.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.416 ' O ' HG23 ' A' ' 53' ' ' VAL . 21.2 t -140.67 118.62 11.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.007 -1.29 . . . . 0.0 110.375 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -74.76 -26.25 59.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.924 . . . . 0.0 109.647 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.682 ' HB2' HG21 ' A' ' 19' ' ' VAL . 11.7 mt-30 -53.44 -27.35 24.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.525 -0.735 . . . . 0.0 110.644 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.834 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -90.05 -48.3 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 110.186 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.653 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -55.05 -35.11 64.14 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.297 -0.877 . . . . 0.0 110.368 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.407 ' HA ' HG11 ' A' ' 90' ' ' VAL . 7.3 tp10 -78.03 -48.24 16.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.361 -0.837 . . . . 0.0 110.635 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.999 HD22 HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -52.83 -65.54 0.54 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.201 -0.937 . . . . 0.0 110.761 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.834 HD12 ' O ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -50.95 -47.01 61.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.458 -0.776 . . . . 0.0 110.823 -179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -55.3 -43.5 74.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.3 tp -60.4 -25.61 66.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.673 ' CG ' HD22 ' A' ' 26' ' ' LEU . 29.3 m-70 -95.98 24.68 5.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.201 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.55 54.41 37.94 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.28 -146.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -1.083 . . . . 0.0 109.464 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.63 70.7 77.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.004 -1.06 . . . . 0.0 110.048 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.502 ' HB2' ' HB2' ' A' ' 96' ' ' ALA . 48.8 Cg_endo -81.57 -24.1 4.51 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.806 1.424 . . . . 0.0 110.134 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -95.75 -29.13 14.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 110.358 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.489 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -64.39 139.58 58.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 110.375 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -128.51 175.12 8.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.335 -0.853 . . . . 0.0 110.5 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.515 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 8.6 t70 -76.95 137.18 65.92 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.753 . . . . 0.0 109.84 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.06 -28.35 3.92 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.519 1.273 . . . . 0.0 111.106 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.49 -22.69 58.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.133 -0.979 . . . . 0.0 110.686 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.754 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 3.5 m -144.25 19.57 1.74 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 111.13 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.422 ' HB2' ' CA ' ' A' ' 103' ' ' ALA . 4.9 mt 40.25 36.68 0.35 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.313 -0.867 . . . . 0.0 110.861 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -87.3 126.16 34.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.405 -0.809 . . . . 0.0 110.851 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.709 ' CG ' HG11 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -92.62 173.25 5.23 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.557 -0.714 . . . . 0.0 110.178 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.09 -18.72 16.25 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.663 1.349 . . . . 0.0 110.348 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.89 -32.79 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.33 -0.856 . . . . 0.0 109.939 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.633 ' HE1' HG13 ' A' ' 100' ' ' VAL . 68.8 m80 -60.92 -46.15 91.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.04 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.403 ' CB ' ' CE ' ' A' ' 48' ' ' MET . 1.2 m-20 -60.21 -57.1 14.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.3 -0.875 . . . . 0.0 110.037 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.621 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -51.64 -30.53 21.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.357 -0.84 . . . . 0.0 109.818 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.16 -23.55 30.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.562 -0.711 . . . . 0.0 109.749 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.448 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -60.38 -35.58 76.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.457 -0.777 . . . . 0.0 110.122 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -94.76 -19.5 20.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.34 -0.85 . . . . 0.0 110.463 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.23 30.63 13.55 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.574 ' CA ' ' HZ ' ' A' ' 84' ' ' PHE . 18.0 t80 -97.65 92.01 5.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -1.004 . . . . 0.0 110.092 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 89' ' ' VAL . 2.7 mt -65.63 -22.45 66.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.273 -0.892 . . . . 0.0 110.349 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 90' ' ' VAL . 6.5 m-20 -57.47 -41.14 80.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.397 -0.814 . . . . 0.0 110.392 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.653 HG23 ' CB ' ' A' ' 54' ' ' ALA . 74.8 m -72.86 -36.38 67.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.349 -0.844 . . . . 0.0 109.96 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.726 ' CD1' HD11 ' A' ' 120' ' ' ILE . 5.4 mp -62.52 -42.26 99.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 109.769 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 85' ' ' LEU . 67.6 t -61.31 -44.59 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.448 -0.783 . . . . 0.0 109.332 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 86' ' ' ASP . 65.1 t -55.49 -44.29 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.444 -0.785 . . . . 0.0 109.857 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 87' ' ' THR . 5.5 mp -62.52 -45.95 90.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.428 -0.795 . . . . 0.0 109.744 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -70.97 -15.91 62.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.0 110.254 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -74.61 -71.64 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.349 -0.844 . . . . 0.0 110.136 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -60.78 -78.47 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.331 -0.855 . . . . 0.0 110.286 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.06 107.61 0.26 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 64' ' ' PRO . . . -160.68 119.36 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -1.046 . . . . 0.0 109.834 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -60.43 126.59 28.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.263 -0.898 . . . . 0.0 110.379 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.768 ' O ' HG22 ' A' ' 128' ' ' THR . 0.3 OUTLIER -111.51 64.64 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 110.283 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -171.29 61.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -0.859 . . . . 0.0 110.053 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.709 HG11 ' CG ' ' A' ' 74' ' ' ARG . 7.3 p -131.86 173.13 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 110.065 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.483 ' N ' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -135.1 160.87 36.98 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 104' ' ' TRP . 29.5 m-20 -68.76 71.91 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.709 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.754 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 56.49 -80.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.64 -0.663 . . . . 0.0 110.113 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.503 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -126.78 32.69 5.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -115.46 -142.15 7.59 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.388 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HB3' ' CB ' ' A' ' 110' ' ' ASP . 5.4 mtt85 -98.06 159.13 15.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -1.024 . . . . 0.0 110.787 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -78.99 175.64 4.53 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.604 -0.685 . . . . 0.0 109.618 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 40.8 Cg_endo -66.12 -16.87 53.7 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.385 1.203 . . . . 0.0 110.174 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.521 HG21 ' CG ' ' A' ' 125' ' ' HIS . 9.7 p -91.69 -34.9 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.873 . . . . 0.0 109.796 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.418 ' N ' HG13 ' A' ' 109' ' ' VAL . 10.0 m-20 -66.91 -41.65 86.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -0.8 . . . . 0.0 109.954 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 111' ' ' LEU . 5.8 tt -57.04 -31.02 64.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.419 -0.801 . . . . 0.0 109.951 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.729 ' HB1' ' HB2' ' A' ' 117' ' ' HIS . . . -83.85 -36.85 23.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.532 -0.73 . . . . 0.0 109.979 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -54.99 -26.21 35.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 0.0 110.644 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -91.88 -47.28 7.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.377 -0.827 . . . . 0.0 110.72 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.432 ' HG2' ' CE1' ' A' ' 117' ' ' HIS . 52.6 tp60 -66.4 -100.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.913 . . . . 0.0 110.547 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.12 24.7 0.2 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.523 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.729 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 1.6 m170 -100.51 86.2 3.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.0 -1.294 . . . . 0.0 109.386 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 122' ' ' ARG . 2.6 mpt_? -80.72 -57.93 3.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.415 -0.803 . . . . 0.0 110.71 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -45.76 -46.84 15.42 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.627 -0.671 . . . . 0.0 110.894 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.726 HD11 ' CD1' ' A' ' 88' ' ' LEU . 2.7 tt -65.41 -37.44 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 0.0 109.644 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -61.82 -39.7 92.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 110.0 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 11.5 mmt180 -63.8 -41.37 97.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -74.34 -30.64 62.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.548 -0.72 . . . . 0.0 109.587 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.504 HD23 HD21 ' A' ' 98' ' ' LEU . 20.4 mt -72.89 -59.55 2.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.522 -0.737 . . . . 0.0 109.972 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.521 ' CG ' HG21 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -56.06 -28.57 58.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.38 -0.825 . . . . 0.0 110.096 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.82 -33.77 71.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.429 -0.794 . . . . 0.0 110.243 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.462 ' HB3' ' CD2' ' A' ' 98' ' ' LEU . . . -99.81 -22.41 15.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.398 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 98' ' ' LEU . 64.2 p . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 0.0 110.354 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 121.236 0.541 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.601 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -148.51 50.74 1.0 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.08 -27.76 46.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.993 HD13 HD21 ' A' ' 57' ' ' LEU . 3.9 pp -57.96 -33.6 69.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.503 -0.998 . . . . 0.0 109.866 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.722 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -76.49 -39.28 53.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.381 -0.824 . . . . 0.0 109.733 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.7 m -62.36 -54.46 40.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.406 -0.809 . . . . 0.0 109.785 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 16' ' ' ARG . . . -64.13 -32.33 73.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 0.0 109.783 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.654 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -67.19 -32.68 73.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.206 -0.934 . . . . 0.0 109.494 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.413 ' CA ' ' HA ' ' A' ' 46' ' ' MET . . . -70.87 -27.02 63.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 110.02 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 19.2 ptt180 -100.17 20.25 14.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.33 -0.856 . . . . 0.0 110.411 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.414 ' HA3' ' CE ' ' A' ' 47' ' ' MET . . . 62.5 83.0 0.07 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.74 ' O ' HG23 ' A' ' 22' ' ' VAL . 35.4 mm-40 -151.74 71.25 0.97 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 110.174 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.822 HG22 HG23 ' A' ' 53' ' ' VAL . 24.8 t -57.0 -43.01 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.236 -0.915 . . . . 0.0 109.889 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -56.89 -52.61 64.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.343 -0.848 . . . . 0.0 110.541 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -41.44 96.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.359 -0.838 . . . . 0.0 110.249 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.818 HG12 HD23 ' A' ' 56' ' ' LEU . 62.1 t -63.24 -38.28 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.45 -0.781 . . . . 0.0 110.024 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.781 ' HD2' HD13 ' A' ' 56' ' ' LEU . 6.8 mmm-85 -69.5 -24.56 63.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 110.148 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 89.8 mm-40 -79.31 -53.6 6.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.836 . . . . 0.0 110.464 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.937 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -59.58 -44.07 93.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.347 -0.846 . . . . 0.0 110.484 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.432 HD11 ' CG ' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -57.24 -53.33 59.35 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.18 -0.95 . . . . 0.0 110.245 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -75.35 -5.56 45.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.427 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -84.1 -39.05 19.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.139 -0.975 . . . . 0.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.98 -20.19 0.14 Allowed Glycine 0 N--CA 1.484 1.881 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.642 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.937 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -47.46 136.27 10.01 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.151 -1.205 . . . . 0.0 111.009 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.92 ' OD2' ' HB2' ' A' ' 34' ' ' ALA . 10.4 p-10 -78.19 150.59 77.61 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 110.203 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.73 4.45 6.91 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.852 1.448 . . . . 0.0 111.051 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -136.35 43.25 2.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.036 -1.04 . . . . 0.0 110.917 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.92 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . . . -109.72 104.69 13.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 35' ' ' LEU . 3.7 pp -73.61 138.76 45.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.201 -0.937 . . . . 0.0 110.253 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.601 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 15.6 p-10 -107.7 82.72 1.69 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.471 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 52.02 -171.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.313 -0.867 . . . . 0.0 110.862 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 39' ' ' GLY . 80.2 m-85 55.56 13.28 0.94 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.571 -0.705 . . . . 0.0 110.924 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' PHE . . . 38.54 35.31 0.31 Allowed Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -107.11 -164.68 1.0 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -1.041 . . . . 0.0 110.478 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.672 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.8 mmp_? -116.71 176.64 1.47 Allowed Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.672 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 43.1 Cg_endo -72.07 -19.78 26.02 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.31 1.163 . . . . 0.0 110.2 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.455 ' O ' ' HG2' ' A' ' 46' ' ' MET . 25.4 mt -104.27 -27.44 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -74.47 -4.26 35.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.536 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.722 HG11 ' HB1' ' A' ' 11' ' ' ALA . 12.4 p -115.03 -17.95 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.084 -1.01 . . . . 0.0 110.748 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -64.34 164.82 10.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.966 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . 0.414 ' CE ' ' HA3' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -55.67 -16.92 4.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.375 -0.828 . . . . 0.0 110.545 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.566 ' HE3' ' CB ' ' A' ' 78' ' ' ASP . 45.3 tpp 58.93 24.66 12.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.294 -0.878 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.23 20.54 5.59 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 m -149.13 96.26 2.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 110.04 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.419 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -52.49 -26.76 13.86 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.274 -0.891 . . . . 0.0 110.296 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.641 ' HB2' HG21 ' A' ' 19' ' ' VAL . 6.0 mt-30 -53.28 -34.8 58.76 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.822 HG23 HG22 ' A' ' 19' ' ' VAL . 60.3 t -84.13 -38.47 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 110.223 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.877 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -68.18 -33.18 73.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.415 -0.803 . . . . 0.0 110.553 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.402 ' O ' HD23 ' A' ' 59' ' ' LEU . 8.5 tt0 -76.6 -39.98 50.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.966 . . . . 0.0 110.659 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.818 HD23 HG12 ' A' ' 22' ' ' VAL . 46.5 tp -56.2 -63.03 1.32 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.284 -0.885 . . . . 0.0 110.732 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.993 HD21 HD13 ' A' ' 10' ' ' LEU . 5.1 mt -59.78 -30.31 68.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.254 -0.904 . . . . 0.0 110.84 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.948 HD22 HG13 ' A' ' 90' ' ' VAL . 2.7 tp -60.13 -67.51 0.38 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.13 -0.981 . . . . 0.0 110.99 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.434 HD11 ' CE1' ' A' ' 60' ' ' HIS . 2.2 pp -51.85 -25.28 7.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.247 -0.908 . . . . 0.0 110.7 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.434 ' CE1' HD11 ' A' ' 59' ' ' LEU . 12.7 m80 -80.88 -67.3 0.79 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.179 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.52 40.9 0.04 OUTLIER Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' A' ' 57' ' ' LEU . . . -61.67 -164.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.314 -1.109 . . . . 0.0 110.13 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.59 74.43 74.63 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.959 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.89 -32.61 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.901 1.474 . . . . 0.0 110.158 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -95.6 -30.18 13.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.388 -0.82 . . . . 0.0 110.012 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 171.08 2.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.438 -0.789 . . . . 0.0 110.139 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.809 ' HB1' ' O ' ' A' ' 73' ' ' THR . . . -169.46 -179.51 3.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.421 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 72' ' ' LEU . 21.8 t0 -78.69 131.44 67.71 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.396 -0.815 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.67 -23.16 11.39 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.544 1.286 . . . . 0.0 110.398 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.83 -29.41 62.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 0.0 110.59 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.827 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 7.8 m -138.92 17.32 2.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.907 . . . . 0.0 110.665 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER 42.38 29.47 0.15 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.317 -0.864 . . . . 0.0 110.794 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.809 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -72.31 134.84 45.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 110.556 -179.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.682 ' HG3' HG11 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -107.72 165.17 13.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 110.324 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.37 -24.68 22.5 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.698 1.367 . . . . 0.0 110.322 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 108' ' ' PRO . 58.9 t -58.7 -29.14 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.353 -0.842 . . . . 0.0 110.007 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.56 ' HE1' HG13 ' A' ' 100' ' ' VAL . 33.4 m80 -68.65 -34.33 75.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.344 -0.848 . . . . 0.0 110.126 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.566 ' CB ' ' HE3' ' A' ' 48' ' ' MET . 43.4 m-20 -77.82 -56.5 4.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.409 -0.807 . . . . 0.0 110.239 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.566 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -52.65 -26.6 14.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.093 -1.004 . . . . 0.0 109.888 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.436 ' O ' ' CD2' ' A' ' 117' ' ' HIS . . . -85.3 -21.31 29.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.435 -0.791 . . . . 0.0 109.566 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.67 ' CD ' HD12 ' A' ' 111' ' ' LEU . 10.3 tpt180 -76.44 -17.25 59.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.429 -0.794 . . . . 0.0 110.341 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.406 ' HG3' ' HB3' ' A' ' 48' ' ' MET . 30.6 mm-40 -100.84 -34.54 9.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.18 -0.95 . . . . 0.0 110.323 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.9 34.18 4.42 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.2 105.61 15.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -1.091 . . . . 0.0 110.123 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.681 HD22 HD12 ' A' ' 120' ' ' ILE . 2.8 mm? -77.6 -21.98 51.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.466 -0.772 . . . . 0.0 110.256 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.692 ' O ' HG23 ' A' ' 90' ' ' VAL . 46.6 t0 -68.0 -48.71 64.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.361 -0.837 . . . . 0.0 110.565 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.877 HG23 ' CB ' ' A' ' 54' ' ' ALA . 97.8 m -65.3 -33.98 77.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.14 -0.975 . . . . 0.0 110.071 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.799 HD13 HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -61.87 -48.53 80.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.226 -0.921 . . . . 0.0 109.857 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 85' ' ' LEU . 67.6 t -60.06 -40.7 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 109.527 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.948 HG13 HD22 ' A' ' 58' ' ' LEU . 91.3 t -53.82 -53.79 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.446 -0.784 . . . . 0.0 110.234 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mp -52.74 -52.01 58.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.387 -0.821 . . . . 0.0 110.581 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -60.99 -24.69 66.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.254 -0.904 . . . . 0.0 110.177 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.42 -22.88 60.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.407 -0.808 . . . . 0.0 110.338 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.752 ' HB3' HD11 ' A' ' 58' ' ' LEU . . . -121.46 35.05 4.99 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.278 -0.889 . . . . 0.0 110.616 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.59 114.05 0.14 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.417 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -155.6 131.56 9.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -1.099 . . . . 0.0 110.034 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 141.47 38.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 109.951 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.754 ' O ' HG22 ' A' ' 128' ' ' THR . 0.5 OUTLIER -133.59 11.09 4.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -0.816 . . . . 0.0 110.307 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -110.73 22.92 14.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 110.019 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.682 HG11 ' HG3' ' A' ' 74' ' ' ARG . 9.5 p -91.56 144.93 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.451 -0.78 . . . . 0.0 109.932 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.542 ' SG ' HD11 ' A' ' 107' ' ' LEU . 53.4 m -115.17 41.96 2.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 110.383 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.671 ' OD1' HG23 ' A' ' 73' ' ' THR . 32.0 t0 52.64 69.47 0.68 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.351 -0.843 . . . . 0.0 110.36 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.827 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 62.89 -77.93 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.519 -0.738 . . . . 0.0 110.254 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -155.5 45.92 0.48 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.356 -0.84 . . . . 0.0 109.801 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -129.42 -118.09 2.03 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -95.83 -178.36 4.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -1.102 . . . . 0.0 110.665 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.542 HD11 ' SG ' ' A' ' 101' ' ' CYS . 3.7 mp -105.14 173.65 3.16 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.498 -0.752 . . . . 0.0 109.942 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 41.6 Cg_endo -67.83 -20.12 46.02 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.551 1.29 . . . . 0.0 110.274 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.741 ' HB ' HD11 ' A' ' 124' ' ' LEU . 14.4 p -83.28 -23.56 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 110.189 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -62.32 -28.34 69.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.225 -0.922 . . . . 0.0 110.266 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.67 HD12 ' CD ' ' A' ' 81' ' ' ARG . 4.4 mm? -58.32 -68.55 0.24 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.308 -0.87 . . . . 0.0 109.941 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.801 ' HB1' ' O ' ' A' ' 117' ' ' HIS . . . -61.64 -43.54 98.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.871 . . . . 0.0 109.725 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.543 ' HG3' HG22 ' A' ' 109' ' ' VAL . 8.8 mm-40 -48.98 -31.99 8.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.513 -0.742 . . . . 0.0 109.51 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 115' ' ' GLN . 10.8 tt0 -66.97 -62.94 1.18 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.608 -0.683 . . . . 0.0 109.212 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER 172.46 113.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.541 -0.724 . . . . 0.0 110.221 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.43 -53.19 0.42 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.628 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.801 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 1.2 m-70 -138.86 75.78 1.54 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.176 -1.19 . . . . 0.0 110.566 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -61.41 -22.78 65.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 0.0 109.979 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.42 ' OD2' HD23 ' A' ' 85' ' ' LEU . 12.5 p-10 -72.87 -42.21 63.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.401 -0.812 . . . . 0.0 110.451 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.799 HD11 HD13 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -61.87 -30.75 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.917 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 125' ' ' HIS . . . -65.1 -52.61 54.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.421 -0.8 . . . . 0.0 109.644 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.43 ' HA ' ' CE1' ' A' ' 125' ' ' HIS . 5.4 mtm180 -45.81 -46.38 15.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.285 -0.884 . . . . 0.0 110.662 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -81.77 -56.74 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 111.057 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.839 ' O ' HG23 ' A' ' 128' ' ' THR . 0.3 OUTLIER -59.51 -39.65 84.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.034 . . . . 0.0 111.158 -178.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.519 ' CD2' ' C ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -67.81 -39.76 83.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.747 -1.22 . . . . 0.0 109.461 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . 0.449 ' N ' ' CD2' ' A' ' 125' ' ' HIS . . . -54.23 -27.94 37.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.412 -0.805 . . . . 0.0 109.548 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.723 ' CB ' HD22 ' A' ' 98' ' ' LEU . . . -90.86 -16.8 27.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.595 -0.69 . . . . 0.0 110.411 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 124' ' ' LEU . 29.1 p . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.194 -0.941 . . . . 0.0 109.71 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.236 0.541 . . . . 3.31 109.873 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.589 ' HB1' ' OD1' ' A' ' 36' ' ' ASN . . . -95.34 18.24 12.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 3.29 110.236 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.96 -37.35 92.08 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.385 -1.486 . . . . 2.63 109.385 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.8 HD13 ' CD2' ' A' ' 57' ' ' LEU . 4.0 pp -59.93 -27.25 66.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.384 -1.068 . . . . 2.24 110.154 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -80.47 -47.08 14.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.45 -0.781 . . . . 1.89 110.0 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.8 p -62.17 -51.2 68.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.373 -0.83 . . . . 2.15 109.837 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.53 -34.01 72.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.377 -0.827 . . . . 1.65 109.791 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.61 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -73.07 -36.18 66.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.536 -0.728 . . . . 1.38 109.91 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 46' ' ' MET . . . -60.75 -27.07 67.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.421 -0.799 . . . . 1.41 110.066 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -93.52 -17.51 23.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.372 -0.83 . . . . 4.94 110.321 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.17 54.04 1.31 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.518 -1.433 . . . . 1.44 109.518 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -124.92 79.42 1.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -1.118 . . . . 2.77 110.521 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.829 HG21 ' HB3' ' A' ' 52' ' ' GLN . 84.5 t -61.71 -38.84 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.222 -0.924 . . . . 1.58 109.66 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.78 -44.57 90.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.348 -0.845 . . . . 2.28 110.346 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 m -64.35 -42.68 96.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.869 . . . . 1.8 109.974 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.607 HG12 HD13 ' A' ' 56' ' ' LEU . 61.0 t -74.66 -25.77 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.429 -0.794 . . . . 1.6 110.198 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.569 ' HA ' HD11 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -64.26 -51.31 64.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.317 -0.864 . . . . 1.96 110.464 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.82 -21.06 60.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.275 -0.89 . . . . 4.45 110.599 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.469 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -71.26 -63.61 1.08 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.202 -0.936 . . . . 2.55 110.551 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.81 HD11 HD23 ' A' ' 57' ' ' LEU . 10.2 mt -56.83 -46.37 81.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.289 -0.882 . . . . 2.71 110.646 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.36 -35.24 75.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.38 -0.825 . . . . 3.3 110.375 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.08 -65.8 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.362 -0.836 . . . . 2.66 110.134 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.99 57.33 0.07 OUTLIER Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.563 -1.415 . . . . 2.97 109.563 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.717 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . . . -109.01 133.93 52.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -1.114 . . . . 2.78 110.168 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 1.2 t0 -69.57 127.65 92.58 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 3.66 109.996 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.86 -17.32 25.61 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.592 1.312 . . . . 2.22 110.547 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -107.93 29.03 7.64 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -0.906 . . . . 2.17 110.227 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -81.22 106.2 13.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.363 -0.836 . . . . 2.32 110.153 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 35' ' ' LEU . 13.2 mt -65.3 164.92 12.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.384 -0.822 . . . . 2.98 110.386 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' OD1' ' HB1' ' A' ' 8' ' ' ALA . 1.3 m120 -107.69 -170.0 1.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 3.25 110.14 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -81.77 -18.58 43.66 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.397 -0.814 . . . . 4.62 110.341 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -91.46 18.46 7.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.311 -0.868 . . . . 3.21 110.43 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.07 37.4 45.62 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.836 -1.306 . . . . 2.18 109.836 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.05 162.94 17.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.37 -1.077 . . . . 2.77 110.325 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.616 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.2 mmp_? -77.08 170.76 14.77 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.503 -0.748 . . . . 2.2 109.516 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 41.1 Cg_endo -67.58 -13.1 37.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.478 1.252 . . . . 1.57 110.52 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.454 HG23 ' HE1' ' A' ' 46' ' ' MET . 74.2 mt -109.92 -17.86 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -0.918 . . . . 1.31 109.862 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.81 -4.97 49.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.218 -0.926 . . . . 2.02 110.282 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.545 HG11 ' HB1' ' A' ' 11' ' ' ALA . 14.2 p -120.36 -6.43 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.251 -0.906 . . . . 1.59 110.903 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.572 ' HE1' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -69.41 162.42 27.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.024 -1.047 . . . . 1.8 110.174 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -54.67 -19.62 6.53 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.344 -0.847 . . . . 1.63 110.865 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.497 ' HE2' ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER 60.96 19.68 10.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.29 -0.881 . . . . 1.36 110.156 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.418 ' HA2' ' CD2' ' A' ' 84' ' ' PHE . . . -124.81 24.39 6.07 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.369 -1.492 . . . . 1.25 109.369 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.9 t -154.59 106.84 2.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -1.083 . . . . 1.72 110.071 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -58.88 -25.68 63.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.419 -0.801 . . . . 1.05 110.348 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.829 ' HB3' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -58.08 -29.54 65.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.269 -0.895 . . . . 2.53 110.185 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.683 ' CG2' HG22 ' A' ' 19' ' ' VAL . 34.6 t -84.19 -47.93 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.396 -0.815 . . . . 1.2 110.504 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.754 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -62.1 -37.15 83.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.31 -0.869 . . . . 1.0 110.661 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.417 ' HA ' HG11 ' A' ' 90' ' ' VAL . 16.4 tt0 -74.93 -33.76 62.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 2.74 110.457 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.804 HD22 HD12 ' A' ' 26' ' ' LEU . 1.9 tt -57.22 -64.31 0.93 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.294 -0.879 . . . . 2.1 110.725 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.81 HD23 HD11 ' A' ' 26' ' ' LEU . 6.6 mt -61.41 -40.24 93.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.353 -0.842 . . . . 1.9 110.9 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.745 HD13 HG12 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -58.47 -57.46 12.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 2.12 110.745 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -53.49 -26.35 20.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.287 -0.883 . . . . 2.08 110.236 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.428 ' CE1' ' HB3' ' A' ' 26' ' ' LEU . 3.1 m170 -84.2 -73.9 0.4 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 2.46 110.054 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.16 50.11 0.05 OUTLIER Glycine 0 N--CA 1.483 1.831 0 N-CA-C 109.741 -1.343 . . . . 1.57 109.741 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -70.8 -162.11 0.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -1.109 . . . . 1.54 110.177 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.408 ' CB ' ' HD3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -121.91 76.83 39.63 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 2.16 110.183 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 96' ' ' ALA . 48.7 Cg_endo -77.75 -24.44 8.69 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.775 1.408 . . . . 1.29 110.573 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -92.84 -50.01 5.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 2.56 110.4 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.07 120.85 6.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.244 -0.91 . . . . 1.86 110.449 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.789 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -109.36 -179.44 3.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.396 -0.815 . . . . 1.98 110.329 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -76.95 125.59 86.71 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 2.51 110.003 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.78 -13.0 24.41 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.495 1.26 . . . . 2.48 110.727 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.0 -30.86 44.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.958 . . . . 2.68 110.557 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.62 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 1.7 m -142.66 17.15 2.0 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 2.71 110.567 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.98 32.08 7.05 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.288 -0.883 . . . . 2.34 110.506 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.42 HG23 ' OD1' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -85.7 121.47 28.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.389 -0.819 . . . . 1.77 110.379 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.802 ' HB2' HG11 ' A' ' 100' ' ' VAL . 1.0 OUTLIER -93.1 172.65 5.78 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.775 . . . . 2.6 110.161 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.45 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 45.1 Cg_endo -72.13 -9.38 24.4 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.719 1.379 . . . . 0.94 110.772 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.83 -23.94 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.178 -0.951 . . . . 0.6 110.141 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.49 ' HE1' HG13 ' A' ' 100' ' ' VAL . 21.2 m80 -72.03 -52.14 18.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.311 -0.868 . . . . 0.87 110.476 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -58.44 -47.48 83.83 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.282 -0.886 . . . . 1.76 110.418 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.497 ' N ' ' HE2' ' A' ' 48' ' ' MET . . . -60.62 -26.36 66.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -0.853 . . . . 0.73 110.211 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -87.7 -21.33 25.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.352 -0.843 . . . . 1.05 110.442 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 -72.6 -30.83 64.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.256 -0.903 . . . . 3.11 110.344 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.404 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 1.3 mm-40 -86.61 -36.11 19.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.872 . . . . 2.1 110.211 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.37 46.06 1.9 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.699 -1.361 . . . . 1.06 109.699 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.418 ' CD2' ' HA2' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -115.13 103.15 10.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.366 -1.079 . . . . 1.69 109.923 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 119' ' ' ASP . 2.3 mt -75.24 -22.62 57.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.847 . . . . 1.92 110.368 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -59.97 -43.31 95.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 1.68 110.114 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.754 HG23 ' HB1' ' A' ' 54' ' ' ALA . 63.7 m -73.24 -39.55 65.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.326 -0.859 . . . . 0.85 109.889 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.775 HD13 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -55.47 -46.51 76.83 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.393 -0.817 . . . . 1.21 109.952 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 85' ' ' LEU . 87.7 t -63.18 -41.15 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.402 -0.811 . . . . 1.41 109.539 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 86' ' ' ASP . 90.2 t -57.2 -47.9 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.596 -0.69 . . . . 1.1 110.276 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.11 -52.5 65.3 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.39 -0.819 . . . . 1.01 110.303 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -60.01 -27.2 66.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.514 -0.741 . . . . 1.66 110.323 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -67.8 -69.03 0.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 3.26 110.265 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.731 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -54.65 -28.19 45.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 1.58 110.669 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.17 87.86 1.21 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.564 -1.415 . . . . 1.55 109.564 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -136.33 134.43 37.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -1.118 . . . . 1.25 110.313 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -71.43 143.05 50.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.802 . . . . 3.46 110.103 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 96' ' ' ALA . 2.1 mp -123.37 -2.78 8.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 1.72 110.823 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -93.69 69.97 4.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.122 -0.986 . . . . 2.12 110.151 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 74' ' ' ARG . 12.2 p -135.27 151.23 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.433 -0.792 . . . . 1.3 110.156 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' CYS . . . . . 0.401 ' O ' ' N ' ' A' ' 103' ' ' ALA . 12.3 m -116.22 159.17 22.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.243 -0.911 . . . . 2.07 109.404 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -68.55 74.54 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 2.65 109.755 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 61.16 -79.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.635 -0.666 . . . . 2.58 110.047 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.448 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.2 p90 -128.41 37.96 4.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 3.81 109.859 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -120.49 -141.25 6.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.99 -1.244 . . . . 2.11 109.99 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -101.74 -164.95 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.4 -1.059 . . . . 4.59 110.48 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -96.18 174.27 3.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.725 . . . . 1.94 110.035 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.8 Cg_endo -68.16 -22.39 40.85 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.697 1.367 . . . . 1.02 110.254 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 107' ' ' LEU . 11.1 p -73.73 -27.31 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 1.34 110.042 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -80.26 -38.93 29.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.836 . . . . 2.42 110.095 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.48 -26.83 65.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.399 -0.813 . . . . 1.99 109.918 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' A' ' 117' ' ' HIS . . . -78.04 -54.26 6.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.51 -0.744 . . . . 1.78 109.971 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -53.09 -25.79 14.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.395 -0.816 . . . . 3.39 110.573 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -79.05 -54.98 5.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 3.16 110.235 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.38 -67.33 0.43 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.399 -0.813 . . . . 4.06 110.052 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 157.6 47.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.595 -1.402 . . . . 2.4 109.595 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' HIS . . . . . 0.565 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 70.1 m-70 -122.23 64.63 0.93 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.361 -1.082 . . . . 2.12 109.999 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -35.43 67.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.283 -0.886 . . . . 4.53 110.158 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.503 ' HB3' HD12 ' A' ' 85' ' ' LEU . 31.4 m-20 -61.9 -48.5 80.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.379 -0.825 . . . . 2.51 110.218 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.775 HD11 HD13 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -71.62 -25.38 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.397 -0.815 . . . . 1.52 110.347 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.0 -45.41 67.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.395 -0.816 . . . . 1.71 110.119 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.5 mtp85 -59.56 -53.54 56.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.357 -0.839 . . . . 3.93 110.126 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.49 ' CB ' HD21 ' A' ' 85' ' ' LEU . 37.7 t80 -60.52 -35.91 77.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.343 -0.848 . . . . 1.96 110.058 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.466 ' CG ' HD21 ' A' ' 88' ' ' LEU . 34.3 mt -72.6 -41.06 66.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.453 -0.78 . . . . 1.42 110.172 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -59.73 -22.53 62.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.401 -0.812 . . . . 3.72 110.327 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -86.47 -30.86 21.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.878 . . . . 2.04 110.308 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -96.84 -21.04 17.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.278 -0.888 . . . . 1.64 110.633 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 98' ' ' LEU . 26.4 p . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 1.96 110.458 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 46.4 t -71.27 146.19 91.82 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.341 -1.094 . . . . 0.0 109.805 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.96 144.49 30.46 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.614 1.323 . . . . 0.0 110.652 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -176.79 174.09 46.78 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' ILE . . . . . 0.925 HG23 ' CD2' ' A' ' 0' ' ' HIS . 5.5 tp -173.42 153.84 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.118 -1.225 . . . . 0.0 111.175 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.925 ' CD2' HG23 ' A' ' -1' ' ' ILE . 26.2 p80 40.52 108.21 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 122.099 0.952 . . . . 0.0 113.207 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.4 mmt 55.21 -163.19 0.14 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.489 -0.757 . . . . 0.0 111.673 178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 13.5 tp -159.16 -55.23 0.06 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.698 -0.626 . . . . 0.0 110.309 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 152.27 167.0 14.72 Favored Glycine 0 N--CA 1.498 2.824 0 C-N-CA 119.823 -1.18 . . . . 0.0 110.25 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 165.64 139.94 2.76 Favored Glycine 0 N--CA 1.498 2.798 0 O-C-N 121.291 -1.123 . . . . 0.0 110.434 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -120.69 -167.1 1.42 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.444 -1.033 . . . . 0.0 109.69 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.273 58.9 m -169.18 178.63 4.3 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-O 123.881 1.8 . . . . 0.0 114.733 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 1.11 ' O ' HD11 ' A' ' 25' ' ' LEU . 6.4 p-10 -115.09 49.23 1.07 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 101.417 -3.549 . . . . 0.0 101.417 171.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 9' ' ' GLY . . . -115.47 5.45 14.49 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.239 -175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.846 ' N ' ' HG ' ' A' ' 25' ' ' LEU . . . -41.22 -33.58 0.81 Allowed Glycine 0 N--CA 1.499 2.844 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.985 HD22 HD21 ' A' ' 57' ' ' LEU . 4.2 pp -53.66 -29.1 36.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.755 -0.85 . . . . 0.0 109.803 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.755 ' N ' HD12 ' A' ' 10' ' ' LEU . . . -88.06 -60.23 2.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.366 -0.834 . . . . 0.0 109.995 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.1 p -53.46 -47.67 69.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.444 -0.785 . . . . 0.0 110.525 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB1' ' HB2' ' A' ' 18' ' ' GLN . . . -67.73 -38.69 83.88 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.312 -0.868 . . . . 0.0 109.778 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.712 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -56.54 -52.88 63.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.413 -0.805 . . . . 0.0 109.706 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.436 ' HA ' ' HB2' ' A' ' 47' ' ' MET . . . -53.46 -30.4 40.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.891 . . . . 0.0 109.078 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -90.51 8.88 31.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.64 -0.662 . . . . 0.0 110.084 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.0 58.64 7.9 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.816 ' O ' HG23 ' A' ' 22' ' ' VAL . 27.0 mt-30 -131.92 81.07 1.95 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.274 -1.133 . . . . 0.0 111.008 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.942 HG21 ' HB3' ' A' ' 52' ' ' GLN . 61.1 t -68.67 -29.39 43.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.065 -1.022 . . . . 0.0 109.217 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -61.8 -42.97 99.68 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.312 -0.868 . . . . 0.0 109.423 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.516 ' HB ' ' CB ' ' A' ' 13' ' ' ALA . 1.8 m -69.08 -41.25 77.76 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.933 HG12 HD13 ' A' ' 56' ' ' LEU . 21.6 t -61.61 -34.32 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.416 ' HA ' HD11 ' A' ' 56' ' ' LEU . 1.6 mmt180 -70.24 -33.73 71.99 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 177.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -75.41 -53.42 8.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.67 -0.643 . . . . 0.0 111.092 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.11 HD11 ' O ' ' A' ' 7' ' ' ASP . 2.9 tm? -55.91 -25.36 42.64 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.008 -1.058 . . . . 0.0 109.145 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -95.34 -68.82 0.78 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.053 -1.03 . . . . 0.0 111.713 -179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -50.54 -17.9 0.58 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.29 -0.881 . . . . 0.0 111.535 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -75.4 2.98 10.0 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.983 -1.073 . . . . 0.0 110.951 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.35 72.93 1.26 Allowed Glycine 0 N--CA 1.482 1.736 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.758 ' HB1' ' HB2' ' A' ' 7' ' ' ASP . . . -132.69 -166.49 1.75 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.412 -1.051 . . . . 0.0 111.42 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.13 140.76 21.55 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.675 -0.64 . . . . 0.0 109.609 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.43 5.36 3.75 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.48 1.253 . . . . 0.0 111.277 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.0 m120 -134.18 42.62 2.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.859 -1.15 . . . . 0.0 111.254 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.723 ' HB2' ' OD2' ' A' ' 7' ' ' ASP . . . -69.36 79.3 0.38 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.96 -1.087 . . . . 0.0 109.186 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 11.1 mt -49.5 158.58 0.41 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.532 -0.73 . . . . 0.0 111.397 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -121.26 159.14 26.59 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.51 -22.79 13.96 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.153 -0.967 . . . . 0.0 110.566 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -77.3 -9.78 59.03 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 110.356 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.72 28.79 31.49 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.43 ' O ' ' CB ' ' A' ' 44' ' ' GLN . 13.4 mtm180 -101.77 37.96 1.72 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -1.079 . . . . 0.0 110.084 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 51.89 177.27 0.02 OUTLIER Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.312 -0.867 . . . . 0.0 110.674 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -81.53 -24.78 4.12 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.608 1.32 . . . . 0.0 110.816 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.0 mt -102.39 -40.9 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.158 -0.963 . . . . 0.0 110.884 -179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.43 ' CB ' ' O ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -52.19 -20.68 2.74 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.029 -1.045 . . . . 0.0 110.777 -179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 45' ' ' VAL . 11.1 p -113.92 44.5 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.21 -0.932 . . . . 0.0 110.85 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.613 ' CE ' HG21 ' A' ' 87' ' ' THR . 16.6 ptt? -111.8 26.58 10.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.032 -1.042 . . . . 0.0 110.163 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.436 ' HB2' ' HA ' ' A' ' 15' ' ' ALA . 3.5 tmm? 67.86 -2.39 1.43 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.583 -0.698 . . . . 0.0 111.086 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.608 ' O ' ' HZ ' ' A' ' 84' ' ' PHE . 14.3 mmt 42.35 31.23 0.25 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.211 -0.931 . . . . 0.0 110.988 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -125.01 -3.36 7.55 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.7 p -133.35 99.69 4.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.993 -1.298 . . . . 0.0 110.695 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.79 -28.0 67.06 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.302 -0.874 . . . . 0.0 109.824 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.942 ' HB3' HG21 ' A' ' 19' ' ' VAL . 8.3 tp60 -52.01 -27.78 14.74 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.428 -0.795 . . . . 0.0 110.043 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.826 ' CG2' HG22 ' A' ' 19' ' ' VAL . 19.3 t -87.68 -36.46 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.828 . . . . 0.0 109.489 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.564 ' HB2' ' HE1' ' A' ' 46' ' ' MET . . . -60.8 -40.16 91.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.428 -0.795 . . . . 0.0 110.424 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.474 ' O ' HD23 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -76.17 -39.95 53.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 0.0 110.614 -179.479 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.933 HD13 HG12 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -49.43 -64.59 0.76 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.335 -0.853 . . . . 0.0 111.54 -179.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.985 HD21 HD22 ' A' ' 10' ' ' LEU . 3.2 mt -67.25 -38.12 84.62 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.106 -0.996 . . . . 0.0 111.152 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.937 HD22 ' CG1' ' A' ' 90' ' ' VAL . 1.1 tp -52.79 -66.74 0.33 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.019 -1.051 . . . . 0.0 110.532 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 55' ' ' GLU . 4.0 pp -52.23 -27.57 15.3 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.283 -0.886 . . . . 0.0 110.004 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.474 ' N ' HD12 ' A' ' 59' ' ' LEU . 3.3 m80 -77.24 -68.42 0.62 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.368 -0.833 . . . . 0.0 110.073 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 170.25 38.34 0.03 OUTLIER Glycine 0 N--CA 1.484 1.842 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.861 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -60.16 -166.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.204 -1.174 . . . . 0.0 110.422 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -121.74 75.26 36.34 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 110.057 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.478 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . 48.5 Cg_endo -77.89 -21.35 11.07 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.831 1.437 . . . . 0.0 110.54 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -95.53 -47.69 6.14 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 0.0 110.457 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -58.58 172.96 0.44 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.276 -0.89 . . . . 0.0 110.22 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.448 ' HB2' ' NE ' ' A' ' 74' ' ' ARG . . . -169.27 -176.67 2.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.278 -0.889 . . . . 0.0 110.492 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -77.41 123.21 86.87 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.425 -0.797 . . . . 0.0 109.95 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.31 -13.98 20.61 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.681 1.358 . . . . 0.0 110.97 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.49 -20.95 56.44 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.197 -0.939 . . . . 0.0 110.85 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.762 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -155.03 27.15 0.42 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.082 -1.011 . . . . 0.0 110.877 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.647 ' HB2' ' H ' ' A' ' 103' ' ' ALA . 86.1 mt 43.14 45.11 4.62 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.277 -0.89 . . . . 0.0 111.417 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.42 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -93.39 103.48 15.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.223 -0.923 . . . . 0.0 110.56 -179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.798 ' HB2' HG11 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -85.54 179.38 1.89 Allowed Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.341 -0.849 . . . . 0.0 110.106 179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD2' ' CG ' ' A' ' 74' ' ' ARG . 48.8 Cg_endo -78.68 -18.29 12.01 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.544 1.286 . . . . 0.0 110.603 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.516 HG11 HD23 ' A' ' 98' ' ' LEU . 75.8 t -67.94 -36.31 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.221 -0.924 . . . . 0.0 110.107 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.557 ' HE1' HG13 ' A' ' 100' ' ' VAL . 74.7 m80 -68.4 -39.62 81.59 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.29 -0.881 . . . . 0.0 110.4 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' A' ' 81' ' ' ARG . 0.7 OUTLIER -57.67 -55.41 35.16 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.352 -0.843 . . . . 0.0 110.062 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -62.91 -18.47 63.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.251 -0.906 . . . . 0.0 110.082 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.743 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -82.27 -44.15 16.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.389 -0.819 . . . . 0.0 110.571 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -64.59 -20.57 66.33 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.186 -0.946 . . . . 0.0 110.126 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' N ' ' HG3' ' A' ' 81' ' ' ARG . 2.2 mm-40 -97.02 -48.04 5.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.299 -0.876 . . . . 0.0 110.017 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.49 14.43 10.57 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.608 ' HZ ' ' O ' ' A' ' 48' ' ' MET . 0.0 OUTLIER -78.66 80.05 5.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.124 -1.221 . . . . 0.0 109.804 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.41 ' HA ' HD13 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -60.07 -23.66 63.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.448 -0.783 . . . . 0.0 110.431 -179.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.4 t0 -61.54 -52.54 64.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.221 -0.924 . . . . 0.0 110.088 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.613 HG21 ' CE ' ' A' ' 46' ' ' MET . 37.6 m -58.59 -34.97 71.68 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.257 -0.902 . . . . 0.0 109.933 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.809 HD11 HD11 ' A' ' 120' ' ' ILE . 1.5 mp -57.4 -46.82 83.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.262 -0.899 . . . . 0.0 109.81 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 71.4 t -57.35 -46.94 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.451 -0.781 . . . . 0.0 109.288 179.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.937 ' CG1' HD22 ' A' ' 58' ' ' LEU . 49.4 t -50.77 -55.4 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.526 -0.734 . . . . 0.0 110.358 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.581 ' C ' ' HB2' ' A' ' 96' ' ' ALA . 1.0 OUTLIER -50.62 -63.11 1.23 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.233 -0.917 . . . . 0.0 110.161 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -61.28 -21.72 64.18 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.357 -0.839 . . . . 0.0 110.133 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 89' ' ' VAL . 48.4 ttt180 -77.91 -8.94 58.78 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.304 -0.873 . . . . 0.0 110.378 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.778 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -135.2 33.93 3.07 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.291 -0.881 . . . . 0.0 110.43 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 70.51 90.49 0.08 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.581 ' HB2' ' C ' ' A' ' 91' ' ' LEU . . . -120.75 154.98 34.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.389 -1.065 . . . . 0.0 110.316 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.56 75.15 7.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.43 -0.794 . . . . 0.0 110.209 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.516 HD23 HG11 ' A' ' 76' ' ' VAL . 3.7 mt -83.81 68.63 10.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.16 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -170.06 44.73 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.393 -0.817 . . . . 0.0 109.725 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.798 HG11 ' HB2' ' A' ' 74' ' ' ARG . 7.8 p -124.5 171.21 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.457 -0.777 . . . . 0.0 110.023 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.442 ' N ' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -121.81 136.71 54.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.253 -0.904 . . . . 0.0 109.281 179.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.589 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -69.37 73.91 0.35 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.845 . . . . 0.0 109.361 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.762 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 66.83 -69.07 0.13 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.344 0.592 . . . . 0.0 109.774 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.421 ' N ' ' O ' ' A' ' 102' ' ' ASP . 1.8 m-90 -140.88 35.5 1.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.482 -0.761 . . . . 0.0 109.379 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.537 ' O ' ' N ' ' A' ' 107' ' ' LEU . . . -107.38 24.54 24.11 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 120.004 -1.093 . . . . 0.0 110.388 -179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.572 ' C ' HD12 ' A' ' 107' ' ' LEU . 21.8 mtm180 59.52 -73.16 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.408 -1.054 . . . . 0.0 110.78 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.572 HD12 ' C ' ' A' ' 106' ' ' ARG . 0.7 OUTLIER -155.84 167.99 13.15 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.198 -0.939 . . . . 0.0 110.022 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.44 ' HB2' HG12 ' A' ' 76' ' ' VAL . 46.3 Cg_endo -70.82 -31.49 15.72 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 O-C-N 123.648 1.341 . . . . 0.0 110.47 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 121' ' ' ALA . 10.8 p -63.64 -38.99 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.285 -0.885 . . . . 0.0 110.042 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 109' ' ' VAL . 75.6 m-20 -66.09 -50.76 62.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.357 -0.839 . . . . 0.0 110.065 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.0 tt -55.54 -29.12 58.36 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.376 -0.828 . . . . 0.0 110.288 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.426 ' HB1' HG23 ' A' ' 120' ' ' ILE . . . -67.71 -75.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.421 -0.799 . . . . 0.0 110.216 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 109' ' ' VAL . 4.5 pt-20 -52.73 -27.2 16.65 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.284 -0.885 . . . . 0.0 110.779 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -58.71 -50.48 73.75 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.321 -0.862 . . . . 0.0 110.685 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 50.0 mm-40 -78.02 -76.65 0.18 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.347 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -167.72 34.81 0.21 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.644 -1.383 . . . . 0.0 109.644 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -122.77 79.37 1.63 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.333 -1.098 . . . . 0.0 109.925 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.9 mtp85 -81.22 -40.05 24.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.27 -0.894 . . . . 0.0 110.172 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -56.61 -43.44 80.15 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.315 -0.865 . . . . 0.0 110.273 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.809 HD11 HD11 ' A' ' 88' ' ' LEU . 17.0 tt -76.64 -38.42 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.386 -0.821 . . . . 0.0 109.982 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.634 ' O ' HG23 ' A' ' 109' ' ' VAL . . . -58.64 -44.78 90.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.559 -0.713 . . . . 0.0 110.006 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 37.0 mtp85 -61.99 -45.2 94.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.352 -0.842 . . . . 0.0 110.012 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -64.53 -37.12 86.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.418 -0.801 . . . . 0.0 109.956 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.684 ' O ' HG22 ' A' ' 128' ' ' THR . 12.1 mt -61.34 -58.94 6.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.328 -0.858 . . . . 0.0 110.196 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.619 ' ND1' HG21 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -53.22 -24.27 10.69 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.347 -0.846 . . . . 0.0 110.489 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -89.2 -11.18 44.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 0.0 110.476 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -128.73 12.08 6.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.967 . . . . 0.0 110.681 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.684 HG22 ' O ' ' A' ' 124' ' ' LEU . 11.9 t -118.61 -23.64 7.03 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.143 -0.973 . . . . 0.0 110.324 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.19 114.87 0.29 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 24.9 t0 . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.363 -1.08 . . . . 0.0 110.508 -179.826 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.213 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 1.1 t 62.24 152.49 0.11 Allowed Pre-proline 0 N--CA 1.497 1.888 0 O-C-N 121.368 -1.077 . . . . 0.0 110.218 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.98 160.21 46.33 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 O-C-N 123.675 1.355 . . . . 0.0 110.54 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -78.19 102.33 1.81 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' ILE . . . . . 0.7 HD13 ' O ' ' A' ' -1' ' ' ILE . 0.3 OUTLIER -80.59 -19.36 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.323 -1.104 . . . . 0.0 110.359 -179.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.411 ' O ' ' O ' ' A' ' 1' ' ' MET . 79.5 t60 54.91 97.53 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.182 -0.949 . . . . 0.0 110.593 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' O ' ' A' ' 0' ' ' HIS . 10.5 tmm? 58.25 119.3 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.539 -0.725 . . . . 0.0 110.937 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.8 mp -75.71 164.83 25.87 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.294 -0.879 . . . . 0.0 109.922 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -60.44 -26.84 64.87 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 122.1 -143.13 15.47 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 36.8 p -105.81 41.3 1.41 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.376 -1.073 . . . . 0.0 110.307 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.8 m -62.41 -84.52 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 0.0 109.941 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.684 ' OD2' ' HB1' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 54.89 14.69 0.95 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.172 -0.955 . . . . 0.0 110.894 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -124.59 -21.88 4.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.925 -1.11 . . . . 0.0 110.603 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.92 -29.21 50.54 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.835 HD11 HD12 ' A' ' 26' ' ' LEU . 63.1 tp -56.78 -53.72 54.52 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.367 -1.078 . . . . 0.0 110.545 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.497 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -65.69 -52.19 53.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.338 -0.851 . . . . 0.0 110.47 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.9 p -59.15 -46.67 87.77 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.351 -0.843 . . . . 0.0 110.452 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.513 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -59.69 -36.65 76.91 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.168 -0.957 . . . . 0.0 109.926 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.432 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -73.92 -31.71 63.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.903 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.562 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -72.72 -28.69 62.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.392 -0.817 . . . . 0.0 110.017 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 51.7 mtt-85 -90.44 11.16 22.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.35 -0.844 . . . . 0.0 110.323 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.11 58.5 13.27 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.669 ' O ' HG23 ' A' ' 22' ' ' VAL . 88.0 mm-40 -126.66 81.88 2.04 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -1.095 . . . . 0.0 110.379 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.673 HG22 HG23 ' A' ' 53' ' ' VAL . 53.8 t -60.43 -50.65 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.409 -0.807 . . . . 0.0 110.142 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -51.66 -51.66 54.05 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.283 -0.885 . . . . 0.0 110.55 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.0 m -61.82 -42.7 99.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.399 -0.813 . . . . 0.0 110.244 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.936 HG12 HD23 ' A' ' 56' ' ' LEU . 97.7 t -67.6 -38.22 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.355 -0.841 . . . . 0.0 110.207 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.509 ' HA ' HD22 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -69.65 -31.23 69.19 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.309 -0.869 . . . . 0.0 110.217 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.505 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 18.5 tm0? -80.48 -51.13 9.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.364 -0.835 . . . . 0.0 110.695 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.932 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -60.35 -60.92 3.05 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.254 -0.903 . . . . 0.0 110.483 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.865 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 1.2 tt -53.28 -43.68 67.65 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.215 -0.928 . . . . 0.0 110.588 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -78.1 1.51 20.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.329 -0.857 . . . . 0.0 110.533 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -105.84 -29.33 10.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 110.3 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 170.75 -26.87 0.1 Allowed Glycine 0 N--CA 1.484 1.858 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.456 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.932 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -48.56 135.25 14.68 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.199 -1.177 . . . . 0.0 110.9 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 30.7 t70 -87.96 141.43 31.44 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.0 110.164 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 46.1 Cg_endo -73.72 -28.35 11.72 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.663 1.349 . . . . 0.0 110.544 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -92.48 18.83 7.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 0.0 110.433 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.684 ' HB1' ' OD2' ' A' ' 7' ' ' ASP . . . -83.33 142.41 31.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.225 -0.922 . . . . 0.0 110.205 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.425 ' HA ' HD23 ' A' ' 35' ' ' LEU . 14.8 mt -99.47 153.84 18.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.364 -0.835 . . . . 0.0 110.196 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 47.1 p-10 -102.08 30.9 4.2 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.331 -0.855 . . . . 0.0 110.206 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 54.77 24.67 5.85 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.363 -0.835 . . . . 0.0 110.496 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.09 2.7 9.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.315 -0.866 . . . . 0.0 110.587 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 54.04 27.31 37.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.445 ' O ' ' CB ' ' A' ' 44' ' ' GLN . 0.5 OUTLIER -120.17 18.1 12.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.334 -1.098 . . . . 0.0 110.38 -179.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.49 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 21.1 mmt-85 53.73 175.63 0.03 OUTLIER Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 121.168 -0.958 . . . . 0.0 110.314 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.585 ' HG2' ' HB1' ' A' ' 62' ' ' ALA . 51.3 Cg_endo -85.17 -0.05 8.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.54 1.284 . . . . 0.0 111.154 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.605 HD13 HD22 ' A' ' 57' ' ' LEU . 50.7 mm -114.29 -41.39 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.987 -1.071 . . . . 0.0 110.628 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.445 ' CB ' ' O ' ' A' ' 40' ' ' ARG . 2.9 tt0 -57.58 -41.49 81.24 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.157 -0.965 . . . . 0.0 109.927 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 15' ' ' ALA . 11.5 p -75.74 -11.86 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.422 -0.799 . . . . 0.0 110.288 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.52 ' HE1' HG21 ' A' ' 87' ' ' THR . 2.3 ttm -51.34 150.07 3.7 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.337 -0.852 . . . . 0.0 110.431 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.405 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 5.0 tmm? -62.42 -15.76 51.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.399 -0.813 . . . . 0.0 110.265 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 55.44 26.27 8.68 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.216 -0.927 . . . . 0.0 110.192 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.14 19.37 5.75 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.487 ' N ' ' CZ ' ' A' ' 84' ' ' PHE . 19.8 t -157.84 101.83 1.81 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.46 -1.024 . . . . 0.0 110.243 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.447 ' HB2' ' CG ' ' A' ' 86' ' ' ASP . . . -57.82 -26.93 62.67 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.387 -0.82 . . . . 0.0 110.107 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.634 ' HB3' ' CG1' ' A' ' 19' ' ' VAL . 1.1 mp0 -54.82 -34.06 62.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.399 -0.813 . . . . 0.0 110.556 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.673 HG23 HG22 ' A' ' 19' ' ' VAL . 89.1 t -76.26 -62.76 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -0.865 . . . . 0.0 110.322 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.867 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -47.71 -27.6 2.05 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.393 -0.817 . . . . 0.0 110.894 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.541 ' HA ' HG11 ' A' ' 90' ' ' VAL . 18.0 tt0 -70.9 -56.05 7.09 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.406 -0.809 . . . . 0.0 110.452 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.936 HD23 HG12 ' A' ' 22' ' ' VAL . 15.4 tp -52.36 -56.28 15.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.331 -0.856 . . . . 0.0 110.681 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.605 HD22 HD13 ' A' ' 43' ' ' ILE . 3.2 mp -52.13 -53.92 36.84 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.326 -0.859 . . . . 0.0 110.731 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.639 ' CD2' ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -61.64 -28.19 69.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.31 -0.869 . . . . 0.0 110.375 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.0 tp -69.83 -38.18 76.46 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.359 -0.838 . . . . 0.0 110.222 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.3 m80 -83.97 -20.35 33.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.398 -0.814 . . . . 0.0 110.297 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 106.54 53.54 0.72 Allowed Glycine 0 N--CA 1.482 1.731 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.585 ' HB1' ' HG2' ' A' ' 42' ' ' PRO . . . -65.09 -147.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.269 -1.136 . . . . 0.0 109.803 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -125.81 70.69 66.61 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.09 -1.006 . . . . 0.0 110.365 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . 50.8 Cg_endo -82.36 -28.36 1.9 Allowed 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.799 1.421 . . . . 0.0 110.042 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 74' ' ' ARG . 2.6 m120 -79.65 -34.98 39.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.41 -0.806 . . . . 0.0 110.255 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.22 129.49 41.53 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.393 -0.817 . . . . 0.0 110.298 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.588 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -118.06 162.69 17.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.32 -0.862 . . . . 0.0 110.24 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 2.8 t0 -69.34 124.21 89.98 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.379 -0.826 . . . . 0.0 109.903 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.89 -23.41 16.4 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.592 1.311 . . . . 0.0 110.556 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -63.35 -33.21 75.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.337 -0.852 . . . . 0.0 110.512 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.788 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -146.63 24.7 1.22 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.284 -0.885 . . . . 0.0 110.42 -179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 45.26 49.87 9.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.373 -0.829 . . . . 0.0 110.863 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.7 HG23 ' OD1' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -99.48 131.8 45.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 0.0 110.36 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.89 ' CG ' HG11 ' A' ' 100' ' ' VAL . 9.8 mtp180 -101.54 165.89 13.25 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.479 -0.763 . . . . 0.0 110.166 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 43.1 Cg_endo -69.11 -11.7 32.33 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.66 1.347 . . . . 0.0 110.803 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.4 t -67.09 -28.29 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.256 -0.903 . . . . 0.0 109.948 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.667 ' HE1' HG13 ' A' ' 100' ' ' VAL . 72.1 m80 -67.75 -53.23 28.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 110.252 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.511 ' HA ' ' HG2' ' A' ' 81' ' ' ARG . 4.3 m-20 -51.84 -57.09 10.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.53 -0.731 . . . . 0.0 110.858 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.39 -16.05 59.35 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.314 -0.866 . . . . 0.0 110.693 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -91.53 -37.08 13.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.162 -0.961 . . . . 0.0 110.53 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.511 ' HG2' ' HA ' ' A' ' 78' ' ' ASP . 14.9 ptt180 -70.76 -18.67 62.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.327 -0.858 . . . . 0.0 110.826 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.95 11.17 38.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.176 -0.953 . . . . 0.0 110.707 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.472 ' HA3' ' CD2' ' A' ' 117' ' ' HIS . . . 56.89 42.15 92.1 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.487 ' CZ ' ' N ' ' A' ' 50' ' ' SER . 0.7 OUTLIER -110.81 98.39 7.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.485 -1.009 . . . . 0.0 110.147 -179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.421 HD12 ' HB2' ' A' ' 119' ' ' ASP . 0.6 OUTLIER -84.15 -34.05 24.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 0.0 110.35 -179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 87' ' ' THR . 14.5 p30 -51.07 -44.43 61.16 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.244 -0.91 . . . . 0.0 110.599 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.867 HG23 ' CB ' ' A' ' 54' ' ' ALA . 45.1 m -76.21 -31.77 58.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.148 -0.97 . . . . 0.0 109.456 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.558 HD22 HG13 ' A' ' 120' ' ' ILE . 8.2 tp -60.48 -37.59 81.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.466 -0.771 . . . . 0.0 109.429 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 97.3 t -68.22 -44.04 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.507 -0.746 . . . . 0.0 109.325 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.574 HG12 HD13 ' A' ' 58' ' ' LEU . 66.9 t -56.77 -41.64 75.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.46 -0.775 . . . . 0.0 110.172 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.452 ' HA ' HD21 ' A' ' 58' ' ' LEU . 2.5 mt -60.03 -52.03 67.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.438 -0.789 . . . . 0.0 109.984 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -72.09 -29.4 64.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 0.0 109.762 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -68.01 -57.76 5.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.439 -0.788 . . . . 0.0 109.89 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.639 ' HB3' ' CD2' ' A' ' 58' ' ' LEU . . . -70.49 -61.85 1.61 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.412 -0.805 . . . . 0.0 110.365 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 170.86 105.92 0.19 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.407 ' HB3' ' C ' ' A' ' 91' ' ' LEU . . . -168.04 133.42 1.86 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.275 -1.132 . . . . 0.0 110.245 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.498 ' CZ ' ' HB ' ' A' ' 100' ' ' VAL . 3.7 ttp180 -65.75 163.43 16.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.853 . . . . 0.0 110.263 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.412 HD23 ' HB3' ' A' ' 127' ' ' ALA . 1.1 tp -148.4 48.59 1.03 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.452 -0.78 . . . . 0.0 109.931 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.843 ' HA ' HG23 ' A' ' 128' ' ' THR . 48.2 t0 -159.31 50.13 0.34 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.391 -0.818 . . . . 0.0 110.054 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.89 HG11 ' CG ' ' A' ' 74' ' ' ARG . 13.2 p -122.7 168.6 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.512 -0.742 . . . . 0.0 110.178 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.605 ' SG ' HD11 ' A' ' 107' ' ' LEU . 0.4 OUTLIER -132.87 166.85 21.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.261 -0.899 . . . . 0.0 109.256 179.388 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.7 ' OD1' HG23 ' A' ' 73' ' ' THR . 4.9 t0 -70.22 71.94 0.44 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.889 . . . . 0.0 109.824 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.788 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 60.84 -79.63 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.642 -0.661 . . . . 0.0 110.051 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.443 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.3 p90 -133.64 26.81 4.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 109.478 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -111.65 -139.38 7.81 Favored Glycine 0 N--CA 1.491 2.303 0 C-N-CA 119.962 -1.113 . . . . 0.0 110.636 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.19 -168.95 2.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.532 -0.981 . . . . 0.0 111.046 -179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.605 HD11 ' SG ' ' A' ' 101' ' ' CYS . 0.3 OUTLIER -119.17 176.41 1.73 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.653 -0.655 . . . . 0.0 109.864 -179.96 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 46.0 Cg_endo -71.29 -27.31 19.76 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.542 1.285 . . . . 0.0 110.263 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.604 ' HA ' HD13 ' A' ' 124' ' ' LEU . 12.5 p -78.05 -37.81 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.395 -0.815 . . . . 0.0 110.337 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.467 ' N ' HG13 ' A' ' 109' ' ' VAL . 74.5 m-20 -66.45 -42.58 87.42 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.37 -0.831 . . . . 0.0 110.237 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 111' ' ' LEU . 1.6 tt -59.76 -36.15 76.06 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.332 -0.855 . . . . 0.0 110.164 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.702 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -61.32 -59.9 4.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.381 -0.825 . . . . 0.0 110.028 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -52.29 -27.18 14.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.385 -0.822 . . . . 0.0 110.465 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.13 -42.96 96.61 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.352 -0.843 . . . . 0.0 110.175 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.44 ' HB3' ' CE1' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -80.98 -32.4 34.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.312 -0.867 . . . . 0.0 110.262 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 118.22 29.16 2.01 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.532 ' CB ' HG22 ' A' ' 120' ' ' ILE . 29.9 m170 -90.85 72.62 6.57 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.346 -1.091 . . . . 0.0 109.984 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -58.75 -28.25 65.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.387 -0.82 . . . . 0.0 110.386 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.421 ' HB2' HD12 ' A' ' 85' ' ' LEU . 12.4 p-10 -74.88 -41.01 60.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.287 -0.883 . . . . 0.0 110.311 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.702 ' CG2' ' HB1' ' A' ' 112' ' ' ALA . 1.9 tt -79.18 -34.02 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.212 -0.93 . . . . 0.0 109.962 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.0 -29.06 69.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.84 . . . . 0.0 109.842 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 126' ' ' ALA . 1.1 ttt180 -73.26 -53.08 11.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 0.0 109.882 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -62.07 -30.13 70.78 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 0.0 110.106 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.604 HD13 ' HA ' ' A' ' 109' ' ' VAL . 36.4 mt -71.15 -71.65 0.25 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.442 -0.786 . . . . 0.0 110.556 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -53.1 -28.49 25.65 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.268 -0.895 . . . . 0.0 110.235 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 122' ' ' ARG . . . -63.92 -36.15 83.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.293 -0.879 . . . . 0.0 109.68 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.412 ' HB3' HD23 ' A' ' 98' ' ' LEU . . . -120.24 23.81 10.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.405 -0.809 . . . . 0.0 110.084 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.843 HG23 ' HA ' ' A' ' 99' ' ' ASP . 89.4 m -131.64 -43.68 1.0 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.332 -0.855 . . . . 0.0 110.327 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -108.57 6.31 33.53 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.1 -1.235 . . . . 0.0 110.596 -179.938 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 47.5 t 51.93 71.52 1.46 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.375 -1.074 . . . . 0.0 110.428 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.94 172.04 15.42 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.744 1.392 . . . . 0.0 110.447 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . 84.24 -0.19 89.4 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' ILE . . . . . 0.434 ' HA ' HD12 ' A' ' -1' ' ' ILE . 10.7 tp -66.84 160.64 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.138 -1.213 . . . . 0.0 110.215 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -103.65 -19.8 14.21 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.325 -0.859 . . . . 0.0 110.909 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -149.82 0.27 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.256 -0.903 . . . . 0.0 110.825 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 53.2 mt -78.08 -155.9 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.227 -0.92 . . . . 0.0 110.426 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.63 -100.05 0.56 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.66 162.19 1.66 Allowed Glycine 0 N--CA 1.495 2.63 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 77.7 p -166.61 -68.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.082 -1.246 . . . . 0.0 111.255 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.56 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -61.57 -80.64 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.425 -0.797 . . . . 0.0 111.183 -178.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.9 t0 54.38 -81.28 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.202 -0.936 . . . . 0.0 109.999 -179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 6' ' ' SER . . . -87.28 29.1 0.88 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 110.386 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.2 -34.24 53.08 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.863 HD13 ' CD2' ' A' ' 57' ' ' LEU . 4.0 pp -53.47 -28.39 30.27 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.623 -0.928 . . . . 0.0 110.049 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.776 ' N ' HD12 ' A' ' 10' ' ' LEU . . . -81.45 -43.81 18.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.445 -0.784 . . . . 0.0 110.209 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 73.1 p -59.11 -57.73 11.77 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.332 -0.855 . . . . 0.0 109.899 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.5 -34.78 69.43 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.3 -0.875 . . . . 0.0 109.787 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.778 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -64.05 -41.69 97.28 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.557 -0.714 . . . . 0.0 109.742 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.404 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -58.92 -30.65 67.99 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.347 -0.845 . . . . 0.0 110.063 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -84.82 5.51 28.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.382 -0.824 . . . . 0.0 110.536 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 68.29 42.4 83.06 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.186 -1.565 . . . . 0.0 109.186 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.51 ' O ' HG23 ' A' ' 22' ' ' VAL . 77.2 mt-30 -112.39 74.85 0.88 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.469 -1.019 . . . . 0.0 110.432 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.71 HG21 ' CB ' ' A' ' 52' ' ' GLN . 42.4 t -57.7 -38.41 64.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.286 -0.884 . . . . 0.0 109.568 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -57.52 -49.08 77.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.811 . . . . 0.0 110.193 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 m -67.18 -39.26 86.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.383 -0.823 . . . . 0.0 110.004 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.913 HG12 HD13 ' A' ' 56' ' ' LEU . 58.2 t -69.83 -29.85 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.434 -0.791 . . . . 0.0 109.757 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.7 ' HA ' HD11 ' A' ' 56' ' ' LEU . 6.0 mmt180 -68.38 -32.67 72.91 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.479 -0.763 . . . . 0.0 110.145 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 79.0 mt-30 -79.31 -52.73 7.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 0.0 110.579 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.611 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -52.0 -54.6 27.97 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.283 -0.886 . . . . 0.0 110.599 -179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.689 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -55.43 -61.63 2.21 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.232 -0.918 . . . . 0.0 110.432 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.22 -23.9 64.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.356 -0.84 . . . . 0.0 110.402 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -72.56 -61.79 1.68 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.238 -0.913 . . . . 0.0 110.297 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 176.48 50.03 0.06 OUTLIER Glycine 0 N--CA 1.48 1.632 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . . . -101.58 135.38 43.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.287 -1.125 . . . . 0.0 110.241 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 3.0 t70 -65.0 140.03 97.98 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.364 -0.835 . . . . 0.0 109.801 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -75.17 -3.35 13.78 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.665 1.35 . . . . 0.0 111.049 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -130.84 17.39 5.17 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.008 -1.058 . . . . 0.0 111.108 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.429 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -65.32 93.46 0.14 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.06 -1.025 . . . . 0.0 109.6 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 6.3 mt -51.9 172.36 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.322 -0.861 . . . . 0.0 110.867 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -103.02 -163.0 0.96 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.471 -0.768 . . . . 0.0 110.075 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.4 mpt_? -96.07 -20.48 18.63 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 0.0 110.418 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.72 33.3 1.67 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.258 -0.901 . . . . 0.0 109.781 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.41 26.01 21.38 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.423 ' HG3' ' CB ' ' A' ' 44' ' ' GLN . 2.1 tpp85 -102.56 163.02 12.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.437 -1.037 . . . . 0.0 110.194 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.477 ' CB ' ' HD2' ' A' ' 42' ' ' PRO . 0.0 OUTLIER -81.0 179.4 1.93 Allowed Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.442 -0.786 . . . . 0.0 110.042 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.5 ' HB2' HD22 ' A' ' 57' ' ' LEU . 42.4 Cg_endo -69.87 -25.63 27.87 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.593 1.312 . . . . 0.0 110.933 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.482 ' O ' ' CG ' ' A' ' 46' ' ' MET . 10.6 mt -102.34 -34.97 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.148 -0.97 . . . . 0.0 109.847 179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.423 ' CB ' ' HG3' ' A' ' 40' ' ' ARG . 56.8 mt-30 -54.74 -17.72 3.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.049 -1.032 . . . . 0.0 110.783 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 45' ' ' VAL . 11.7 p -115.27 26.37 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.095 -1.003 . . . . 0.0 110.575 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.686 ' HE1' HG21 ' A' ' 87' ' ' THR . 0.4 OUTLIER -95.73 32.07 1.92 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.187 -0.945 . . . . 0.0 110.2 179.67 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.416 ' CB ' ' O ' ' A' ' 46' ' ' MET . 3.4 tmm? 68.41 -7.4 0.69 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.469 -0.769 . . . . 0.0 111.102 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.451 ' CE ' ' HB3' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 46.9 27.28 0.69 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.003 -1.06 . . . . 0.0 110.716 179.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.46 ' HA2' ' CD2' ' A' ' 84' ' ' PHE . . . -130.67 13.45 5.6 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.0 p -143.78 90.34 2.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.253 -1.145 . . . . 0.0 110.257 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.46 -26.31 12.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.918 . . . . 0.0 110.19 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.71 ' CB ' HG21 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -55.13 -34.24 63.57 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.397 -0.815 . . . . 0.0 110.247 179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.778 HG11 ' HB1' ' A' ' 14' ' ' ALA . 26.8 t -83.41 -33.06 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.466 -0.771 . . . . 0.0 110.465 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.649 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -63.08 -52.34 63.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.194 -0.941 . . . . 0.0 110.216 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.63 ' O ' HD23 ' A' ' 59' ' ' LEU . 12.3 pt-20 -66.55 -34.03 77.01 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.429 -0.794 . . . . 0.0 110.564 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.913 HD13 HG12 ' A' ' 22' ' ' VAL . 1.6 tt -53.3 -63.58 1.1 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.288 -0.883 . . . . 0.0 110.736 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.863 ' CD2' HD13 ' A' ' 10' ' ' LEU . 1.8 mt -70.4 -33.76 71.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.373 -0.83 . . . . 0.0 110.654 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.013 HD21 ' HB2' ' A' ' 94' ' ' ALA . 0.6 OUTLIER -58.14 -61.51 2.51 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -0.921 . . . . 0.0 110.409 -179.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.63 HD23 ' O ' ' A' ' 55' ' ' GLU . 3.1 pp -60.06 -25.1 65.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 110.448 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.627 ' CE1' HD12 ' A' ' 26' ' ' LEU . 2.9 m-70 -78.61 -63.55 1.38 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.344 -0.848 . . . . 0.0 110.228 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 172.85 38.16 0.04 OUTLIER Glycine 0 N--CA 1.484 1.844 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.492 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -71.02 -175.67 1.2 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.053 -1.263 . . . . 0.0 110.242 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -119.12 76.8 15.93 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.492 -0.755 . . . . 0.0 110.002 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.641 ' HB2' ' HB2' ' A' ' 96' ' ' ALA . 47.5 Cg_endo -76.56 -5.72 16.34 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.86 1.453 . . . . 0.0 110.632 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.93 -51.95 2.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.316 -0.865 . . . . 0.0 110.049 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.24 134.73 39.18 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.366 -0.834 . . . . 0.0 110.445 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.883 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -119.51 -174.79 2.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.358 -0.839 . . . . 0.0 110.394 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 16.7 t0 -86.59 127.52 60.26 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.549 -0.719 . . . . 0.0 109.994 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.31 -29.49 11.3 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.518 1.273 . . . . 0.0 110.57 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.62 80.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.361 -0.837 . . . . 0.0 110.411 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.811 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 0.8 OUTLIER -143.76 38.88 1.36 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.255 -0.903 . . . . 0.0 110.557 -179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.535 ' C ' ' O ' ' A' ' 71' ' ' THR . 1.6 mt 25.45 61.83 0.06 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.765 -0.584 . . . . 0.0 111.561 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.0 OUTLIER -113.08 119.81 39.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.259 -0.9 . . . . 0.0 110.468 -179.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.883 ' HG2' ' HB2' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -93.39 173.33 4.94 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.479 -0.763 . . . . 0.0 110.345 179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.463 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 45.1 Cg_endo -71.87 -22.26 23.65 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.835 1.439 . . . . 0.0 110.33 179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 52.0 t -59.45 -39.0 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.322 -0.861 . . . . 0.0 109.981 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.538 ' HE1' HG13 ' A' ' 100' ' ' VAL . 73.5 m80 -64.1 -45.19 89.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.404 -0.81 . . . . 0.0 110.09 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.451 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 0.3 OUTLIER -52.82 -65.7 0.51 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.447 -0.783 . . . . 0.0 110.429 -179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.68 -26.77 24.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.33 -0.856 . . . . 0.0 110.132 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.66 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -78.28 -43.05 29.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 0.0 109.754 179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -61.32 -21.75 64.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 0.0 110.223 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.41 -32.47 12.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 0.0 109.735 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.82 24.9 24.18 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.46 ' CD2' ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -88.95 93.81 9.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.226 -1.161 . . . . 0.0 109.993 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.463 HD21 ' O ' ' A' ' 119' ' ' ASP . 0.1 OUTLIER -61.97 -34.71 76.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.526 -0.733 . . . . 0.0 110.798 -179.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.491 ' O ' HG23 ' A' ' 90' ' ' VAL . 39.5 t0 -58.67 -35.65 72.91 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.247 -0.908 . . . . 0.0 110.97 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.686 HG21 ' HE1' ' A' ' 46' ' ' MET . 0.2 OUTLIER -75.15 -41.03 59.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.007 -1.058 . . . . 0.0 110.228 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.96 HD22 HG13 ' A' ' 120' ' ' ILE . 2.4 tp -55.3 -40.79 71.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.349 -0.845 . . . . 0.0 109.873 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 84.2 t -62.39 -45.72 98.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.417 -0.802 . . . . 0.0 109.373 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.723 HG12 HD13 ' A' ' 58' ' ' LEU . 88.1 t -53.72 -45.86 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.551 -0.718 . . . . 0.0 110.227 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 96' ' ' ALA . 6.2 mp -64.78 -20.93 66.64 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.399 -0.813 . . . . 0.0 110.676 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -78.13 -62.78 1.57 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.196 -0.94 . . . . 0.0 110.715 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.704 HH21 HG22 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -54.1 -33.06 56.73 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.469 -0.769 . . . . 0.0 110.553 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.013 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -68.69 -34.89 76.44 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.284 -0.885 . . . . 0.0 110.216 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 111.15 45.79 0.85 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.641 ' HB2' ' HB2' ' A' ' 64' ' ' PRO . . . -97.9 138.62 34.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.403 -1.057 . . . . 0.0 110.321 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.2 ttt180 -73.0 151.84 41.6 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.405 -0.81 . . . . 0.0 110.225 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.81 HD23 HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -127.35 -8.15 5.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.395 -0.816 . . . . 0.0 110.843 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -92.73 39.94 1.04 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.207 -0.933 . . . . 0.0 110.807 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.774 HG21 ' HG3' ' A' ' 74' ' ' ARG . 14.6 p -100.65 148.33 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.278 -0.889 . . . . 0.0 110.039 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 71.9 m -99.17 154.2 18.32 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.293 -0.879 . . . . 0.0 110.231 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.549 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 27.1 p-10 -81.86 57.01 3.27 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.303 -0.873 . . . . 0.0 110.253 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.811 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 64.95 -67.9 0.11 Allowed 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.598 -0.688 . . . . 0.0 110.586 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.44 ' N ' ' O ' ' A' ' 102' ' ' ASP . 1.7 m95 -59.37 -61.14 2.85 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.261 -0.899 . . . . 0.0 110.169 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 167.01 -28.89 0.18 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -56.5 124.05 16.88 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.252 -1.146 . . . . 0.0 110.43 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.479 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 82.3 mt -80.06 167.02 36.6 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.38 -0.825 . . . . 0.0 110.081 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.9 Cg_endo -69.65 -23.36 31.36 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.642 1.338 . . . . 0.0 110.378 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.732 ' HA ' HD13 ' A' ' 124' ' ' LEU . 14.4 p -75.41 -35.67 33.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.43 -0.794 . . . . 0.0 109.956 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.43 ' N ' HG13 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -67.15 -42.1 84.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.492 -0.755 . . . . 0.0 109.705 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.3 mt -62.06 -30.32 70.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.44 -0.788 . . . . 0.0 109.944 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.585 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -65.33 -73.38 0.13 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.503 -0.748 . . . . 0.0 109.954 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.449 ' N ' ' HB2' ' A' ' 121' ' ' ALA . 1.3 pt-20 -53.37 -22.19 7.08 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.461 -0.775 . . . . 0.0 110.949 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -67.49 -71.22 0.21 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.244 -0.91 . . . . 0.0 110.642 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -59.69 -94.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.284 -0.885 . . . . 0.0 110.711 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -151.45 30.63 0.95 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -110.56 79.11 1.17 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.375 -1.074 . . . . 0.0 109.7 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.8 ttm-85 -79.31 -42.25 26.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.283 -0.885 . . . . 0.0 109.88 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.463 ' O ' HD21 ' A' ' 85' ' ' LEU . 20.7 p-10 -59.37 -37.35 77.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.442 -0.786 . . . . 0.0 110.049 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.96 HG13 HD22 ' A' ' 88' ' ' LEU . 3.1 tt -80.48 -31.32 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.327 -0.858 . . . . 0.0 109.755 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.449 ' HB2' ' N ' ' A' ' 113' ' ' GLU . . . -63.78 -54.17 39.33 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.922 0.868 . . . . 0.0 109.815 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.509 ' HA ' ' CE1' ' A' ' 125' ' ' HIS . 8.3 ttt-85 -59.11 -52.96 63.48 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.866 -0.521 . . . . 0.0 110.347 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.751 ' HD2' HD23 ' A' ' 88' ' ' LEU . 78.9 t80 -61.07 -26.67 67.81 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.089 -1.007 . . . . 0.0 110.363 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.841 ' O ' HG22 ' A' ' 128' ' ' THR . 4.1 mt -66.63 -60.07 3.04 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.261 -0.899 . . . . 0.0 110.667 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.509 ' CE1' ' HA ' ' A' ' 122' ' ' ARG . 2.6 p-80 -54.95 -24.68 25.01 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.263 -0.898 . . . . 0.0 110.519 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.457 ' N ' ' CD2' ' A' ' 125' ' ' HIS . . . -77.13 -24.89 51.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 110.633 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -107.65 -23.96 11.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.297 -0.877 . . . . 0.0 110.995 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.841 HG22 ' O ' ' A' ' 124' ' ' LEU . 10.0 t -92.12 15.64 13.04 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.144 -0.973 . . . . 0.0 110.959 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -166.1 -67.36 0.03 OUTLIER Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.444 ' HB2' ' HA ' ' A' ' 126' ' ' ALA . 1.8 m-20 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.41 -1.053 . . . . 0.0 110.489 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 26.3 t -91.35 150.84 42.08 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.313 -1.11 . . . . 0.0 110.121 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -74.02 -37.51 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.786 1.414 . . . . 0.0 110.381 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . 90.94 63.55 1.2 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' ILE . . . . . 0.432 HG23 ' H ' ' A' ' 0' ' ' HIS . 2.3 tp -159.77 -47.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -1.13 . . . . 0.0 110.158 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.432 ' H ' HG23 ' A' ' -1' ' ' ILE . 64.4 t-80 -177.2 137.09 0.21 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.208 -0.932 . . . . 0.0 110.337 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -170.52 149.1 3.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.286 -0.884 . . . . 0.0 110.213 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.54 HD12 ' N ' ' A' ' 2' ' ' LEU . 6.4 mp -75.67 158.18 32.69 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.267 -0.896 . . . . 0.0 110.157 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -108.24 113.31 3.81 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.71 69.22 0.41 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.9 p -61.86 -168.93 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.36 -1.082 . . . . 0.0 110.207 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.5 m -94.74 123.89 38.46 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.409 -0.807 . . . . 0.0 110.225 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.458 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 56.2 m-20 -120.73 174.89 6.31 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 0.0 110.172 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 7' ' ' ASP . . . 58.35 19.59 6.51 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.398 -0.814 . . . . 0.0 110.508 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -76.97 -17.45 79.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.728 HD11 HD13 ' A' ' 26' ' ' LEU . 60.4 mt -78.9 -44.24 23.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.355 -1.085 . . . . 0.0 109.819 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -62.31 -44.86 95.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.496 -0.752 . . . . 0.0 110.065 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.0 p -57.12 -55.51 33.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.298 -0.876 . . . . 0.0 109.94 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.88 -31.96 72.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.34 -0.85 . . . . 0.0 109.898 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -65.18 -49.92 67.93 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.824 . . . . 0.0 110.141 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.772 ' HB2' ' O ' ' A' ' 45' ' ' VAL . . . -63.91 -23.97 67.55 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.353 -0.842 . . . . 0.0 110.147 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -91.52 3.48 54.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 0.0 110.636 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 67.61 45.97 72.6 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -110.96 66.12 0.62 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.358 -1.084 . . . . 0.0 110.231 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.833 HG22 HG23 ' A' ' 53' ' ' VAL . 19.1 t -52.31 -34.63 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.324 -0.86 . . . . 0.0 110.113 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -65.55 -54.64 25.19 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.405 -0.809 . . . . 0.0 110.937 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.6 m -57.3 -34.94 69.22 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.235 -0.915 . . . . 0.0 110.941 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.668 HG12 HD13 ' A' ' 56' ' ' LEU . 58.9 t -73.59 -26.71 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.261 -0.9 . . . . 0.0 110.417 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.734 ' HA ' HD11 ' A' ' 56' ' ' LEU . 18.9 mmt180 -68.59 -45.75 71.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.202 -0.936 . . . . 0.0 110.476 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 11.8 tm0? -73.81 -58.44 3.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.452 -0.78 . . . . 0.0 111.28 -179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.905 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.7 OUTLIER -55.25 -53.49 55.41 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.252 -0.905 . . . . 0.0 111.328 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.861 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -52.61 -61.29 2.38 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.134 -0.979 . . . . 0.0 111.147 -179.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -65.49 -13.07 58.04 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.136 -0.977 . . . . 0.0 110.688 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -83.28 -26.71 30.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -0.989 . . . . 0.0 110.743 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 154.07 -7.64 0.39 Allowed Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.643 -1.265 . . . . 0.0 111.326 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.905 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -50.95 142.46 11.84 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.842 -1.387 . . . . 0.0 110.77 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.647 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 27.0 t70 -72.83 125.33 91.21 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.453 -0.779 . . . . 0.0 110.21 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.65 -21.05 22.43 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.573 1.302 . . . . 0.0 110.765 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.37 26.31 10.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.194 -0.941 . . . . 0.0 110.262 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.647 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -73.37 135.16 44.25 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.313 -0.867 . . . . 0.0 110.156 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.0 mt -84.22 170.13 14.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.833 . . . . 0.0 110.149 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.526 ' OD1' HG21 ' A' ' 45' ' ' VAL . 2.5 t-20 -106.94 -168.47 1.41 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.417 -0.802 . . . . 0.0 110.167 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ttt180 -77.92 -23.44 48.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.389 -0.819 . . . . 0.0 110.27 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -96.28 25.38 4.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.315 -0.865 . . . . 0.0 110.095 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.54 32.09 37.98 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.05 -156.57 0.55 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.446 -1.032 . . . . 0.0 110.283 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.617 ' O ' HG12 ' A' ' 45' ' ' VAL . 28.0 mmt-85 -110.49 170.29 5.46 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.541 -0.724 . . . . 0.0 109.598 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.604 ' HB2' HD22 ' A' ' 57' ' ' LEU . 41.0 Cg_endo -68.01 -21.67 42.87 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.484 1.254 . . . . 0.0 110.334 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.564 ' O ' ' HG2' ' A' ' 46' ' ' MET . 73.4 mt -107.67 -44.1 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.272 -0.892 . . . . 0.0 109.703 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.58 -22.54 3.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.155 -0.966 . . . . 0.0 110.501 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.772 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 7.1 p -105.29 25.73 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 0.0 110.798 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.906 ' HE2' ' HB2' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -95.83 165.63 12.19 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.102 -0.999 . . . . 0.0 109.891 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.411 ' N ' ' HA ' ' A' ' 15' ' ' ALA . 9.5 tmm? -61.06 -13.17 15.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.275 -0.891 . . . . 0.0 110.677 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 23.0 mmt 55.3 23.23 5.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.256 -0.902 . . . . 0.0 110.327 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -115.37 -19.71 5.74 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.416 ' HB3' ' CG2' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -118.15 105.77 12.16 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.234 -1.156 . . . . 0.0 110.341 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' ' 86' ' ' ASP . . . -59.36 -22.42 61.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.306 -0.872 . . . . 0.0 110.598 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.796 ' HB2' ' CG2' ' A' ' 19' ' ' VAL . 3.4 mm-40 -61.46 -18.16 57.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.244 -0.91 . . . . 0.0 110.434 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.833 HG23 HG22 ' A' ' 19' ' ' VAL . 88.4 t -86.26 -41.7 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.714 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.906 ' HB2' ' HE2' ' A' ' 46' ' ' MET . . . -72.45 -25.31 61.4 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.502 -0.749 . . . . 0.0 110.166 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.46 ' HA ' HG11 ' A' ' 90' ' ' VAL . 7.7 tm-20 -79.03 -43.94 23.25 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.375 -0.828 . . . . 0.0 110.346 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.734 HD11 ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -59.06 -63.06 1.44 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.372 -0.83 . . . . 0.0 110.481 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.801 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 4.0 mt -52.52 -48.76 65.85 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.445 -0.784 . . . . 0.0 110.679 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.622 HD11 ' HB3' ' A' ' 94' ' ' ALA . 0.7 OUTLIER -58.11 -38.65 76.9 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.35 -0.844 . . . . 0.0 110.213 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.8 tp -63.85 -33.69 76.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.366 -0.834 . . . . 0.0 110.188 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.461 ' CE1' ' HG ' ' A' ' 26' ' ' LEU . 12.5 m170 -84.69 -63.84 1.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 110.013 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 167.26 54.38 0.03 OUTLIER Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.965 -1.254 . . . . 0.0 109.965 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -69.76 -158.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.305 -1.115 . . . . 0.0 110.112 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -126.71 71.87 74.01 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.368 -0.833 . . . . 0.0 109.988 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.424 ' HA ' ' HG3' ' A' ' 75' ' ' PRO . 49.6 Cg_endo -79.43 -21.36 8.93 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 123.809 1.426 . . . . 0.0 110.59 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -89.33 -52.55 4.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.857 . . . . 0.0 110.31 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.27 166.42 1.16 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.34 -0.85 . . . . 0.0 110.481 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -146.54 -167.75 2.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 0.0 110.198 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.472 ' OD1' ' HB3' ' A' ' 70' ' ' ALA . 7.4 t70 -86.77 127.23 60.89 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.094 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.76 -25.28 14.76 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.573 1.302 . . . . 0.0 110.378 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.472 ' HB3' ' OD1' ' A' ' 68' ' ' ASP . . . -63.66 -51.43 65.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.373 -0.829 . . . . 0.0 110.372 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.806 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -124.78 26.63 7.06 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.334 -0.854 . . . . 0.0 110.463 -179.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 44.17 37.73 2.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.334 -0.854 . . . . 0.0 110.959 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.5 125.67 42.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.298 -0.876 . . . . 0.0 110.559 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.594 ' HD2' ' HB ' ' A' ' 76' ' ' VAL . 0.5 OUTLIER -94.4 -175.99 0.52 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.0 110.144 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.559 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 47.7 Cg_endo -75.81 -35.45 2.59 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 O-C-N 123.386 1.203 . . . . 0.0 111.622 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.628 ' CG1' HD23 ' A' ' 98' ' ' LEU . 93.5 t -52.92 -31.61 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.049 -1.032 . . . . 0.0 110.301 -179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.403 ' CE1' ' HB3' ' A' ' 108' ' ' PRO . 14.8 m80 -62.29 -44.34 96.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 109.969 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.68 -49.23 66.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.386 -0.821 . . . . 0.0 110.082 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.639 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -53.89 -28.44 36.44 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.32 -0.862 . . . . 0.0 110.109 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -86.01 -30.31 22.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.384 -0.823 . . . . 0.0 109.805 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.413 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 2.5 mmt85 -61.0 -24.62 66.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.462 -0.774 . . . . 0.0 110.235 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -100.58 -27.27 13.49 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 110.416 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.73 35.35 6.88 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.65 ' HD1' ' HB2' ' A' ' 86' ' ' ASP . 0.2 OUTLIER -98.68 94.64 6.75 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.446 -1.032 . . . . 0.0 110.251 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.885 HD22 HD12 ' A' ' 120' ' ' ILE . 3.5 mm? -64.75 -25.67 68.02 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.356 -0.84 . . . . 0.0 110.524 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.669 ' O ' HG23 ' A' ' 90' ' ' VAL . 2.9 m-20 -61.66 -56.36 20.57 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.192 -0.942 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.527 HG23 ' CB ' ' A' ' 54' ' ' ALA . 23.1 m -57.6 -42.77 83.91 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.241 -0.912 . . . . 0.0 109.991 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.99 HD13 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -57.68 -44.42 85.77 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.325 -0.859 . . . . 0.0 109.772 179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.746 HG23 ' O ' ' A' ' 85' ' ' LEU . 86.9 t -63.84 -42.51 96.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.373 -0.83 . . . . 0.0 109.003 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.669 HG23 ' O ' ' A' ' 86' ' ' ASP . 93.4 t -57.21 -46.18 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.647 -0.658 . . . . 0.0 109.981 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.672 ' O ' ' HB2' ' A' ' 96' ' ' ALA . 5.6 mp -61.8 -47.04 86.92 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.418 -0.801 . . . . 0.0 109.929 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.414 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 2.7 t-160 -66.34 -26.25 67.2 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 110.165 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -68.38 -30.67 69.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.38 -0.825 . . . . 0.0 110.267 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.622 ' HB3' HD11 ' A' ' 58' ' ' LEU . . . -114.47 41.84 2.23 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.361 -0.837 . . . . 0.0 110.406 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.33 109.97 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.672 ' HB2' ' O ' ' A' ' 91' ' ' LEU . . . -149.01 105.46 3.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.356 -1.085 . . . . 0.0 110.722 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.509 ' O ' ' NE ' ' A' ' 74' ' ' ARG . 0.3 OUTLIER -58.91 107.28 0.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.395 -0.816 . . . . 0.0 109.133 179.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.746 ' O ' HG23 ' A' ' 128' ' ' THR . 1.1 mt -104.14 23.62 12.73 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.166 -0.959 . . . . 0.0 110.347 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.422 ' HA ' HG23 ' A' ' 128' ' ' THR . 18.8 t0 -126.95 17.64 7.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.852 . . . . 0.0 110.499 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 74' ' ' ARG . 3.4 p -67.98 162.0 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 109.81 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 93.7 m -100.64 137.17 39.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 110.025 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 104' ' ' TRP . 13.0 t70 -73.71 60.69 0.71 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.243 -0.911 . . . . 0.0 110.294 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 58.17 -79.6 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.591 -0.693 . . . . 0.0 110.655 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.471 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.9 OUTLIER -53.76 -42.92 68.73 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.269 -0.894 . . . . 0.0 110.115 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 146.25 -18.94 1.72 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.28 123.98 15.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.209 -1.171 . . . . 0.0 110.518 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.451 ' O ' HD12 ' A' ' 111' ' ' LEU . 22.1 mt -79.85 168.32 27.03 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.809 . . . . 0.0 109.891 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.0 Cg_endo -69.13 -25.51 31.45 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.684 1.36 . . . . 0.0 110.39 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.433 ' HA ' HD13 ' A' ' 124' ' ' LEU . 10.8 p -82.09 -23.13 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.385 -0.822 . . . . 0.0 110.14 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -67.07 -43.29 82.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.381 -0.824 . . . . 0.0 110.202 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 107' ' ' LEU . 0.5 OUTLIER -59.08 -31.66 69.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -0.829 . . . . 0.0 110.151 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HB1' HG22 ' A' ' 120' ' ' ILE . . . -64.86 -65.26 0.7 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.415 -0.803 . . . . 0.0 110.109 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -51.94 -26.31 10.12 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.457 -0.777 . . . . 0.0 110.567 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.91 -43.35 16.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.342 -0.848 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -77.21 -77.79 0.14 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.27 -0.894 . . . . 0.0 110.181 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 165.12 43.83 0.02 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.413 ' CE1' ' O ' ' A' ' 81' ' ' ARG . 24.1 m80 -117.5 60.14 0.77 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.331 -1.099 . . . . 0.0 109.782 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -50.41 -29.64 10.63 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.32 -0.863 . . . . 0.0 110.568 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -69.99 -39.13 76.08 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 110.22 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.99 HD11 HD13 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -75.41 -35.08 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.868 . . . . 0.0 110.264 -179.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -63.73 -29.27 70.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.398 -0.814 . . . . 0.0 110.026 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -73.74 -55.19 6.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.326 -0.859 . . . . 0.0 110.044 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -36.38 83.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.317 -0.865 . . . . 0.0 110.09 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.615 HD12 HG23 ' A' ' 120' ' ' ILE . 16.8 mt -59.03 -62.44 1.88 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.376 -0.828 . . . . 0.0 110.283 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -51.01 -26.27 5.87 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.339 -0.851 . . . . 0.0 110.315 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.17 -38.51 51.6 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.382 -0.824 . . . . 0.0 110.136 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -112.67 29.1 8.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.87 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 98' ' ' LEU . 95.7 m -134.35 44.68 2.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 109.876 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.32 30.53 10.74 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.9 t0 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.351 -1.088 . . . . 0.0 110.571 -179.883 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . 0.46 ' N ' ' HD2' ' A' ' -3' ' ' PRO . 0.5 OUTLIER -70.41 -56.39 6.69 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.325 -1.103 . . . . 0.0 110.349 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' -4' ' ' SER . 47.2 Cg_endo -72.77 90.45 0.83 Allowed 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.456 1.24 . . . . 0.0 110.4 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . 168.11 171.24 33.81 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' ILE . . . . . 0.409 HG13 ' N ' ' A' ' 0' ' ' HIS . 4.2 pt -113.1 -20.6 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.269 -1.136 . . . . 0.0 110.434 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.409 ' N ' HG13 ' A' ' -1' ' ' ILE . 6.8 t60 -65.15 121.91 15.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.2 -0.938 . . . . 0.0 110.166 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 ptp -102.12 -22.92 14.13 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.385 -0.822 . . . . 0.0 110.33 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.406 ' O ' ' CD2' ' A' ' 0' ' ' HIS . 0.9 OUTLIER -100.28 142.95 31.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.329 -0.857 . . . . 0.0 110.261 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -122.12 167.82 14.71 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.33 -12.33 8.24 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.421 ' O ' ' OG ' ' A' ' 6' ' ' SER . 16.4 m -101.92 154.76 18.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.21 -1.17 . . . . 0.0 110.291 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 5' ' ' SER . 82.1 p 45.17 -168.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.764 -0.585 . . . . 0.0 110.947 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 47.38 22.07 0.25 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.474 -0.767 . . . . 0.0 110.955 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -138.88 -48.64 0.5 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -0.959 . . . . 0.0 109.958 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -60.63 -22.02 58.78 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 1.036 HD12 HG13 ' A' ' 22' ' ' VAL . 27.3 tp -67.27 -49.62 63.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.462 -1.023 . . . . 0.0 110.314 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.8 -49.55 24.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 110.62 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.8 p -58.15 -49.18 77.91 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.298 -0.876 . . . . 0.0 110.623 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -60.46 -38.41 84.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.204 -0.935 . . . . 0.0 110.184 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.479 ' HA ' HG11 ' A' ' 53' ' ' VAL . . . -62.96 -29.94 71.19 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.35 -0.844 . . . . 0.0 110.033 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.742 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -83.35 -33.45 25.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.336 -0.853 . . . . 0.0 110.047 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.9 tpp180 -75.91 -24.9 55.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.168 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 101.98 45.12 1.8 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.472 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.5 OUTLIER -119.86 96.84 5.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -1.069 . . . . 0.0 110.001 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.743 ' CG2' ' HB2' ' A' ' 52' ' ' GLN . 38.4 t -76.76 -39.32 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.473 -0.767 . . . . 0.0 110.163 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -59.78 -46.0 90.56 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.276 -0.89 . . . . 0.0 110.757 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.2 m -64.6 -42.28 95.66 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.344 -0.847 . . . . 0.0 110.577 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.036 HG13 HD12 ' A' ' 10' ' ' LEU . 65.1 t -70.28 -45.24 76.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.284 -0.885 . . . . 0.0 110.501 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.593 ' CA ' HD21 ' A' ' 56' ' ' LEU . 0.3 OUTLIER -59.29 -39.89 84.42 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.276 -0.89 . . . . 0.0 110.722 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.521 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 1.0 OUTLIER -72.76 -44.2 61.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.365 -0.834 . . . . 0.0 110.783 -179.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.964 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.6 OUTLIER -63.62 -48.03 78.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.236 -0.915 . . . . 0.0 110.689 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.565 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 3.1 mt -54.11 -63.99 0.97 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.283 -0.886 . . . . 0.0 110.602 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.0 -16.22 40.67 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 0.0 110.305 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.521 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -84.2 -37.91 21.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.302 -0.873 . . . . 0.0 110.543 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.71 -23.63 0.09 OUTLIER Glycine 0 N--CA 1.484 1.843 0 C-N-CA 119.955 -1.117 . . . . 0.0 110.745 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.964 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -48.05 124.82 8.12 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.092 -1.24 . . . . 0.0 110.997 -179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -83.37 126.92 70.51 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.385 -0.822 . . . . 0.0 109.955 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.53 -9.72 20.13 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.606 1.319 . . . . 0.0 110.864 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.12 29.55 7.4 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.118 -0.989 . . . . 0.0 110.257 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -119.17 103.48 9.56 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.436 -0.79 . . . . 0.0 110.26 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.532 ' C ' HD12 ' A' ' 35' ' ' LEU . 2.4 pp -84.53 145.65 27.98 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.272 -0.893 . . . . 0.0 110.22 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.478 ' O ' HD12 ' A' ' 35' ' ' LEU . 62.8 m-80 -104.42 -154.48 0.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.424 -0.797 . . . . 0.0 109.814 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' A' ' 38' ' ' PHE . 2.0 ptp180 -57.95 -171.16 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.0 110.252 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.422 ' CB ' ' O ' ' A' ' 37' ' ' ARG . 0.6 OUTLIER 66.66 1.94 2.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.438 -0.789 . . . . 0.0 111.268 179.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 45.85 31.98 4.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.77 -168.54 1.54 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.244 -1.15 . . . . 0.0 110.662 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.716 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 0.1 OUTLIER -118.27 177.67 1.24 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 0.0 109.391 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.716 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 43.4 Cg_endo -70.53 -19.29 32.62 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.383 1.202 . . . . 0.0 110.847 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' A' ' 46' ' ' MET . 53.5 mt -115.01 -34.83 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.134 -0.979 . . . . 0.0 110.001 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 41' ' ' ARG . 17.8 tt0 -53.43 -29.11 33.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.066 -1.021 . . . . 0.0 110.144 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.742 HG22 ' HB2' ' A' ' 15' ' ' ALA . 11.8 p -92.85 -2.76 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.407 -0.808 . . . . 0.0 110.339 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.841 ' HE1' ' HB2' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -56.05 154.54 7.47 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.398 -0.814 . . . . 0.0 110.345 -179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -70.97 -6.9 42.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.356 -0.84 . . . . 0.0 110.149 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.633 ' HE3' ' HB2' ' A' ' 78' ' ' ASP . 23.4 mmt 53.59 25.25 4.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.9 . . . . 0.0 110.411 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -118.03 -11.7 8.16 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 m -129.51 113.45 14.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -1.163 . . . . 0.0 110.296 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.551 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -64.53 -13.9 54.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.429 -0.794 . . . . 0.0 110.598 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.743 ' HB2' ' CG2' ' A' ' 19' ' ' VAL . 0.2 OUTLIER -73.08 -22.93 60.5 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.216 -0.928 . . . . 0.0 109.821 179.807 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.549 ' CG2' HG22 ' A' ' 19' ' ' VAL . 22.0 t -84.2 -36.84 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.149 -0.969 . . . . 0.0 110.188 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.841 ' HB2' ' HE1' ' A' ' 46' ' ' MET . . . -70.35 -57.14 5.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.421 -0.799 . . . . 0.0 110.299 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -59.32 -45.82 90.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.439 -0.788 . . . . 0.0 110.474 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.593 HD21 ' CA ' ' A' ' 23' ' ' ARG . 52.1 tp -52.63 -52.63 54.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.371 -0.83 . . . . 0.0 110.666 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.811 HD21 HD11 ' A' ' 10' ' ' LEU . 7.6 mt -69.89 -30.39 67.81 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.262 -0.899 . . . . 0.0 110.854 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.506 HD22 ' CB ' ' A' ' 94' ' ' ALA . 1.1 tt -75.72 -55.23 5.84 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.178 -0.951 . . . . 0.0 110.944 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.704 HD11 ' CD2' ' A' ' 60' ' ' HIS . 3.1 pp -54.07 -28.5 39.3 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.136 -0.978 . . . . 0.0 110.07 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.704 ' CD2' HD11 ' A' ' 59' ' ' LEU . 3.0 m-70 -75.61 -56.87 4.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.359 -0.838 . . . . 0.0 109.821 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 157.49 44.61 0.02 OUTLIER Glycine 0 N--CA 1.484 1.846 0 N-CA-C 109.669 -1.373 . . . . 0.0 109.669 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 57' ' ' LEU . . . -76.27 -169.55 1.21 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.335 -1.097 . . . . 0.0 110.62 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -115.38 80.83 7.98 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.393 -0.817 . . . . 0.0 110.236 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.77 -27.0 9.19 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.854 1.45 . . . . 0.0 110.325 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -93.08 -41.44 9.96 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.358 -0.839 . . . . 0.0 110.081 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -54.35 151.37 7.59 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.273 -0.892 . . . . 0.0 110.277 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.512 ' HB2' ' NE ' ' A' ' 74' ' ' ARG . . . -143.87 -172.72 3.81 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.416 -0.802 . . . . 0.0 110.565 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.495 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 15.5 t0 -89.69 125.07 62.34 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -73.33 -21.55 19.8 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.484 1.255 . . . . 0.0 110.62 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.24 -20.89 65.74 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 110.678 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.726 HG23 ' OG1' ' A' ' 73' ' ' THR . 5.3 t -158.42 22.03 0.23 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.19 -0.944 . . . . 0.0 111.027 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 8.4 mt 44.05 65.29 1.06 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.306 -0.871 . . . . 0.0 110.403 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.726 ' OG1' HG23 ' A' ' 71' ' ' THR . 0.1 OUTLIER -119.21 103.23 9.33 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.092 -1.005 . . . . 0.0 111.156 -178.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.907 ' HB2' HG11 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -75.29 169.65 19.4 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.536 -0.728 . . . . 0.0 109.197 179.152 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.497 ' HD2' ' CG ' ' A' ' 74' ' ' ARG . 46.7 Cg_endo -74.49 -4.34 15.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.458 1.241 . . . . 0.0 110.904 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.684 HG13 HD23 ' A' ' 98' ' ' LEU . 62.6 t -71.84 -35.39 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.082 -1.011 . . . . 0.0 110.211 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.67 ' HE1' HG13 ' A' ' 100' ' ' VAL . 56.8 m80 -62.16 -43.17 99.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.324 -0.86 . . . . 0.0 110.331 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.633 ' HB2' ' HE3' ' A' ' 48' ' ' MET . 50.5 m-20 -56.33 -57.98 9.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.477 -0.764 . . . . 0.0 110.438 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.87 -28.25 65.95 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.284 -0.885 . . . . 0.0 109.876 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.52 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -79.94 -27.9 39.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 0.0 110.032 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.1 ttm180 -71.9 -23.42 61.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.826 . . . . 0.0 110.367 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -97.08 -44.52 6.94 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.368 -0.832 . . . . 0.0 110.227 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 112.85 29.62 3.03 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.458 ' CZ ' ' CA ' ' A' ' 84' ' ' PHE . 4.3 t80 -93.61 91.8 7.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.43 -1.041 . . . . 0.0 110.224 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' A' ' 123' ' ' TYR . 1.5 mt -62.22 -27.85 69.28 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.333 -0.855 . . . . 0.0 109.863 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.726 ' O ' HG23 ' A' ' 90' ' ' VAL . 4.3 t0 -59.07 -54.44 47.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.397 -0.815 . . . . 0.0 110.348 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.473 HG23 ' HB1' ' A' ' 54' ' ' ALA . 29.9 m -61.46 -35.19 76.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.326 -0.859 . . . . 0.0 109.962 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.811 HD22 HG13 ' A' ' 120' ' ' ILE . 5.7 tp -59.53 -51.97 67.57 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.212 -0.93 . . . . 0.0 109.776 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 93.0 t -59.78 -45.01 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.284 -0.885 . . . . 0.0 109.269 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 86' ' ' ASP . 96.4 t -50.48 -46.47 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.614 -0.679 . . . . 0.0 110.452 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.498 ' HA ' HD11 ' A' ' 58' ' ' LEU . 1.3 mp -65.01 -57.35 8.92 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.46 -0.775 . . . . 0.0 110.088 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 t-160 -63.68 -17.43 62.94 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.412 -0.805 . . . . 0.0 110.36 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -87.78 -13.88 41.11 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 0.0 110.615 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.506 ' CB ' HD22 ' A' ' 58' ' ' LEU . . . -133.46 49.57 2.28 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.186 -0.946 . . . . 0.0 110.512 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.64 108.83 0.01 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -168.63 104.98 0.43 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -1.101 . . . . 0.0 110.248 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -68.04 108.7 3.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.418 -0.802 . . . . 0.0 110.071 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.795 HD13 ' HB1' ' A' ' 127' ' ' ALA . 1.4 mp -93.18 -21.58 19.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.313 -0.867 . . . . 0.0 110.449 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.663 ' HA ' HG23 ' A' ' 128' ' ' THR . 6.1 p-10 -70.4 72.71 0.49 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.361 -0.837 . . . . 0.0 110.165 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.907 HG11 ' HB2' ' A' ' 74' ' ' ARG . 7.5 p -143.37 161.18 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -0.86 . . . . 0.0 110.341 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.423 ' N ' HG22 ' A' ' 100' ' ' VAL . 13.3 p -128.6 147.33 50.71 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.51 -0.744 . . . . 0.0 109.422 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 104' ' ' TRP . 5.1 p-10 -69.86 65.3 0.23 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.254 -0.904 . . . . 0.0 110.607 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.714 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 56.66 -81.02 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.688 -0.632 . . . . 0.0 111.097 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.467 ' N ' ' O ' ' A' ' 102' ' ' ASP . 8.2 m-90 -91.52 43.98 1.16 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.265 -0.897 . . . . 0.0 110.359 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -133.54 -162.62 10.15 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.506 ' O ' ' CD1' ' A' ' 107' ' ' LEU . 10.5 mtm180 -120.79 -51.45 2.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.395 -1.062 . . . . 0.0 110.259 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.817 ' HG ' ' HD2' ' A' ' 108' ' ' PRO . 2.0 tp -174.13 162.72 2.91 Favored Pre-proline 0 N--CA 1.497 1.884 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.817 ' HD2' ' HG ' ' A' ' 107' ' ' LEU . 42.8 Cg_endo -70.39 -31.54 17.53 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.026 1.014 . . . . 0.0 110.24 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.624 HG12 ' HB3' ' A' ' 107' ' ' LEU . 7.4 p -62.05 -21.03 25.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 0.0 109.648 179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -77.56 -45.29 25.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.383 -0.823 . . . . 0.0 109.621 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mt -57.59 -26.85 62.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 109.874 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.743 ' HB1' ' O ' ' A' ' 117' ' ' HIS . . . -78.0 -50.13 12.72 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.507 -0.746 . . . . 0.0 109.962 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -52.77 -23.28 6.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.478 -0.763 . . . . 0.0 110.898 -179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -94.63 -54.12 3.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.262 -0.899 . . . . 0.0 110.667 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 28.7 mm100 -59.73 -95.77 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.254 -0.904 . . . . 0.0 110.435 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -170.29 31.79 0.15 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.743 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 9.0 m-70 -117.03 79.47 1.34 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.441 -1.035 . . . . 0.0 109.536 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 121' ' ' ALA . 30.0 mmt85 -81.32 -40.54 23.46 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.386 -0.821 . . . . 0.0 110.167 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.4 -54.45 43.57 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.307 -0.871 . . . . 0.0 109.702 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.811 HG13 HD22 ' A' ' 88' ' ' LEU . 10.0 tt -60.13 -34.75 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.468 -0.77 . . . . 0.0 109.359 179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 118' ' ' ARG . . . -61.7 -39.42 91.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.658 -0.651 . . . . 0.0 109.799 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 78.5 mtt85 -56.17 -53.21 59.8 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.392 -0.817 . . . . 0.0 109.571 179.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.679 ' HB3' HD23 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -58.71 -45.19 90.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.396 -0.815 . . . . 0.0 109.357 179.18 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.752 ' HG ' HD21 ' A' ' 88' ' ' LEU . 78.3 mt -55.9 -48.53 75.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.435 -0.79 . . . . 0.0 109.928 179.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 79.2 t60 -53.5 -27.33 24.91 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.295 -0.878 . . . . 0.0 110.191 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -88.19 -38.69 15.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.316 -0.865 . . . . 0.0 110.467 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.795 ' HB1' HD13 ' A' ' 98' ' ' LEU . . . -98.02 10.62 39.93 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.304 -0.872 . . . . 0.0 110.783 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.784 HG22 HD21 ' A' ' 107' ' ' LEU . 7.4 m -133.39 -52.02 0.88 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.13 -0.981 . . . . 0.0 110.365 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 90.95 101.37 1.23 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.294 -1.121 . . . . 0.0 110.673 -179.837 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 11.5 t 52.17 92.29 0.06 OUTLIER Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.284 -1.127 . . . . 0.0 110.617 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.43 -24.41 19.26 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.685 1.36 . . . . 0.0 110.29 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . 77.19 76.97 0.83 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 0' ' ' HIS . 4.3 tp -153.05 -42.36 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -1.102 . . . . 0.0 110.372 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.468 ' N ' HG23 ' A' ' -1' ' ' ILE . 6.8 t60 -110.25 163.69 13.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.178 -0.951 . . . . 0.0 110.344 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 tpt -107.32 120.84 43.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.81 . . . . 0.0 110.331 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.1 mp -109.57 26.47 10.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.516 -0.74 . . . . 0.0 109.921 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.23 -28.73 21.9 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.6 91.73 0.1 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.9 m -78.51 84.0 4.67 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.318 -1.107 . . . . 0.0 110.073 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 70.3 m -68.39 -83.58 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.269 -0.895 . . . . 0.0 110.348 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 49.77 23.96 1.14 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.055 -1.028 . . . . 0.0 110.638 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -135.8 -22.07 1.45 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.376 -0.828 . . . . 0.0 110.835 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -53.91 -32.58 48.9 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.959 HD13 HD11 ' A' ' 57' ' ' LEU . 3.8 pp -61.23 -27.69 68.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.444 -1.033 . . . . 0.0 110.09 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.456 ' N ' HD12 ' A' ' 10' ' ' LEU . . . -83.4 -50.7 8.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.412 -0.805 . . . . 0.0 110.257 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.2 p -63.18 -50.17 71.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.421 -0.8 . . . . 0.0 110.08 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.426 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -58.5 -40.8 83.81 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.342 -0.849 . . . . 0.0 109.769 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 10' ' ' LEU . . . -61.01 -38.93 87.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 0.0 110.038 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 45' ' ' VAL . . . -60.73 -32.6 71.87 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.309 -0.869 . . . . 0.0 110.168 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.87 15.43 11.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.394 -0.816 . . . . 0.0 110.543 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 60.47 52.97 49.3 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -119.67 72.26 0.91 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.326 -1.102 . . . . 0.0 110.536 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.909 HG21 ' HB3' ' A' ' 52' ' ' GLN . 58.0 t -56.96 -35.69 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.048 -1.032 . . . . 0.0 109.496 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -59.62 -54.95 40.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.557 -0.715 . . . . 0.0 109.988 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 84.0 m -56.92 -38.3 72.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.438 -0.789 . . . . 0.0 110.129 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.534 HG12 HD12 ' A' ' 26' ' ' LEU . 57.7 t -79.76 -22.05 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.433 -0.792 . . . . 0.0 110.475 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.54 ' HA ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -62.65 -45.87 90.81 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.163 -0.961 . . . . 0.0 110.422 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.441 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 24.7 tt0 -76.41 -51.22 12.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.46 -0.775 . . . . 0.0 111.408 -179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 25' ' ' LEU . 4.0 mt -51.2 -62.06 1.85 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.117 -0.989 . . . . 0.0 111.227 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.665 ' HA ' ' HB3' ' A' ' 30' ' ' ALA . 2.0 mt -53.56 -46.82 70.38 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.15 -0.969 . . . . 0.0 111.365 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -81.66 9.34 7.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.06 -1.025 . . . . 0.0 110.962 -179.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -114.47 -31.33 6.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.137 -0.977 . . . . 0.0 110.68 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.35 -27.81 0.08 OUTLIER Glycine 0 N--CA 1.484 1.849 0 C-N-CA 119.918 -1.134 . . . . 0.0 110.598 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.808 ' HB1' HD23 ' A' ' 10' ' ' LEU . . . -48.22 128.65 14.5 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.136 -1.214 . . . . 0.0 110.758 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.793 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 0.5 OUTLIER -74.22 145.36 82.97 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.397 -0.814 . . . . 0.0 110.301 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . 0.415 ' HB3' ' HB3' ' A' ' 60' ' ' HIS . 48.9 Cg_endo -76.98 -25.97 8.34 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.753 1.396 . . . . 0.0 110.784 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -114.44 32.38 5.98 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.324 -0.86 . . . . 0.0 110.403 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.793 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -89.8 96.87 10.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.354 -0.841 . . . . 0.0 110.281 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.94 HD13 ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -71.62 157.69 37.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.32 -0.862 . . . . 0.0 110.083 179.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.838 ' N ' HD22 ' A' ' 35' ' ' LEU . 47.7 p30 -112.9 173.83 6.19 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.121 -0.987 . . . . 0.0 110.97 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -49.73 -26.9 4.2 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.368 -0.832 . . . . 0.0 110.608 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -11.93 60.65 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.28 -0.887 . . . . 0.0 109.887 179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.658 ' HA2' HD23 ' A' ' 35' ' ' LEU . . . 52.21 25.61 18.86 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.41 ' HG2' ' HB3' ' A' ' 44' ' ' GLN . 17.8 ttt180 -93.99 1.2 56.3 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.475 -1.014 . . . . 0.0 110.227 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? 55.89 171.45 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.25 -0.906 . . . . 0.0 109.959 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.634 ' HB2' HD12 ' A' ' 57' ' ' LEU . 45.7 Cg_endo -72.65 169.44 21.89 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.534 1.281 . . . . 0.0 110.724 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.583 ' HA ' ' HG2' ' A' ' 46' ' ' MET . 30.7 mt 62.95 -60.56 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.821 -0.549 . . . . 0.0 111.017 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.475 ' N ' ' O ' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -43.12 -29.2 0.35 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.879 -1.138 . . . . 0.0 110.793 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 45' ' ' VAL . 11.0 p -113.79 35.55 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.405 -0.809 . . . . 0.0 109.942 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.828 ' CE ' ' HB2' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -110.46 171.86 7.21 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.256 -0.903 . . . . 0.0 110.267 -179.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 8.5 ttp -73.45 98.91 2.85 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.319 -0.863 . . . . 0.0 108.685 178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.488 ' O ' ' CD2' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -61.73 -6.16 2.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.378 -0.826 . . . . 0.0 111.138 -179.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -89.5 20.78 32.58 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.618 ' N ' ' HD2' ' A' ' 84' ' ' PHE . 27.9 t -154.06 109.05 3.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.281 -1.129 . . . . 0.0 110.227 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.676 ' HB2' ' HB2' ' A' ' 86' ' ' ASP . . . -66.25 -29.54 69.8 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.404 -0.81 . . . . 0.0 110.033 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.909 ' HB3' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -51.35 -32.88 27.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.543 -0.723 . . . . 0.0 110.297 179.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.495 HG11 ' HB2' ' A' ' 46' ' ' MET . 41.2 t -75.17 -47.94 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.359 -0.838 . . . . 0.0 110.053 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.849 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -70.56 -23.44 62.61 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.399 -0.813 . . . . 0.0 110.158 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.522 ' HA ' HG11 ' A' ' 90' ' ' VAL . 0.8 OUTLIER -66.71 -53.1 37.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.361 -0.837 . . . . 0.0 110.689 -179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.54 HD11 ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -61.58 -57.11 13.37 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.245 -0.909 . . . . 0.0 110.647 -179.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.959 HD11 HD13 ' A' ' 10' ' ' LEU . 2.8 mm? -47.36 -50.37 22.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.417 -0.802 . . . . 0.0 110.97 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.033 HD23 HG12 ' A' ' 90' ' ' VAL . 60.5 tp -70.68 -24.7 62.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.406 -0.809 . . . . 0.0 110.544 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.1 tp -67.67 -41.28 83.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.184 -0.947 . . . . 0.0 109.982 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.518 ' ND1' HD22 ' A' ' 26' ' ' LEU . 12.0 m170 -78.91 -30.89 45.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.348 -0.845 . . . . 0.0 109.864 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 133.42 54.89 0.07 OUTLIER Glycine 0 N--CA 1.482 1.758 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.484 ' HB2' ' C ' ' A' ' 57' ' ' LEU . . . -69.83 -168.3 0.19 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.273 -1.133 . . . . 0.0 110.051 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -117.21 78.52 10.36 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.853 . . . . 0.0 110.007 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.78 -27.47 7.2 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.719 1.378 . . . . 0.0 110.417 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -87.55 -59.27 2.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.433 -0.792 . . . . 0.0 110.29 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.1 168.59 0.13 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.308 -0.87 . . . . 0.0 110.444 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 74' ' ' ARG . . . -167.93 -158.74 0.26 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.875 . . . . 0.0 110.734 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -79.7 123.85 83.81 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.499 -0.75 . . . . 0.0 110.292 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.39 -24.11 14.54 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.549 1.289 . . . . 0.0 110.401 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -58.39 -46.24 86.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -0.892 . . . . 0.0 110.424 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.783 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 41.9 p -146.65 68.69 1.17 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 110.355 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.604 ' C ' ' O ' ' A' ' 71' ' ' THR . 13.9 mt 5.41 86.75 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.933 -0.479 . . . . 0.0 112.175 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.05 83.57 2.17 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 110.363 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.756 ' HD3' HG21 ' A' ' 100' ' ' VAL . 5.2 mpt_? -61.51 161.31 20.11 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.481 -0.762 . . . . 0.0 110.31 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.36 -18.74 29.68 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.855 1.45 . . . . 0.0 110.422 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.88 -32.13 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.35 -0.844 . . . . 0.0 109.997 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.498 ' HE1' HG13 ' A' ' 100' ' ' VAL . 64.0 m80 -64.63 -41.72 95.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.428 -0.795 . . . . 0.0 110.34 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -70.31 -48.44 56.61 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.355 -0.841 . . . . 0.0 110.416 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.36 -29.18 14.58 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.293 -0.879 . . . . 0.0 110.448 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.899 ' CB ' HG21 ' A' ' 120' ' ' ILE . . . -96.55 -27.92 14.62 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.4 -0.812 . . . . 0.0 109.796 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -53.47 -28.43 30.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.402 -0.811 . . . . 0.0 109.765 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -99.5 -28.44 13.24 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.814 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.69 44.92 2.03 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.809 -1.317 . . . . 0.0 109.809 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.618 ' HD2' ' N ' ' A' ' 50' ' ' SER . 12.7 t80 -108.0 96.43 6.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.368 -1.078 . . . . 0.0 110.046 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.765 ' CD2' HD13 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -72.25 -24.29 61.35 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.516 -0.74 . . . . 0.0 110.663 -179.619 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.676 ' HB2' ' HB2' ' A' ' 51' ' ' ALA . 63.9 m-20 -59.67 -54.35 47.41 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.407 -0.808 . . . . 0.0 110.499 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.849 HG23 ' CB ' ' A' ' 54' ' ' ALA . 90.9 m -61.2 -36.75 80.72 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.094 -1.004 . . . . 0.0 110.157 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.48 HD21 ' HG ' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -57.54 -48.79 78.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.318 -0.864 . . . . 0.0 110.252 -179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 85' ' ' LEU . 96.0 t -59.66 -50.95 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.279 -0.888 . . . . 0.0 109.914 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 1.033 HG12 HD23 ' A' ' 58' ' ' LEU . 85.1 t -54.27 -45.57 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.36 -0.838 . . . . 0.0 110.221 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.547 HD13 HG22 ' A' ' 87' ' ' THR . 0.4 OUTLIER -57.23 -56.06 26.68 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.39 -0.819 . . . . 0.0 110.35 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -64.32 -23.32 67.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.446 -0.784 . . . . 0.0 110.657 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -78.77 -33.75 46.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.202 -0.936 . . . . 0.0 110.575 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.987 ' HB3' HD21 ' A' ' 58' ' ' LEU . . . -98.12 39.69 1.22 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.322 -0.862 . . . . 0.0 111.012 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 62.55 108.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.412 ' O ' HD11 ' A' ' 98' ' ' LEU . . . -168.31 132.45 1.62 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.532 -0.981 . . . . 0.0 110.05 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.55 140.01 42.46 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.242 -0.911 . . . . 0.0 110.071 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.808 ' O ' HG22 ' A' ' 128' ' ' THR . 2.4 mp -128.31 19.49 6.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.315 -0.866 . . . . 0.0 110.48 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.437 ' HB3' ' HA ' ' A' ' 128' ' ' THR . 4.3 p30 -123.29 55.87 1.2 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.151 -0.968 . . . . 0.0 110.421 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.756 HG21 ' HD3' ' A' ' 74' ' ' ARG . 12.6 p -112.76 164.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 110.383 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.43 ' N ' HG22 ' A' ' 100' ' ' VAL . 98.8 m -106.47 150.88 25.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.474 -0.767 . . . . 0.0 109.802 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.562 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 22.6 t70 -78.89 58.87 2.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.229 -0.919 . . . . 0.0 110.324 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.783 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 64.69 -71.97 0.07 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.519 -0.738 . . . . 0.0 110.719 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.431 ' N ' ' O ' ' A' ' 102' ' ' ASP . 2.1 m95 -65.49 -56.09 14.28 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.413 -0.804 . . . . 0.0 110.443 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.578 ' O ' HD12 ' A' ' 107' ' ' LEU . . . 168.63 -28.15 0.14 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.01 105.79 0.14 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.237 -1.155 . . . . 0.0 110.423 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.578 HD12 ' O ' ' A' ' 105' ' ' GLY . 0.8 OUTLIER -73.62 170.64 13.4 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.277 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.3 -43.19 0.74 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 O-C-N 123.738 1.388 . . . . 0.0 110.425 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.487 HG23 ' HA ' ' A' ' 121' ' ' ALA . 9.9 p -58.97 -36.02 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.35 -0.844 . . . . 0.0 110.115 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.442 ' N ' HG13 ' A' ' 109' ' ' VAL . 2.5 m-20 -66.06 -45.8 80.06 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.441 -0.787 . . . . 0.0 110.187 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.652 HD23 ' O ' ' A' ' 111' ' ' LEU . 4.0 tt -60.84 -27.74 68.3 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.396 -0.815 . . . . 0.0 110.222 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.3 -63.98 0.97 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 0.0 110.137 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -53.99 -23.63 13.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.318 -0.864 . . . . 0.0 110.695 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -68.92 -40.66 78.95 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.676 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.426 ' HB3' ' NE2' ' A' ' 117' ' ' HIS . 0.9 OUTLIER -91.29 5.32 49.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.228 -0.92 . . . . 0.0 110.77 -179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 86.63 37.06 8.92 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.465 ' HB3' ' CG1' ' A' ' 120' ' ' ILE . 23.9 m-70 -113.09 55.34 0.7 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.327 -1.102 . . . . 0.0 109.791 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.96 -30.5 24.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.435 -0.791 . . . . 0.0 109.988 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -62.39 -40.62 97.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.427 -0.796 . . . . 0.0 109.735 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.899 HG21 ' CB ' ' A' ' 80' ' ' ALA . 4.1 mm -75.87 -36.28 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.509 -0.744 . . . . 0.0 109.601 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.487 ' HA ' HG23 ' A' ' 109' ' ' VAL . . . -64.33 -59.11 4.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.591 -0.693 . . . . 0.0 111.178 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 123' ' ' TYR . 14.2 ptm180 -53.99 -41.27 67.75 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.007 -1.058 . . . . 0.0 110.133 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.408 ' N ' ' HG3' ' A' ' 122' ' ' ARG . 11.7 t80 -68.86 -42.48 76.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.227 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.722 ' O ' HG23 ' A' ' 128' ' ' THR . 21.2 mt -66.24 -47.56 73.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.475 -0.766 . . . . 0.0 109.741 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -50.24 -32.11 15.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.411 -0.806 . . . . 0.0 110.333 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.49 -27.0 46.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.522 -0.737 . . . . 0.0 110.293 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.497 ' HB1' HD13 ' A' ' 98' ' ' LEU . . . -102.73 -11.45 18.37 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.342 -0.849 . . . . 0.0 110.85 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.808 HG22 ' O ' ' A' ' 98' ' ' LEU . 73.2 p -90.16 -29.79 18.04 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.142 -0.974 . . . . 0.0 110.48 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -54.88 -98.57 0.01 OUTLIER Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 . . . . . 0 C--N 1.307 -1.249 0 O-C-N 121.41 -1.053 . . . . 0.0 110.254 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 7.5 t -78.73 138.51 58.11 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.345 -1.091 . . . . 0.0 110.192 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -72.94 -35.29 5.6 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.683 1.359 . . . . 0.0 110.427 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . 123.36 118.27 2.41 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' ILE . . . . . 0.491 HD12 ' N ' ' A' ' 0' ' ' HIS . 1.3 pp -64.47 -153.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.339 -1.095 . . . . 0.0 110.078 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.491 ' N ' HD12 ' A' ' -1' ' ' ILE . 57.7 m80 -52.14 -75.13 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.171 -0.956 . . . . 0.0 110.731 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.463 ' C ' ' O ' ' A' ' 0' ' ' HIS . 9.8 ptp 32.07 87.95 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.293 0 CA-C-O 121.422 0.63 . . . . 0.0 111.64 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 2' ' ' LEU . 4.4 mm? -63.44 100.09 0.24 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.361 -0.837 . . . . 0.0 110.241 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -152.8 147.86 17.98 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 62.58 159.94 0.18 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.4 p -168.83 108.13 0.47 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.26 -1.141 . . . . 0.0 110.506 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.68 -27.64 40.75 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.492 -0.755 . . . . 0.0 109.896 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 68.3 m-20 -59.35 -36.92 76.62 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.322 -0.861 . . . . 0.0 110.019 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.45 -19.53 62.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.482 -0.761 . . . . 0.0 110.048 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -57.34 -25.95 55.57 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.828 HD11 ' HB1' ' A' ' 30' ' ' ALA . 80.7 mt -64.15 -37.41 87.37 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.404 -1.057 . . . . 0.0 110.178 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -78.28 -49.03 14.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.286 -0.884 . . . . 0.0 110.107 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 76.9 p -56.39 -54.93 39.81 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.419 -0.801 . . . . 0.0 110.267 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.94 -33.55 74.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.327 -0.858 . . . . 0.0 110.071 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.511 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -73.7 -43.75 58.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.771 . . . . 0.0 110.134 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.638 ' HB2' ' O ' ' A' ' 45' ' ' VAL . . . -61.44 -28.53 69.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.386 -0.821 . . . . 0.0 110.189 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -72.84 -27.77 62.14 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.409 -0.807 . . . . 0.0 110.159 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.34 28.04 4.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -106.65 143.0 35.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.379 -1.071 . . . . 0.0 110.483 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.747 HG11 ' HB3' ' A' ' 52' ' ' GLN . 95.0 t -109.53 -54.42 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.442 -0.787 . . . . 0.0 109.9 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -54.9 -32.54 61.16 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.51 -0.744 . . . . 0.0 110.418 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.3 m -62.07 -60.89 2.95 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 110.292 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.443 HG13 ' CD2' ' A' ' 10' ' ' LEU . 58.3 t -61.49 -27.51 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.27 -0.894 . . . . 0.0 110.146 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.645 ' HD2' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -67.1 -43.44 82.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 0.0 110.161 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -63.31 -38.47 91.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.449 -0.782 . . . . 0.0 110.587 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.7 mt -70.17 -44.68 68.27 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.0 110.619 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.499 HD22 ' CG ' ' A' ' 60' ' ' HIS . 14.2 mt -65.88 -57.0 8.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.311 -0.868 . . . . 0.0 110.481 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -53.84 -25.29 18.93 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.233 -0.917 . . . . 0.0 110.097 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -78.55 -67.92 0.7 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.367 -0.833 . . . . 0.0 110.046 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.88 47.21 0.06 OUTLIER Glycine 0 N--CA 1.481 1.695 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.828 ' HB1' HD11 ' A' ' 10' ' ' LEU . . . -85.93 169.79 12.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.256 -1.143 . . . . 0.0 110.175 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.782 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 7.3 t70 -89.85 125.37 61.09 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.351 -0.843 . . . . 0.0 110.04 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.95 -17.46 25.18 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.603 1.318 . . . . 0.0 110.649 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -126.32 39.86 3.85 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 110.062 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.782 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -71.91 109.79 5.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.403 -0.81 . . . . 0.0 110.224 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 36' ' ' ASN . 1.9 tm? -72.83 99.26 2.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.309 -0.87 . . . . 0.0 109.744 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.553 ' O ' HD13 ' A' ' 35' ' ' LEU . 33.9 m120 -54.82 -179.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.468 -0.77 . . . . 0.0 110.439 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -93.94 22.7 5.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.27 -0.894 . . . . 0.0 110.263 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 64.8 m-85 -111.8 21.57 15.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 110.202 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.74 26.9 26.47 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.7 mtt180 -131.2 -168.71 2.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.381 -1.07 . . . . 0.0 110.393 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.67 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 1.2 mmt180 -104.16 176.19 1.88 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.47 -0.769 . . . . 0.0 109.421 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 42.9 Cg_endo -69.76 -19.49 36.08 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.273 1.144 . . . . 0.0 110.648 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.463 ' O ' ' HG2' ' A' ' 46' ' ' MET . 44.7 mt -104.17 -27.94 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.287 -0.883 . . . . 0.0 109.775 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -60.32 -19.68 56.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.094 -1.004 . . . . 0.0 109.875 179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.638 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 14.4 p -126.75 35.7 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.289 -0.882 . . . . 0.0 110.232 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.487 ' CE ' ' HB2' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -96.16 31.59 2.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.259 -0.9 . . . . 0.0 110.298 179.861 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.473 ' CB ' ' O ' ' A' ' 46' ' ' MET . 4.8 tmm? 72.15 -18.08 0.34 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.557 -0.714 . . . . 0.0 111.208 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.44 ' CE ' ' HB3' ' A' ' 78' ' ' ASP . 0.0 OUTLIER 50.43 26.2 2.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.019 -1.05 . . . . 0.0 110.679 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -125.32 28.88 4.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -165.11 100.87 0.75 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.318 -1.107 . . . . 0.0 110.312 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.436 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -59.52 -26.96 65.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.301 -0.874 . . . . 0.0 110.063 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.747 ' HB3' HG11 ' A' ' 19' ' ' VAL . 5.7 mm-40 -55.04 -29.39 57.33 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.488 -0.757 . . . . 0.0 110.591 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.564 HG23 HG22 ' A' ' 19' ' ' VAL . 55.2 t -88.24 -33.16 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 109.932 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.8 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -64.77 -39.72 94.08 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.323 -0.86 . . . . 0.0 110.115 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -80.08 -38.68 31.22 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.341 -0.849 . . . . 0.0 110.559 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.645 HD22 ' HD2' ' A' ' 23' ' ' ARG . 37.5 tp -53.98 -58.04 8.76 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.295 -0.878 . . . . 0.0 110.32 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.451 ' HB3' ' HB2' ' A' ' 62' ' ' ALA . 8.2 mt -67.15 -28.04 67.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.958 . . . . 0.0 110.21 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.958 HD22 HG13 ' A' ' 90' ' ' VAL . 1.3 tp -66.92 -64.96 0.74 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.332 -0.855 . . . . 0.0 110.637 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.533 HD11 ' ND1' ' A' ' 60' ' ' HIS . 3.9 pp -49.91 -27.78 5.74 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.266 -0.896 . . . . 0.0 110.315 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.533 ' ND1' HD11 ' A' ' 59' ' ' LEU . 4.3 m80 -77.22 -62.81 1.53 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.332 -0.855 . . . . 0.0 109.788 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 165.56 41.71 0.02 OUTLIER Glycine 0 N--CA 1.483 1.777 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -61.17 -170.62 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.312 -1.111 . . . . 0.0 110.329 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -125.28 73.73 67.3 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.461 -0.774 . . . . 0.0 110.282 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -80.28 -12.38 12.9 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.848 1.446 . . . . 0.0 110.601 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.423 ' HA ' ' NH1' ' A' ' 74' ' ' ARG . 39.3 m-80 -89.93 -50.01 6.28 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.211 -0.931 . . . . 0.0 110.725 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.21 172.24 0.22 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.173 -0.954 . . . . 0.0 110.459 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.716 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -156.76 -178.14 7.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.299 -0.876 . . . . 0.0 110.483 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.43 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 4.4 t0 -89.59 116.67 66.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 0.0 110.036 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.89 -17.18 32.63 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.61 1.321 . . . . 0.0 110.363 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.26 -24.12 63.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.363 -0.836 . . . . 0.0 110.686 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.737 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 2.1 m -150.73 21.48 0.8 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.25 -0.906 . . . . 0.0 110.599 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.478 HD12 ' HA ' ' A' ' 103' ' ' ALA . 17.9 mt 49.23 27.64 1.92 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.176 -0.952 . . . . 0.0 110.385 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.43 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.5 OUTLIER -84.79 121.9 28.36 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.422 -0.799 . . . . 0.0 110.722 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.76 ' CG ' HG11 ' A' ' 100' ' ' VAL . 2.2 mtt180 -94.79 173.59 4.35 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 0.0 110.003 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 42.1 Cg_endo -68.39 -17.55 44.13 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.654 1.344 . . . . 0.0 110.23 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 64.1 t -69.96 -32.33 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.363 -0.836 . . . . 0.0 109.605 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.676 ' HE1' HG13 ' A' ' 100' ' ' VAL . 60.7 m80 -67.97 -43.73 78.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.477 -0.764 . . . . 0.0 110.082 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.44 ' HB3' ' CE ' ' A' ' 48' ' ' MET . 0.6 OUTLIER -59.73 -60.63 3.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.274 -0.891 . . . . 0.0 109.648 179.614 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.84 -24.34 8.82 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.478 -0.764 . . . . 0.0 109.624 179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.419 ' HA ' HD12 ' A' ' 120' ' ' ILE . . . -83.56 -30.11 27.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.523 -0.736 . . . . 0.0 109.613 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -57.35 -35.59 70.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.3 -0.875 . . . . 0.0 109.638 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 8.6 mp0 -98.01 -15.65 19.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.494 -0.754 . . . . 0.0 110.291 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.444 ' HA3' ' CG ' ' A' ' 117' ' ' HIS . . . 76.71 49.33 7.99 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -102.14 88.42 3.32 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.378 -1.072 . . . . 0.0 110.037 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.412 HD21 ' CB ' ' A' ' 123' ' ' TYR . 6.2 mt -60.09 -31.65 70.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.398 -0.814 . . . . 0.0 110.47 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 21.2 t0 -56.88 -48.17 78.78 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.279 -0.888 . . . . 0.0 110.15 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.8 HG23 ' HB1' ' A' ' 54' ' ' ALA . 97.7 m -68.64 -32.87 73.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.372 -0.83 . . . . 0.0 109.814 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 mp -57.8 -44.06 86.05 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.343 -0.848 . . . . 0.0 109.821 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.42 ' O ' ' HG2' ' A' ' 93' ' ' ARG . 34.1 t -60.89 -54.29 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.448 -0.783 . . . . 0.0 109.439 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.958 HG13 HD22 ' A' ' 58' ' ' LEU . 96.9 t -44.8 -45.91 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.714 -0.616 . . . . 0.0 110.807 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -54.07 24.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 110.512 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -64.59 -46.83 81.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.331 -0.855 . . . . 0.0 110.996 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 89' ' ' VAL . 0.1 OUTLIER -69.19 -10.05 55.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.178 -0.951 . . . . 0.0 110.922 -179.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.943 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -120.02 26.71 9.11 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 121.156 -0.965 . . . . 0.0 110.447 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 79.77 107.18 0.25 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -170.54 114.99 0.47 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.328 -1.101 . . . . 0.0 110.143 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 74' ' ' ARG . 6.4 ttt85 -69.78 132.89 46.79 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.375 -0.828 . . . . 0.0 110.082 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.4 mp -119.8 26.83 9.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.418 -0.801 . . . . 0.0 110.191 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -115.54 53.03 0.85 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.27 -0.894 . . . . 0.0 110.287 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.76 HG11 ' CG ' ' A' ' 74' ' ' ARG . 14.4 p -123.06 153.75 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.401 -0.812 . . . . 0.0 110.103 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 78.2 m -109.48 147.47 32.84 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 0.0 109.924 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 6.6 p-10 -70.75 67.25 0.37 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.298 -0.876 . . . . 0.0 110.325 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.791 ' HB1' ' CZ3' ' A' ' 104' ' ' TRP . . . 57.48 111.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.424 -0.797 . . . . 0.0 110.481 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.791 ' CZ3' ' HB1' ' A' ' 103' ' ' ALA . 38.4 p90 35.64 34.96 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 O-C-N 121.76 -0.588 . . . . 0.0 111.432 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 103' ' ' ALA . . . -122.84 -126.9 3.22 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.38 179.01 6.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -1.09 . . . . 0.0 110.269 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.544 ' HB2' HG12 ' A' ' 109' ' ' VAL . 96.9 mt -62.85 166.72 7.14 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.477 -0.764 . . . . 0.0 110.013 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.7 Cg_endo -69.94 -16.91 36.99 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.67 1.353 . . . . 0.0 110.536 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.544 HG12 ' HB2' ' A' ' 107' ' ' LEU . 11.6 p -61.64 -35.21 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.218 -0.926 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.428 ' N ' HG13 ' A' ' 109' ' ' VAL . 6.1 m-20 -69.3 -41.74 76.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.414 -0.804 . . . . 0.0 110.153 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.9 tp -58.01 -31.15 66.68 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.0 110.068 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.753 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -68.92 -67.72 0.45 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.352 -0.843 . . . . 0.0 110.225 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.75 -25.72 20.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.641 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -73.85 -27.12 60.93 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.358 -0.839 . . . . 0.0 110.53 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 73.4 tp60 -95.29 -16.02 22.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.0 110.667 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 125.28 -13.99 7.4 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.47 ' HB3' ' CG2' ' A' ' 120' ' ' ILE . 24.0 m-70 -75.87 96.87 3.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -1.196 . . . . 0.0 109.594 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' A' ' 119' ' ' ASP . 2.7 ptm180 -91.38 -41.82 10.68 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.327 -0.858 . . . . 0.0 110.923 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.414 ' N ' ' CG ' ' A' ' 118' ' ' ARG . 74.4 m-20 -63.29 -38.85 92.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.23 -0.919 . . . . 0.0 109.634 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.753 ' CG2' ' HB1' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -65.63 -37.24 79.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.567 -0.708 . . . . 0.0 109.92 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.435 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -60.66 -37.0 80.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.453 -0.779 . . . . 0.0 109.9 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.09 -51.15 70.85 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.408 -0.807 . . . . 0.0 109.759 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.412 ' CB ' HD21 ' A' ' 85' ' ' LEU . 30.9 t80 -60.28 -28.24 67.93 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.39 -0.819 . . . . 0.0 110.066 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 60.9 mt -85.59 -38.1 18.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.426 -0.796 . . . . 0.0 110.266 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.45 ' CG ' HG21 ' A' ' 109' ' ' VAL . 18.7 m-70 -54.62 -29.3 51.6 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.215 -0.928 . . . . 0.0 110.355 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -99.86 -20.63 16.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.362 -0.836 . . . . 0.0 110.312 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -92.68 -26.85 17.61 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.284 -0.885 . . . . 0.0 110.582 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 36.2 p -98.51 15.71 24.09 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.319 -0.863 . . . . 0.0 110.378 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -107.73 -111.98 3.58 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 130' ' ' ASP . 21.2 p-10 . . . . . 0 N--CA 1.486 1.361 0 O-C-N 121.363 -1.081 . . . . 0.0 110.403 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 44.6 m -74.07 160.45 81.65 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.33 -1.1 . . . . 0.0 110.206 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.91 134.79 22.24 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.882 1.464 . . . . 0.0 110.456 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -141.13 53.43 0.66 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' ILE . . . . . . . . . . . . . 29.2 pt -110.95 34.01 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -1.116 . . . . 0.0 110.258 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -95.35 14.35 22.75 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.436 -0.79 . . . . 0.0 110.439 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttm 58.33 163.8 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.246 -0.909 . . . . 0.0 110.393 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.409 HD12 ' OG ' ' A' ' 5' ' ' SER . 13.9 tp -154.66 96.52 1.89 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.22 -0.925 . . . . 0.0 110.153 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -137.67 -56.62 0.05 OUTLIER Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.91 -26.72 74.01 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.409 ' OG ' HD12 ' A' ' 2' ' ' LEU . 8.6 p -88.7 -179.18 5.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.305 -1.115 . . . . 0.0 110.179 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 55.71 22.9 5.77 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.379 -0.826 . . . . 0.0 110.439 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -70.62 -36.96 73.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.166 -0.959 . . . . 0.0 109.967 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.46 -21.7 61.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.399 -0.813 . . . . 0.0 110.321 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.422 ' HA2' ' CG2' ' A' ' 12' ' ' THR . . . -57.65 -25.21 55.19 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.703 HD13 ' HG ' ' A' ' 26' ' ' LEU . 13.5 tp -75.92 -38.52 57.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.378 -1.071 . . . . 0.0 110.506 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -83.17 -38.09 22.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.091 -1.005 . . . . 0.0 111.041 -179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.511 HG23 ' N ' ' A' ' 13' ' ' ALA . 15.2 t -61.81 -41.11 97.35 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.144 -0.972 . . . . 0.0 110.487 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.515 ' HB3' HG22 ' A' ' 22' ' ' VAL . . . -68.15 -50.56 53.76 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.175 -0.953 . . . . 0.0 109.534 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 46' ' ' MET . . . -52.57 -45.88 66.61 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.91 . . . . 0.0 110.563 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.589 ' HB2' HG22 ' A' ' 45' ' ' VAL . . . -71.4 -18.02 62.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.422 -0.799 . . . . 0.0 110.648 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -97.15 26.03 5.05 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 0.0 110.587 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 56.93 37.85 81.2 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.625 ' HB3' ' OG1' ' A' ' 21' ' ' THR . 62.6 mm-40 -112.96 93.87 4.63 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.42 -1.047 . . . . 0.0 110.271 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.682 HG21 ' HB2' ' A' ' 52' ' ' GLN . 11.3 t -82.78 -59.31 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.215 -0.928 . . . . 0.0 110.47 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -50.23 -48.99 54.28 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.399 -0.813 . . . . 0.0 110.319 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.625 ' OG1' ' HB3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -53.88 -34.57 59.82 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.518 -0.739 . . . . 0.0 110.362 179.518 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.872 HG12 HD13 ' A' ' 56' ' ' LEU . 95.3 t -81.12 -30.15 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.25 -0.906 . . . . 0.0 109.779 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.751 ' HA ' HD11 ' A' ' 56' ' ' LEU . 4.5 mmm180 -58.9 -37.56 76.9 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.296 -0.877 . . . . 0.0 110.108 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.449 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 4.2 tt0 -79.28 -51.42 9.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 0.0 110.42 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mt -53.73 -53.93 45.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 0.0 110.672 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.999 HD13 HD22 ' A' ' 56' ' ' LEU . 8.5 mt -56.56 -59.88 4.35 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.247 -0.908 . . . . 0.0 110.404 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -60.67 -24.15 65.38 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.369 -0.832 . . . . 0.0 110.266 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -74.43 -64.93 0.92 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.283 -0.886 . . . . 0.0 110.143 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.35 48.69 0.07 OUTLIER Glycine 0 N--CA 1.482 1.705 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.637 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . . . -88.4 172.24 9.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.35 -1.088 . . . . 0.0 110.22 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 6.5 t0 -110.82 102.75 53.25 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.384 -0.823 . . . . 0.0 110.239 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.3 -15.08 31.55 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.655 1.345 . . . . 0.0 110.64 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -109.31 26.83 10.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.245 -0.909 . . . . 0.0 110.163 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -95.63 102.62 14.44 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.365 -0.835 . . . . 0.0 110.405 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 35' ' ' LEU . 25.7 mt -65.82 123.08 18.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.355 -0.841 . . . . 0.0 110.076 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -62.48 175.64 0.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.395 -0.815 . . . . 0.0 109.886 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -6.12 45.22 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.305 -0.872 . . . . 0.0 110.459 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 0.4 OUTLIER -93.3 17.59 10.97 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.173 -0.955 . . . . 0.0 110.084 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.98 24.0 18.27 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.1 mtt85 -110.15 155.85 21.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.387 -1.066 . . . . 0.0 109.836 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.565 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.9 mmp_? -73.61 168.86 21.65 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.387 -0.821 . . . . 0.0 109.524 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.565 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 41.0 Cg_endo -68.03 -14.98 42.48 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.454 1.239 . . . . 0.0 110.173 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.54 ' HA ' ' HG2' ' A' ' 46' ' ' MET . 58.0 mt -107.95 -17.94 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.85 . . . . 0.0 109.87 179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -69.12 -20.93 64.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 0.0 110.15 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.589 HG22 ' HB2' ' A' ' 15' ' ' ALA . 8.9 p -109.59 -17.0 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.355 -0.841 . . . . 0.0 110.399 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.54 ' HG2' ' HA ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -55.92 164.49 1.17 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.195 -0.941 . . . . 0.0 110.31 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 2.2 tmm? -63.14 89.27 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.335 -0.853 . . . . 0.0 109.171 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.424 ' HG3' ' HA ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -49.82 -19.93 0.76 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.47 -0.768 . . . . 0.0 111.28 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 84' ' ' PHE . . . -86.66 20.44 23.55 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.416 ' O ' HG23 ' A' ' 53' ' ' VAL . 21.2 t -140.67 118.62 11.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.007 -1.29 . . . . 0.0 110.375 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -74.76 -26.25 59.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.221 -0.924 . . . . 0.0 109.647 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.682 ' HB2' HG21 ' A' ' 19' ' ' VAL . 11.7 mt-30 -53.44 -27.35 24.24 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.525 -0.735 . . . . 0.0 110.644 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.834 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -90.05 -48.3 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.419 -0.801 . . . . 0.0 110.186 -179.526 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.653 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -55.05 -35.11 64.14 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.297 -0.877 . . . . 0.0 110.368 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.407 ' HA ' HG11 ' A' ' 90' ' ' VAL . 7.3 tp10 -78.03 -48.24 16.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.361 -0.837 . . . . 0.0 110.635 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.999 HD22 HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -52.83 -65.54 0.54 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.201 -0.937 . . . . 0.0 110.761 -179.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.834 HD12 ' O ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -50.95 -47.01 61.25 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.458 -0.776 . . . . 0.0 110.823 -179.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' A' ' 94' ' ' ALA . 1.0 OUTLIER -55.3 -43.5 74.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.198 -0.939 . . . . 0.0 110.254 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.3 tp -60.4 -25.61 66.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.286 -0.884 . . . . 0.0 110.075 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.673 ' CG ' HD22 ' A' ' 26' ' ' LEU . 29.3 m-70 -95.98 24.68 5.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.365 -0.834 . . . . 0.0 110.201 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.55 54.41 37.94 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.28 -146.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.359 -1.083 . . . . 0.0 109.464 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.63 70.7 77.05 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.004 -1.06 . . . . 0.0 110.048 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.502 ' HB2' ' HB2' ' A' ' 96' ' ' ALA . 48.8 Cg_endo -81.57 -24.1 4.51 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.806 1.424 . . . . 0.0 110.134 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -95.75 -29.13 14.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.41 -0.806 . . . . 0.0 110.358 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.489 ' HB3' ' HD2' ' A' ' 41' ' ' ARG . 0.5 OUTLIER -64.39 139.58 58.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.349 -0.844 . . . . 0.0 110.375 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.492 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -128.51 175.12 8.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.335 -0.853 . . . . 0.0 110.5 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.515 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 8.6 t70 -76.95 137.18 65.92 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.496 -0.753 . . . . 0.0 109.84 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -79.06 -28.35 3.92 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.519 1.273 . . . . 0.0 111.106 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.49 -22.69 58.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.133 -0.979 . . . . 0.0 110.686 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.754 ' C ' ' HB2' ' A' ' 103' ' ' ALA . 3.5 m -144.25 19.57 1.74 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.113 -0.992 . . . . 0.0 111.13 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.422 ' HB2' ' CA ' ' A' ' 103' ' ' ALA . 4.9 mt 40.25 36.68 0.35 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.313 -0.867 . . . . 0.0 110.861 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -87.3 126.16 34.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.405 -0.809 . . . . 0.0 110.851 -178.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.709 ' CG ' HG11 ' A' ' 100' ' ' VAL . 0.2 OUTLIER -92.62 173.25 5.23 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.557 -0.714 . . . . 0.0 110.178 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.09 -18.72 16.25 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.663 1.349 . . . . 0.0 110.348 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.89 -32.79 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.33 -0.856 . . . . 0.0 109.939 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.633 ' HE1' HG13 ' A' ' 100' ' ' VAL . 68.8 m80 -60.92 -46.15 91.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.34 -0.85 . . . . 0.0 110.04 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.403 ' CB ' ' CE ' ' A' ' 48' ' ' MET . 1.2 m-20 -60.21 -57.1 14.24 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.3 -0.875 . . . . 0.0 110.037 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.621 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -51.64 -30.53 21.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.357 -0.84 . . . . 0.0 109.818 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -84.16 -23.55 30.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.562 -0.711 . . . . 0.0 109.749 179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.448 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 0.0 OUTLIER -60.38 -35.58 76.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.457 -0.777 . . . . 0.0 110.122 179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -94.76 -19.5 20.31 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.34 -0.85 . . . . 0.0 110.463 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.23 30.63 13.55 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.574 ' CA ' ' HZ ' ' A' ' 84' ' ' PHE . 18.0 t80 -97.65 92.01 5.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -1.004 . . . . 0.0 110.092 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.557 ' O ' HG23 ' A' ' 89' ' ' VAL . 2.7 mt -65.63 -22.45 66.66 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.273 -0.892 . . . . 0.0 110.349 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.627 ' O ' HG23 ' A' ' 90' ' ' VAL . 6.5 m-20 -57.47 -41.14 80.05 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.397 -0.814 . . . . 0.0 110.392 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.653 HG23 ' CB ' ' A' ' 54' ' ' ALA . 74.8 m -72.86 -36.38 67.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.349 -0.844 . . . . 0.0 109.96 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.726 ' CD1' HD11 ' A' ' 120' ' ' ILE . 5.4 mp -62.52 -42.26 99.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.0 109.769 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 85' ' ' LEU . 67.6 t -61.31 -44.59 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.448 -0.783 . . . . 0.0 109.332 179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 86' ' ' ASP . 65.1 t -55.49 -44.29 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.444 -0.785 . . . . 0.0 109.857 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 87' ' ' THR . 5.5 mp -62.52 -45.95 90.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.428 -0.795 . . . . 0.0 109.744 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -70.97 -15.91 62.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.0 110.254 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -74.61 -71.64 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.349 -0.844 . . . . 0.0 110.136 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -60.78 -78.47 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.331 -0.855 . . . . 0.0 110.286 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -172.06 107.61 0.26 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 64' ' ' PRO . . . -160.68 119.36 2.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.422 -1.046 . . . . 0.0 109.834 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.7 ttm-85 -60.43 126.59 28.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.263 -0.898 . . . . 0.0 110.379 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.768 ' O ' HG22 ' A' ' 128' ' ' THR . 0.3 OUTLIER -111.51 64.64 0.62 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 110.283 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -171.29 61.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -0.859 . . . . 0.0 110.053 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.709 HG11 ' CG ' ' A' ' 74' ' ' ARG . 7.3 p -131.86 173.13 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 110.065 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.483 ' N ' HG22 ' A' ' 100' ' ' VAL . 0.0 OUTLIER -135.1 160.87 36.98 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 104' ' ' TRP . 29.5 m-20 -68.76 71.91 0.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.149 -0.969 . . . . 0.0 109.709 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.754 ' HB2' ' C ' ' A' ' 71' ' ' THR . . . 56.49 -80.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.64 -0.663 . . . . 0.0 110.113 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.503 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.3 OUTLIER -126.78 32.69 5.09 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -115.46 -142.15 7.59 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.966 -1.111 . . . . 0.0 110.388 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.416 ' HB3' ' CB ' ' A' ' 110' ' ' ASP . 5.4 mtt85 -98.06 159.13 15.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.459 -1.024 . . . . 0.0 110.787 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.476 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 1.0 OUTLIER -78.99 175.64 4.53 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.604 -0.685 . . . . 0.0 109.618 179.565 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 40.8 Cg_endo -66.12 -16.87 53.7 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.385 1.203 . . . . 0.0 110.174 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.521 HG21 ' CG ' ' A' ' 125' ' ' HIS . 9.7 p -91.69 -34.9 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.873 . . . . 0.0 109.796 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.418 ' N ' HG13 ' A' ' 109' ' ' VAL . 10.0 m-20 -66.91 -41.65 86.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -0.8 . . . . 0.0 109.954 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.749 HD23 ' O ' ' A' ' 111' ' ' LEU . 5.8 tt -57.04 -31.02 64.75 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.419 -0.801 . . . . 0.0 109.951 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.729 ' HB1' ' HB2' ' A' ' 117' ' ' HIS . . . -83.85 -36.85 23.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.532 -0.73 . . . . 0.0 109.979 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -54.99 -26.21 35.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.391 -0.818 . . . . 0.0 110.644 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -91.88 -47.28 7.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.377 -0.827 . . . . 0.0 110.72 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.432 ' HG2' ' CE1' ' A' ' 117' ' ' HIS . 52.6 tp60 -66.4 -100.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.913 . . . . 0.0 110.547 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -163.12 24.7 0.2 Allowed Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.523 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.729 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 1.6 m170 -100.51 86.2 3.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.0 -1.294 . . . . 0.0 109.386 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 122' ' ' ARG . 2.6 mpt_? -80.72 -57.93 3.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.415 -0.803 . . . . 0.0 110.71 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -45.76 -46.84 15.42 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.627 -0.671 . . . . 0.0 110.894 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.726 HD11 ' CD1' ' A' ' 88' ' ' LEU . 2.7 tt -65.41 -37.44 80.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.336 -0.853 . . . . 0.0 109.644 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.421 ' N ' ' CG2' ' A' ' 120' ' ' ILE . . . -61.82 -39.7 92.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.497 -0.752 . . . . 0.0 110.0 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 11.5 mmt180 -63.8 -41.37 97.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.284 -0.885 . . . . 0.0 109.354 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -74.34 -30.64 62.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.548 -0.72 . . . . 0.0 109.587 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.504 HD23 HD21 ' A' ' 98' ' ' LEU . 20.4 mt -72.89 -59.55 2.66 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.522 -0.737 . . . . 0.0 109.972 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.521 ' CG ' HG21 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -56.06 -28.57 58.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.38 -0.825 . . . . 0.0 110.096 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.82 -33.77 71.04 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.429 -0.794 . . . . 0.0 110.243 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.462 ' HB3' ' CD2' ' A' ' 98' ' ' LEU . . . -99.81 -22.41 15.35 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 110.398 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.768 HG22 ' O ' ' A' ' 98' ' ' LEU . 64.2 p -93.99 16.1 15.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.276 -0.89 . . . . 0.0 110.354 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -83.15 67.34 3.76 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.629 -179.71 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . 0.463 ' N ' ' HD2' ' A' ' -3' ' ' PRO . 1.2 t -64.89 -56.8 18.78 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.363 -1.081 . . . . 0.0 110.404 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' -4' ' ' SER . 47.2 Cg_endo -72.34 -32.27 10.49 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.472 1.249 . . . . 0.0 110.64 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . . . . . . . . . . . -66.29 127.19 29.25 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' ILE . . . . . . . . . . . . . 13.4 pt -144.72 23.64 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.369 -1.077 . . . . 0.0 110.564 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -170.17 -141.62 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.224 -0.923 . . . . 0.0 110.438 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.92 175.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.236 -0.915 . . . . 0.0 111.17 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.538 ' O ' HD23 ' A' ' 2' ' ' LEU . 2.0 tt -154.16 87.42 1.19 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.508 -0.745 . . . . 0.0 109.991 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.45 -160.37 36.29 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -113.82 -101.84 2.48 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 24.6 p -135.22 -78.14 0.44 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.284 -1.127 . . . . 0.0 110.626 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.8 m -125.57 95.49 4.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.201 -0.937 . . . . 0.0 110.695 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.88 -17.93 51.95 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.358 -0.839 . . . . 0.0 110.01 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.601 ' HB3' ' HB3' ' A' ' 36' ' ' ASN . . . -148.51 50.74 1.0 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.08 -27.76 46.77 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.009 -1.637 . . . . 0.0 109.009 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.993 HD13 HD21 ' A' ' 57' ' ' LEU . 3.9 pp -57.96 -33.6 69.02 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.503 -0.998 . . . . 0.0 109.866 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.722 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -76.49 -39.28 53.61 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.381 -0.824 . . . . 0.0 109.733 179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 84.7 m -62.36 -54.46 40.15 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.406 -0.809 . . . . 0.0 109.785 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' O ' ' HG2' ' A' ' 16' ' ' ARG . . . -64.13 -32.33 73.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 0.0 109.783 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.654 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -67.19 -32.68 73.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.206 -0.934 . . . . 0.0 109.494 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.413 ' CA ' ' HA ' ' A' ' 46' ' ' MET . . . -70.87 -27.02 63.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.489 -0.757 . . . . 0.0 110.02 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 19.2 ptt180 -100.17 20.25 14.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.33 -0.856 . . . . 0.0 110.411 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.414 ' HA3' ' CE ' ' A' ' 47' ' ' MET . . . 62.5 83.0 0.07 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.74 ' O ' HG23 ' A' ' 22' ' ' VAL . 35.4 mm-40 -151.74 71.25 0.97 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.228 -1.16 . . . . 0.0 110.174 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.822 HG22 HG23 ' A' ' 53' ' ' VAL . 24.8 t -57.0 -43.01 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.236 -0.915 . . . . 0.0 109.889 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -56.89 -52.61 64.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.343 -0.848 . . . . 0.0 110.541 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -41.44 96.94 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.359 -0.838 . . . . 0.0 110.249 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.818 HG12 HD23 ' A' ' 56' ' ' LEU . 62.1 t -63.24 -38.28 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.45 -0.781 . . . . 0.0 110.024 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.781 ' HD2' HD13 ' A' ' 56' ' ' LEU . 6.8 mmm-85 -69.5 -24.56 63.78 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.42 -0.8 . . . . 0.0 110.148 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.426 ' O ' ' HB2' ' A' ' 28' ' ' ALA . 89.8 mm-40 -79.31 -53.6 6.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.363 -0.836 . . . . 0.0 110.464 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.937 HD22 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -59.58 -44.07 93.44 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.347 -0.846 . . . . 0.0 110.484 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.432 HD11 ' CG ' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -57.24 -53.33 59.35 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.18 -0.95 . . . . 0.0 110.245 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -75.35 -5.56 45.44 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.427 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 24' ' ' GLN . . . -84.1 -39.05 19.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.139 -0.975 . . . . 0.0 110.431 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 163.98 -20.19 0.14 Allowed Glycine 0 N--CA 1.484 1.881 0 C-N-CA 120.009 -1.091 . . . . 0.0 110.642 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.937 ' HB2' HD22 ' A' ' 25' ' ' LEU . . . -47.46 136.27 10.01 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.151 -1.205 . . . . 0.0 111.009 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.92 ' OD2' ' HB2' ' A' ' 34' ' ' ALA . 10.4 p-10 -78.19 150.59 77.61 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.423 -0.798 . . . . 0.0 110.203 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.73 4.45 6.91 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.852 1.448 . . . . 0.0 111.051 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -136.35 43.25 2.49 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.036 -1.04 . . . . 0.0 110.917 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.92 ' HB2' ' OD2' ' A' ' 31' ' ' ASP . . . -109.72 104.69 13.71 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 35' ' ' LEU . 3.7 pp -73.61 138.76 45.07 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.201 -0.937 . . . . 0.0 110.253 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.601 ' HB3' ' HB3' ' A' ' 8' ' ' ALA . 15.6 p-10 -107.7 82.72 1.69 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.827 . . . . 0.0 110.471 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 mmt180 52.02 -171.48 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.313 -0.867 . . . . 0.0 110.862 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 39' ' ' GLY . 80.2 m-85 55.56 13.28 0.94 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.571 -0.705 . . . . 0.0 110.924 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 38' ' ' PHE . . . 38.54 35.31 0.31 Allowed Glycine 0 N--CA 1.497 2.723 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.0 mtm-85 -107.11 -164.68 1.0 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -1.041 . . . . 0.0 110.478 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.672 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 8.8 mmp_? -116.71 176.64 1.47 Allowed Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.672 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 43.1 Cg_endo -72.07 -19.78 26.02 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.31 1.163 . . . . 0.0 110.2 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.455 ' O ' ' HG2' ' A' ' 46' ' ' MET . 25.4 mt -104.27 -27.44 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.27 -0.894 . . . . 0.0 109.546 179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -74.47 -4.26 35.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.172 -0.955 . . . . 0.0 110.536 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.722 HG11 ' HB1' ' A' ' 11' ' ' ALA . 12.4 p -115.03 -17.95 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.084 -1.01 . . . . 0.0 110.748 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.455 ' HG2' ' O ' ' A' ' 43' ' ' ILE . 0.5 OUTLIER -64.34 164.82 10.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.966 -179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . 0.414 ' CE ' ' HA3' ' A' ' 17' ' ' GLY . 0.5 OUTLIER -55.67 -16.92 4.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.375 -0.828 . . . . 0.0 110.545 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.566 ' HE3' ' CB ' ' A' ' 78' ' ' ASP . 45.3 tpp 58.93 24.66 12.8 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.294 -0.878 . . . . 0.0 110.107 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -128.23 20.54 5.59 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.1 m -149.13 96.26 2.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -1.109 . . . . 0.0 110.04 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.419 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -52.49 -26.76 13.86 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.274 -0.891 . . . . 0.0 110.296 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.641 ' HB2' HG21 ' A' ' 19' ' ' VAL . 6.0 mt-30 -53.28 -34.8 58.76 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.341 -0.849 . . . . 0.0 110.047 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.822 HG23 HG22 ' A' ' 19' ' ' VAL . 60.3 t -84.13 -38.47 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.555 -0.716 . . . . 0.0 110.223 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.877 ' CB ' HG23 ' A' ' 87' ' ' THR . . . -68.18 -33.18 73.96 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.415 -0.803 . . . . 0.0 110.553 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.402 ' O ' HD23 ' A' ' 59' ' ' LEU . 8.5 tt0 -76.6 -39.98 50.84 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.155 -0.966 . . . . 0.0 110.659 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.818 HD23 HG12 ' A' ' 22' ' ' VAL . 46.5 tp -56.2 -63.03 1.32 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.284 -0.885 . . . . 0.0 110.732 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.993 HD21 HD13 ' A' ' 10' ' ' LEU . 5.1 mt -59.78 -30.31 68.79 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.254 -0.904 . . . . 0.0 110.84 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.948 HD22 HG13 ' A' ' 90' ' ' VAL . 2.7 tp -60.13 -67.51 0.38 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.13 -0.981 . . . . 0.0 110.99 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.434 HD11 ' CE1' ' A' ' 60' ' ' HIS . 2.2 pp -51.85 -25.28 7.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.247 -0.908 . . . . 0.0 110.7 -179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.434 ' CE1' HD11 ' A' ' 59' ' ' LEU . 12.7 m80 -80.88 -67.3 0.79 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.303 -0.873 . . . . 0.0 110.179 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 173.52 40.9 0.04 OUTLIER Glycine 0 N--CA 1.482 1.711 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' A' ' 57' ' ' LEU . . . -61.67 -164.66 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.314 -1.109 . . . . 0.0 110.13 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.59 74.43 74.63 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.393 -0.817 . . . . 0.0 109.959 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -77.89 -32.61 2.55 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.901 1.474 . . . . 0.0 110.158 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -95.6 -30.18 13.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.388 -0.82 . . . . 0.0 110.012 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 171.08 2.24 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.438 -0.789 . . . . 0.0 110.139 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.809 ' HB1' ' O ' ' A' ' 73' ' ' THR . . . -169.46 -179.51 3.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.362 -0.836 . . . . 0.0 110.421 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.433 ' O ' ' N ' ' A' ' 72' ' ' LEU . 21.8 t0 -78.69 131.44 67.71 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.396 -0.815 . . . . 0.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.67 -23.16 11.39 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.544 1.286 . . . . 0.0 110.398 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.83 -29.41 62.12 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.309 -0.869 . . . . 0.0 110.59 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.827 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 7.8 m -138.92 17.32 2.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.248 -0.907 . . . . 0.0 110.665 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.433 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER 42.38 29.47 0.15 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.317 -0.864 . . . . 0.0 110.794 179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.809 ' O ' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -72.31 134.84 45.74 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.412 -0.805 . . . . 0.0 110.556 -179.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.682 ' HG3' HG11 ' A' ' 100' ' ' VAL . 0.1 OUTLIER -107.72 165.17 13.25 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 110.324 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.37 -24.68 22.5 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.698 1.367 . . . . 0.0 110.322 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.451 HG12 ' HB2' ' A' ' 108' ' ' PRO . 58.9 t -58.7 -29.14 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.353 -0.842 . . . . 0.0 110.007 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.56 ' HE1' HG13 ' A' ' 100' ' ' VAL . 33.4 m80 -68.65 -34.33 75.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.344 -0.848 . . . . 0.0 110.126 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.566 ' CB ' ' HE3' ' A' ' 48' ' ' MET . 43.4 m-20 -77.82 -56.5 4.45 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.409 -0.807 . . . . 0.0 110.239 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.566 ' HB1' HD12 ' A' ' 88' ' ' LEU . . . -52.65 -26.6 14.2 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.093 -1.004 . . . . 0.0 109.888 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.436 ' O ' ' CD2' ' A' ' 117' ' ' HIS . . . -85.3 -21.31 29.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.435 -0.791 . . . . 0.0 109.566 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.67 ' CD ' HD12 ' A' ' 111' ' ' LEU . 10.3 tpt180 -76.44 -17.25 59.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.429 -0.794 . . . . 0.0 110.341 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' HG3' ' HB3' ' A' ' 48' ' ' MET . 30.6 mm-40 -100.84 -34.54 9.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.18 -0.95 . . . . 0.0 110.323 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 101.9 34.18 4.42 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.2 105.61 15.82 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -1.091 . . . . 0.0 110.123 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.681 HD22 HD12 ' A' ' 120' ' ' ILE . 2.8 mm? -77.6 -21.98 51.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.466 -0.772 . . . . 0.0 110.256 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.692 ' O ' HG23 ' A' ' 90' ' ' VAL . 46.6 t0 -68.0 -48.71 64.99 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.361 -0.837 . . . . 0.0 110.565 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.877 HG23 ' CB ' ' A' ' 54' ' ' ALA . 97.8 m -65.3 -33.98 77.27 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.14 -0.975 . . . . 0.0 110.071 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.799 HD13 HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -61.87 -48.53 80.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.226 -0.921 . . . . 0.0 109.857 179.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 85' ' ' LEU . 67.6 t -60.06 -40.7 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.259 -0.901 . . . . 0.0 109.527 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.948 HG13 HD22 ' A' ' 58' ' ' LEU . 91.3 t -53.82 -53.79 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.446 -0.784 . . . . 0.0 110.234 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.6 mp -52.74 -52.01 58.15 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.387 -0.821 . . . . 0.0 110.581 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -60.99 -24.69 66.34 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.254 -0.904 . . . . 0.0 110.177 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.42 -22.88 60.11 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.407 -0.808 . . . . 0.0 110.338 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.752 ' HB3' HD11 ' A' ' 58' ' ' LEU . . . -121.46 35.05 4.99 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.278 -0.889 . . . . 0.0 110.616 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 76.59 114.05 0.14 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.417 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -155.6 131.56 9.99 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.332 -1.099 . . . . 0.0 110.034 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 141.47 38.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.335 -0.853 . . . . 0.0 109.951 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.754 ' O ' HG22 ' A' ' 128' ' ' THR . 0.5 OUTLIER -133.59 11.09 4.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.394 -0.816 . . . . 0.0 110.307 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -110.73 22.92 14.84 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.196 -0.94 . . . . 0.0 110.019 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.682 HG11 ' HG3' ' A' ' 74' ' ' ARG . 9.5 p -91.56 144.93 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.451 -0.78 . . . . 0.0 109.932 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.542 ' SG ' HD11 ' A' ' 107' ' ' LEU . 53.4 m -115.17 41.96 2.32 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.187 -0.946 . . . . 0.0 110.383 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.671 ' OD1' HG23 ' A' ' 73' ' ' THR . 32.0 t0 52.64 69.47 0.68 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.351 -0.843 . . . . 0.0 110.36 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.827 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 62.89 -77.93 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.519 -0.738 . . . . 0.0 110.254 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.424 ' N ' ' O ' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -155.5 45.92 0.48 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.356 -0.84 . . . . 0.0 109.801 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -129.42 -118.09 2.03 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -95.83 -178.36 4.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -1.102 . . . . 0.0 110.665 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.542 HD11 ' SG ' ' A' ' 101' ' ' CYS . 3.7 mp -105.14 173.65 3.16 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.498 -0.752 . . . . 0.0 109.942 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 41.6 Cg_endo -67.83 -20.12 46.02 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.551 1.29 . . . . 0.0 110.274 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.741 ' HB ' HD11 ' A' ' 124' ' ' LEU . 14.4 p -83.28 -23.56 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.396 -0.815 . . . . 0.0 110.189 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -62.32 -28.34 69.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.225 -0.922 . . . . 0.0 110.266 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.67 HD12 ' CD ' ' A' ' 81' ' ' ARG . 4.4 mm? -58.32 -68.55 0.24 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.308 -0.87 . . . . 0.0 109.941 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.801 ' HB1' ' O ' ' A' ' 117' ' ' HIS . . . -61.64 -43.54 98.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -0.871 . . . . 0.0 109.725 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.543 ' HG3' HG22 ' A' ' 109' ' ' VAL . 8.8 mm-40 -48.98 -31.99 8.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.513 -0.742 . . . . 0.0 109.51 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.4 ' O ' ' CB ' ' A' ' 115' ' ' GLN . 10.8 tt0 -66.97 -62.94 1.18 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.608 -0.683 . . . . 0.0 109.212 179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.4 ' CB ' ' O ' ' A' ' 114' ' ' GLU . 0.4 OUTLIER 172.46 113.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.541 -0.724 . . . . 0.0 110.221 179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 156.43 -53.19 0.42 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.628 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.801 ' O ' ' HB1' ' A' ' 112' ' ' ALA . 1.2 m-70 -138.86 75.78 1.54 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.176 -1.19 . . . . 0.0 110.566 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -61.41 -22.78 65.31 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.239 -0.913 . . . . 0.0 109.979 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.42 ' OD2' HD23 ' A' ' 85' ' ' LEU . 12.5 p-10 -72.87 -42.21 63.9 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.401 -0.812 . . . . 0.0 110.451 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.799 HD11 HD13 ' A' ' 88' ' ' LEU . 0.6 OUTLIER -61.87 -30.75 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.919 . . . . 0.0 109.917 -179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' A' ' 125' ' ' HIS . . . -65.1 -52.61 54.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.421 -0.8 . . . . 0.0 109.644 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.43 ' HA ' ' CE1' ' A' ' 125' ' ' HIS . 5.4 mtm180 -45.81 -46.38 15.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.285 -0.884 . . . . 0.0 110.662 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -81.77 -56.74 3.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.352 -0.842 . . . . 0.0 111.057 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.839 ' O ' HG23 ' A' ' 128' ' ' THR . 0.3 OUTLIER -59.51 -39.65 84.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.046 -1.034 . . . . 0.0 111.158 -178.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.519 ' CD2' ' C ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -67.81 -39.76 83.91 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.747 -1.22 . . . . 0.0 109.461 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . 0.449 ' N ' ' CD2' ' A' ' 125' ' ' HIS . . . -54.23 -27.94 37.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.412 -0.805 . . . . 0.0 109.548 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.723 ' CB ' HD22 ' A' ' 98' ' ' LEU . . . -90.86 -16.8 27.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.595 -0.69 . . . . 0.0 110.411 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.839 HG23 ' O ' ' A' ' 124' ' ' LEU . 29.1 p -98.16 26.03 5.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.194 -0.941 . . . . 0.0 109.71 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -70.73 65.28 0.84 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.419 -1.047 . . . . 0.0 110.606 -179.886 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.672 -1.371 . . . . 11.96 109.672 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' SER . . . . . . . . . . . . . 83.9 p 44.45 72.79 1.1 Allowed Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.614 -0.933 . . . . 10.58 110.876 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.68 -17.5 42.64 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 O-C-N 123.995 1.524 . . . . 10.23 110.609 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' GLY . . . . . 0.868 ' O ' ' N ' ' A' ' 0' ' ' HIS . . . -96.41 -34.03 5.98 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.106 -1.198 . . . . 10.45 110.106 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' -2' ' ' GLY . 11.1 tt 43.6 -51.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.481 0 O-C-N 121.947 -0.737 . . . . 11.59 112.384 -179.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' HIS . . . . . 0.868 ' N ' ' O ' ' A' ' -2' ' ' GLY . 11.5 t-80 -68.87 -32.13 71.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.634 -1.291 . . . . 10.43 110.224 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.92 129.78 41.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.237 -0.914 . . . . 9.03 110.247 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.5 33.07 4.22 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 6.09 110.029 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 101.86 30.87 5.62 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.734 -1.346 . . . . 4.57 109.734 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.47 73.23 2.07 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.486 -1.446 . . . . 3.6 109.486 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.24 -58.75 0.75 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.369 -1.077 . . . . 3.98 110.5 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.904 ' HB3' HD21 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -154.14 27.59 0.47 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.233 -0.917 . . . . 2.96 110.613 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.64 -54.75 34.74 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.209 -0.932 . . . . 3.31 109.873 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.589 ' HB1' ' OD1' ' A' ' 36' ' ' ASN . . . -95.34 18.24 12.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.319 -0.863 . . . . 3.29 110.236 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.96 -37.35 92.08 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.385 -1.486 . . . . 2.63 109.385 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.8 HD13 ' CD2' ' A' ' 57' ' ' LEU . 4.0 pp -59.93 -27.25 66.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.384 -1.068 . . . . 2.24 110.154 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.545 ' HB1' HG11 ' A' ' 45' ' ' VAL . . . -80.47 -47.08 14.84 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.45 -0.781 . . . . 1.89 110.0 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 64.8 p -62.17 -51.2 68.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.373 -0.83 . . . . 2.15 109.837 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.53 -34.01 72.11 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.377 -0.827 . . . . 1.65 109.791 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.61 ' HB1' HG11 ' A' ' 53' ' ' VAL . . . -73.07 -36.18 66.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.536 -0.728 . . . . 1.38 109.91 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.432 ' HA ' ' HA ' ' A' ' 46' ' ' MET . . . -60.75 -27.07 67.68 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.421 -0.799 . . . . 1.41 110.066 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -93.52 -17.51 23.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.372 -0.83 . . . . 4.94 110.321 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 97.17 54.04 1.31 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.518 -1.433 . . . . 1.44 109.518 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -124.92 79.42 1.78 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -1.118 . . . . 2.77 110.521 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.829 HG21 ' HB3' ' A' ' 52' ' ' GLN . 84.5 t -61.71 -38.84 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.222 -0.924 . . . . 1.58 109.66 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -58.78 -44.57 90.73 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.348 -0.845 . . . . 2.28 110.346 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 m -64.35 -42.68 96.1 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.869 . . . . 1.8 109.974 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.607 HG12 HD13 ' A' ' 56' ' ' LEU . 61.0 t -74.66 -25.77 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.429 -0.794 . . . . 1.6 110.198 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.569 ' HA ' HD11 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -64.26 -51.31 64.18 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.317 -0.864 . . . . 1.96 110.464 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.82 -21.06 60.27 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.275 -0.89 . . . . 4.45 110.599 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.904 HD21 ' HB3' ' A' ' 6' ' ' SER . 0.5 OUTLIER -71.26 -63.61 1.08 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.202 -0.936 . . . . 2.55 110.551 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.81 HD11 HD23 ' A' ' 57' ' ' LEU . 10.2 mt -56.83 -46.37 81.74 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.289 -0.882 . . . . 2.71 110.646 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.36 -35.24 75.22 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.38 -0.825 . . . . 3.3 110.375 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.08 -65.8 0.64 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.362 -0.836 . . . . 2.66 110.134 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 177.99 57.33 0.07 OUTLIER Glycine 0 N--CA 1.482 1.737 0 N-CA-C 109.563 -1.415 . . . . 2.97 109.563 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.717 ' HB3' ' HA ' ' A' ' 26' ' ' LEU . . . -109.01 133.93 52.32 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.305 -1.114 . . . . 2.78 110.168 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 34' ' ' ALA . 1.2 t0 -69.57 127.65 92.58 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 3.66 109.996 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.86 -17.32 25.61 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 O-C-N 123.592 1.312 . . . . 2.22 110.547 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -107.93 29.03 7.64 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.251 -0.906 . . . . 2.17 110.227 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . . . -81.22 106.2 13.02 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.363 -0.836 . . . . 2.32 110.153 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 35' ' ' LEU . 13.2 mt -65.3 164.92 12.56 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.384 -0.822 . . . . 2.98 110.386 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' OD1' ' HB1' ' A' ' 8' ' ' ALA . 1.3 m120 -107.69 -170.0 1.62 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.819 . . . . 3.25 110.14 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.1 mtt85 -81.77 -18.58 43.66 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.397 -0.814 . . . . 4.62 110.341 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -91.46 18.46 7.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.311 -0.868 . . . . 3.21 110.43 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 52.07 37.4 45.62 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.836 -1.306 . . . . 2.18 109.836 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.05 162.94 17.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.37 -1.077 . . . . 2.77 110.325 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.616 ' HB3' ' HD2' ' A' ' 42' ' ' PRO . 9.2 mmp_? -77.08 170.76 14.77 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.503 -0.748 . . . . 2.2 109.516 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 41' ' ' ARG . 41.1 Cg_endo -67.58 -13.1 37.89 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.478 1.252 . . . . 1.57 110.52 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.454 HG23 ' HE1' ' A' ' 46' ' ' MET . 74.2 mt -109.92 -17.86 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.231 -0.918 . . . . 1.31 109.862 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -77.81 -4.97 49.17 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.218 -0.926 . . . . 2.02 110.282 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.545 HG11 ' HB1' ' A' ' 11' ' ' ALA . 14.2 p -120.36 -6.43 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.251 -0.906 . . . . 1.59 110.903 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.572 ' HE1' ' HB2' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -69.41 162.42 27.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.024 -1.047 . . . . 1.8 110.174 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' MET . . . . . . . . . . . . . 3.2 tmm? -54.67 -19.62 6.53 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.344 -0.847 . . . . 1.63 110.865 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.497 ' HE2' ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER 60.96 19.68 10.06 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.29 -0.881 . . . . 1.36 110.156 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.418 ' HA2' ' CD2' ' A' ' 84' ' ' PHE . . . -124.81 24.39 6.07 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.369 -1.492 . . . . 1.25 109.369 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.9 t -154.59 106.84 2.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -1.083 . . . . 1.72 110.071 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . . . -58.88 -25.68 63.57 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.419 -0.801 . . . . 1.05 110.348 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.829 ' HB3' HG21 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -58.08 -29.54 65.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.269 -0.895 . . . . 2.53 110.185 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.683 ' CG2' HG22 ' A' ' 19' ' ' VAL . 34.6 t -84.19 -47.93 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.396 -0.815 . . . . 1.2 110.504 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.754 ' HB1' HG23 ' A' ' 87' ' ' THR . . . -62.1 -37.15 83.98 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.31 -0.869 . . . . 1.0 110.661 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.417 ' HA ' HG11 ' A' ' 90' ' ' VAL . 16.4 tt0 -74.93 -33.76 62.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.206 -0.934 . . . . 2.74 110.457 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.804 HD22 HD12 ' A' ' 26' ' ' LEU . 1.9 tt -57.22 -64.31 0.93 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.294 -0.879 . . . . 2.1 110.725 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.81 HD23 HD11 ' A' ' 26' ' ' LEU . 6.6 mt -61.41 -40.24 93.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.353 -0.842 . . . . 1.9 110.9 -179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.745 HD13 HG12 ' A' ' 90' ' ' VAL . 0.7 OUTLIER -58.47 -57.46 12.84 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 2.12 110.745 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.542 ' O ' HD12 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -53.49 -26.35 20.31 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.287 -0.883 . . . . 2.08 110.236 -179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.428 ' CE1' ' HB3' ' A' ' 26' ' ' LEU . 3.1 m170 -84.2 -73.9 0.4 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 2.46 110.054 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 174.16 50.11 0.05 OUTLIER Glycine 0 N--CA 1.483 1.831 0 N-CA-C 109.741 -1.343 . . . . 1.57 109.741 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.71 ' HB2' ' HB3' ' A' ' 57' ' ' LEU . . . -70.8 -162.11 0.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.314 -1.109 . . . . 1.54 110.177 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.408 ' CB ' ' HD3' ' A' ' 41' ' ' ARG . 0.3 OUTLIER -121.91 76.83 39.63 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.363 -0.836 . . . . 2.16 110.183 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 96' ' ' ALA . 48.7 Cg_endo -77.75 -24.44 8.69 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.775 1.408 . . . . 1.29 110.573 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -92.84 -50.01 5.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 2.56 110.4 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -54.07 120.85 6.98 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.244 -0.91 . . . . 1.86 110.449 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.789 ' HB2' ' HG2' ' A' ' 74' ' ' ARG . . . -109.36 -179.44 3.83 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.396 -0.815 . . . . 1.98 110.329 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -76.95 125.59 86.71 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.412 -0.805 . . . . 2.51 110.003 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.78 -13.0 24.41 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.495 1.26 . . . . 2.48 110.727 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.0 -30.86 44.51 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.168 -0.958 . . . . 2.68 110.557 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.62 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 1.7 m -142.66 17.15 2.0 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.346 -0.846 . . . . 2.71 110.567 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 50.98 32.08 7.05 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.288 -0.883 . . . . 2.34 110.506 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.42 HG23 ' OD1' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -85.7 121.47 28.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.389 -0.819 . . . . 1.77 110.379 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.802 ' HB2' HG11 ' A' ' 100' ' ' VAL . 1.0 OUTLIER -93.1 172.65 5.78 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.459 -0.775 . . . . 2.6 110.161 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.45 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 45.1 Cg_endo -72.13 -9.38 24.4 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.719 1.379 . . . . 0.94 110.772 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 57.4 t -77.83 -23.94 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.178 -0.951 . . . . 0.6 110.141 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.49 ' HE1' HG13 ' A' ' 100' ' ' VAL . 21.2 m80 -72.03 -52.14 18.41 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.311 -0.868 . . . . 0.87 110.476 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -58.44 -47.48 83.83 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.282 -0.886 . . . . 1.76 110.418 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.497 ' N ' ' HE2' ' A' ' 48' ' ' MET . . . -60.62 -26.36 66.96 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -0.853 . . . . 0.73 110.211 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 120' ' ' ILE . . . -87.7 -21.33 25.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.352 -0.843 . . . . 1.05 110.442 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 -72.6 -30.83 64.7 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.256 -0.903 . . . . 3.11 110.344 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.404 ' O ' ' CE1' ' A' ' 117' ' ' HIS . 1.3 mm-40 -86.61 -36.11 19.02 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.304 -0.872 . . . . 2.1 110.211 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 100.37 46.06 1.9 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.699 -1.361 . . . . 1.06 109.699 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.418 ' CD2' ' HA2' ' A' ' 49' ' ' GLY . 0.5 OUTLIER -115.13 103.15 10.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.366 -1.079 . . . . 1.69 109.923 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.503 HD12 ' HB3' ' A' ' 119' ' ' ASP . 2.3 mt -75.24 -22.62 57.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.344 -0.847 . . . . 1.92 110.368 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.798 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.6 OUTLIER -59.97 -43.31 95.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.259 -0.901 . . . . 1.68 110.114 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.754 HG23 ' HB1' ' A' ' 54' ' ' ALA . 63.7 m -73.24 -39.55 65.38 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.326 -0.859 . . . . 0.85 109.889 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.775 HD13 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -55.47 -46.51 76.83 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.393 -0.817 . . . . 1.21 109.952 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 85' ' ' LEU . 87.7 t -63.18 -41.15 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.402 -0.811 . . . . 1.41 109.539 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.798 HG23 ' O ' ' A' ' 86' ' ' ASP . 90.2 t -57.2 -47.9 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.596 -0.69 . . . . 1.1 110.276 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.11 -52.5 65.3 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.39 -0.819 . . . . 1.01 110.303 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -60.01 -27.2 66.7 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.514 -0.741 . . . . 1.66 110.323 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.6 ttp180 -67.8 -69.03 0.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 3.26 110.265 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.731 ' HB2' HD21 ' A' ' 58' ' ' LEU . . . -54.65 -28.19 45.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 1.58 110.669 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 118.17 87.86 1.21 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.564 -1.415 . . . . 1.55 109.564 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.613 ' O ' HD12 ' A' ' 98' ' ' LEU . . . -136.33 134.43 37.9 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.3 -1.118 . . . . 1.25 110.313 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 -71.43 143.05 50.23 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.416 -0.802 . . . . 3.46 110.103 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 96' ' ' ALA . 2.1 mp -123.37 -2.78 8.47 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.864 . . . . 1.72 110.823 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -93.69 69.97 4.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.122 -0.986 . . . . 2.12 110.151 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 74' ' ' ARG . 12.2 p -135.27 151.23 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.433 -0.792 . . . . 1.3 110.156 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.401 ' O ' ' N ' ' A' ' 103' ' ' ALA . 12.3 m -116.22 159.17 22.21 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.243 -0.911 . . . . 2.07 109.404 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 1.0 OUTLIER -68.55 74.54 0.26 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.342 -0.849 . . . . 2.65 109.755 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.62 ' HB2' ' O ' ' A' ' 71' ' ' THR . . . 61.16 -79.46 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.635 -0.666 . . . . 2.58 110.047 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.448 ' N ' ' O ' ' A' ' 102' ' ' ASP . 9.2 p90 -128.41 37.96 4.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.326 -0.859 . . . . 3.81 109.859 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -120.49 -141.25 6.23 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.99 -1.244 . . . . 2.11 109.99 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -101.74 -164.95 1.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.4 -1.059 . . . . 4.59 110.48 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.463 ' HB3' ' HD2' ' A' ' 108' ' ' PRO . 0.5 OUTLIER -96.18 174.27 3.54 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.541 -0.725 . . . . 1.94 110.035 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 107' ' ' LEU . 42.8 Cg_endo -68.16 -22.39 40.85 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.697 1.367 . . . . 1.02 110.254 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.422 HG12 ' HB3' ' A' ' 107' ' ' LEU . 11.1 p -73.73 -27.31 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.381 -0.824 . . . . 1.34 110.042 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 56.9 m-20 -80.26 -38.93 29.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.363 -0.836 . . . . 2.42 110.095 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.48 -26.83 65.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.399 -0.813 . . . . 1.99 109.918 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.565 ' HB1' ' HB2' ' A' ' 117' ' ' HIS . . . -78.04 -54.26 6.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.51 -0.744 . . . . 1.78 109.971 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -53.09 -25.79 14.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.395 -0.816 . . . . 3.39 110.573 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -79.05 -54.98 5.46 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.336 -0.853 . . . . 3.16 110.235 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -62.38 -67.33 0.43 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.399 -0.813 . . . . 4.06 110.052 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 157.6 47.57 0.01 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.595 -1.402 . . . . 2.4 109.595 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' HIS . . . . . 0.565 ' HB2' ' HB1' ' A' ' 112' ' ' ALA . 70.1 m-70 -122.23 64.63 0.93 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.361 -1.082 . . . . 2.12 109.999 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -35.43 67.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.283 -0.886 . . . . 4.53 110.158 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.503 ' HB3' HD12 ' A' ' 85' ' ' LEU . 31.4 m-20 -61.9 -48.5 80.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.379 -0.825 . . . . 2.51 110.218 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.775 HD11 HD13 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -71.62 -25.38 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.397 -0.815 . . . . 1.52 110.347 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -70.0 -45.41 67.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.395 -0.816 . . . . 1.71 110.119 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 5.5 mtp85 -59.56 -53.54 56.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.357 -0.839 . . . . 3.93 110.126 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.49 ' CB ' HD21 ' A' ' 85' ' ' LEU . 37.7 t80 -60.52 -35.91 77.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.343 -0.848 . . . . 1.96 110.058 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.466 ' CG ' HD21 ' A' ' 88' ' ' LEU . 34.3 mt -72.6 -41.06 66.04 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.453 -0.78 . . . . 1.42 110.172 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -59.73 -22.53 62.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.401 -0.812 . . . . 3.72 110.327 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -86.47 -30.86 21.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.296 -0.878 . . . . 2.04 110.308 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -96.84 -21.04 17.74 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.278 -0.888 . . . . 1.64 110.633 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 98' ' ' LEU . 26.4 p -104.36 -15.87 15.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.279 -0.888 . . . . 1.96 110.458 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.42 -73.9 0.41 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.807 -1.317 . . . . 3.14 109.807 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.382 0 O-C-N 121.463 -1.022 . . . . 5.89 110.057 179.904 . . . . . . . . 1 1 . 1 stop_ save_